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Summary
Results of detailed investigation of 100 vomiting dogs, including the use of either or 
endoscopy and radiology as a means of diagnosis are presented. Endoscopy proved 
to be better of the two investigative aids as it allowed widespread examination of the 
gastric mucosa, but it was decided that both methods should be applied as they 
compliment each other.
Many of the canine patients examined endoscopically were found to have bile present 
in their stomachs or actively refluxing, which was interpreted as a duodenogastric 
reflux gastritis in these vomiting dogs. However, a number of control dogs also had 
bile reflux identified to varying degrees. A number of dogs were found to have peptic 
ulcers that had been caused or exacerbated by the ingestion of non-steroidal anti­
inflammatory drugs. Most were managed successfully by the short term 
administration of H2 receptor antagonists and the cessation of non-steroidal anti­
inflammatory drug therapy. However, the severity of the degenerative joint disease 
required the continued use of non-steroidal anti-inflammatory drug with the 
concomitant use of H2  antagonist in one dog to prevent the unwanted gastric-side 
effects. The results of the studies on the vomiting dogs indicated clearly that gastric 
abnormalities in this species are, as yet, not fully understood and the diagnosis, 
treatment and prevention of gastric abnormalities warrants further investigation.
The effect on the gastric mucosa of the administration of acid, bile and two non­
steroidal anti-inflammatory drugs (aspirin and carprofen) individually and in 
combination was studied in the rat. It was found that carprofen appeared to cause as 
much damage as aspirin and that this damage was exacerbated by the concomitant 
administration of bile. The effect of prior treatment of the rats with famotidine, an 
H2  receptor antagonist, or sucralfate, a mucoprotective drug, before challenge with 
aspirin and carprofen both appeared to effect changes in the mucosa, but that 
sucralfate appeared to be slightly better in its effect on the gastric mucosa, though this 
was not statistically significant.
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1. General Introduction
1.1 Anatomy and Histology
The mammalian stomach is primarily a storage organ where initial digestion takes 
place. Although not essential, this preliminary digestion is designed to present the 
small intestine with material with which it can deal more easily, and on which it can 
perform the major digestive processes. There is some variability between the species 
as far as the shape of the stomach is concerned and the proportion each of the regions 
of the stomach occupies. Indeed, in some omnivores such as the pig and rat, there is 
a non-glandular portion to the stomach that resembles the oesophagus. The
stomach, being a dilation of the alimentary canal for accommodating larger volumes
of food, has been divided into four or five main regions (Kammeraad 1942, Ellenport 
1975, Warwick and Williams 1973).
i] the non-glandular or oesophageal part as exemplified by the rat and pig.
ii] the cardia - the entrance to the stomach.
iii] the fundus - the reservoir area.
iv] the body - where much of the mixing of food and secretion takes place.
v] the pyloric part divided into the antrum, where hormones or regulatory 
peptides, such as gastrin, are produced and sensors for gastric emptying 
are located, and the pylorus which is the sphincter between the stomach 
and the duodenum.
Unfortunately, there is some confusion regarding the descriptive terms applied to 
particular regions in different species. For example, the fundus in the rat is non- 
glandular, whereas in man and the dog it is glandular. In the rat, the body is that part 
of the stomach between the limiting ridge and the antrum, whereas in the dog and 
man the body is that part of the stomach between the fundus and the antrum (Berg 
1942, Shay and others 1945, Robert 1971). Thus there are comparable regions 
between species but the same anatomical names are not always applied. However, 
each comparable area plays the same part in the function of the stomach regardless of 
species. The stomach is roughly J-shaped with a short margin on the hepatic aspect - 
the lesser curvature. The lesser curvature starts at the cardia and slopes down the 
body before taking a very sharp upward angle, called the incisure angularis, into the 
pyloric part. The opposite margin is longer, and is called the greater curvature. The 
stomach has a dorsal (parietal) and a ventral (visceral) surface, which meet at the 
greater and lesser curvatures.
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The stomach wall consists of four layers or coats:
i] Serous - a peritoneal covering of which there are two layers, one on the 
dorsal and the other on the ventral surface, which fuse to form the lesser and greater 
omenta.
ii] Muscular - consists of an outer longitudinal and inner circular layer. At 
the cardia, the circular layer forms a weak and ineffectual cardiac sphincter. 
However, at the pylorus this muscle layer becomes thicker to form the pyloric 
sphincter. The pylorus represents a physical narrowing, but there is debate over 
whether there is a zone of high pressure here analogous to the pressure zone in the 
lower oesophagus (Fisher and Cohen 1973, Kaye, Mehta and Showalter 1976, Winans 
1976). However, both muscle coats cover the whole stomach except at the incisure 
where only the circular layer is present.
iii] Submucosa - a thin layer of connective tissue that attaches the muscular 
and mucosal layers to each other.
iv] Mucosa - the epithelium is covered by a thick layer of mucus composed 
mainly of water and protein. In the empty stomach the mucosa is thrown into a series 
of folds known as the rugae or plicae gastrica, which run in a longitudinal direction. 
Once the mucus layer is cleared, the mucosal surface can be seen to have a rather 
granular appearance. This is caused by small raised areas, which are covered in 
microscopic openings or gastric pits (foveolae gastricae). Into these pits a variable 
number of gastric glands open. The surface of the mucosa including the pits is lined 
by surface mucous cells.
Embryologically, the endoderm (the innermost of the three germ layers) that will 
form the stomach consists of a single layer of epithelium. This layer becomes 
stratified and vacuoles form in the epithelium which burst to form the gastric pits. 
Evaginations from the pits then develop into gastric glands (Kirk 1910, Kammeraad 
1942, Salenius 1962).
1.1.1 Gland Types
There are three types of glands within the mucosa. The anatomical names assigned 
to these branched tubular glands do not correspond exactly to the anatomical regions 
they occupy. Indeed, there has been some divergence of opinion on the terminology 
applied to these glands since their geographical or anatomical location does not quite 
relate to definitions applied by either histologists or physiologists (Grossman 1958). 
However, the glands, themselves, have been well defined (Harvey 1906, Berger 1934):
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i] Cardiac glands are located in a narrow region around the cardia and lie 
at the bottom of the deep pits found in this region. These glands are coiled with a 
wide lumen, the walls of which are composed mainly of mucous cells and a few 
parietal cells. Thus they are concerned with the production of mucus.
ii] Gastric or fundic glands occupy the fundic and body regions of the 
stomach, which forms nearly 60% of the mucosa. The function of these glands is the 
secretion of acid and enzymes into the lumen of the stomach. They are simple 
tubular glands and comprise a variety of cells. Each gland has three regions, an 
isthmus at the bottom of the pit, a neck and a base. The isthmus is made up of 
surface epithelial cells. The neck region is composed mainly of mucous neck cells 
and parietal cells. As one goes deeper into the gland, the proportion of these two 
cells changes so that the parietal cell predominates. The mucous neck cell is 
irregular in shape, with a narrow base and expanded apex. The function of this cell is 
to produce an acid mucus. The parietal cell is a large pyramidal cell with a pale 
cytoplasm producing hydrochloric acid (HC1). As the base of the gland is 
approached, a third cell appears - the chief cell, which is concerned with the 
production of the enzyme precursor pepsinogen. On contact with the highly acid 
luminal contents, pepsinogen becomes the enzyme pepsin. This chief cell is also 
pyramidal but the nucleus lies at the base of the cell and the cytoplasm is filled with 
granules. At the base of the gland, mixed with chief cells, are a small number of 
argentaffin cells that produce regulatory peptides such as gastrin (Bloom and Fawcett 
1970, Ito 1967). Thus these glands are primarily concerned with the production of 
acid, pepsin and mucus (Grossman 1958).
iii] Pyloric glands the pits in the pyloric region are deep, therefore the 
glands are short and coiled so that perpendicular sections are rarely seen by light 
microscopy. These glands are principally involved in the production of gastrin and 
mucus (Grossman 1958). Most cells in the pyloric gland are mucus secreting, but 
they also contain a few parietal cells, argentaffin cells, and some chief cells producing 
proteolytic enzyme (Grossman and Marks 1960).
1.1.2 Parietal Cell
The parietal cell is dominated by a proliferation of mitochondria and canalicular 
structures. These mitochondria are essential because of the energy requirements 
needed for hydrogen ion (H+) secretion. The canalicular structures contain several 
enzymes, one of which a hydrogen-potassium-adenosine triphosphatase exchanges 
hydrogen for potassium ions across the apical membrane (Ray and Tague 1978). 
This enzyme has been referred to as the proton pump (Sachs 1986). The precise 
source of parietal, and chief cells, is uncertain, but the cells in the neck of the gland 
are thought to be involved. Hunt and Hunt (1962) suggested that mucous neck cells
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transform into parietal cells especially at the neck. It is worth noting that their 
evidence was derived by damaging the mucosa with compound 48/80, and observing 
cell division.
However, other workers looking at cell renewal have been unable to find evidence to 
support this assertion, at least in the normal uninjured mucosa (Messier 1960). 
Similarly, Messier and Leblond (1960), Lipkin, Sherlock and Bell (1963), MacDonald, 
Trier and Everett (1964) were unable to find substantive evidence that the parietal 
cells and chief cells evolved from mucous neck cells, though, they added the caveat 
that their results had been derived from investigations of mucosa under normal 
conditions. The lack of agreement appears to have been laid to rest by the work of 
Matsuyama and Suzuki (1970). They examined regenerating gastric mucosa that had 
been neonatally grafted subcutaneously to littermate mice and found that immature 
mucous cells are totipotent and will ultimately transform into mature mucous, 
parietal, chief and argyrophil cells.
1.13 Surface Epithelial Cell (SEC)
The surface epithelial cell is simple columnar, and uniformly lines the entire stomach 
extending into the gastric pits. The nuclei are located at the base of the cell. The 
cytoplasm is occupied by dense mucin granules (Leeson 1985), which have been 
shown ultrastructurally to be densely packed under the apical surface of the cell (Ito 
and Winchester 1963). The combination of acid and the proteolytic enzyme pepsin 
in the lumen produces a highly hostile environment. The function of the surface 
epithelial cell and the overlying mucus is to assist in protecting the underlying cells 
and so prevent digestion of the gastric mucosa and deeper layers. The mucus is a gel 
composed of water and mucus glycoprotein, a large molecule with a molecular weight 
of 2 x 106 (Clamp 1980). The viscosity is some 30-260 times that of water, is alkaline 
in nature and permeable to ions and small molecules (Davenport 1977). Food and 
vagal stimulation have no effect on the production of mucus, but starvation and 
serotonin, cause respectively decreased and increased mucus production (Menguy 
1969).
The cells on the luminal surface are extruded as they age, to be replaced by less 
mature cells migrating along the basement membrane from the isthmus. Messier 
(1960) and Hunt and Hunt (1962) showed, using autoradiography, that there were two 
mucous cell types - the surface epithelial cells and mucous neck cells that are 
independent of each other. The surface epithelial cells are said to be mucus 
secreting, producing a neutral mucus in contrast to the acid mucus of the mucous neck 
cell (Leeson 1985).
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1.1.4 Scanning Electron Microscopy
The topography of the surface cell has been studied by scanning electron microscopy 
in a variety of species (Pfeiffer 1970a). This study showed that the apex of the cell is 
covered by microvilli. The surface epithelial cells are arranged in circles or whorls 
around the openings of the gastric pits. The apical membranes slightly bulge and 
where the cells are in contact with each other an intercellular junction is visible. Thus 
the cells form an integral surface, and rather than giving a flat-sheet appearance, the 
convexity of individual cells produces the appearance of cobblestones (Dubois and 
others 1985).
Knowledge of mucus secretion by the surface epithelial cells is scant. Pfeiffer 
(1970ab) did not find any evidence of mucus secretion by the surface cell. This is in 
contrast to evidence from transmission electron microscopical studies carried out by 
Ito and Winchester (1963) and Sedar (1964). Ito and Winchester (1963), studying the 
fine structure of the gastric mucosa of the bat, found granules beneath the apical 
surface in close contact with the cell membranes near the bases of adjacent microvilli. 
Occasional invaginations of the cell membranes were found in the same region 
suggesting that these were the empty residues of mucous granules which had 
discharged their contents into the lumen. However, in a number of observations 
active secretory images were noted suggesting apocrine secretion.
Beneath the cell membrane the mucous granules are densely packed as quite dark 
structures which on higher magnifications have a stippled appearance. Between the 
subsurface cluster of mucous granules and the nucleus, the cytoplasm is dotted with 
occasional mucous granules, Golgi apparatus and smooth endoplasmic reticulum 
(Lillibridge 1964). Between adjacent cells, tight junctions and desmosomes are 
evident as dense trilaminar plaques - parts of the junctional complex (Lillibridge 
1964, Toner and Carr 1971, and Fawcett 1981). Transmission electron microscopy 
also shows that there is intimate contact between the basal lamina and the basement 
membranes (Kelly and others 1979).
Ito (1967) and Zalewsky and Moody (1979) summarised three possible mechanisms of 
secretion, namely, extrusion of the entire cell containing the mucous granules, fusion 
of the mucus granule with the apical cell membrane or passage of soluble mucus 
through the intact cell membrane. The difference of opinion over surface epithelial 
secretion may be due to Pfeiffer (1970b) primarily examining the surface cells on the 
luminal surface, these cells being the oldest and therefore, most likely to have ceased 
production and secretion of mucus.
As these cells age and reach the apices of the gland they are inevitably discarded. By 
scanning electron microscopy, the degeneration of the normal surface epithelial cell
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has been shown to begin as a small pit located in the centre of the convex surface of 
the cell. This cavitation enlarges and eventually the contents are dissipated. The 
adjacent viable cells then converge on the site of cell degeneration (Pfeiffer 1970b), 
thus matching one of the proposed mechanisms for mucus secretion (Ito 1967).
1.2 Cell Renewal
Since cells double their deoxyribonucleic acid (DNA) prior to mitosis, they take up 
DNA precursors. Therefore, the most frequently used method of determining 
turnover or renewal is by measuring the uptake by cells of 3H labelled thymidine, 
which is incorporated into the DNA of rapidly dividing cells (MacDonald, Trier and 
Everett 1964). They and others, who have used this method have made the 
assumption that the tritium does not alter the behaviour of such labelled cells. 
Alternatively, Bertalanffy (1960) used colchinine to measure both the mitotic rate and 
renewal times in the gastric epithelium of the rat.
The normal turnover rate of the surface epithelial cell is approximately three days. 
However, variability arises between different parts of the stomach and between 
species. Indeed, Clark and Baker (1963) demonstrated in the rat a circadian 
periodicity to the mitotic division of the mucous neck and surface epithelial cells. 
Under standard conditions of light (6am to 6pm), they found the peak mitotic rate to 
occur mid-morning, troughing during the night.
In man, the turnover time is between 48 and 96 hours (Lipkin, Sherlock and Bell
1963). In the mouse, it is 24 hours (Creamer, Shorter and Bamforth 1961). In the 
rat, 72 hours is a consistent finding (Leblond and Walker 1956, Messier 1960, Baker
1964) so that by the sixth day the labelled cells are found free in the lumen (Hunt and 
Hunt 1962).
13 Gastric Secretion
13.1 Stimuli
In the normal stomach, the measurement of gastric secretion is awkward because of 
such added effects as the physical presence of saliva, food, antral secretions and 
refluxed duodenal content. To overcome this difficulty but still allow the normal 
stimuli of alimentation, portions of the stomach can be surgically isolated. Examples 
of these are Pavlov and Heidenhain pouches (Konturek 1974). Thus much of the 
information relating to the physiological processes of gastric secretion has been 
gleaned from the use of such pouches in the dog, or the use of isolated perfused 
portions of gastric mucosa in the rat or frog.
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Sight, smell and taste are potent stimulators of acid secretion (Feldman and 
Richardson 1986). Acid is produced at a low basal rate when the stomach is empty, 
but when food is experienced acid output is stimulated and there are three distinct 
phases apart from the basal rate; cephalic, gastric and intestinal (Konturek and others 
1976, Konturek, Rayford and Thompson 1977).
132  Gastric Control
Distension of the stomach will provoke acid production through cholinergic nerve 
fibres. In the antrum, not only distension, but also the excitation of chemoreceptors 
will lead to acid secretion (Elwin and Uvnas 1967). The effect of this stimulation is 
the release of gastrin from the G-cells in the antrum.
133  Cellular Control
The actual concentration of acid in the lumen is determined by the rate of secretion, 
the buffering effect of food and the diffusion of acid into the mucosa. Cells 
producing hormones are influenced by the luminal contents. As an example, a low 
antral pH will abolish antral gastrin and stimulate duodenal secretin, and secretin has 
been shown to affect pyloric motility (Golenhofen and others 1980). Uvnas- 
Wallensten (1977) showed that gastrin is released into the lumen of the stomach 
either directly from the apices of gastrin (G) cells, or through release of gastrin into 
the interstitial tissue from where it reaches the lumen.
Stimulation of acid secretion at the cell level is thought to occur through three distinct 
pathways which provide chemical messengers to the parietal cell (Wolfe and Soil 
1988).
i] Neural pathway: Acetylcholine is discharged from post-ganglionic 
nerves in the gastric wall.
ii] Endocrine pathway: Hormones such as gastrin are released from 
endocrine cells.
iii] Paracrine pathway: Tissue factors such as histamine are released from 
storage sites to diffuse across intercellular spaces to the parietal cell.
Yet, these three pathways, though distinct, are in fact interdependent. Histamine H2- 
receptor antagonists prevent acid secretion not only from histamine stimulation but 
also from gastrin and vagal stimulation (Wolfe and Soil 1988).
The accepted model of parietal cell secretion of acid is the pump model where 
hydrogen and chloride ions are pumped across the membranes independently. The 
presence of a potential difference across the mucosa tends to support this. To reach 
the gastric lumen it must pass through the mucus layer. Recently, a mechanism of
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mucus channels that allows acid to reach the lumen without interfering with the 
mucus layer has been suggested (Ramakrishnan and others 1992).
13.4 Suppression
As a result of the various excitatory pathways, acid floods the stomach mixing with the 
food and other secretions present. However, the acid flood will eventually produce 
an environment in the antrum such that when a pH of 3 or less is induced, the acid 
will act directly on the gastrin cells and halt the release of gastrin (Walsh and 
Grossman 1975).
As with other secretions produced in the digestive tract, gastric juice includes an 
inhibitor. In the gastric juice, the inhibitor is directed against acid production. The 
inhibitor has been identified and named gastrone, although consisting of two 
components - the active inhibitor is a gylcoprotein with a molecular weight between 1- 
4 xlO4 (Fiasse, Code and Glass 1968).
Somatostatin has been found in the antrum and the pancreas (Arimura and others 
1975). In cats which have been given infusions of pentagastrin, acid liberation is 
suppressed by the administration of somatostatin (Albinus and others 1977). 
Further evidence for this suppressing action was found by noting the effect of 
somatostatin antiserum on gastrin secretion in the perfused rat stomach. From this, 
the authors deduced that somatostatin inhibits gastrin secretion, in the basal state at 
least (Saffouri and others 1979). Importantly, it would also appear that somatostatin 
inhibits cell proliferation and the trophic action of gastrin (Lehy, Dubrasquet and 
Bonfils 1979, lipkin 1985). Somatostatin, as well as being found in the cat and other 
small animals, has been identified immunocytochemically in the small intestine of the 
horse (Kitamura and others 1984).
Using isolated duodenal and distal intestinal pouches, with hydrochloric acid instilled 
into them, it has been shown in the dog, at least, that there are also acid receptors 
which are located only in the duodenal bulb or ascending duodenum. The 
acidification of a duodenal pouch with topical acid caused a pronounced inhibition of 
the acid secretory response to gastrin, with little effect obtained by acidification of the 
distal intestinal pouch. The nerves from these receptors would either directly inhibit, 
or potentiate humoral suppression of acid secretion (Andersson, Nilsson and Uvnas 
1967). In man and dog, secretin, a local intestinal hormone, is a potent inhibitor of 
acid secretion (Andersson and Grossman 1966, Berstad and Petersen 1970). 
Shoemaker and Buckner (1976) in considering the secretion as a complex pathway, 
concluded that secretin acted after histamine in the pathway but before cyclic 
adenosine monophosphate (AMP). A molecule known as peptide YY was shown by
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Taylor (1985) to be released postprandially in the dog. In the same year it was 
demonstrated that among other actions it inhibited gastric secretion that had been 
induced by vagal stimulation (Adrian and others 1985). The suppressing effect of 
secretin (25%) is enhanced in an additive manner by the release of peptide YY (21%) 
following a meal to 38% (Olsen and Christiansen 1991).
13.5 Histamine
Over the years attempts have been made to distinguish a common mediator for the 
various pathways that lead to acid secretion. The suggestion that mucosal histamine 
might be the mediator for acid secretion was made as early as 1938 by Macintosh. 
Much work since then has confirmed the crucial role histamine has in acid secretion 
by the parietal cell, particularly the recognition and blocking of a specific H2 receptor 
on the parietal cell (Code 1977).
Histamine directly stimulates the parietal cell to produce and release acid into the 
luminal environment. But it has also been proposed, by no means unanimously, that 
it is the final common mediator in the pathways of gastrin and acetylcholine 
stimulated release of acid, since it has been shown that the vagus and histamine have 
specific and separate receptors (Soil 1977). Fromm, Silen and Robertson (1976) 
presented findings which showed that histamine decreased antral luminal acid loss 
that could not be accounted for by active H + secretion, and proposed that histamine 
had caused a spontaneous decrease in antral mucosal permeability. This change in 
permeability was also noted in the fundus and antrum, where a salicylate provoked 
increase in permeability was repressed. They drew the conclusion that there were 
two H2 receptors, one that governs permeability and the other related to acid 
secretion, thus bestowing on histamine two roles; as acid secretion mediator and a 
mediator of permeability.
Further conflicting evidence was provided by Smith and others (1977) found that 
histamine protected rabbit mucosa from hydrochloric acid, in contrast Hansen, Aures 
and Grossman (1978) showed that histamine enhanced aspirin induced antral 
ulceration in the cat. Possible explanations for this disparity are that in the cat the 
aspirin was given intravenously, and actively secreting stomachs are more resistant to 
back-diffusion of H +.
1*3.6 Gastrin
The name gastrin was given to the active principle of antral mucosal extracts, which 
stimulated acid secretion, by Edkins in 1905. Now gastrin refers to a local hormone 
that was first purified by Gregory and Tracy (1961), sequenced by Gregory and others
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(1964) and synthesized by Anderson and others (1964). The cell of origin was first 
definitively identified by McGuigan (1968) using immunofluorescence. He 
considered the cells similar to argentaffin or argyrophil classes of cells and found 
them in the antral or pyloric region interspersed between other cells of the mucosa. 
In the dog there is variation in the numbers of gastrin cells found in different 
individuals (Delaney and others 1978). Gastrin has been shown repeatedly to be an 
extremely potent stimulator of acid secretion. However, there is a variable response 
to gastrin by parietal cells (Soil and Berglindhi 1987). Gastrin is not simply involved 
in acid secretion control. Amongst other factors that need to be taken into account 
in mucosal healing is the trophic effect of gastrin (H&kanson, Oscarson and Sundler
1986). Takeuchi and Johnson (1979) found that pentagastrin increased fundic 
mucosal DNA synthesis in rats with gastric ulcers, affording some protection to the 
gastric mucosa.
1.3.7 Acetylcholine
Acetylcholine, a low molecular weight ester, has been shown to release gastrin from 
the antrum (Pe Thein and Schofield 1959). Less certain is it s ability to stimulate the 
parietal cell directly, although there is evidence for (Pesvner and Grossman 1955) and 
against (Kasbekar 1972). However, electrical stimulation of the vagus in the cat, has 
been shown to deplete the gastrin pool (Uvnas-Wallensten, Uvnas and Nilsson 1976).
There are, therefore, three agents that can stimulate acid secretion by the parietal 
cell. It is unclear how many receptors there are on the parietal cell. Whether each 
agent acts synergistically with the others, or thorough one agent pathway such as 
histamine is also unresolved (Walsh and Grossman 1975), since atropine will inhibit 
not only cholinergic stimulation of acid, but also that of histamine and gastrin 
(Konturek, Wysocki and Oleksy 1968). A similar effect is seen with the use of 
histamine blockers (Gibson, Hirschowitz and Hutchison 1974).
1*3*8 Cyclic Adenosine Monophosphate
From the above, it is clear that there has been uncertainty over the final pathway, 
with histamine as the favourite final messenger. In 1965, Sutherland, Qye and 
Butcher ascribed cyclic 3\5’-AMP (cAMP) the role as second messenger in the action 
of some hormones. Following this work, Harris, Nigon and Alonso (1969) showed 
that cAMP was involved in the intracellular mediation of gastric acid secretion. They 
demonstrated that theophylline, a methyl xanthine which inhibits the 
phosphodiesterase that destroys cAMP, stimulated the production of hydrochloric 
acid, and that exogenous cyclic AMP stimulated H + and Cl' transport. Similar 
results also implicated cAMP (Levine 1970). Later, Sjostrand, Ryberg and Olbe
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(1978), using in vitro preparations of guinea pig gastric mucosa and administering 
histamine, histamine blockers and the dibutyrl form of cAMP, showed that cAMP is a 
link between histamine receptors and hydrogen ion output.
1.3.9 Proton Pump
With the identification of the role of cAMP came the concept of such a proton pump, 
though the possibility of a pump had been speculated on by Hogben (1955). This 
biochemical pump would pump the hydrogen ions from the parietal cell into the 
lumen. Ganser and Forte (1973) found a potassium-stimulated adenosine 
triphosphatase (ATPase) in microsomes of the fundus of a number of species, but not 
the antral mucosa (Forte, Ganser and Ray 1976). In attempting to characterize the 
microsomal membrane location of the biochemical pump, Lewin and others (1978) 
were able to identify potassium stimulated phosphatase activity, but not potassium 
stimulated ATPase activity. In contrast, Scholes and Lee (1978) considered that an 
ATPase catalysed an exchange of hydrogen ions for potassium ions, suggesting that 
this ATPase was located on the membrane vesicles of the parietal cell and was 
responsible for the transport by the luminal membrane of acid.
Soil (1980a) using aminopyrine uptake as a measure of parietal cell response to 
stimulation, showed that prostaglandin (PG) E2 inhibited histamine stimulated 
aminopyrine uptake. However, this prostaglandin did not block the response to 
dibutyrl cylic adenosine monophosphate (cAMP). From this he drew the conclusion 
that, at least in isolated parietal cells, PGE2 inhibited histamine stimulation of cAMP.
1.3.10 Calcium
Soil (1981) investigated the role of calcium gating in cholinergic stimulation of 
parietal cell function and found a close link between stimulation of parietal cell 
function and enhancement of calcium influx by cholinergic agents. The obvious 
conclusion from this was that if the extracellular calcium was blocked from moving 
intracellular, then acid production would be stopped. The receptors for the control 
of secretion have been divided into two groups, those which elicit the production of 
cAMP, and those which stimulate inositol phospholipid turnover and calcium ion 
mobilization (Rask-Madsen 1987, Levine, Nandi and King 1990).
1.4 Blood Supply
Measurement of gastric mucosal blood flow formerly presented a number of 
difficulties, but these were largely overcome by the introduction of the aminopyrine 
clearance method by Jacobson, Linford and Grossman in 1966. An increased gastric
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secretion is attended by an enhancement of mucosal blood flow, but that the 
converse does not occur was noted by Bynum and Jacobson (1971) and Gerber and 
Nies (1982). The effect of increased mucosal blood flow, as result of increased acid 
secretion, has been confirmed when the increased secretion has been stimulated by 
pentagastrin (Curwain and Holton 1972), histamine (Main and Whittle 1973), and the 
vagus (Lanciault 1975). This blood flow response is probably due to the direct 
vasodilator action on arteriolar smooth muscle, local vasodilators and redistribution 
(Jacobson, Swan and Grossman 1967). It has been shown that suppression of acid 
secretion by drugs also leads to a fall in mucosal blood flow (Tsukamoto and others
1987). Bennett and Curwain (1977) suggested that aspirin induced bleeding by 
causing vasocontriction followed by ischaemia. It has also been shown that 
enhancement of the mucosal blood flow will protect the mucosa against aspirin- 
induced erosions (McGreevy and Moody 1977) and that aspirin will suppress the 
mucosal blood flow (Gerkins and others 1977).
1.5 Gastric Emptying
The passage of material from the stomach is determined by the activity of the 
peristaltic waves pushing ingesta from the fundus and body through to the antrum, a 
fact recognised radiologically as long ago as 1898 by Cannon. The force of the waves 
is determined partially by the particle size and constituents of the food, but is 
primarily a phasic activity (Crider and Thomas 1937, Carlson, Code and Nelson 1966, 
Code and Martlett 1975, Ehrlein, Prove and Schweiker 1980). The pyloric sphincter 
is often thought to prevent the egress of food material that is not of the right 
constitency from the stomach to the duodenum. However, the pylorus does act, to a 
certain extent, as a barrier to passage of food because of its physical size, rather than 
by acting as a physiological bottle-neck (Ehrlein, Prove and Schweiker 1980), and to 
minimise to-and-fro movements of chyme across the gastro-duodenal junction 
(Miiller-Lissner and Blum 1984). In the oesophagus there is a high pressure zone in 
the caudal thoracic area that helps prevent reflux of gastric contents (Frank, Walker 
and Fordtran 1973, Cohen and others 1976, Corrazziari and others 1978). In man, an 
analogous pressure area was noted by Fisher and Cohen (1973). Similarly, in normal 
fasting dogs there is a zone of high pressure at the gastro-duodenal junction (Brink, 
Schlegel and Code 1985) and this, coupled with the action of the pyloric sphincter 
should ensure that little material refluxes into the stomach. After a bolus leaves the 
stomach the pylorus is often not completely closed, hence, it is not possible for the 
pylorus to prevent reflux of duodenal content if an abnormal orally directed peristaltic 
wave forms in the duodenal bulb (Ehrlein 1981). The small volume of duodenal 
content that may enter the stomach is not important because of a number of factors.
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The stomach is filled with food at this time thus diluting duodenal content, which 
post-prandially is a mixture of food, pancreatic juice and bile. The peristaltic activity 
causes thorough mixing of the refluxed material and gastric emptying is occurring 
throughout, and the reflux of duodenal contents does not adversely affect gastric 
emptying (Donovan and others 1984). Thus contact time with the antral mucosa is 
very short.
The stomach is, therefore, a glandular organ that has an extremely acidic luminal 
environment where significant concentrations of proteolytic enzyme are present. 
This combination of acid and proteolytic enzyme means that the stomach lining must 
protect itself from autodigestion. Failure to do so will lead to cellular damage.
1.6 Mucosal Barrier
The phrase "gastric mucosal barrier" (Silen 1977) is proffered as a physiological 
concept, which refers to the ability of the mucosa to prevent rapid invasion of 
hydrogen ions from the gastric lumen into the interstitial space, and the rapid 
diffusion of sodium ions (Na+) in the reverse direction. The barrier has, to date, no 
definite anatomical analogy, though the nearest that can approach the analogy is the 
mucus layer, surface epithelial cells and their tight junctions acting as a physical 
barrier. However, a comparison between two barrier breakers, urea and ethanol 
showed that urea produces damage to the intercellular junctions by distorting the 
tight junctions through the formation of vacuoules or blebs, whereas ethanol 
produced cytoplasmic changes within the surface epithelial cells without disrupting 
the cell membrane (Eastwood and Kirchner 1974). The essential function of this 
barrier is to maintain a high luminal acid concentration and low pH, and in the 
process evade digesting itself in the presence of the activated enzyme pepsin.
In 1939, Teorell demonstrated, in the anaesthetised cat, that the acid which is 
secreted by parietal cells into the lumen could, under certain circumstances, diffuse 
back into the mucosa. In doing so, he found that when hydrogen ions were absorbed, 
sodium ions were pumped out into the lumen. He further showed that certain 
molecules such as weak acids were rapidly absorbed by the mucosa, whereas other 
molecules such as glycine were not absorbed. He concluded that the gastric mucosa 
acted as a semi-permeable membrane. He further postulated that a mechanism 
existed that prevented hydrogen ion back-diffusion by the selective absorption of 
sodium ions.
In 1946, Hollander, Stein and Lauber in looking at some features of gastric mucus
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described the concept of a "mucous barrier". Code and others (1955) actually used 
the term "barrier■" in the title of a paper, which showed the resistance of the mucosa to 
absorption of sodium ions was complete when the gastric mucosa was secreting acid. 
This work, like that of Teorell (1939), was done in anaesthetised animals, and they 
noted a difference in the absorption of sodium when the use of pentobarbitone was 
compared to ether. That a barrier exists to sodium was also confirmed in healthy 
conscious human subjects where there could be no effect of anaesthesia on absorption 
(Reitemeier, Code and Orvis 1957). Similar work has shown that the same effect 
occurs in the dog and therefore pan-species. Code and others (1963), using isotopes 
of sodium and potassium, demonstrated that acid in the stomach stopped absorption 
of sodium. However, these studies were concerned with the gastric mucosa as a 
barrier to intraluminal absorption of sodium ions.
Hollander (1954) in attempting to explain the failure of peptic ulcer patients to 
prevent the autodigestion of the gastric mucosa postulated a two-component mucous 
barrier. The first element was the viscous mucus layer that sits on the surface of the 
epithelium. In the normal unchallenged stomach, the mucus is translucent and 
contains few cells. When irritated the mucus then contains large numbers of cells 
(Hollander, Stein and Lauber 1946) or when in the presence of food (Grant 1944). 
However, Janowtiz, Hollander and Jackson (1951) found, by suppressing stimulation 
of gastric secretion with atropine, that the alkaline opalescent viscid secretion of 
mucus was free of cells and concluded that exfoliation was not intrinsic to the process 
of mucus secretion. Hollander (1954) felt that the mucus, because of its properties of 
adhesiveness, viscosity and acid neutralizing capacity, retarded the penetration of 
chemical irritants. The second element was the surface epithelium that under 
normal conditions provides mucus, but when irritated will rapidly desquamate. 
Heatley (1959) inferred that mucus safeguarded the epithelium by supplying an 
unstirred layer on top of the mucosa. The theory propounded was that H+ ions 
diffusing from the lumen were neutralised by bicarbonate (HC03~) ions in the mucus 
layer. The unstirred layer maintained the bicarbonate ions at the mucosal surface 
and thus avoided the ions mixing with the luminal hydrochloric acid, that this layer 
was a dynamic barrier with the constant production of mucus, rather than as one 
might mistakenly imagine, a static layer (Thomson 1984).
In 1969, Menguy reviewed the role of mucus as part of the gastric barrier. Whilst 
finding that antral acidification stimulated and starvation reduced dramatically mucus 
production, he was unable, from reviewing the actions of several non-steroidal anti­
inflammatory drugs (NSAIDs), to be convinced conclusively that mucus played a 
major role in gastric mucosal ulceration. He did accept that NSAIDs such as aspirin 
and indomethacin did reduce mucus secretion.
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Davenport (1975) in contemplating a personal decade’s work on the barrier was 
uncertain of the role of mucus in the barrier, but confident that the cell membrane 
played an imperative role. Indeed his conclusion, arising from experimental work, 
was that the barrier consisted of the apical membrane and the intercellular tight 
junctions (Davenport, Warner and Code 1964, Davenport 1967a). Flemstom (1976) 
found that there was an alkaline secretion in the immediate vicinity of the luminal 
membrane of the gastric epithelium in both the antrum and the fundus, which, by 
raising the border pH, would contribute towards the limitation of damage due to the 
low intragastric p H .
This uncertainty over the role of the mucus layer was also felt by Silen (1977), 
considering, in his view, the layer’s weak neutralising and buffering power and its 
inability to prevent diffusion of acid through it.
Nonetheless it seemed difficult to dismiss mucus - "the slimy secretion of the stomach 
lining' (LaMont and others 1983) - as merely a lubricant. And in 1980 Allen and 
Gamer set out to explain that the role of the mucus layer, bicarbonate ions or mucus 
would individually have a limited barrier effect, but by integrating these two elements 
as a single system they could see this system as providing a competent measure of 
protection. The gastric transport of bicarbonate probably occurring by C1/HC03- 
exchange at the luminal membranes of the surface epithelial cells. Lowering luminal 
pH did indeed increase transport of HC03' (Flemstrom and Gamer 1982) as may be 
caused by bile (Konturek and others 1984a). Further work demonstrated that this 
bicarbonate transport was not affected by the common local hormones and 
transmitters such as histamine, secretin and gastrin (Flemstrom, Heylings and Gamer 
1982), but could be stimulated locally by prostaglandins (Kauffman, Reeve and 
Grossman 1980).
In pulmonary surfactant there are amphoteric phospholipids that markedly enhance 
the water repellency of surfaces when adsorbed to negatively charged membranes 
(Hills 1982). These same phospholipids have been shown to be present in high 
concentrations in the gastric juice of the rat and dog (Slomiany and others 1978). In 
particular, phosphatidylcholine represented 50% of total phospholipids in the rat and 
dipalmitoyl diglyceride was present in similar concentrations as those found in the 
lung - this being the major active component of pulmonary surfactant (Wassef, Lin 
and Horowitz 1979). In 1983, Hills, Butler and Lichtenberger, using the contact 
angle subtended between a droplet of aqueous fluid and a non-wettable surface as a 
direct estimation of the hydrophobicity of the non-wettable surface, found that the 
mean angle in the fundus of the dog to be 85.2°. This angle is similar to that 
displayed by acid resistant substances such as polyethylene.
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In the same year Butler, Lichtenberger and Hills Lumen
published results which showed that these mucus 
phospholipids could form an adsorbed layer of surface- 
active phospholipids beneath the gel phase of the 
mucus on the luminal surface of the gastric epithelium,
with this layer having the property of hydrophobicity Q a g t r i c  Mucosal Surface 
(Figure 1.1). Figure 1.1. Diagram of
Provocative testing for this surfactant has confirmed its adsorbed layer of surface- 
presence and ability to protect the mucosa, where acid active phospolipids. 
induced gastric ulceration and bleeding in rats was markedly reduced (Lichtenberger 
and others 1983). Szelenyi and Engler (1986) showed that ambroxanol, a stimulant 
of pulmonary surfactant, increased the level of phospholipid content of the mucosa, 
and also showed that when the mucosa had been pre-treated with phospholipase C 
and challenged with ethanol, the degree of damage was greater than ethanol used 
solely. Using fluorescent hydrophobic probes and a phospholipid selective 
cytochemical stain, Kao and Lichtenberger (1991) showed that the source of the 
phospholipid in the mucus layer resided in the mucous cells as large intranuclear 
inclusion bodies. They also noted that these organelles were specific for mucous cells 
and not a general feature of degenerating cells. Therefore, evidence has been 
presented that the mucus layer may have a chemical component by producing pH 
gradients and a physical property of hydrophobicity.
The mucus that coats the mucosa is considered to consist of two layers, a so called 
"visible" layer that is insoluble in water and contains glycoproteins. The second 
"dissolved" layer is contains essentially the same components. The mucus layer acts as 
a partial barrier producing a concentration gradient so that fewer ions reach the cell, 
representing the first solid line of defence (Allen and Carroll 1985). The chemical 
and physical properties of the apical membranes and tight junctions that bind the cells 
together are such that water soluble substances are very slowly admitted. This 
impermeability is an important factor in the defense of the gastric mucosa against 
injurious agents (Code 1981). Thus the mucus layer has emerged with an important 
role in the mucous barrier and consequently its source and production are of some 
importance. Zalewsky and Moody (1979) and Moody, Zalewsky and Larsen (1981) 
have demonstrated three possible routes through which mucus reaches the lumen, 
namely through exocytosis, apical expulsion and by actual exfoliation of an intact 
surface cell.
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In summary then, protection or defence of stomach wall integrity depends on a 
number of features of the stomach, the main ones being the mucus layer or mucus gel 
(Menguy 1969), epithelial cells (Code 1981) and blood flow (Konturek and Robert 
1982).
1.6.1 Mucosal Restitution
Superficial injury, without deeper mucosal damage and vascular injury, is repaired 
rapidly by cell migration, so called "mucosal restitution" (Pihan and others 1986). 
Flaws created in the surface of the gastric mucosa are restored by re-epithelialisation. 
The cells closing the defect are produced from proliferating stem cells in the neck 
zone of the gastric glands. Regeneration by mitotic activity requires from one to 
three days (depending upon species) for differentiation and migration (Leblond and 
Walker 1956, Messier 1960, Creamer, Shorter and Bamforth 1961, Lipkin, Sherlock 
and Bell 1963, Baker 1964). Yet it has been known for some time that superficial 
injury can be repaired rapidly by the stomach in less than four hours (Grant 1945). 
Clearly there is a disparity in the time sequence and some other mechanism must 
come into play to rebuild the defences. Mucosal restitution is the phrase that has 
been coined to describe the process whereby the differentiated and mature surface 
epithelial cells migrate across the basal lamina to cover the exposed basal lamina, 
thus re-establishing epithelial continuity (Silen and Ito 1985).
Restitution of frog surface epithelium was demonstrated in vitro in 1982 by Svanes 
and others. In vivo work in the rat, using ethanol as the injurious agent, has also 
shown that restitution occurs (Lacy and Ito 1984). In this study 4ml of absolute 
alcohol was injected into the gastric lumen for 30-45 seconds and the stomachs fixed 
at time intervals thereafter. The ethanol destroyed the majority of the superficial 
epithelial cells without extensive hyperaemia, or causing deeper macroscopic 
haemorrhagic lesions. The migrating cells flattened themselves and extended feet­
like projections so that after 15 minutes the basal lamina was covered, and by 60 
minutes the flattened epithelial cells had become a more normal columnar shape. 
The first evidence of response was within 3 minutes of injury. Similar findings using 
ethanol have also been reported by Terano and others (1986). Svanes and others 
(1982) considered the role of two factors, luminal pH and bicarbonate ions, on 
epithelial restitution using frog fundic mucosa in Ussing chambers. They found that 
a low luminal pH inhibited, and high nutrient bicarbonate ion concentration 
supported restitution after damage, histologically, there being a layer of sloughed cells 
and mucus above the epithelium.
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Two factors that have been identified as essential to the whole process are an intact 
basal lamina, and adequate microvascular perfusion (Morris 1986). This author was 
sceptical of any direct role being played by prostaglandins in restitution. This partly 
confirmed the work of Whittle and Steel (1985) who found that low doses of 16,16- 
dimethyl prostaglandin E2 did not protect the superficial epithelial cell, though a 
higher dose of 20/ugkg-1 did reduce the severity of damage. They felt it more likely 
that prostaglandins have their main effect on perfusion of the tissue. Grenbech and 
others (1987) demonstrated that low intraluminal pH had no effect on restitution in 
anaesthetised cats, but that hyperaemic response is important for satisfactory 
restitution (Grenbech and others 1988).
Apart from the role in mediating acid secretion Soil (1981), calcium has been 
implicated in the restitution of the surface cell. Critchlow and others (1982) bathed 
amphibian gastric fundus in 1M NaCl for 10 minutes. They found uniform disruption 
of the surface epithelial cells, the integrity being restored in 4-6 hours. If the bathing 
solution had calcium ions added then recovery was much more rapid compared to 
calcium deprived solutions. Whether the action of the calcium ions was intracellular 
or not was not determined. However, calcium is necessary for the migration of 
undamaged surface cells that move to cover exposed basal lamina and for the 
formation of tight junctions (Morris 1986). Thus mucosal restitution results in only 
transient functional impairment, and represents the first line of defence against mild 
gastric injury (Pihan and others 1986, Haglund 1990).
1.6.2 Mucoid Cap
Morris and Wallace (1981) and Lacy (1985) amongst others have shown that 
following injury there is extensive mucus secretion. This mucus secretion may have a 
role in the restitution process by providing a congenial climate for quick cell 
migration (Morris and Harding 1974, Ito and Lacy 1985, Whittle and Steel 1985). 
The mucus secretion forms a gelatinous layer with exfoliated surface epithelial cells, 
and has been termed localized mucus cap. However, mucus secretion is not 
dependent upon exfoliation or desquamation of cells as has been shown by topical 
application of acetylcholine to the gastric mucosa. The resultant secretion was 
alkaline, opalescent and viscid but free of cells (Janowitz, Hollander and Jackson 
1951). The cap may be stabilized by fibrin, and a further effect is the presence of 
bicarbonate in the fluid producing a high pH environment (Svanes and others 1984, 
Wallace and McKnight 1990). However, the environment created by this cap can be 
dissipated by acid (Morris and Wallace 1981). They flushed the rat stomach with 
40% ethanol and found the released mucus stabilised by a network of fibrin, with 
underlying cell migration. However, by repeating the experiment with 50mM HC1,
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they found the platelet thrombi and fibrin network destroyed by the acid dissipating 
the adherent mucus coat, leading to irreversible damage of vulnerable cells and 
devastation of the basal lamina. Dissipation is also caused by the inhibitors of 
prostaglandin synthesis, such as non-steroidal anti-inflammatory drugs, and by 
reduction in mucosal blood flow (Wallace and McKnight 1990). Evidence confirming 
the role of mucus in the barrier was reported by Wallace and Whittle (1986). They 
tested the hypothesis that mucus provides a microenvironment when the mucosa is 
damaged. To do this they evaluated the epithelial damage that occurred following 
exposure to 50% ethanol, with or without mucolytic agents being used. The mucus 
was removed with either N-acetylcysteine (5%) or pepsin (0.5%). In doing so they 
showed that the mucoid cap disintegrated, macroscopic damage was greater, there 
was increased mucosal leakage of albumin, the recovery of transmucosal potential 
difference was retarded and less epithelium covered the denuded areas.
1.6.3 Mucosal Regeneration
Regeneration is the relatively more long-term recovery of the gastric epithelium to 
injury, including that caused by daily wear and tear. Regeneration of the epithelium 
of artificial ulcers has been shown to be quite rapid (Ferguson 1928, Williams 1953, 
Finckh and Milton 1960). Townsend (1961) reviewing the work done on injury 
concluded that by 24 hours the blood clot formed after the initial trauma would have 
a ledge of epithelial cells oval in shape and that by 36 hours that ledge would be wider 
and the cells flatter. So that by six days following trauma, gland structure would be 
identifiable with mucous neck, parietal and chief cells clearly discernible. 
Concurring, Yeomans, St. John and de Boer (1973) discerned that injury by aspirin 
could produce superficial erosions that would be healed in 24 hours, but that deeper 
erosions healed more slowly taking on average 5 days. Lempinen, Penttila and Fock 
(1968) looking at the regeneration of fundic mucosa histochemically found that the 
epithelium regenerated rapidly, but at four months the general glandular 
arrangement resembled antral mucosa and the parietal and chief cells had still not 
fully differentiated. With scanning electron microscopy, the normal cobblestone 
appearance is lost and the cells become flatter with obvious gaps between cells 
(Yeomans 1976). Changes seen, ultrastructurally, of nuclear swelling, chromatin 
clumping and cytoplasmic oedema were considered to be initially reversible in the 
light of previous findings (Luft and Hechter 1957, Hingson and Ito 1971).
1.6.4 Prostaglandins
Prostaglandins were found first in the seminal fluid of man (Goldblatt 1933). These 
molecules are saturated long chain fatty acids, and members of different groups (E,F 
and I) have been found in the gastrointestinal mucosa (Robert 1974, Robert 1981).
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Prostaglandins have been proven to have a number of effects on the gastrointestinal 
tract such as acid and mucus secretion and mucosal blood flow. The precursor 
arachidonic acid is released from tissue phospholipids by phospholipases. The 
prostanoids that are derived from arachidonic acid are all cyclooxygenase products 
(Rask-Madsen 1987).
Under conditions of maximal histamine stimulation, intravenous PGEj was shown to 
inhibit acid output (Wilson and Levine 1972). However, such drastic stimulation is 
not required to demonstrate this suppressor effect (Robert, Nezamis and Phillips 
1967, Nezamis, Robert and Stowe 1971, Miller 1983). The mode of action in 
suppressing acid secretion has been demonstrated, in isolated canine parietal cells, to 
be the prevention of cAMP production (Soil 1980a).
Prostaglandins (PGE and PGF) have been shown to stimulate secretion of gastric 
mucus, mucin and bicarbonate in a variety of species (Bolton and Cohen 1978, 
Bolton, Palmer and Cohen 1978, LaMont and others 1983). Bolton and Cohen 
(1979a) demonstrated that prostaglandins would stimulate fluid production from the 
non-parietal cells that contained sodium and chloride ions. The movement of sodium 
ions into the lumen occurred without an equal flux of hydrogen ions moving in the 
opposite direction - a feature associated with barrier disruption.
Kauffman, Reeve and Grossman in 1980, demonstrated that topical 16,16-dimethyl 
PGE2 stimulated bicarbonate secretion, but that topical prostaglandin was more 
effective than prostaglandin delivered intravenously and also stimulated mucus as 
measured by glucosamine output. Lichtenberger and others (1983) and LaMont and 
Szabo (1984) found that 16,16-dimethyl prostaglandin E2 and prostaglandin F26 
caused a swift accumulation of hydrophobic phospholipids in the mucosa.
Extensive experimental evidence has also established that various prostaglandins 
increase gastric blood flow (Main and Whittle 1973, Kauffman and others 1979). In 
1980, Cheung exteriorized part of dogs’ greater curvatures and measured blood flow 
by venous outflow a-labelled microspheres. He found that in the resting state 
dimethyl PGE2 increased blood flow almost twofold from 4.2 to 7.4mlmin_1, but in 
histamine stimulated stomachs the blood flow was reduced from 14.6 to 9.2mlmin'1. 
These apparently anomalous results were explained by the fact that the reduction in 
the actively secreting stomach was due to secretory inhibition. Gerber and Nies 
(1982) concurred using radioactive labelled spheres and electromagnetic 
measurement of blood flow.
Apart from local factors causing prostaglandin release, nerve stimulation has been 
found to cause significant increases in release of prostaglandin, particularly PGE2 and
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PGE^, from the stomach, indicating that there are more distant control mechanisms 
(Bennett, Friedman and Vane 1967, Coceani and others 1967). Fringes, Lorenz and 
Oehlert (1985) used PGE2 to treat rat gastric mucosa challenged with 80mM sodium 
taurocholate and found that there was increase in mucus production to explain the 
cytoprotective effect of PGE2.
Synthetic prostaglandins such as riprostil (a synthetic E1 analog) have been found to 
have"antigastrolesive", antisecretory and mucus stimulating effects in the experimental 
rat and also in fistulated dogs (Katz, Shriver and Rosenthale 1987, Katz and others 
1987ab). This effect was equally effective whether riprostil was given orally or as a 
topical preparation.
1.6.5 Cytoprotection
The observation that prostaglandins are able to prevent injury to the gastric mucosa 
by a number of diverse agents distinct from their acid suppressing effects has been 
termed "cytoprotection" (Robert 1976). The precise mechanism whereby 
prostaglandins effect protection and indeed the exact cell of origin has not been 
defined, but they exert their activity at the site where they are produced and 
experimentally non-antisecretory doses can afford protection (Miller 1983). 
However, prostaglandins inhibit basal and stimulated acid secretion, stimulate blood 
flow, mucus and bicarbonate secretion, thus it may well be that there is no single 
mechanism involved, but each of these recognised biological actions is cumulative, 
thus giving cytoprotection (Johansson and Bergstrom 1982).
Prostaglandins have been shown to effect protection of the mucosa in a wide range of 
species. Ferguson and others (1973) induced ulcers in the rat by using serotonin, the 
mode of injury being through intense vasoconstriction with breakdown of lysosomal 
membranes. They showed that treatment with PGEj prevented such ulcer formation 
and stabilized the lysosomal membranes. Cohen and Pollett (1976) found in man 
that challenge to the barrier with aspirin or indomethacin was warded off by the use 
of PGE2, indicating that prostaglandins are definitely contributory to mucosal 
integrity.
A similar effect was noted in the dog where mucosal permeability was used as a 
measure of barrier stability. Here intravenous prostaglandins returned the 
permeability to normal where there was already established mucosal damage caused 
by exposure to aspirin (Bolton and Cohen 1979b). Pihan and others (1978) explored 
the effect of ethanol on mucosal blood flow, which they found to be reduced and 
correlated well with the extent of haemorrhagic mucosal lesions. Pre-treatment with 
16, 16-dimethyl PGE2 prevented capillary stasis and the development of
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haemorrhagic gastric mucosal lesions.
Much of the original work on prostaglandin cytoprotection used macroscopic change 
or transmucosal potential differences as gauges. Lacy and Ito (1982) looked at the 
microscopic changes of mucosa damaged by ethanol, but treated with prostaglandins. 
They noted that, whilst oral PGE2 prevented the typical haemorrhagic necrotic 
lesions, destruction of gastric mucosal cells still occurred. Konturek and others 
(1982a) and Schmidt and others (1985) found that prostaglandins produced almost 
complete macroscopic protection against injury induced by aspirin/HCl and absolute 
ethanol respectively. But when the mucosa was examined by light, transmission and 
scanning microscopy, superficial surface cell necrosis had still occurred, though the 
deeper damage had certainly been prevented.
From the work that has been published it is clear that prostaglandins will protect 
against deeper damage accompanied by vascular impairment, but not against 
superficial mucosal injury, particularly where the damage has been caused by 
intraluminal exogenous agents, where the effect is in all probability caused by direct 
chemical or physical damage of those cells (Tamawski and others 1985a, Szabo and 
Goldberg 1990). This failure is not complete, as was found by Whittle and Steel 
(1985) using high doses of 16,16-dimethyl prostaglandin E^ and by restoration of 
surface hydrophobicity demonstrated by Lichtenberger, Richards and Hills (1985). 
Moody, Zalewsky and Larsen (1981), in a review of gastric epithelial protection, 
broadened the definition of cytoprotection to include other factors that protect, such 
as the epithelium itself, the overlying mucus and mucosal blood flow.
Local blood flow has been shown to be cytoprotective in experimental erosive 
gastritis, where injurious agents, which produce a high rate of back-diffusion of H+ 
and Na+ efflux, failed to produce erosive gastritis (Moody and others 1978). The 
increased blood flow ensures adequate oxygen and energy for the hungry intracellular 
metabolism. It provides a reservoir of ions to supply the cells with sodium and 
bicarbonate ions, which act to prevent hydrogen ion back-diffusion. Secondly, blood 
flow is stimulated by, and allows the circulation of prostaglandins, thus preventing 
circulatory stasis (Main and Whittle 1973, Moody and others 1978, Cheung 1980, 
Cloud and Ritchie 1982, Konturek and Robert 1982, Pihan and others 1986).
One interesting phenomenon that has been recognised is that of adaptive 
cytoprotection. Chaudhury and Robert (1980) examined the effect of 80mM 
acidified taurocholate on rat gastric mucosa. They found that this agent produced 
extensive lesions within one hour. However, if 5mM acidified taurocholate was given 
orally 15 minutes before the 80mM taurocholate, the development of lesions was 
avoided. Their theory was that prostaglandins stimulated by the 5mM bile and
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released before the administration of 80mM bile prevented injury. As confirmation 
of this proposed mechanism they found that indomethacin would suppress this 
protective effect. Further, evidence provided by Scheurer and others (1981) 
indicated that chronic exposure to bile increases resistance of the mucosa to bile, 
possibly by stimulating prostaglandin production. Support for this possibility comes 
form the work of Lev, Siegel and Glass (1972), Eastwood (1984), Coleman and others 
(1987). Lev, Siegel and Glass (1972) found that following chronic administration of 
aspirin to dogs, areas that were grossly normal had a cuboidal regenerative-type 
surface epithelium histologically, with a reduction in the amount of intracellular 
mucin. Eastwood (1984) found that, in the fundus, doses of aspirin and indomethacin 
would stimulate epithelial proliferation at levels that produced no detectable injury. 
Similar stimulation of epithelial proliferation was found with chronic feeding of 
aspirin to rats. No such effect was noted in the antrum (Eastwood and Quimby 
1982).
1.7 Iqjurious Agents
Damage to either the mucus or the surface epithelium allows attack on the 
physiological integrity of the barrier (Davenport 1975). This can arise in a number of 
well recognised situations. Examples are bums, spinal shock, administration of 
NSAIDs and following resection of the pylorus (Fletcher and Harkins 1954, Van 
Heerden and others 1969, DenBesten and Hamza 1972, Goodman and Osbome 1972, 
Lucas and others 1972).
Ritchie (1975) found that 5mM taurocholate could be recovered from benign ulcer 
patients. This concentration of bile was enough in the dog to break the barrier, but 
not to produce ulceration unless acid and impaired blood flow was present. The 
importance of mucosal blood flow has been stressed by others (Ritchie and Shearburn 
1976, McGreevy and Moody 1977, Kivilaakso, Fromm and Silen 1978, Ritchie and 
Cherry 1979, Watt, Sloan and Kennedy 1984, Lanza and others 1986, Haglund 1990).
Experimentally produced ulcers often have a characteristic shape, being elongated or 
focal and follow a linear pattern. This pattern was thought to be related to the 
presence of mucosal folds. Using a rat gastric chamber and three ulcerogenic 
treatments (acid pHl, haemorrhagic shock and complete ischaemia), Mersereau and 
Hinchey (1982) showed that the apex of a fold is more sensitive to injury. They found 
that the mucosal potential difference at the crest of a fold was lower than at the 
trough. They postulated that this could be due to the thin peak, the lack of gastric 
musculature to absorb the acid and a lower potential difference indicating a different 
blood flow in this region.
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1.7.1 Acid
The gastric mucosa, as a whole, must protect itself from a highly acid environment 
created by the secretion of acid from its own parietal cells. It is recognised that a 
feature of barrier disruption is back-diffusion of hydrogen ions. Hydrochloric acid 
120mM pHl added to rabbit fundic pouches caused superficial erosions, and in 
isolated frog mucosa produced deterioration in potential difference across the mucosa 
when the mucosa was in the resting state. If acid secretion was stimulated, by 
histamine, the aforementioned mucosal changes did not occur, and if histamine was 
suppressed the lesions were again found (Smith and others 1977). These findings 
indicated that the gastric mucosa could be protected from exogenous luminal acid if 
the mucosa was actively secreting. The reason postulated for this was a greater 
alkaline tide during active or stimulated secretion (Fromm, Silen and Robertson 
1976). Thus the stomach is able to protect itself by virtue of the fact that acid is 
usually present in the lumen of an actively secreting stomach.
The lipoprotein layer of the plasma membrane is relatively impermeable to ions, but 
is extremely permeable to un-ionised and fat soluble chemicals. Thus when acidic 
drugs are given they are almost always un-ionised (depending upon their pKa) and 
move rapidly into mucosal cells by passive diffusion. Once in the cell (pH7) these 
acidic drugs will become ionised and damage the cell due to build up, because of the 
cell’s inability to diffuse these ions out rapidly enough (Martin 1963). When the 
mucosa is damaged, acid diffuses into the mucosa and stimulates the release of 
histamine from the injured cells into the venous circulation in both the rat (Johnson 
1966) and the dog (Johnson and Overholt 1967). Histamine stimulates acid 
secretion, vasodilation and increased permeability of the capillary walls to proteins 
(Johnson 1968). The mucosa becomes oedematous and interstitial ions filter across 
the mucosa into the lumen. The effect is that sodium ions, potassium ions and 
proteins leak into the lumen and hydrogen ions re-enter the mucosa. The hydrogen 
ion stimulus in the mucosa leads to further acid and pepsin secretion (Johnson 1971, 
Code 1981).
Acid plays a role in accentuating the damage caused by injurious agents, aspirin being 
a particular example (Brodie and Chase 1967). Rats that were rendered achlorhydric 
by irradiation did not develop gastric erosions when given large doses (600mgkg_1 
four times daily) of aspirin subcutaneously (Gottschalk and Menguy 1970). In a 
complimentary study, Hansen, Aures and Grossman (1978) found that intravenous 
aspirin had little gross effect in the cat, but when the aspirin was augmented by 
histamine mainly antral ulcers were induced. In a major review, Flower (1974) 
recognised that aspirin, amongst other NSAIDs, inhibits prostaglandin biosynthesis. 
Roth, Stanford and Majerus (1975) demonstrated that aspirin acts as an active-site
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acetylating agent for cyclo-oxygenase, thus explaining its anti-inflammatory and anti­
platelet action. Fromm (1981) reviewing the role of add in gastric injury considered 
that the case had been made, that the presence of add was required for many 
injurious agents to produce clinically significant injury, the injury induced by the 
drugs/agents acting to increase the permeability of the mucosa to its own secreted 
add.
1.7.2 Bile
Early evidence that bile was implicated in gastric damage came from work carried out 
by Smith (1914), and Berg and Jobling (1930) who found that 50% of dogs with 
Peyton-Rous permanent biliary fistula had gastroduodenal ulcers. In 1959, Borg 
examined the frequency of bile-stained gastric aspirates in patients with peptic ulcer, 
found that occurrence increased during the night, peaking at l-2am in the morning. 
He speculated that this nocturnal peaking may be due to recumbency and dominant 
parasympathetic activity during sleep. Similar findings were recorded by Rhodes and 
others (1969), where the concentration of bile in the stomach due to reflux was higher 
in ulcer patients. Thus evidence has been found that either bile reflux is a causative 
factor in peptic ulcer, or if not a primary cause, then a factor that may delay healing.
Hoffman and Small (1967) drew attention to the detergent properties of bile in an 
extensive review. Then Davenport (1968), Ivey, DenBesten and Clifton (1970) and 
Werther and others (1970) demonstrated by studying the net ion fluxes, in particular 
movement of H + ions out of the lumen, that in man and animals the mucosal barrier 
would break after exposure to bile. Davenport (1968) chose bile since it was the 
detergent most likely to come in contact with the gastric mucosa. He found that bile 
in sodium chloride, acid or liquid meal damaged or destroyed the mucosal barrier. 
Confirming earlier work when looking at the effect of acid, aspirin and alcohol 
Davenport (1969) found that aspirin in neutral solution did not break the barrier, but 
it would if mixed with 0.001 or 0.01N hydrochloric acid. In one further piece of work 
Davenport (1970) also showed that lysolecithin would break the barrier when applied 
to antral vagally denervated pouches. The effect of pH was also studied by Black, 
Hole and Rhodes (1971), where they noted that the back-diffusion of H+ was most 
marked at pH2 and least at pH8. Kuo and Shanbour (1976) accounted for the 
alteration in ion fluxes that take place by way of increased permeability, the above 
changes being related to cellular change.
Martin, Marriot and Kellaway (1978) suggested that bile salts decreased the elasticity 
and viscosity of gastric mucus and that the ulcerogenic properties were related in part 
to their ability to reduce mucus consistency. Hills, Butler and Lichtenberger (1983) 
confirmed that this effect was due to bile (and aspirin) eliminating the hydrophobicity
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of the mucus layer. Duane and Wiegand (1980) and Duane, Wiegand and Sievert 
(1982) challenged the gastric mucosa of Heidenhain pouches with lOmM bile and 
found not only the typical ion fluxes, but also detected an increased phospholipid 
efflux from the gastric mucosa. However, the result that whilst mucus is solubilized 
rapidly by pepsin (Allen and Carroll 1985), but unchanged by acid and bile is 
conflicting.
Cheung, Moody and Reese (1975) examining the effect of various agents on mucosal 
blood flow found that change in blood flow was directly related to the severity of the 
injury, and of the three agents used (20mM aspirin, 40mM sodium taurocholate and 
ethanol) the change in blood flow was most marked with bile. Ritchie (1981a) and 
Cloud and Ritchie (1982) also showed that topical sodium taurocholate at a low pH 
increased gastric mucosal blood flow in a dose related fashion. Indomethacin 
blocked this change and further supplementation with prostaglandins reversed this 
blocking effect of indomethacin on perfusion, proving that bile-stimulated increased 
perfusion was mediated by prostaglandins.
Ritchie and Cherry (1979), Harmon, Lewis and Gadacz (1981) and Ritchie (1981b) 
recognising the ulcerogenic potential of topical bile established that lesion severity 
was a function of the concentration of H + and bile in the lumen. However, Ritchie
(1975), Ritchie (1981a) and Cloud and Ritchie (1982) reported topical bile acids not 
to be ulcerogenic in non-ischaemic mucosa, because of a compensatory increase in 
blood flow that was related to the induced H + loss. Yet Ritchie and Shearbura
(1976) found that, in the dog, physiological concentrations of bile salts were sufficient 
to induce acute mucosal damage. Corroborative evidence was provided by Mann 
(1976), who noted that bile caused an acute erosive gastritis in rats after one hour.
Eastwood (1974) discovered that taurocholate at 2mM pHl for 2 minutes produced a 
reduction in cytoplasmic density and clumping of the nuclear chromatin, when the 
mucosa was examined by electron microscopy. In 1975, Eastwood found that with 
bile alone the tight junctions and surface cell membranes remained intact, and 
confirmed that in the presence of bile, surface cell membranes could be disrupted. 
Consequently, he concluded that bile salt alters the surface cell membrane in a way 
that allows either the ingress of the bile salt, or H + to cause intracellular damage. 
Forte, Silen and Forte (1976) recognised large areas of partially damaged cells, 
ranging from loss of microvilli to complete cell disintegration, but intact junctional 
complexes. Ritchie (1977) noted consistent transmission electron microscopical 
findings in barrier damage, namely clumped nuclear chromatin, swollen 
mitochondria, decreased cytoplasmic and nuclear density, cytoplasmic vacuolization, 
dilation of the perinuclear spaces and cellular swelling. Yet, admittedly from a
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different region of the gastrointestinal tract, in vitro ileum of the rabbit, bile appeared 
to loosen the tight junctions (Fasano and others 1990).
Using scanning electron microscopy to study taurocholate damage Winborn, 
Guerrero and Hodge (1976) found two types of effect following the application of 
pure rat bile to the gastric mucosa. Either a massive sloughing with the exposure of 
the honeycomb lamina propria, or surface cell damage where there was an absence of 
sloughing were noted. Diserens and others (1984) studied duodenogastric reflux in 
experimental dogs after diversional surgery and viewed apical cell erosions, exposure 
of cell contents and cell shells. Again using the scanning electron microscope, 
Fringes, Lorenz and Oehlert (1985) demonstrated that remnants of surface epithelial 
cells presented as empty shells, and that the apical membranes of others were covered 
in mucus vesicles.
Byers and Jordan (1962) implanted part of the fundus, with preserved blood supply, 
into the gallbladder and looked at the histological changes after the elapse of one to 
12 months. They found no histological abnormalities and concluded that pure bile 
was not an aetiological factor in gastritis, and explained the lack of change as the 
absence of intestinal juice or adequate gastric secretion. In contrast, Menguy and 
Max (1970), using the dog as an experimental model, anastomosed part of the antrum 
to the gallbladder and found that chronic exposure lead to a gastritis with increased 
rugal folding and occasional polyp formation on these folds. Supporting evidence was 
the finding that diverting the upper or lower bile duct in the rat produced erosions 
and ulcers (Kirk 1970).
If bile refluxes, then so also can pancreatic juice. Johnson and McDermott (1974) 
recovered high levels of lysolecithin from patients with gastric ulcers (198jLigml-1 
compared to 18jLtgml-1 normally). They recognised lysolecithin to be a strong 
detergent, and also highly toxic to cell membranes. Concluding that lysolecithin was 
as important as bile in destruction of the gastric barrier. Lawson (1964) noted 
experimentally that the effects of pancreatic secretions on gastric mucosa were 
minimal. Rudick and others (1977) were also unable to substantiate this claim, 
failing to find any change in ion fluxes when the antrum of dogs was exposed to 
pancreatic juice, or pancreatic juice that had been in contact with the duodenal 
mucosa for 30 minutes.
Further, bile reflux has also been implicated as a cause of alkaline reflux gastritis in 
patients following gastric resection for a variety of conditions; Van Heerden and 
others (1969) - retained gastric antrum, Keighley, Asquith, and Alexander-Williams
(1975) - peptic ulcer, Delaney and others (1978), Hoare and others (1978) - gastric 
remnant, Gaffner, Florin and Nilsson (1984), Watt, Sloan and Kennedy (1984),
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Gough (1985) - vagotomy and drainage.
Rhodes and others (1969) looked at bile acids in gastric aspirates from two groups of 
patients in two situations; a normal and ulcer group following fasting, and after a test 
meal. In the normal group, fasting bile aspirate from the stomach ranged from 0.01- 
0.033mM, statistically different compared to 0.03-3.17mM in patients with ulcers on 
the lesser curvature. Following a test meal, the difference became even more 
marked with a mean in the normal patients of 0.06mM, and l.lmM in the ulcer group. 
Similar findings were reported by Wormsley (1972), with duodenogastric reflux being 
slight or absent in normal subjects and those with duodenal ulcer, but appreciable in 
gastric ulcer patients. However, Collins and others (1984) measured total bile acids 
in gastric juice of patients who had undergone vagotomy and gastrojejunostomy, and 
found surprisingly wide variations in bile acids in normal and operated patients. They 
concluded that bile reflux can occur without producing symptoms, but that mucosal 
changes could be present without producing symptoms.
Delaney, Broadie and Robbins (1975), using the dog as an experimental animal, 
created tubes of gastric corpus and chronically exposed these to bile, pancreatic juice 
and pancreatic contents. They found extensive gastritis in all three preparations, but 
the changes were most marked in those exposed to jejunal contents. Robbins and 
others (1976) found in man that while bile and pancreatic juices both damage the 
gastric mucosa, the effects were additive, as would arise when duodenogastric reflux 
occurred "naturally". In man, partial gastrectomy for duodenal ulcer leads to 
increased frequency of gastritis, in particular atrophic gastritis (Gjeruldsen, Myren 
and Fretheim 1968). Chronic exposure caused round cell infiltration into the lamina 
propria, disorder of the gastric tubules manifested as a "corkscrew" appearance and 
hyperplasia of the mucous cells leading to a "papillary" configuration (Delaney, 
Broadie and Robbins 1975, Robbins and others 1976). Confirmatory experimental 
evidence from the dog was published by Lawson (1981a). Lawson (1981b) found that 
the Roux-en-Y, which minimises passage of bile into the gastric remnant, prevented 
the development of gastritis in experimental dogs. Dragstedt and others (1971) using 
the dog as an experimental animal found histological evidence of gastritis after 
exposure to bile, but were unable to substantiate the claim from other authors that 
bile causes peptic ulcers.
Duodenal contents were implicated as presenting carcinogens with an absorptive 
route when combined with the presence of intestinal metaplasia (seen in atrophic 
gastritis), since duodenal contents increased lipid solubility and were more active in 
an alkaline gastric environment (Siurula and Tawast 1956). The incidence of 
alkaline reflux after diversional surgery has prompted speculation that bile reflux may
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be partially responsible for the high occurrence of gastric stump carcinoma 
(Domelloff 1979 and Domelloff, Reedy and Weisburger 1980). Though finding no 
evidence of malignant change Watt Sloan and Kennedy (1983) were disturbed by the 
frequent occurrence of dysplasia in operated patients.
1.7.3 Non-Steroidal Anti-Inflammatory Drugs
From the original discovery by Stone, in 1763, that willow bark reduced fever, 
salicylate, the active ingredient in willow bark, came to be used extensively. 
Attention was drawn to the serious manifestations of aspirin as far back as 1930 
(Dodd, Minot and Arena). The proliferation of drugs related to salicylate has been 
marked in the last 15 years and have become to be known as a group - non-steroidal 
anti-inflammatory drugs (NSAIDs). Many of the new NSAIDs have been associated 
with serious side-effects in man (Simon and Mills 1980ab). In the veterinary field 
NSAIDs, as a group, account for a major portion of the drugs dispensed by the small 
animal practitioner. When new drugs appear on the human market, these are often 
taken up eagerly by the veterinary profession. Unfortunately because of different 
species responses, the effectiveness/side-effect balance, as seen in man, is not always 
mirrored in the species with which the veterinary profession deals. Aspirin 
(acetylsalycylic acid) is one of the most commonly used NSAIDs, partly because of it’s 
long availability, and secondly because it is obtainable without prescription. The 
NSAIDs act by suppressing the biosynthesis of prostaglandins (Flower 1974, Roth, 
Stanford and Majerus 1975, Vane and Botting 1978).
1.7.4 Aspirin
That aspirin damages the mucosa has been recognised for many years in many 
species; for example in the dog, cat, rabbit and the rat (Barbour and Dickerson 1938, 
Roth and others 1963, Hurley and Crandall 1964). These last authors found that the 
mucus coagulated and the mucosa became opacified due to the denaturation of the 
mucus protein layer and desquamation of underlying cells. Croft (1963) also found 
exfoliation of cells following the administration of aspirin in man. In 1968, Kent and 
Allen showed that the biosynthesis of gastric mucus in man was suppressed by aspirin.
Martin (1963) commented that in the gastric lumen all acidic drugs are largely in an 
un-ionised form. Whereas in the mucosal cell, where the pH is assumed to be 7, the 
percentage of ionised form will depend upon the pKa of the acid. In 1964, Davenport 
showed, using canine vagally denervated pouches, that compounds which are fat 
soluble cross into the gastric mucosa rapidly. Aspirin dissociates at an acid pH (pKa 
3.5), but being lipid soluble penetrates the apical cell lipoprotein membrane and is 
rapidly absorbed. Aspirin at pH2 is 95% unionized, fat soluble and diffuses rapidly
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across the mucosa. Once inside the cell, it becomes ionised at the higher 
intracellular pH and is thus able to exert its toxic effects, including bleeding 
(Davenport 1967a, Gamer 1978).
Ample evidence has been provided to show that acid plays a crucial role in the 
damage that aspirin inflicts to the gastric mucosa. Brodie and Chase (1967) showed 
that if vagotomised rats were challenged with aspirin and examined 4 hours later, the 
level of damage was much less than in normal rats challenged with aspirin. They 
recognised that to induce the typical change in vagotomised rats, 0.1N HC1 needed to 
be added to the stomach of the rats. They also noted that whilst in contact with 
injurious agents the level of H + in the lumen dropped. This feature was due not to 
acid suppression but to back-diffusion of H +. In a similar series of experiments 
confirming the deleterious role of acid, whether it be endogenous or exogenous, 
Brodie and Chase (1969) demonstrated that the sparing effect of vagotomy was 
counteracted by the administration of histamine stimulating endogenous acid 
secretion.
Davenport (1967a) proved that when aspirin diffused across the mucosa, the mucosal 
characteristics changed with increased fluxes of hydrogen, sodium, potassium and 
chloride ions. He felt that agents that may be innocuous in contact with the mucosa 
become toxic if they are able to move into it, and that aspirin would carry hydrogen 
ions into the cell, or that aspirin was a potent protein precipitor, or enzyme inhibitor. 
Similar alteration in permeability with back-diffusion of hydrogen ions has been 
demonstrated in man following aspirin (and also ethanol administration) by Smith 
and others (1971), which may also affect the alkaline secretion of the mucosal cells 
(Rees, Gibbons and Turnberg 1984). Equally, aspirin-induced falls in potential 
difference have been described in man (Murray, Stroltman and Cooke 1974).
Croft (1963) found that in man aspirin caused exfoliation of cells within five minutes 
of ingesting the drug. The three effects noted by Menguy and Masters (1965) were a 
local necrosis, mucosal damage and systemic damage. This information was 
determined from the short term (72 hours) administration of aspirin to young rats. 
They further noted, histologically, that the amount of Periodic Acid Schiff (PAS) 
positive material in the mucosa was reduced, indicating that neutral mucoproteins 
were reduced.
Lynch, Shaw and Wilton (1964) examined the effect of six hour exposure to aspirin on 
gastric secretion in the cat and found that it was noticeably increased. Grossly, they 
recorded evidence of bleeding, and histologically there were erosions with the normal 
cuboidal cells becoming flattened. Taylor and Crawford (1968) demonstrated 
experimentally that high doses of aspirin produced consistently longitudinal ulceration
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in the pyloric part of the stomach. Chvasta and Cooke (1972) looking at the effect of 
several ulcerogenic drugs on the canine gastric mucosa showed that aspirin produced 
the highest incidence and the most severe lesions. The aspirin used was mixed in 
water to produce a solution of 20mM at pHl, which caused bleeding in all dogs. 
Cohen and MacDonald (1982) studied the damage caused by aspirin to human gastric 
mucosa and found that prostaglandins were inhibited, but felt that this alone could 
not explain all the damage present, and found evidence of a direct irritant action 
causing alteration in mucosal permeability, supporting the conclusions of Roth and 
others (1963). However, these two proposed methods of action can be linked by the 
work of Lichtenberger, Richards and Hills (1985) and Kao, Goddard and 
Lichtenberger (1990), where they discovered that the nonwettable surface of the 
gastric mucosa is disrupted by aspirin. This disruption would allow direct irritant 
action, but they found that the nonwettable surface could be preserved by 
prostaglandins (16,16-dimethyl PGE2).
Apart from the action on the surface cell, the parietal cell is also affected. Levine, 
Nandi and King (1990) found that aspirin potentiated acid secretion that had already 
been stimulated, and that the mode of action was by mobilizing intracellular calcium. 
They felt that this aspirin-induced augmentation may have been modulated by 
suppression of prostaglandins.
In the dog, attempts to demonstrate changes radiographically when aspirin has been 
administered over a short term have not been successful, though the lesions seen at 
endoscopy of superficial linear erosions and haemorrhage in the antrum and body 
were confirmed grossly and histologically. The most severe lesions were found at the 
incisure angularis (Bonneau and others 1972). In man, short courses of aspirin within 
the therapeutic range will, in normal subjects, produce easily endoscopically 
recognised damage (Cohen and MacDonald 1982).
Morphologically in mice, Hingson and Ito (1971) established that 20mM aspirin, in 
combination with various concentrations of hydrochloric acid, produced rapid surface 
cellular change. Damaged cells were lysed and became exfoliated. Their study, of 
the fine structural alterations caused by the administration of aspirin/HCl, found 
nuclear enlargement and chromatin clumping. The cytoplasm became paler and the 
subsurface mucous granules less uniformly clustered. The apical surface became 
distorted with blebs of cytoplasm ballooning from the cell. They further noted that 
the sloughed cells were relatively intact, but trapped in the overlying mucus. The 
clumping of chromatin and the presence of an agranular space beneath the mucous 
granules were confirmed by Harding and Morris (1976) and considered characteristic 
by Eastwood (1985). Work presented by Trabucchi and others (1986) showed that
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after one hour exposure to aspirin (200mgkg-1) and acid (0.15N), the mucous cells 
were difficult to distinguish with transmission electron microscopy (TEM), due to the 
damage done by the aspirin/acid combination.
Frenning and Obrink (1971) speculating on the theory that aspirin increased gastric 
mucosal permeability leading to swelling of cells, due to intracellular accumulation of 
ionized acids, used scanning electron microscopy to show that feline gastric mucosal 
cells did indeed become swollen, being more circular than polygonal in shape and 
accompanied by some incomplete breakdown of intracellular junctions. Harding and 
Morris (1976), also using scanning electron microscopy, found apical rounding and 
holes, degeneration and exposure of intracellular contents.
In contrast, Pfeiffer and Weibel (1973), using ferrets as the experimental animal, 
demonstrated that cell disruption occurred in localised regions, and importantly 
intracellular junctions remained intact; and with transmission electron microscopy, 
partial disappearance of microvilli and lack of ground substance between the apical 
mucous granules were evident, these changes leading to generalized cellular 
disintegration.
Rats receiving a single dose of 120mgkg_1 aspirin per os were found histologically to 
have superficial lesions with desquamation of surface epithelial cells, mainly in the 
corpus after 30 minutes. These lesions were found to have healed within 24 hours. 
Similar changes were seen in chronically aspirin-dosed rats (Yeomans, St. John and 
de Boer 1973). With electron microscopy, repair was visible as flattened surface 
epithelial cells, which appeared to be derived from adjacent surviving cells, with 
intercellular gaps (Yeomans 1976). Ohno, Ohtsuki and Okabe (1985) administered 
aspirin by gastric intubation and found apical erosions of the surface epithelial cells 
after 10 minutes exposure, using scanning electron microscopy.
1.7.5 Indomethacin and Piroxicam
Chvasta and Cooke (1972) compared the effect of several ulcerogenic drugs on canine 
fundic mucosa, using a Heidenhain pouch. Indomethacin was found to break the 
barrier, as measured by Na+, H + and Cl' fluxes after 30 minutes exposure at pHl or 
pH7.3, in contrast to aspirin that required an acidic environment. Similar work by 
Mann and Saachdev (1976) compared the ulcerogenic effects of aspirin, ketoprofen, 
ibuprofen and naproxen on the rat gastric mucosa. They found that all four NSAIDs 
caused erosions, but they were most marked with aspirin with little to choose between 
the other three.
Thus aspirin is not unique amongst the NSAIDs in its ability to cause toxic damage to
32
Ch a pt e r  l
surface epithelial cells and induce disruption of the gastric mucosal barrier. Indeed, 
indomethacin has been shown to induce acid secretion by significantly inhibiting 
prostaglandin synthesis (Levine and Schwartzel 1984), presumably by acting in the 
same manner as aspirin and mobilizing intracellular calcium.
1.7.6 Effect of Combinations
It has already been shown that acid enhances the damaging effects of many barrier 
breakers. Davenport (1967b) having noted the fact that gastric mucosa, if damaged 
by salicylates, became more permeable, wondered what would happen if bile was 
present in such a situation. He found that with luminal concentrations of 
taurocholate at 10, 20 and 40mM, bile could be found in the venous blood of dogs 
with Heidenhain pouches, the mucosa of which had been damaged by aspirin. He 
concluded that bile salt absorption from the stomach was the result of passive 
diffusion through large pores rather than by active absorption. Guth and others
(1976) found that bile duct ligation reduced the effect of aspirin in inducing gastric 
mucosal lesions, and postulated that this effect was through inhibition of acid 
secretion.
1.8 Protective Drugs
1.8.1 Histamine H2 receptor Antagonists
In 1972, Black and others published a paper on the definition and antagonism of H2 
receptors. Recognising that Hl antagonists did not inhibit gastric acid secretion, they 
defined two types of receptor and demonstrated the suppressive action of burimamide 
on acid secretion. The fact that acid was suppressed indicated that histamine was a 
local common mediator, but also that the actions of gastrin were coupled to those of 
histamine. Gibson, Hirshowitz and Hutchison (1974) using metiamide reported that 
histamine blockers of the H2 variety suppressed histamine, gastrin and cholinergic 
stimulated acid secretion. Cimetidine was the first of a range of H2 antagonists to be 
released for general use (Brimblecome and others 1975, Burland and others 1975). 
Cimetidine is an analog of histamine that has a bulky side chain substituted for the 
ethylamine moiety. It retains the imidazole ring of histamine, which has been 
replaced in more recently released H2 blockers, ranitidine and famotidine (Ostro 
1987, Brunton 1990). Code (1977) found that the receptor on the parietal cell 
was a major controller of parietal cell hydrogen ion output and that cimetidine 
attached to this receptor blocking the pathway of activation. In the same year 
Hirschowitz and Hutchison reported that cimetidine inhibition of H + stimulation was 
competitive, and that pepsin secretion was also suppressed. However, Code (1977) 
was unable to find evidence that gastrin was a histamine liberator, and Soli (1980b)
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reported that gastrin-stimulated acid was not suppressed by cimetidine as gastrin 
acted at another receptor site.
Rees and others (1977a) found that sodium taurocholate increased ionic fluxes in 
Heidenhain pouches, but if the animals were given histamine antagonists (Hx and t y  
this flux change could be prevented. This action was due to the suppression of 
histamine release, obviating the normal vascular response. However, earlier work 
reported by O’Brien and Carter (1975), with metiamide, and Kenyon, Ansell and 
Carter (1977), with cimetidine did not support this potentially cytoprotective effect. 
They could find no evidence of restoration of normal ion fluxes in dogs that had the 
mucosal barriers disrupted by 5mM or 20mM sodium taurocholate and which had 
been treated with cimetidine. The argument being that whilst H2 antagonists 
blocked acid they did not block other actions of Hx receptors. Microscopic damage 
was similarly unchanged by pre-treatment with cimetidine when rat mucosa was 
challenged with absolute ethanol, where extensive damage occurred to the superficial 
and pit cells (Lacy 1986, O’Brien and others 1990). Despite this, its role in mucosal 
injury would be to reduce the amount of H + available to exacerbate a barrier 
damaged by other agents (Carmichael, Nelson and Russell 1978).
Support for this rationale came from MacKercher and others (1977). Here the 
induced damage to surface epithelial cells by aspirin was cut dramatically by the 
administration of cimetidine. The consequence of suppressing acid secretion was 
twofold; firstly, the suppression of acid caused the intraluminal pH to rise dissociating 
the aspirin and preventing its absorption by surface epithelial cells; secondly, by 
suppressing acid, any damage done by aspirin, which is lipid soluble, was minimised 
because of the lack of H + ions available for back-diffusion. One further possible 
mode of protection would be the inhibition of increased ionic permeability. The 
evidence for this action is incomplete as both Hx and H2 blockers were required to 
achieve this type of effect (Rees and others 1977a), yet seemingly supported by the 
results produced by Kauffman and Grossman (1978), demonstrating that the action of 
PGE2 and cimetidine, in protecting the mucosa from aspirin ulceration, was not by 
influencing acid and pepsin output. Support, again using aspirin, for this contention 
came from Guth, Aures and Paulsen (1979), and with bile from Levine, Sirinek and 
Pruitt (1979). Noburhara and Takeuchi (1984) providing further evidence for this 
benefit, found that cimetidine abolished the inhibitory effect of indomethacin on the 
gastric alkaline response by increasing luminal bicarbonate ion concentration and 
positively influencing potential difference recovery, accelerating the re-establishment 
of mucosal integrity.
On the other hand, Gronbech and others (1987) showed that whilst cimetidine
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treatment of damage caused by topical sodium chloride increased mucosal blood flow, 
it alone did not affect restitution, but would do so in the presence of pentagastrin. 
They concluded that low pH did not prevent restitution, which is somewhat at odds 
with those supporters of the mucoid cap, which is dissolved by acid (Morris and 
Wallace 1981). In contrast, Tsukamoto and others (1987) showed that blood flow 
was decreased by cimetidine at 5 or 20mgkg_1.
When ulcers were produced in the dog by injecting acetic acid subserosally, the rate of 
healing of the established gastric ulcers did not seem to be affected by the 
administration of cimetidine, though those in the duodenum healed faster (Okabe 
and others 1978).
Although cimetidine was the first of the commercial H2 antagonists, ranitidine is now 
more widely used (Bohman, Myren and Larsen 1980, Woodings and others 1980), and 
possibly in the future famotidine (Smith and others 1985). All three suppress basal 
and stimulated acid secretion (Ostro 1987). Konturek and others (1981a) 
investigated the cytoprotective effect of ranitidine and compared it to prostaglandins. 
They found that, even at doses that did not suppress secretion, ranitidine was 
cytoprotective in the rat against a challenge of aspirin and acid. They also noted that 
prostaglandin levels did not change, thus the effect of ranitidine was not due to 
endogenous prostaglandin, or secretory inhibition. In contrast, Konturek (1985) 
considered that the healing effect (as opposed to acid suppression) of cimetidine, 
amongst others, was due to the mediating release of endogenous prostaglandins.
1.8.2 Mucus Stimulants
Sucralfate is an aluminium salt formed from sucrose octasulphate and polyaluminium 
hydroxide. Extensive polymerisation and cross-linking of the sucralfate occurs at pH 
less than four. The formed polymer is a gel that is sticky and viscid (Nagashima 
1981a). It adheres to epithelial cells and ulcer craters (Spiro 1982, Brogden and 
others 1984). The postulated mechanisms for the protective action of sucralfate are 
that it forms a barrier on eroded mucosal surfaces, deactivates and binds pepsin, and 
also binds bile, actions that are pH dependent (McGraw and Caldwell 1981, 
Nagashima 1981b, Samloff and O’Dell 1985). Other further actions hypothesized to 
explain the efficacy of sucralfate are that the aluminium ions act to buffer the 
hydrogen ions as they permeate the sucralfate/mucus layer (Samloff 1983), and 
stimulate the output of bicarbonate ions by the gastric mucosa (Guslandi 1985). One 
other suggested mechanism of action (apart from prostaglandins) may involve 
endogenous sulphydryls (Vergin and Kori-Linder 1990).
However, Danesh, Duncan and Russell (1987) tested the effect of two different pH
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environments on the protective action of sucralfate in the rat. The injurious agents 
chosen were aspirin alone, and aspirin combined with bile. They discovered that 
sucralfate reduced erosions regardless of pH.
There is evidence that sucralfate stimulates prostaglandins in the gastric mucosa 
conferring a cytoprotective property, and that indomethacin (inhibiting prostaglandin 
synthetase) abolishes this sucralfate protection (Hollander and others 1984, 
Iigumsky, Karmski and Rochmilewitz 1984, Konturek 1985, Coleman and others 
1987, Stern, Ward and Hartley 1987). Contrary evidence has been provided by 
Maclaurin, Watts and Palmer (1985), that whilst indomethacin damage was 
exacerbated in the guinea-pig by bile salts, sucralfate prevented this damage 
completely. Corroborative evidence for this protective action against bile, in the face 
of indomethacin, was published by Romano, Razandi and Ivey (1990), suggesting that 
there is indeed a protective action that is not dependent on prostaglandins as the 
mediators. Morris and others (1989) and O’Brien and others (1990) found that pre- 
treatment with indomethacin made no difference to the protective properties of 
sucralfate, that sucralfate interacted with the unstirred layer and with the epithelial 
cells to promote release of mucus and speculated that it may also affect either 
inflammatory mediator release or synthesis. Tasman-Jones and others (1989) 
considered that sucralfate did not form a layer on top of the mucus but interacted 
with the whole layer, and specifically with the superficial portion of mucus, retaining it 
when it would normally be lost.
Harrington, Schegel and Code (1981) reported that sucralfate enhanced mucus 
secretion. It has also been shown, using a viscometer, to increase the viscosity of 
mucus in a concentration related fashion, and also to reduce the permeability of 
mucus to H + (Slomiany and others 1985). In an attempt to define precisely what 
exactly sucralfate did to the mucus layer Slomiany and others (1989) investigated the 
effect of five days ingestion of sucralfate in the rat. The features and the results 
obtained are listed below;
Factor Increase
Mucus gel dimension 8%
Mucin content 63-81%
Viscosity 190%
H + retardation 9%
Hydrophobicity 60%
Their results show that the beneficial effects of sucralfate on the mucus layer are 
based largely on the increased mucin content, viscosity and hydrophobicity. The 
mode of action for these features was through sucralfate affinity for proteins, and thus 
interaction with the proteins of the gastric mucus, which has been proved using 14C
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labelled sucralfate (Steiner and others 1982, Slomiany, Laszewicz and Slomiany 
1986).
Sucralfate is effective in the treatment of, and recurrence of, peptic ulcer disease in 
man (Hollander 1981, McHardy 1981, Marks and others 1981). However, apart from 
it s property of correcting chronic injury, where it binds to the proteinaceous ulcer 
base and fabricates a barrier over the ulcer site (Garnett 1982, Nakazawa, Nagashima 
and Samloff 1981), Okabe and others (1983) have shown that it has the ability to 
protect the mucosa against acute injury. Harrington, Schegel and Code (1981) found 
that it minimised hydrogen ion back-diffusion, and plasma leakage (Nagashima and 
others 1983). Nonetheless, a number of reports indicate that it has no antacid 
properties (McGraw and others 1981, Garnett 1982).
Nagashima and others (1983) and Kuwayama, Miyake and Matsou (1987) compared 
sucralfate and cimetidine as protectors in the face of ethanol challenge. They found 
that 200mgkg_1 sucralfate produced a 90% inhibition of erosion development 
compared to controls. Tamwaski and others (1985b) agreed, and found that H2 
antagonists actually increased the mucosal damage.
Hollander and others (1985) and O’Brien and others (1990) established in rats that 
pre-treatment with sucralfate would prevent deep mucosal necrosis caused by ethanol, 
but not superficial disruption. The consequence of this protection from deeper 
mucosal damage was that restitution occurred rapidly. Those rats used by Hollander 
and others (1985) were examined between 15 minutes and 4 hours after ethanol 
instillation. There was a statistically significant reduced drop in potential difference 
across the mucosa when the ethanol group was compared to the sucralfate group. 
Histologically, disruption and desquamation of the surface epithelium, notable 
oedema, as well as leukocyte infiltration were found in both control and sucralfate 
pretreated rats. They concluded that sucralfate protected the mucosa 
morphologically and functionally. The restraint of the drop in potential difference by 
sucralfate suggested to these authors that sucralfate enhanced the mucosal defence 
mechanisms, perhaps via prostaglandins. However, work by Coleman and others 
(1987) suggests that any prostaglandin stimulation is of short duration. Interestingly, 
Shorrock and Rees (1989) found indomethacin had no effect on the secretory 
response engendered by sucralfate. In the presence of sucralfate the output of 
bicarbonate ions increased, but returned to basal levels once sucralfate had been 
removed. In contrast, luminal PGE2 only rose after sucralfate had been withdrawn. 
Their conclusion being that prostaglandins and bicarbonate played a significant role 
in the sucralfate protection.
Work carried out in man has proved that sucralfate decreases the absorption, but not
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the eventual bioavailability of naproxen and other non-salicylate NSAIDs. This 
indicates that sucralfate can be given to ameliorate the gastrointestinal effects of 
NSAIDs without interfering with their clinical usefulness (Pugh and others 1984, 
Caille and others 1987, Caldwell and others 1987). Indeed giving aspirin to human 
volunteers, Tesler and Lim (1981) found that sucralfate afforded complete protection 
to 8/12 and partial to 3/12 human "guinea-pigs". Further, measurement of serum 
salicylate levels showed that there had been no inhibition of absorption.
Importantly, sucralfate is stable when confronted with exogenous injurious agents 
such as aspirin (Okabe and others 1983). It has already been stated that sucralfate is 
recognised for its ability to bind to bile. The clinical effectiveness of this property 
for treating alkaline reflux oesophagitis was shown by Weiss and others (1983), and 
post-surgical reflux gastritis (Corsini and others 1984).
1.8.3 Adenosine Triphosphate/Calcium Blockers and Others
Prior to the development of H2 blockers, antacids were the main method of 
controlling gastritis and ulcers. Antacids are basic compounds that neutralise acid in 
the stomach. In the presence of food the action of this group of substances is 
extended to about two hours, compared to total clearance in 30 minutes on an empty 
stomach. Apart from the ability to neutralise intraluminal acid, aluminium 
hydroxide, one of the main members of this group, has been shown to chelate bile 
salts (Clain and others 1977), stimulate mucoprotein secretion (James and Marriott 
1982), and decrease pepsin concentration (Sepelyak, Feldkamp and Regneir 1984), 
and by acting as be cytoprotective (Konturek and others 1991a). However, one other 
mode of action, which is cytoprotective, is the recognised ability to stimulate output of 
prostanoids (Berstad and others 1987). Gasbarrini and others (1990) were able to 
show healing of erosive gastritis and ulcers with high doses of a suspension of 
aluminium-magnesium hydroxide and an increase in levels of 6-keto-PGFla, 
presumably causing an increase in mucosal blood flow and thus cytoprotection. Of 
some concern was the drop in levels of PGE2, which these authors put down to lesion 
improvement. Other drugs such as carbenoxolone have been shown to protect the 
gastric mucosa against bile for example, but have significant side-effects (Calcraft and 
others 1973).
Recently introduced is omeprazole, which interferes with the hydrogen ion pump 
(Lind and others 1983). Omeprazole acts as a H +,K+-ATPase inhibitor (Ekman and 
others 1985, M&rdh 1986). Therefore, it quashes the production of acid (Wallmark 
1986), and unlike cimetidine it does not affect mucosal blood flow (Tsukamoto and 
others 1987). At a neutral pH it is inactive, and requires an acid environment to 
transform into molecules that can enzyme-bind (Clissold and Campoli-Richards 1986,
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Sachs and others 1988). Not only is it able to suppress acid production, but has also 
been shown to have a protective action (Mattsson 1986).
1.9 Aim of Present Work
The first part of the study will involve a partially retrospective analysis of the 
endoscopic findings in dogs referred to Glasgow University Veterinary School for 
gastroscopic evaluation, compared with a prospective gastroscopic examination of a 
group of normal dogs, anaesthetised for problems unrelated to the upper 
gastrointestinal tract.
The experimental work using the rats aimed to study a number of features of damage 
to specific parts of the gastric mucosal barrier and to observe the effect of protective 
drugs on the action of these injurious agents. The action of aspirin and bile alone, 
and in combination, on the surface epithelial cell will be investigated and compared 
to the action of carprofen, a new non-steroidal anti-inflammatory drug, alone and in 
combination, also on the surface epithelial cell.
The efficacy of pre-treatment with protective drugs sucralfate and famotidine will be 
compared in the face of challenge from aspirin/bile and carprofen/bile combinations.
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2. A Study of Vomiting Dogs
2.1 Introduction
The type of food presented to the canine stomach is similar to that consumed by the 
human and many of the drugs used to treat abnormalities of the stomach of the dog 
are derived from, or identical to, those used in the treatment of gastric complaints in 
man. Thus it has been assumed that many of the abnormalities affecting this region 
of the alimentary tract in the human can occur in the canine. This assumption has 
been substantiated to some extent with the increase in our knowledge of the variety of 
conditions known to occur in the dog because of the technology now applied in small 
animal clinical practice (Else and Head 1980, Strombeck and Guilford 1991).
The spectrum of conditions currently recognised to affect the stomach of the dog 
include foreign bodies lodged in the stomach, bacterial and viral gastritis, non-specific 
gastritides, hypertrophic gastropathies, peptic ulceration and gastric neoplasia 
(Strombeck and Guilford 1991).
The stomach can be involved in pathological processes that also affect other regions 
of the alimentary tract. On the other hand, the stomach can also be affected by 
conditions that are primarily associated with other areas of the body, but which cause 
a secondary response in the stomach ~ the clinical signs of which may be the first 
indication that something is amiss. An example of this is the gastrin secreting islet 
cell tumour of the pancreas causing hypergastrinaemia (Jones, Nicholls and Badman 
1976, Johnson 1989). In man hypergastrinaemia is commonly associated with 
hypertrophic gastritis (Lewin and others 1984, Clark and others 1986). However, this 
sequence of events has not been reported to occur as frequently in the dog where 
hypertrophic gastritis is common (Walter and others 1985, Sikes and others 1986), but 
hypergastrinaemia is not (Happe and others 1980, Happe, van der Gaag and 
Wolvekamp 1981, Breitschwerdt and others 1986, Zerbe and others 1989). Thus 
there appear to be some differences in the two syndromes between the two species, 
and this might equally apply in other conditions of the canine stomach. Obviously, 
therefore, abnormal conditions of the stomach of the dog warrants further 
investigation especially as, as already stated, much of the treatment presently used in 
veterinary practice is based on that given to humans.
During the past ten years dogs, with stomach complaints were investigated by clinical 
examination, radiology, gastroscopy and gastric biopsy in an attempt to reach a 
diagnosis and also to identify the cause of the condition with special reference to any 
previous treatment given to the animals, not just as treatment for the stomach
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complaint but for any other disease suffered by the patient. Finally, the outcome of 
treatment once a diagnosis was reached was monitored.
22  Material & Methods
2.2.1 Control Animals
The control group consisted of 30 German Shepherd dogs. There were 17 males and 
13 females ranging in age from 2-10 years, with a mean of 5 years. These animals 
had been referred for management of anal furunculosis, and had no history or clinical 
evidence of gastric disease.
22 2  Clinical Cases
Details were collected from 100 dogs referred over a 10 year period to Glasgow 
University Veterinary School with chronic vomiting (Figure 2.1). Initial clinical 
details recorded included breed, age, sex and duration. Subsequently, these animals 
were divided into three groups: "no diagnosis", non-neoplastic and neoplastic.
2.2.3 Radiological Investigation
The dogs were originally not sedated for the contrast studies, but following and to 
comply with the Ionising Radiations Regulations (1985) the dogs were given 
acepromazine at a dose of 0.05mgkg_1 30 minutes before the start of the study. No 
narcotic analgesics were given to accentuate the effect of the sedative for handling 
and positioning. The bariuma was administered as a liquid via a short oesophageal 
tube at a dose of between 5-lOmlkg-1. The animal was positioned in dorsal 
recumbency for most of the examination, but right and left lateral positions were also 
used. The examination was monitored with either image intensification or serial 
films. The features looked for were evidence of:
delayed emptying > 90 minutes
intraluminal filling defects large radiolucent areas in the contrast filled stomach 
mucosal irregularity loss of the normal smooth rugal indentations
retention of contrast presence of small areas of contrast after lumen has
emptied
immotile gastric wall lack of peristaltic waves
intramural outpouching contrast pouching out from the line of the
mucosal/contrast interface
2*2.4 Haematological Investigation
Blood (10ml) was obtained by venipuncture from the jugular vein using 10ml plastic
a: Micropaque Standard -100% barium sulphate, Nicholas, Slough, U.K.
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syringes and 21 gauge hypodermic needles. A 2.5ml sample of this blood was placed 
immediately in a plastic ethyl diamine tetracetic acid blood tube to prevent 
coagulation. Parameters looked at were red blood cell numbers, haemoglobin 
concentration, haematocrit, mean haemoglobin content, white blood cell numbers 
and changes in the proportion of different white blood cells. Where considered 
appropriate, platelet and reticulocyte numbers were evaluated and a blood film 
examined.
2.2.5 Biochemical Investigation
The remainder of the extracted blood (7.5ml) was put immediately into a heparanised 
container and submitted for biochemical estimation. In most cases the parameters 
evaluated were blood urea, creatinine, phosphate, serum alkaline phosphatase, 
alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total protein.
2.2.6 Endoscopy
The endoscopic examination was undertaken with either an Olympus GIF Type P2 
paediatric panendoscope (lm long 9mm diameter) or latterly an Olympus EVIS 200 
videoendoscope GIF XQ200 (lm long 10mm diameter), both equipped with round 
cup forceps*5. After a standard overnight fast with no water restriction the dogs were 
premedicated with acepromazine at a dose of 0.05mgkg_i. They were then 
anaesthetised by induction with 2.5% sodium thiopentone at approximately lOmgkg-1. 
Once induced the animals were intubated with endotracheal tubes of appropriate size 
and maintained on a halothane/nitrous oxide/oxygen mixture using a variety of 
circuits depending upon the animals’ size. The dogs were placed in left lateral 
recumbency before introduction of the endoscope into the stomach. First, the gastric 
contents were evaluated. The presence of hair, foam and bile reflux were noted. 
The presence of foam or bubbles was graded in accordance with system proposed by 
McNally, Maydonovitch and Wong (1988):
+ = no foam or bubbles
+ + = minimal
+ + + = moderate
+ + + + = abundant obscuring mucosal surface
b: Olympus endoscopic forceps FB-1K (GIF type P2) and FB-25K (GIF XQ200), KeyMed, Southport, 
U.K.
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The presence of food was graded as being absent/trace, occasional lumps or near
complete mucosal coating. The presence of a bile pool (yellowish green) was graded
subjectively on the basis of the apparent volume present on a scale of 4, where
0=none and 3=large pool. It was not possible to remove fluid for most of the study
period, but latterly an Olympus suction pumpc was available and the bile could be
withdrawn from the stomach (Figure 2.2). Where bile reflux (bright yellow) from the
duodenum was observed it was described as:
+ = minimal
+ + = moderate
+ + + = severe
The colour of the antral mucosa was recorded. Inability to examine the whole 
mucosal surface was noted if the volume of foam or fluid was excessive.
Second, the stomach surface was divided into fundus, body, antrum and pylorus for 
the purposes of localising change, which was defined as single, focal or generalised. 
Specific change looked for included:
mucosal inflammation reddened mucosa
follicular speckling where the mucosa develops red areas and gives the mucosa
a "measles" like appearance 
mucosal hypertrophy where the rugal folds were subjectively wider and deeper
and tended not to disappear on insufflation 
erosions shallow ulcer-like lesions < 0.5cm in diameter
ulcers >lcm in diameter. The size of the ulcers were measured by
passing a graduated flexible polythene tube through the 
biopsy channel of the endoscope
C* Olympus Key Vac II Endoscopic suction pump, KeyMed, Southport, U.K.
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Figure 2.1. The "Foamy Boke”. Vomited saliva and gastric juice.
Figure 22. Sample of aspirated bile from a dog with duodenogastric reflux.
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121  Pathology
The samples were obtained by
1] endoscopic biopsy forceps - the forceps were passed through the biopsy port, down
the biopsy channel and pushed firmly against the area of interest by driving 
both the open forceps and endoscope forwards. The angle of approach was 
preferably between 45-90° to the mucosal surface. The jaws were closed, 
the endoscope withdrawn a little and the forceps retracted into the biopsy 
channel.
2] laparotomy - when the stomach was exposed for a surgical procedure full-thickness
samples could be obtained.
3] post-mortem examination - where a specific lesion had been identified the sample
was from that area, where the change was generalised a representative 
sample was taken, usually, from the body of the stomach on the dorsal face.
Samples were placed in fixative (4% buffered normal formalin (BNF)) immediately 
after harvesting and immersion fixed in 4% BNF for a minimum of 48 hours. The 
sections were cut at 3-5/xm and stained with haematoxylin and eosin (H&E). Further 
details applicable to this and other chapters are supplied in Appendix 9.
2.2.8 Treatment and Outcome
The animals from the "no diagnosis" group were not treated, other than to advise 
avoidance of scavenging. In the non-neoplastic group the animals were treated 
according to the diagnosis reached thus therapeutic regimes including antibiotic 
therapy, FL^  blocker therapy, antiemetics, corticosteroids, surgery and altered diet 
were used. Those animals with neoplasia were nearly all destroyed shortly after 
diagnosis was reached.
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23 Results
23.1 Details of Animals in Each Group
"No diagnosis" = 18 Non-neoplastic =60 Neoplastic =22
chronic gastritis 9 carcinoma 17
hypertrophic gastropathy 9 lymphosarcoma 3
peptic ulcer 9 leiomyosarcoma 1
gastroenteropathy 9 APUDoma 1
erosive gastritis 6
duodenogastric reflux 5
follicular gastritis 3
atrophic gastritis 2
foreign body 2
pyloric stenosis 2
gastric dilation 2
parasitic ulceration 1
piroxicam toxicity 1
Table 2.1. Dogs grouped by diagnosis in a series of 100 vomiting dogs.
232  Age and Duration of Clinical Signs
The minimum and maximum age of the animals presented differed little between the 
first two groups of animals. However, in the neoplastic group the mean age was 
about twice that of the other two groups (Table 2.2, Figure 2.3). The youngest dog 
recorded with a tumour was a 2 year-old West Highland White terrier with a 
neuroendocrine tumour or APUDoma.
The average length of time that the vomiting had been present was very similar for 
the "no diagnosis" and non-neoplastic groups. However, there was considerable 
variation between the conditions comprising the non-neoplastic group from the dogs 
with peptic ulcer (3.83 weeks) to the dogs with gastroenteropathy (40.78 weeks) 
(Table 2.3). The maximum time and the average time that vomiting had been 
present prior to referral was much shorter for those dogs that had neoplasia (Table 
2.2, Figure 2.3).
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age (years) 
min max mean
duration (weeks) 
min max mean
hospital population 
"no diagnosis" 
non-neoplastic 
neoplastic
0.04 18.00 6.10 
0.50 11.50 4.00 
0.38 13.00 5.09 
2.00 15.00 8.98
2.00 182.00 19.17 
0.40 156.00 20.40 
1.43 52.00 11.47
Table 22. Age and duration (mean and range) of clinical signs in 100 vomiting dogs 
by group, with age range from hospital population.
Age Spread
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’no non­
diagnosis” neoplastic
Groups
neoplastic
Figure 2.3. Bar charts of age of animals and duration of signs in 100 vomiting 
animals.
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Condition no M
Number
C F s Age
years
Mean
Duration
weeks
None Diagnosed 18 7 2 7 2 4.00 19.17
Chronic gastritis 9 4 0 2 3 4.45 17.17
Hypertrophic gastritis 9 3 1 2 2 5.21 21.77
Peptic ulcer 9 6 0 1 1 6.40 3.85
Gastroenteropathy 9 5 0 2 1 4.96 40.78
Erosive gastritis 6 2 0 4 0 5.67 33.83
Duodenogastric reflux 5 3 1 1 0 6.07 15.00
Follicular gastritis 3 2 0 1 0 4.19 3.33
Atrophic gastritis 2 1 0 1 0 2.00 20.00
Foreign body 2 1 0 1 0 3.50 21.00
Pyloric stenosis 2 2 0 0 0 0.46 12.00
Gastric dilation 2 2 0 0 0 5.00 8.50
Parasitic ulceration 1 0 0 1 0 4.00 104.00
Piroxicam toxicity 1 1 0 0 0 10.00 0.60
Gastric carcinoma 17 12 0 3 2 9.68 12.44
Lymphosarcoma 2 0 0 1 7.33 7.67
Leiomyosarcoma 1 0 0 1 0 15.00 52.00
APUDoma 1 0 0 0 1 2.00 52.00
(M = male, C =castrate, F =female, S = speyed, no=number)
Table 23. Age, sex and duration of 100 vomiting dogs by condition.
233  Breed
Only three giant breeds were found in this review which matches the typical hospital 
population over a similar period (Table 2.4). In the "no diagnosis" group 6/18 were 
terrier type dogs and 5/18 were Labradors. The number of Labradors found 
matched the percentage found in the hospital population. A wide variety of breeds 
were found in the non-neoplastic group with no breed preponderance. In the 
neoplastic group 5/22 were Rough collies and 4/22 were Labradors. The number of 
Rough collie dogs was more than would be found in the general hospital population.
23.4 Sex
The distribution of males to females in the general hospital population was 0.96:1. 
The ratios for male to female for the three groups were "no diagnosis" 1:1, non­
neoplastic 1.3:1 and neoplastic 1.75:1. Within the non-neoplastic group only those 
animals with peptic ulcer had a ratio (3:1) that differed markedly from the whole 
group (Table 2.3). For those dogs with gastric carcinoma the ratio was 2.4:1. The
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reproductive status of the males and the females across the groups was broadly 
similar with few of the male dogs being castrate and a third of the females being 
neutered.
Breeds
.
No
diagnosis
.. .  . . . . . .  .. .
Non-
Neoplastic neoplastic
10 year hospital 
population (%)
Cross 0 9 2 7.96
Labrador 5 4 4 10.26
Retriever 0 3 1 4.10
Boxer 2 3 0 2.99
Border collie 0 0 1 4.07
Rough collie 2 2 5 2.47
Shetland collie 0 2 0 2.34
Yorkshire terrier 2 0 0 2.58
Border terrier 1 0 1 0.35
Cairn terrier 1 2 0 1.78
Jack Russell terrier 0 4 0 1.95
Scottish terrier 1 0 0 0.80
Staffordshire Bull terrier 0 0 1 0.70
West Highland White terrier 1 4 2 3.14
Irish setter 1 2 1 1.58
German Shepherd dog 1 4 3 10.43
Cocker spaniel 1 1 0 3.21
Springer spaniel 0 4 0 2.52
Tibetan spaniel 0 2 0 0.07
German Shorthaired pointer 0 2 0 0.37
Bull Mastiff 0 1 0 0.78
Beagle 0 1 0 1.14
Bernese Mountain dog 0 1 0 0.12
Corgi 0 1 0 0.85
Doberman pinscher 0 1 0 1.91
Dalmation 0 1 0 0.42
Great Dane 0 1 0 1.03
Deerhound 0 0 1 0.19
Miniature Schnauzer 0 1 0 0.09
Poodle 0 1 0 2.70
Rottweiler 0 1 0 0.70
Weimar aner 0 1 0 0.21
Whippet 0 1 0 0.41
Total 18 60 22
Table 2.4. Breeds encountered in each group of vomiting dogs and numbers of these 
breeds found in hospital population over 10 years.
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2.3.5 Haematology
The range of haematological findings are displayed in Table 2.5. Only 17/100 cases 
had abnormal findings recorded. In the "no diagnosis" group 4/18 had abnormal 
findings. One Labrador had a hypochromic microcytic anaemia due to iron 
deficiency. Of the other three dogs, one had an elevated white blood cell count 
mainly due to neutrophils, the other two had mild eosinophilia (7% and 9%)
Two animals from the neoplastic group had abnormal haematological findings. One 
animal with lymphosarcoma had target cells and reactive lymphocytes, and the dog 
with an APUDoma had a normochromic normocytic anaemia.
The other 11 cases were from the non-neoplastic group and no particular diagnosis 
showed consistently abnormal results. Only 3/6 dogs with eosinophilic 
gastroenteropathy had elevated circulating eosinophils. Of the cases of hypertrophic 
gastropathy, one had target cells, Howell-Jolly bodies, anisocytosis and polychromasia 
and the second some evidence of anaemia. Three of the nine cases with peptic ulcer 
had anaemia, as did the dog with piroxicam toxicity. One dog with chronic gastritis 
had a relatively normal picture with only polychromasia noted. Only one animal with 
duodenogastric reflux had abnormal features indicating some blood loss. The sole 
case of duodenal ulcer had evidence of blood loss, but also an elevated white blood 
cell count of 21.2 xl09L'1.
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Condition RBC Hct Hb MCV WBC N L E
units
Normal
105mm ^  
6-8
%
35-40
glOOmH fl 
11-14 65-75 6-12
KPL-l 
3-11.8 1-4.8 0.01-1.25
"no diagnosis" (18) 
mean 7.96 44.12 15.19 69.17 12.01 9.45 1.74 030
min 531 28.20 8.70 54.00 7.20 4.82 0.22 0.07
max 17.30 53.20 18.90 76.00 22.20 20.65 4.66 2.00
Chronic 
gastritis (9) 
mean 9.45 4833 1738 6825 730 77.75 18.13 2.17
min 6.49 44.70 16.00 66.00 530 46.00 5.00 0
max 18.40 53.60 19.50 71.00 10.00 95.00 48.0 5.50
DGR (5) 
mean 4.71 3037 1125 61.67 1325 10.40 2.17 024
min 3.32 14.00 3.70 43.00 5.50 3.96 0.82 0.03
max 5.48 40.90 14.00 74.00 21.20 19.93 5.09 0.64
GEP (9) 
mean 634 44.71 15.97 7131 9.91 726 134 038
min 4.02 29.00 10.50 67.60 7.70 4.70 0.54 0.08
max 7.56 52.40 18.30 72.00 13.30 11.30 3.19 1.46
HG (9) 
mean 532 38.03 13.90 69.67 833 6.05 1.64 0.19
min 4.64 33.30 12.40 68.00 4.60 2.76 0.51 0.02
max 6.03 41.30 15.20 72.00 14.20 11.36 4.12 0.57
Peptic ulcer (9) 
mean 3.64 25.40 10.10 74.67 3.10 2.14 035 0.03
min 1.77 16.80 4.90 54.00 1.50 0.69 0.08 0
max 5.68 40.50 15.60 96.00 32.80 28.37 13.78 0.66
Erosive 
gastritis (6) 
mean 5.95 43.70 15.43 73.67 8.78 6.76 1.14 0.62
min 5.60 40.60 13.80 72.00 5.50 3.9 0.66 0.11
max 6.18 45.80 18.90 75.00 13.30 11.04 1.86 1.6
Neoplasia (22) 
mean 6.47 4438 16.65 6933 11.72 9.90 1.15 026
min 5.24 32.50 11.10 63.00 6.30 4.72 0.44 0
max 7.82 54.90 19.80 73.00 17.90 15.93 2.06 1.61
min=minimum, max=maximum, RBC=red blood cells, Hct= haematocrit, Hb= haemoglobin,
MCV=mean corpuscular volume, WBC=white blood cells count, N =neutrophils, L=lymphocytes, 
E=eosinophils, DGR = duodenogastric reflux, GEP=gastroenteropathy, HG=hypertrophic gastritis.
Table 2.5. Haematological values of vomiting dogs based on condition (only those 
diseases with >4 cases are included and the neoplastic group are treated as one).
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23.6 Biochemistry
A summary of the biochemical values examined are shown in Table 2.6, these are 
grouped according to diagnosis.
Condition SAP AST ALT TP
units UL-1 UL-1 UL-l gL-1
Normal 0-105 0-40 0-40 50-78
None diagnosed mean 125.70 29.40 7630 6530
minimum 54.00 21.00 31.00 54.00
maximum 257.00 48.00 250.00 85.00
Chronic Gastritis mean 18620 5620 58.40 57.40
minimum 51.00 27.00 29.00 41.00
maximum 554.00 129.00 121.00 73.00
Duodenogastric reflux mean 99.75 2630 3230 5930
minimum 37.00 20.00 22.00 55.00
maximum 264.00 29.00 42.00 68.00
Gastroenteropathy mean 164.00 3830 5030 61.40
minimum 74.00 24.00 26.00 55.00
maximum 343.00 68.00 79.00 69.00
Hypertrophic gastritis mean 425.00 3930 6430 7030
minimum 128.00 29.00 55.00 70.00
maximum 722.00 50.00 74.00 71.00
Peptic ulcer mean 26830 24.70 27.00 5730
minimum 67.00 18.00 18.00 50.00
maximum 620.00 34.00 34.00 64.00
Erosive gastritis mean 87.40 2330 43.00 5620
minimum 46.00 17.00 24.00 40.00
maximum 156.00 34.00 79.00 60.00
Neoplasia mean 9030 3425 64.00 65.15
minimum 32.00 18.00 20.00 49.00
maximum 217.00 73.00 210.00 80.00
SAP=serum alkaline phosphatase, ALT=alanine aminotransferase, AST=aspartate aminotransferase, 
TP=total protein.
Table 2.6. Serum biochemical values of vomiting dogs based on condition (only those 
diseases with >4 cases are included and the neoplastic group are treated as one).
Twenty six animals had abnormal biochemical findings. These deviations from 
normal were largely restricted to elevation in liver enzymes particularly ALT, with a 
few cases demonstrating hypoproteinaemia. Six of the 18 "no diagnosis" cases had 
elevated liver enzymes. Alanine aminotranferase was higher than normal in all six, 
two of these also had mildly raised serum alkaline phosphatase, and one had raised 
AST. Three dogs with neoplasia had abnormal biochemical findings. Two had
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elevation of all three enzymes but no evidence of hypoproteinaemia, in addition one 
dog with lymphosarcoma was hypoproteinaemic.
The remaining 17 dogs fell into the non-neoplastic category and there was no 
apparent pattern as regards disease, though 5/9 with chronic gastritis had abnormal 
liver enzymes. ALT was the most commonly elevated enzyme in 10 dogs, alkaline 
phosphatase was higher than normal in seven dogs with three >500uL_1, and AST in 
five.
In none of the 100 cases was there electrolyte imbalance, or elevated urea, creatinine 
and phosphate levels.
2.3.7 Radiology
The radiological features are summarised in Table 2.7.
delayed poor intraluminal mucosal contrast
Condition no emptying peristalsis filling defect irregularity retention ulcer
None Diagnosed 18 0 0 0 0 0 0
Chronic gastritis 9 0 0 0 0 0 0
Hypertrophic gastritis 9 9 7 5 0 4 0
Peptic ulcer 9 1 0 0 3 3 6
Gastroenteropathy 9 0 0 0 0 0 0
Erosive gastritis 6 0 0 0 0 0 0
Duodenogastric reflux 5 0 0 0 0 0 0
Follicular gastritis 3 0 0 0 0 0 0
Atrophic gastritis 2 1 0 2 2 2 0
Foreign body 2 0 0 0 0 0 0
Pyloric stenosis 2 2 0 0 1 0 0
Gastric dilation 2 2 2 0 0 0 0
Parasitic ulceration 1 0 0 0 1 1 1
Piroxicam toxicity 1 ND ND ND ND ND ND
Gastric carcinoma 17 1 0 10 10 3 13
Lymphosarcoma 3 0 0 1 2 1 1
Leiomyosarcoma 1 1 0 1 0 1 1
APUDoma 1 0 0 1 0 0 1
ND = not done, no = number
Table 2.7. Some radiological features found in 100 vomiting dogs.
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No abnormalities were detected on radiological investigation of the "no diagnosis" 
category and in most animals from the non-neoplastic group. The exceptions were 
the hypertrophic gastropathies, atrophic gastritis and one case of duodenogastric 
reflux. In those cases of hypertrophic gastropathy there was exaggeration of the rugal 
folds which were wider than the inter-rugal areas and in a few cases there was also 
pyloric outflow obstruction evident (Figures 2.4-2.8). Similar changes were obtained 
from the studies of the two cases of atrophic gastritis, one of which had a large 
intraluminal filling defect (Figure 2.9). In the case of duodenogastric reflux there 
was marked reflux of the liquid barium through the pylorus during the examination, a 
feature not noted in the other cases. Only six of those animals with peptic ulcer had 
the ulcers detected radiographically and the other three had a non-specific mucosal 
irregularity and mucosal retention of contrast. The peptic ulcers were seen as small 
ulcers at the edge of the contrast rather than en face. The ulcers were evident as 
small mushroom-like outpouchings of contrast in the mucosal wall. In only one dog 
was the classical Hampton line seen, though in all cases there was a lack of a tall 
shoulder that indicates marked stomach wall thickening (Figure 2.10). In 50% of the 
tumour cases the radiographic studies were diagnostic. These were all gastric 
carcinomas where narrowing of the pyloric canal, poor motility of the antral wall, 
mucosal irregularity and ulceration were all noted (Figure 2.11). In some there were 
equivocal findings, which were inadequate to justify making a diagnosis. In the 
lymphosarcoma cases no abnormalities were detected.
54
Ch a pt e r  2
Figure 2.4. Hypertrophic gastritis. Lateral abdominal radiograph. The rugal 
hypertrophy has produced large intraluminal indentations in the contrast.
Figure 2.5. Hypertrophic gastritis. Lateral abdominal radiograph. Semi-annular 
thickened rugal fold at the pyloric sphincter.
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Figure 2.6. Hypertrophic gastritis. Ventro-dorsal abdominal radiograph. There is 
gross distension of the stomach, which is extending caudally to fill the abdominal 
cavity. The stomach contains a large volume of ingesta and retained mineralised 
material - the gravel sign.
Figure 2.7. Hypertrophic gastritis. Lateral abdominal radiograph. There is caudal 
displacement of the pylorus, and also the gravel sign indicating chronic partial 
obstruction.
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Figure 2.8. Pyloric stenosis. Lateral abdominal radiograph. Following the 
administration of barium, the stomach is seen to be grossly distended with barium and 
retained ingesta.
Figure 2.9. Atrophic gastritis. Dorso-ventral abdominal radiograph. A large filling 
defect in the contrast filled stomach is present. This is most obvious in the fundus 
with an undulating margin extending to the greater curvature of the body of the 
stomach.
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Figure 2.10a & 2.10b. NSAID induced peptic ulcer. Dorso-ventral abdominal 
radiograph. The barium contrast illustrates a small outpouching of contrast in the 
mucosal wall with a low shoulder of surrounding mucosa. The ulcer has a 
radiolucent ring midway down the ulcer - the Hampton line.
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Figure 2.11. Gastric carcinoma. Dorso-ventral abdominal radiograph. The lumen of 
the pylorus and antrum is narrowed with an extremely narrow lumen with an intense 
corrugated pattern to the contrast/mucosa interface caused by ulcerated mucosa.
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23.8 Endoscopy
The contents found in the stomachs and their effect on endoscopy are summarised in 
table 2.8 for both control German shepherd dogs and those vomiting dogs.
Group
number
Controls
30
"no diagnosis" 
18
Non-neoplastic
60
Neoplastic
22
food -none/trace 19 16 52 22
-lumps 7 0 4 0
-coating mucosa 4 2 4 0
hair 7 4 15 2
white foam 11 1 7 3
bile pool score 0 19 18 35 20
1 6 0 4 2
2 5 0 10 0
3 0 0 11 0
total 11 0 25 2
bile reflux score 0 22 22 42 20
1 8 0 0 1
2 0 0 8 1
3 0 0 10 0
total 8 0 18 2
antrum red 7 0 11 2
mucosa obscured 7 0 11 2
-foam 4 0 3 0
-fluid pool 3 0 .8 2
-blood 0 0 2 0
Table 2.8. Gastric luminal contents found at endoscopy in the control dogs and 100 
vomiting dogs.
Despite starvation, the stomachs of four control dogs (13.33%) and six (6%) vomiting 
dogs retained sufficient food to line the whole mucosal surface (Figure 2.12). 
Insufflation of air did allow windows of mucosa to be created to permit areas of the 
gastric mucosa to be viewed. In seven of the control dogs (23.33%) occasional lumps 
of food were found in the body and antrum, in comparison to only four of the 
vomiting dogs. The presence of hair (23.33% and 22%) in small volumes of adherent 
fluid did not impair appraisal.
The presence of white froth or foam in 11 animals in both groups (36.66% and 11%) 
obscured the mucosal surface. This hindrance to the evaluation of the mucosa could, 
to a certain extent, be overcome by insufflating the stomach. However, in four
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control animals it rendered appraisal impossible, and insufflation had the drawback of 
largely ablating the rugal folds, thus they could not be adequately assessed (Figures 
2.13 and 2.14).
Bile was recognized in the stomachs of 11 (36.66%) of the controls dogs and appeared 
as a greenish yellow pool of fluid. In the vomiting groups no pooling was seen in 
those animals where "no diagnosis" was reached but pooling was present in 41.67% of 
those belonging to the non-neoplastic group. In five control dogs the volume was 
sufficiently large to form a puddle in the dependent portion of the stomach (score 2) 
(Figure 2.15). The volume of the bile pool in 11/25 of the non-neoplastic group was 
greater that in the controls (score 3). By turning the dogs from left to right lateral 
recumbency, the area submerged in bile could be examined satisfactorily. In only 
one dog, a control, was both white foam and bilious fluid noted.
No animals from the "no diagnosis" group were noted to have bile reflux during the 
endoscopic examination. Actual reflux of bile from the duodenum was visible when 
the antrum and pylorus were examined in eight dogs (26.67%) from the control group 
compared to 18/60 (30%) from the non-neoplastic group. The reflux was seen as 
bubbling yellow fluid emerging from the pyloric canal. In six control dogs and 11/18 
non-neoplastic dogs, the reflux gave the antral mucosa a red hue, either due to 
inflammation or to coating of the mucosa and altering the reflected cold-light. 
Existing luminal bilious fluid together with definite duodenal reflux of bile was 
observed in three control dogs and 16 of the non-neoplastic dogs.
The mucosal surface was obscured by luminal contents in 7/30 control dogs and 
13/100 vomiting dogs. In the controls dogs this was due to the presence of foam (4) 
or the fluid pool (3), whereas in the non-neoplastic group it was more likely to be due 
to fluid (8) as opposed to foam (3). In two dogs it was due to the overwhelming 
presence of blood.
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Figure 2.12. Endoscopic view of a filled-food antrum obviating adequate 
examination.
Figure 2.13. Froth in the stomach of a control dog.
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Figure 2.14. Froth partially coating the rugal folds of a dog with gastritis.
 iliiufj
Figure 2.15. Retroflexed view of the cardia with a large yellow bile pool filling the 
stomach.
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Endoscopic Findings
inflamed follicular mucosal erosion size distribution
Condition no mucosa speckling hypertrophy < 0.5cm ulcer (cm) S F G
None Diagnosed 18 0 0 0 0 0 - - - -
Chronic gastritis 9 9 0 0 0 0 * - - 9
Hypertrophic gastritis 9 5 0 9 1 0 - - 9 -
Peptic ulcer 9 0 0 0 0 9 2 8 1 -
Gastroenteropathy 9 4 1 0 0 0 - - - 4
Erosive gastritis 6 6 3 0 6 0 - - - 6
Duodenogastric reflux 5 5 0 0 0 0 - - 5 -
Follicular gastritis 3 1 3 0 0 0 - - - 3
Atrophic gastritis 2 2 0 2 0 0 - - 2 -
Foreign body 2 2 0 0 0 0 - 2 - -
Pyloric stenosis 2 0 0 0 0 0 - - - -
Gastric dilation 2 0 0 0 0 0 - - - -
Parasitic ulceration 1 0 0 0 0 1 1.5 - 1 -
Piroxicam toxicity 1 0 0 0 0 0 - - - 1
Gastric carcinoma 17 13 0 0 0 14 >2 13 - 4
Lymphosarcoma 3 3 0 0 0 3 1-5 1 - 2
Leiomyosarcoma 1 0 0 0 0 1 >2 1 - -
APUDoma 1 0 0 0 0 1 >2 1 - -
S = single lesion, F =focal lesions, G =generalised, no=number
Table 2.9. Mucosal features as determined by endoscopy in 100 vomiting dogs.
In those cases where no diagnosis was reached the endoscopic examination was 
normal (Table 2.9, Figures 2.16-2.21). In the neoplastic group there were two sets of 
findings. In those dogs with lymphosarcoma there were multiple small shallow ulcers 
(l-2cm) dotted throughout the mucosal surface, with only one dog having a large 5cm 
fundic ulcer (Figures 2.22-2.24). In those animals with gastric carcinoma, there was 
either an ulcer on the lesser curvature (14) or a blanched and irregular mucosal 
appearance due to submucosal spread (3). The ulcer was usually centred on the 
incisure angularis, but was present at the cardia in one and at the pylorus in another. 
These ulcers were large (4-5cm), deep, excavating with irregular edges, and bases 
filled with necrotic debris and blood. The inner walls of the ulcer were ragged with 
the rim occasionally overhanging the inner wall. Fixed and thickened rugae ran up to 
the outer walls of the ulcers, which were raised well above the surrounding mucosa 
(Figures 2.25 and 2.26). In three cases there was evidence of retrograde oesophageal 
spread. Here the oesophagogastric sphincter was open with the Z-line visible 
accompanied by a loss of the normal plicae of the oesophagus.
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In the non-neoplastic group the animals with peptic ulcers were those that most 
required differentiation from gastric neoplasia. The peptic ulcers were always single 
and found in the antral area, with the incisure angularis being the predilection site. 
The ulcers, in contrast to tumour ulcers, were smaller (never more than l-2cm in 
diameter) and shallower. Six of the nine cases had stigmata of haemorrhage with 
staining of the ulcer base (Figure 2.27). Three had an adherent clot, but none were 
actively bleeding at the time of examination. The bases had a cleaner appearance 
and the inner walls were more upright. The rim of the ulcer rarely projected much 
above the surrounding mucosal surface (Figure 2.28). Although rugae ran into the 
walls of the ulcers these were small and did not appear particularly fixed.
The dog with parasitic infestation had three ulcers 1.5cm in diameter running in a 
semicircle from the dorsal part of the incisure angularis across dorsal surface. These 
ulcers closely resembled peptic ulcers in size, location and appearance.
The dogs with pyloric stenosis had folds that failed to disappear on insufflation due to 
underlying muscle hypertrophy (Figure 2.29).
Those animals with hypertrophic gastropathy had either large folds of mucosa present 
in the pyloric canal (Figure 2.30), or large areas of irregular "morocco leather"-like 
mucosa that did not disappear once the stomach had been fully inflated with air 
(Figures 2.31-2.32).
The animals with chronic gastritis had an inflamed mucosa surface with a glistening 
appearance of oedema in some cases. In some classified as follicular gastritis the 
changes gave the impression of "measles" (Figure 2.33). Those animals with 
duodenogastric reflux had the above findings but also excessive luminal bile and bile 
reflux (Figure 2.34). In those animals with erosive gastritis similar changes were 
present, but in addition there were innumerable small erosions less than 5mm in 
diameter pitting the surface. Few of these bled and where there were large numbers 
they gave a "paintbrush effect" (Figures 2.35-2.37).
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Figure 2.16. Normal oesophago-gastric junction seen from the oesophagus.
Figure 2.17. Normal view of the greater curvature of the body on entry to the 
stomach.
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Figure 2.18. The pylorus of a partially insufflated stomach.
Figure 2.19. Open gastroduodenal junction following duodenoscopy. The blood 
streaked mucus is iatrogenic.
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Figure 23,0. The bulk of the rugal folds are ablated following insufflation.
v :M H R R
Figure 231. The normal submucosal vascular pattern is demonstrated when the 
stomach is fully insufflated.
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Figure 2.22. Endoscopic view- Lymphosarcoma. A small shallow ulcer is present on 
the mucosal surface without extensive depression or elevation from the surrounding 
mucosa.
Figure 2.23. Endoscopic view- Lymphosarcoma. One of a large number of active 
bleeding ulcers on the mucosal surface.
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Figure 2.24. Endoscopic view- Lymphosarcoma. Small lymphoid nodule in the 
antrum of the stomach of a dog with generalised alimentary lymphosarcoma.
Figure 2.25. Endoscopic view- Gastric carcinoma. Large flat based ulcerated lesion 
at the junction between the body and the antrum. The walls have a chewed out 
appearance and a large thickened rugal fold is visible.
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Figure 2*26. Endoscopic view- Gastric carcinoma. Large deep ulcer with overhanging 
irregular thick rim and blood-stained base.
Figure 221. Endoscopic view- Peptic ulcer. A small ulcer on the incisure angularis. 
The base is largely white with an active bleeding point at one end.
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Figure 2.28. Endoscopic view- Peptic ulcer. A small ulcer on the visceral surface. 
The ulcer is not elevated above the surrounding mucosa.
II
Figure 229. Endoscopic view- Pyloric stenosis. The rugal folds are normal but are 
unable to disappear on insufflation because of underlying mucosal hypertrophy.
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Figure 230. Endoscopic view- Hypertrophic gastritis. A series of thickened rugal 
folds are present around the sphincter.
Figure 231. Endoscopic view- Hypertrophic gastritis. Large folding of hypertrophied 
mucosa appearing as an intraluminal mass.
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Figure 2.30. Endoscopic view- Hypertrophic gastritis. A series of thickened rugal 
folds are present around the sphincter.
Figure 2.31. Endoscopic view- Hypertrophic gastritis. Large folding of hypertrophied 
mucosa appearing as an intraluminal mass.
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Figure 2.32. Endoscopic view- Atrophic gastritis. There is a surfeit of folded mucosa 
appearing as an intraluminal mass.
Figure 2.33. Endoscopic view- Follicular gastritis. The measles like pattern is dotted 
throughout the stomach.
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Figure 234. Endoscopic view- Duodenogastric reflux. A volume of bile is present 
amongst some swollen rugae.
Figure 235. Endoscopic view- Erosive gastritis. One active erosion is visible and a 
number of healing stellate scars are visible (arrows).
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Figure 236. Endoscopic view- Erosive gastritis. An area of erosion on the pillar that 
represents the incisure angularis in an insufflated stomach.
Figure 237. Endoscopic view- Erosive gastritis. Multiple areas of erosion in the 
antrum giving a paintbrush effect.
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A comparison of the radiological and endoscopic features of selected diseases is 
shown in Table 2.10. Inflamed mucosa was not detected by radiology and mucosal 
hypertrophy was more sensitively picked up by endoscopy. Similarly, endoscopy was 
more sensitive in the detection of peptic ulcers. However, in animals with gastric 
carcinoma radiology was almost as accurate in the recognition of neoplastic 
ulceration.
Condition
Number
Chronic
gastritis
9
Hypertrophic
gastritis
9
Peptic
ulcer
9
Gastric
carcinoma
17
Radiology
intraluminal filling defect 0 5 0 10
mucosal irregularity 0 0 3 10
contrast retention 0 4 3 3
ulcer 0 0 6 13
Endoscopy
inflamed mucosa 9 0 0 13
mucosal hypertrophy 0 9 0 0
erosion 0 1 0 0
ulcer 0 0 9 14
Table 2.10. Comparison of selected diseases - radiology versus endoscopy.
23.9 Pathology
Biopsies from the "no diagnosis" group were all normal or inconclusive (Figures 2.42 
and 2.43). Biopsies from those cases where a diagnosis was reached were sometimes 
unhelpful (Figure 2.47). The animals with chronic gastritis had thickening of the 
lamina propria with increased numbers of lymphoid and plasma cells scattered 
diffusely or forming small aggregates. The gastric pits showed some degree of 
dilation and distortion (Figures 2.44 and 2.48). Those cases of eosinophilic 
gastroenteropathy had oedema and thickening of the lamina propria with marked 
infiltration of eosinophils into the lamina propria. Hypertrophic gastropathy was 
characterised by follicular hyperplasia with an increase in the amount of connective 
tissue present in the lamina propria (Figure 2.46). There were also scattered 
mononuclear cells with a plasma cell component present between the mucous glands 
(Figure 2.38). In those animals with peptic ulcer that had biopsies taken the 
ulcerated areas showed complete loss of the mucosa and adjacent congestion of the 
submucosa (Figures 2.39 and 2.45). The defects contained necrotic debris and were 
bounded by active granulation tissue.
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Cases of lymphosarcoma had areas of ulceration with raised and thickened areas of 
white tissue centred ulcers. The sheets of tumour cells formed solid nodules in the 
submucosa with infiltration of the surrounding mucosa. Gastric carcinomas had large 
single ulcers (Figure 2.41). There was extensive invasion by cords and sheets of large 
epithelial cells containing varying amounts of mucin. In most cases there was 
extensive permeation of the lymphatics. The sole case of APUDoma also had a large 
ulcerated lesion, which contained sheets and clumps of spindly cells with oval nuclei 
and indistinct eosinophilic granular cytoplasm (Figure 2.40). The nuclei had 
moderate mitotic rates with abnormal mitotic activity. The cells were separated by 
fine connective tissue septae. In areas the cells appeared to be lined up in a 
"dendocrine pattern" with small islands of similar cells in the lamina propria.
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Figure 2.38. Surgical specimen of hypertrophic gastritis. Strips of gastric mucosa were 
removed from the body and antrum to alleviate pyloric outflow obstruction.
Figure 239. Surgical specimen of a peptic ulcer. The peptic ulcer has fresh blood 
filling the crater and on the surrounding gastric mucosa indicating active bleeding.
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Figure 2.40. Surgical specimen of an APUDoma. The large ulcerated mass was 
found to be somewhat pedunculated at surgery.
Figure 2.41. Post-mortem specimen of a gastric carcinoma. This is a large ulcerated 
mass with thick irregular rim. Several rugae can be seen running into the outer face 
of the tumour wall.
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Figure 2.42a & 2.42b. Photomicrographs of an endobiopsy. The tissue is distorted 
with no base included in the biopsy. Inconclusive. (PAS/Alcian Blue x60, x300)
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Figure 2.43a & 2.43b. Photomicrographs of an endobiopsy. The tissue is distorted 
and is not full thickness. There is some congestion. Inconclusive. (H&E x60, x300)
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Figure 2.44a & 2.44b. Photomicrographs of an endobiopsy. There is crush artefact 
which has caused distortion of the mucosal architecture. Follicular gastritis. (H&E 
x40, Southgate x60)
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Figure 2.45a & 2.45b. Photomicrographs of a peptic ulcer The lateral wall of the 
ulcer is delineated. The granulation tissue at the base is highlighted by the Masson 
stain. (H&E x30, Masson’s x30)
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Figure 2.46a & 2.46b. Photomicrographs of hypertrophic gastritis. There is cystic 
dilation of the glands and intestinal metaplasia. (H&E xlO, x40)
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Figure 2.47. Photomicrograph of a gastric biopsy. Part of the epithelium has been 
sliced off during the biopsy procedure. No diagnosis. (H&E x30)
Figure 2.48. Photomicrograph of a gastric biopsy. There is subepithelial oedema and 
some lymphoid cellular infiltrate. Chronic gastritis. (H&E x75)
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23.10 Treatment and Outcome
A summary of the treatments used and the outcome is presented in Table 2.11.
Diagnosis no Treatment Outcome
None Diagnosed 18 none C17:S1
Chronic gastritis 9 antibiotics (5), H2 blocker (4) C9
Hypertrophic gastritis 9 FR(3), HM(3), Y-U(3) S7:C2
Peptic ulcer 9 H2 blocker (7), GJ (2) C9
Gastroenteropathy 9 corticosteroids C9
Erosive gastritis 6 H2 blocker N1:S5
Duodenogastric reflux 5 metodopramide/fatty meal S2:C3
Follicular gastritis 3 H2 blocker C3
Atrophic gastritis 2 none N1:E1
Foreign body 2 gastrotomy and retrieval C2
Pyloric stenosis 2 FR pyloromyotomy S2
Gastric dilation 2 metoclopramide and gastropexy S2
Parasitic ulceration 1 fenbendazole Cl
Piroxicam toxicity 1 NSAID withdrawal and H2 blocker Cl
Gastric carcinoma 17 none E
Lymphosarcoma none E
Leiomyosarcoma 1 none E
APUDoma 1 resection E
C=complete resolution, E=euthanasia, N=no improvement, S = satisfactory. FR = Fredet-Ramstedt 
pyloromyotomy, HM = Heineke-Mikulicz pyloroplasty, Y-U=Y-U pyloroplasty, GJ=gastrojejunostomy.
Table 2.11. Treatment and outcome of 100 vomiting dogs.
Those animals in the neoplastic group were ultimately euthanased following 
endoscopic diagnosis, exploratory laparotomy, or once the histopathological 
confirmation had been made. The dog with the APUDoma stopped vomiting for 2 
months after resection, but relapsed following regrowth and the owners opted for 
euthanasia at this point.
Those animals where "no diagnosis" was reached were, in general, given no treatment. 
Where scavenging was implicated or suspected the owners were advised to attempt to 
curtail this activity by restricting the animals freedom to roam, particularly on those 
days when refuse collection was anticipated. Follow-up on these animals found that 
all (with one exception) had ceased to vomit within three months of discharge from 
the hospital.
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Figure 2.49. Endoscopic appearance of a foreign body lying between rugal folds.
Figure 2.50. The foreign body, a piece of chewed furniture upholstery, after removal 
by gastrostomy.
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The animals from the non-neoplastic group were treated in a variety of ways. Those 
animals with foreign body, hypertrophic gastropathy or pyloric stenosis were treated 
by surgery to improve the outflow from the stomach. Removal of the foreign body 
was done via a gastrotomy in the dorsal surface of the stomach (Figures 2.38 and 
2.39). Those animals with outflow problems were treated by, either a 
pyloromyotomy, Heineke-Mikulicz or Y-U pyloroplasty. These animals showed a 
marked improvement, but 50% continued to vomit occasionally despite surgery. The 
animals with duodenogastric reflux were managed by either metoclopramide or by 
increasing frequency of feeding with the introduction of a fatty meal in the late 
evening. Those given metoclopramide were reported to have made some 
unsatisfactory improvement, with frequency of vomiting little reduced. Those given a 
changed dietary regime made satisfactory improvement.
The animals with gastroenteropathies were treated with prednisolone starting at 
lmgkg'1 twice daily. This dose was gradually reduced over four weeks to 0.5mgkg-1 
every other day. Once this course had been completed the owners were directed to 
try and find a maintenance dose less than 0.5mgkg_1 every other day that kept the 
signs of vomiting under control. All owners reported that a significant improvement 
took place and was maintained as long as the steroid therapy was continued. Some 
owners had been unable to find a maintenance dose below O.Smgkg*1 every other day. 
Those animals with chronic and follicular gastritis were treated speculatively with 
cimetidine for 30 days or a 21 day course of potentiated sulphonamide, and the 
owners of those with a history of scavenging were given the same advice as those in 
the "no diagnosis" group (see above). All this group improved within the first month 
of discharge from hospital and none had recommenced vomiting three months later. 
Those with erosive gastritis were also treated speculatively with cimetidine at 5mgkg_1 
four times daily. After this most owners reported some improvement. No treatment 
was given to the two dogs with atrophic gastritis.
Those dogs with peptic ulcers were treated in two ways. Four dogs had surgery to 
remove the peptic ulcer. In one dog this was for biopsy purposes, in two it was 
because of the massive haemorrhage that the dogs were sustaining if cimetidine 
therapy was stopped. In these dogs the antrum and pylorus were removed and a 
gastrojejunostomy was done. In the fourth dog that had multiple peptic ulcers one 
was removed for histopathology and the dog was treated with cimetidine. However, 
this dog subsequently proved to have a parasitic infestation of the stomach thought to 
be due to Ollulanus tricuspis, which was treated successfully with a one month course 
of fenbendazole.
Six of the seven dogs with peptic ulcers that were treated with H2 antagonists alone
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had a history of NSAID ingestion (Table 2.12). This prior treatment included 
ibuprofen, piroxicam, phenylbutazone and aspirin, and was stopped immediately on 
presentation. Three dogs had been receiving two NSAIDs prior to presentation. 
The first drug in each case was phenylbutazone and shortly before presentation this 
drug had been substituted by a different NSAID. In one further dog with piroxicam 
toxicity it was not possible to identify a gastric lesion because of the volume of blood 
in the stomach, and it was treated successfully with cimetidine. Only one dog was 
treated with ranitidine. These animals all responded to anti-ulcer therapy and had 
healed ulcers at the end of 1-2 months treatment. In two dogs the treatment was 
continued for a further month as a precaution because the ulcer scar did not look 
sufficiently quiescent on repeat endoscopy. In nearly all cases the treatment was then 
discontinued with no resumption of clinical signs. In one Bernese Mountain dog it 
was necessary to continue the H2 antagonist therapy because the severity of 
degenerative joint disease made continued NSAID therapy essential.
breed 
age, sex
NSAIDs
ingested
length of
> ingestion
> signs X-ray Endoscopy
Treatment 
> length of
JRT
8years female
PBZ
ASP
12months
7days
no ulcer ulcer 1.5cm 
bloody base
cimetidine
2months
Bernese 
3years male
PBZ
IBF
6months
lOdays
ulcer ulcer 1.75cm 
bloody base
cimetidine
continuous
WHW
4.5years female
PBZ
IBF
3months
lOdays
ulcer ulcer 1cm 
clean base
ranitidine
lmonth
GSD
12years male
PBZ uncertain
90days
ulcer ulcer 1.5cm 
clean base
cimetidine
lmonth
Doberman 
3years male
IBF lldays
5days
no ulcer ulcer 2cm 
bloody base
cimetidine
lmonth
Cross
13years male
ASP lOdays
5days
focal
mucosal
irregularity
ulcer 1.5cm 
clean base
cimetidine
2months
JRT
lOyears male
PIR 4days soft tissue 
opacity in 
stomach
bloody fluid cimetidine
lmonth
JRT=Jack Russell terrier, WHW=West Highland White terrier, GSD = German shepherd dog, 
Bernese = Bernese Mountain dog, PBZ=phenylbutazone, ASP = aspirin, IBF=ibuprofen,
PIR = piroxicam, lm = 1 month.
Table 2.12. Details of dogs with gastric damage arising from non-steroidal anti­
inflammatory ingestion: drugs ingested, investigation, treatment and outcome.
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2.4 Discussion
The population of dogs that are referred for second opinion consultations are a 
selected group of animals and the mean ages of those animals in the "no diagnosis" 
group and the non-neoplastic group thus probably reflect the general hospital 
population, and are possibly of little significance with regard to the age of occurrence 
of gastric problems in dogs. However, one explanation for the low mean age range in 
these two groups could be that younger animals are more prone to gastrointestinal 
upset because they are more inclined to scavenge. The material that they scavenge is 
very different from their normal diet. The introduction of, for example, a decaying 
chicken carcase is likely to upset the normal digestive processes and cause the animal 
to vomit in an attempt to remove the "'foreign" material. However, this contact with 
strange food would need to occur on a regular basis to account for the duration of the 
vomiting in some of these dogs. The mean age of those dogs with gastric neoplasia 
was approximately twice that of the "no diagnosis" and non-neoplastic groups. This is 
not unexpected as, in general, neoplasia affects the older animal, and tumours of the 
alimentary tract are no exception (Church, Melhaff and Patnaik 1987, Kosovsky, 
Matthieson and Patnaik 1988). The results presented here agree with other studies 
of gastric neoplasia in the dog (Lingeman, Gamer and Taylor 1971, Sautter and 
Hanlon 1975, Patnaik, Hurvitz and Johnson 1977, Krauser 1985). In man, and as yet 
with no evidence to suggest that a similar situation is not the case in the dog, gastric 
carcinoma is thought to be present in the stomach for 20-30 years before the person is 
thoroughly investigated for the complaint. The evidence for this long occult period 
comes from two sources. First, endoscopic examination has revealed that the mean 
age of patients with early gastric cancer in man is 10 years less than when patients are 
more commonly seen with the advanced stage (Demling and others 1982). Second, 
using radiology Kawai, Miyaoka and Kohli (1974) found that the time taken for a 
tumour to increase twofold is relatively long, implying that development of the 
condition is fairly slow. The most likely explanation for not seeing cases of gastric 
neoplasia in the early stages is that the nascent tumour is small and produces few 
symptoms until it ulcerates. Initially, the small area of ulceration heals quickly 
because of the normal rapid repair processes that occur in the stomach. Thus this 
cycle of ulcer/repair may be repeated many times in the years before the tumour 
reaches such a size that it causes either significant or persistent symptoms such that 
the patient undergoes thorough investigation.
Considering the effect of breed on the different types of gastric abnormalities in the 
dogs investigated in these studies, in the neoplastic group the Rough collie was the 
breed in which gastric carcinoma occurred most frequently. However, this apparent 
breed predilection commented on previously by Sullivan and others (1987) could not
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be substantiated in this series as the numbers were not large enough to allow 
statistical confirmation. In that series the terrier type, as well as the Rough collie, 
was thought to show a breed predisposition. Breed predisposition has been identified 
in other reports of gastric carcinoma in dogs. Scanziani and others (1991) reported 
that the Belgian shepherd dog suffered from the condition more frequently than 
others. The variation in the affected breeds identified in different parts of the world 
could be because of a difference in diet and/or environmental influence rather than a 
specific genetic predisposition (Lingeman, Gamer and Taylor 1971, Murray and 
others 1972a, Sautter and Hanlon 1975, Patnaik, Hurvitz and Johnson 1977).
Support for this comes from man where there has been a general decline in mortality 
(Howson, Hiyama and Wynder 1986), and where it has been shown that a reduced 
incidence of gastric carcinoma occurs in second generation Japanese people living in 
the United States of America compared to those suffering from the complaint in 
Japan. Indeed, the incidence in the United States approached the incidence of 
gastric carcinoma in native bom Americans (Haenszel, Kurihara and Segi 1972). 
The explanation proposed by these authors was that the change in diet resulted in the 
drop in incidence. As dog food comes from the same food chain as humans, diet may 
also be related to the occurrence of some gastric cancers in the dog. Environmental 
influences are also thought to be of importance with excessive ingestion of salt and 
nitrates implicated in the occurrence of gastric carcinoma in humans and similar 
findings have been reported from experiments in the rat (Correa, Cuello and Duque 
1970, Hill, Hawksworth and Tattersall 1973, Correa 1984, Fontham and others 1985, 
Takahashi and Hasegawa 1986, Takahashi and others 1986). In the dog, 
dimethylamine, a precursor of the implicated carcinogen nitrosodimethylamine, has 
been found to concentrate in the gastric juices with little absorption into the blood 
(Zeisel and others 1986).
Genetic influence cannot be ruled out as the genetic pool of pedigree dogs in one 
particular area is often quite small with marked in-breeding used to establish 
particular lines. It is possible that this may explain the discrepancy in the breeds 
reported to be susceptible to gastric carcinoma from across the globe. Evidence to 
support this assertion comes from the fact that crossbred dogs are almost always 
under-represented in published series (Lingeman, Garner and Taylor 1971, Sullivan 
and others 1987). There is also some evidence in man of a genetic factor in that 
relations of those who have had gastric carcinoma have a higher incidence of atrophic 
gastritis and therefore are more at risk of developing gastric cancer (Kekki and others 
1991).
In the non-neoplastic group there was no specific breed identified with any one
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condition. This is most probably because, although the group contained the largest 
number of animals, it consisted of a wide and disparate range of conditions such that 
meaningful conclusions as to breed disposition were difficult to draw from the results 
recorded. In the subgroup of dogs with hypertrophic gastropathy there was no breed 
predilection as has been reported previously by Matthiesen and Walter (1986) in the 
largest study (45 dogs) published to date. This may be because the number presented 
here is small. However, the results from two other publications where the numbers 
of animals investigated were also small, indicated that toy breeds, such as the Lhaso 
Apso and miniature poodle showed a predilection for hypertrophic gastropathy 
(Walter and others 1985, Sikes and others 1986).
In the "no diagnosis" group small breeds and Labradors predominated. In 
considering the numbers of toy breeds in this situation, owners of such dogs are 
inclined to be more involved with their animals than those who own larger breeds and 
thus be more aware and concerned when the animal vomits. Thus there may be an 
owner effect in the frequency of presentation in these cases. Furthermore, small 
breeds by being more temperamental in their eating habits are frequently tempted by 
and fed on the same diet as their owners. This diet may be more inconstant and less 
acceptable to the canine digestive system than food normally fed to pets and so cause 
the gastric upset. These explanations do not apply to Labradors. Here a more likely 
explanation is that this breed, apart from being very common, are notorious 
scavengers and their frequent appearance in this group may represent the effects of 
refuse eating and the problems it presents, as already discussed.
There was no apparent sex predilection for those animals in the "no diagnosis" group. 
Where there were reasonable numbers of a specific condition in the non-neoplastic 
group only those with peptic ulcer showed a male preponderance. In man, this 
relationship was recognised by Menguy 1970, but not by Murray and others (1972b) in 
the dog. The most likely explanation for the disparity between the animals in this 
study and those reported by Murray and others (1972b) is that both were comprised 
of small numbers and therefore contained the element of chance, which is not the 
case in man where large cohorts with peptic ulcers have been studied. The male was 
more prone to gastric carcinoma in this series of dogs as has been reported by other 
workers (Lingeman, Garner and Taylor 1971, Murray and others 1972a, Sautter and 
Hanlon 1975, Patnaik, Hurvitz and Johnson 1977, Krauser 1985, Sullivan and others 
1987). In man, the male predisposition is probably influenced by co-factors such as 
smoking and excessive alcohol intake (Domellof 1979, Fontham and others 1985). 
Other dietary factors such as charred or overheated fats and oils in the diet have been 
suggested (Ivy 1955). This would not be the case in the dog fed proprietary dog food 
suggesting that there is a genuine male predilection.
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The variation in duration of clinical signs prior to referral possibly includes a human 
factor in that referral depends to some extent on the owner recognising the severity of 
the vomiting and also on the primary veterinary surgeon referring an animal 
promptly. Obviously, the nature of the vomiting has great bearing on the owners’ 
response. Animals that are intermittent vomiters producing foam or small volumes 
of bilious fluid from an empty stomach are likely to be dismissed initially by the 
owners as not requiring investigation. However, the spectacular production of blood 
explains why such animals tend to be referred quickly usually within three days after 
the onset of haematemesis. The same situation occurs in man where acute upper 
gastrointestinal haemorrhage is a serious problem (Dawson and Cockel 1982).
The mean and maximum duration of symptoms in those animals with neoplasia was 
approximately one third less than the other two groups. Animals with neoplasia 
often have other signs that aggravate the problem in the owners eyes, namely that 
these dogs develop polydipsia and significant weight loss which encourages owners to 
seek advice (Murray and others 1972a, Sullivan and others 1987).
With regard to the haematological investigations carried out, the eosinophil count in 
two dogs from the "no diagnosis" group and one with erosive gastritis was elevated. 
Eosinophilic gastroenteropathy may have been missed in these two animals. On the 
other hand the eosinophilia may merely have been the result of injury to the 
gastrointestinal tract with the release of histamine. In only 3/6 dogs with 
eosinophilic gastroenteropathy was there a circulating eosinophilia, which was not 
particularly marked in any of the three animals. This is not surprising as other forms 
of eosinophilic disease such as eosinophilic bronchitis or pulmonary infiltrate with 
eosinophils do not always have a corresponding circulating eosinophilia (Lord, Schaer 
and Tilley 1975, Calvert and others 1988, Brownlie 1990, Moon 1991). Coracoran 
and others (1991) found that circulating eosinophil counts of 6/14 cases of 
eosinophilic bronchitis were normal. This apparent lack of haematological evidence 
in haematologically related disease also occurs in man. Talley and others (1990) 
found that 23% of their patients with eosinophilic gastroenteritis had normal 
peripheral eosinophil counts. This may be because eosinophils are rapidly attracted 
to tissue with increased concentrations of histamine, which can arise as a result of 
"injury" (Archer 1970, Honsinger, Silverstein and van Arsdel 1972), or because the 
sample may have been taken during that part of the diurnal variation where the 
circulating numbers are lower and so any response is less exaggerated and appears to 
fall within normal range. Few authors have offered much of an explanation for this 
apparent anomaly. Parasitic infections have been implicated as being one of the 
causes of this eosinophilic syndrome (Hayden and Van Kruinigen 1973, Moon 1991), 
but could also be due to diet (Narama and others 1990).
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In those animals with neoplastic ulceration accompanied by blood loss into the 
alimentary tract only the dog with an APUDoma demonstrated anaemia. This 
situation was reported previously (Sullivan and others 1987), and contradicts the 
findings of Murray and others (1972a). In contrast 3/9 cases of dogs with peptic 
ulcers, which had been vomiting for more than a few days, had some evidence of 
anaemia. This is in agreement with the findings of Murray and others (1972b) and 
Stanton and Bright (1989). The discrepancy between the occurrence of anaemia in 
two groups of animals may be because the peptic ulcer, although smaller than the 
neoplastic lesions, is provided with a richer profusion of blood vessels supplying the 
granulation bed of the ulcer. Indeed in humans it is the rupture of larger blood 
vessels in the base of the peptic ulcer that is responsible for the acute upper 
gastrointestinal haemorrhage, which results in emergency hospitalisation (Brearley 
and others 1985).
Overall the haematological investigation undertaken in all three groups of dogs was 
not particularly rewarding as most of the animals had normal values in the parameters 
investigated. There is often a delay in the receipt of the results of haematological 
investigations and treatment or further investigations have already taken place before 
their return. This tends to discourage more intensive use of haematological 
investigations in either the diagnosis or treatment of gastric abnormalities in the 
canine. A faster return of information and an adoption of the latest haematological 
procedures now able to be undertaken needs to be encouraged as advances in 
haematology are providing very useful ancillary aids to diagnosis in so many other 
previously under-diagnosed conditions in both animals and man (Norbum and 
Tvedten 1992, Klag, Giger & Shofer 1993).
The biochemical screening did not reveal any dramatic findings in the groups of 
animals investigated. However, animals investigated did not include dogs with 
associated renal disease where biochemistry can be of particular benefit in reaching a 
diagnosis. In a number of the animals there was a small and inconsistent rise in the 
non-specific enzymes serum alkaline phosphatase and AST, which may merely 
indicate an ongoing increase in metabolism arising from cell necrosis in the gut and 
increased catabolism in the liver as a result of vomiting (Kramer 1980).
Elevation of ALT was the most commonly encountered biochemical change in all 
three groups. In the "no diagnosis" group it was elevated in 6/18 cases. ALT activity 
is elevated in plasma under circumstances where there is an increase in hepatocyte 
membrane permeability. There may therefore be a number of possible explanations 
for the rise in these cases.
One possible explanation for the increase in this specific hepatic enzyme in the group
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where no diagnosis was reached is that these animals were vomiting not because of 
gastrointestinal disease, but because of some non-specific mild hepatic disease. This 
then implies that 10 animals from the non-neoplastic group also had evidence of liver 
damage. However, the increase in permeability could also have arisen from 
ascending infection or inflammation, or where there may have been some period of 
anoxia, so that the cause of the increase in ALT need not be strictly hepatic in origin. 
Indeed many dogs with alimentary signs have mild elevation of enzyme activities 
(Sherding 1989). None of the animals with peptic ulceration had elevated ALT 
interpreted as hepatic dysfunction, in contrast to the hepatic pathology reported by 
Murray and others (1972b) in their series of peptic ulcers. Hypoproteinaemia was 
rare in this study and was found in only three dogs. Certainly one might have 
expected hypoproteineamia in those gastroenteropathies that had a inflammatory cell 
infiltrate. However, there was little change in total protein in any of these animals 
suggesting that the disease was not severe enough for the animal’s compensatory 
mechanisms to be overcome. Thus although serum biochemistry was not pursued to 
any extent in the animals referred to in this thesis there were certain biochemical 
findings in some of the cases of gastric abnormalities that warrant further 
investigation.
The use of radiology both as a straightforward approach and in combination with 
barium, in the investigation of gastric complaints in the dog has been the mainstay of 
diagnostic aids for many years (Douglas and Williamson 1970, Gibbs and Pearson 
1973). The recent necessity for sedation to minimise handling of the animal, has not 
reduced the usefulness of this technique as it does not affect the emptying of barium 
from the stomach (Zontine 1973, Leib, Wingfield and Twedt 1985). However, the 
results of radiographic examination in some of the gastric abnormalities in the dogs 
investigated were disappointing. This was mainly associated with the detection of 
small lesions and in differentiating between pathological lesions and artefacts. 
Radiology is especially effective in detecting forms of outflow obstruction (Gibbs and 
Pearson 1973, Couto and others 1989, Brawer and Bartels 1990), and whilst this 
certainly was the situation with the cases of pyloric stenosis, atrophic and hypertrophic 
gastropathy in this study, there were the two cases of foreign bodies that escaped 
detection. This was most probably due to the shape and size of the foreign bodies. 
These were flat and composed of materials that project as radiolucent or faint soft 
tissue opacities on radiographs. Such objects may not be sufficiently radiolucent or 
radiopaque to be demonstrable against the inherent or added contrast that barium 
supplies. Furthermore because of their size and shape they do not show up well even 
in the presence of barium and are easily overwhelmed by the volume of barium given 
and become masked. An anticipated delay in emptying may not occur because liquid 
barium is used. The lack of impairment of barium emptying arises because fluid is
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preferentially and more rapidly emptied since the emptying rate is determined largely 
by particle size (Carlson, Code and Nelson 1966, Kelly 1980, Miyabayashi and 
Morgan 1984, Leib and others 1986, Bums and Fox 1990). Unfortunately, if food is 
added to the barium to demonstrate a delay in emptying of particulate material, then 
the mottled appearance of this medium camouflages the small flat foreign bodies that 
escaped detection in this series (Bums and Fox 1990).
Radiographic examination failed to detect all of the peptic ulcers in this series of 
dogs. Such ulcers are small and in addition they are often located on that part of the 
gastric wall that is most difficult to image, namely the junction of incisure angularis 
and dorsal wall (Wallace, Zawie and Garvey 1991). This is because on lateral views 
the pylorus and duodenum curve cranially across this area, and on the dorso-ventral 
or ventro-dorsal views the area is overlain by the incisure angularis (O’Brien 1978).
In man this problem is overcome by the extensive use of double contrast studies 
(Ichikawa 1973), which have not been found to be very helpful in the dog (Jakovljevic 
1988). The success of the technique in man is in no small measure due to the 
radiologist being able to instruct his human patients to contort their bodies into 
specific positions to encourage specific movement of the contrast within the gastric 
lumen (Ichikawa 1971).
In the normal stomach some areas on radiographic examination can project in such a 
way as to mimic quite severe ulceration, and so differentiating normal mucosa from 
ulcerated mucosa can be difficult. This can be overcome, to a certain extent, with the 
use of image intensification that allows continuous examination of the barium-filled 
stomach, but results in a poorer quality image. Image intensification allows 
peristalsis to be examined and thus the appearance of an area of interest on a spot 
film that may or may not be artefactual can be viewed repeatedly and a diagnosis 
reached. However, even the use of image intensification does not always permit 
definitive diagnosis of neoplasia on the basis of radiological examination alone 
(Sautter and Hanlon 1975, Sullivan and others 1987). In one series of 31 cases of 
gastric carcinoma in which 17 had image intensification used, only 10/17 could be 
reliably interpreted as having a neoplastic lesion present (Sullivan and others 1987). 
Thus the results of the radiological examinations carried out in this study, while 
providing useful information, did not always provide sufficient information to permit 
a definitive diagnosis to be reached.
Endoscopy is being used with increasing frequency in diagnosing gastric conditions in 
both humans and animals (Happ6 and van der Gaag 1983, McCloy 1985). 
Endoscopy already has overcome many of the problems of radiology, especially those 
related to the examination of abnormalities of the gastric mucosal surface as it allows
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direct detailed examination of this aspect of the stomach (Happ6 and van der Gaag 
1983, Happ6 1986, Sullivan and Miller 1985). However, a combination of radiology 
and endoscopy should be used as a means of diagnosis as they compliment each other 
(Wittenberg and Kantrowitz 1970). The limiting factors in endoscopy are that it does 
not allow examination of peristalsis, or the subsurface tissues and is severely limited if 
there is excessive gastric content present. However, the recent introduction of more 
sophisticated equipment that combines the endoscope with an ultrasonographic unit 
has permitted the subsurface tissue to be investigated (Kimmey and others 1989, 
Silverstein and others 1989, Lightdale 1992).
When the dogs in the control group underwent endoscopic examination many had 
bile, fluid and foam present in the gastric lumen, which limited thorough evaluation of 
the luminal surface in a few animals. Excessive fluid can be removed by aspiration if 
suitable suction pumps are available. The foam can be reduced by the use of anti- 
foaming agents given prior to endoscopy (Gasster, Westwater and Molle 1954). In 
man the administration of pre-procedural simethicone mixed with 100ml of water has 
been found to clear the stomach and duodenum of foam and bubbles; this must be 
given less than 10 minutes before examination (Bertoni and others 1992). In the 
initial examination carried out none of these measures were taken in the dogs 
examined, but would certainly be well worthwhile considering for future endoscopic 
examinations in the dog.
As the "no diagnosis" group could be described as being most similar to the control 
group in most of the parameters examined by endoscopy, it is difficult to explain why 
these animals had an emptier stomach at the time of examination. There are two 
possible explanations, either the vomiting "no diagnosis" group were eating less 
because of a temporary gastric upset and therefore had less to empty from their 
stomachs, or because the clinical cases were fasted for two successive nights to allow 
examination of a barium meal after the first night of fasting and an endoscopic 
examination after the second night of fasting.
The assumption that the finding of duodenogastric reflux of bile on endoscopic 
examination indicates the cause of the gastritis in some of the clinical cases must be 
re-evaluated in the light of the frequency with which pools of bile were seen in the 
control dogs. However, in man the presence of bile was found in 28% of normal 
stomachs in contrast to 68% of abnormal stomachs and there is some association 
between dyspepsia and endoscopic evidence of bile reflux (Eyre-Brock, Holroyd and 
Johnson 1984). Normal dogs with duodenogastric reflux may or may not have 
abnormal histological changes in the gastric mucosa (Happ6, van den Brom and van 
der Gaag 1983). Experimentally in the dog it has been shown that pyloric sphincter
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incompetence with duodenal reflux will lead to chronic gastritis (Adair and Wlodek 
1968). In man the occurrence of duodenal regurgitation has been found to vary 
between individuals and between examinations. Siurala and Tawast (1956) found 
duodenal contents in the gastric contents of many fasting patients and some of these 
patients had evidence of atrophic gastritis. That duodenogastric reflux occurs in the 
dog following feeding is accepted (Sonnenberg and others 1982).
The duodenogastric reflux found in normal dogs and in the clinical cases may have 
been due to fasting. Nevertheless, the inflammatory effect of bile has been 
confirmed experimentally by Lawson 1964, and reflux of bile through the pylorus will 
induce a gastric mucosal hyperaemia (Keighley, Asquith and Alexander-Williams 
1975). Furthermore evidence has been presented to show that duodenogastric reflux 
can produce clinical signs in human beings (Kilby 1970, Keighley, Asquith and 
Alexander-Williams 1975, Brough, Taylor and Torrance 1984). In man reflux of bile 
can be demonstrated not only after diversional surgery of the antrum and pylorus 
(Capper, Butler and Buckler 1966, Kilby 1970, Graffner, Flor6n and Nilsson 1984), 
but also in the patient with normal antrum and pylorus (Johnson 1972). In one study 
in man (Glikmanas and others 1984) patients were divided into two groups on the 
basis of the endoscopic identification of a bile pool and a telemetry device was placed 
in the stomach to measure subsequent pH. Those patients who had a clear mucus 
were found to have few and short lasting rises in pH. In contrast those patients with 
a bile pool had frequent and prolonged rises in pH suggesting that duodenogastric 
reflux causes the bile pool and that it is not necessarily induced by endoscopy. 
Despite much work, just what the importance reflux of bile in the stomach of man and 
animals is not fully understood and requires further investigation. In the control dogs 
used in this study a bile pool was found in 36.67% of animals. However, in those 
animals from the non-neoplastic group a similar sized bile pool was found in 23%, 
and in a further 18% of dogs a large pool was found. Although bile reflux was 
observed in both control and non-neoplastic groups, there was a difference in severity. 
None from the control group had a bile reflux scored 2 or 3 in contrast 30% from the 
non-neoplastic group. Bile reflux occurs during normal alimentation but the bile is 
not very concentrated and is rapidly swept from the stomach, but bile will injure the 
mucosa of an empty stomach where it lies in contact with the mucosa without being 
swept away. The time that this situation is most likely to occur is during the night 
when the animal is asleep. Borg (1959) has shown in man that the bile reflux occurs 
during the night and rises to a peak between l-2am in the morning. His explanation 
for this was that there was a nocturnal relaxation of the pylorus possibly induced by a 
preponderance of parasympathetic stimulation during sleep and by the recumbent 
pose adopted by sleeping people.
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If the classification of Karvonen and others (1983) of erosive gastritis in man is 
applied to the findings in the animals in this study with the same condition, then the 
incomplete flat erosions seen were of an acute nature. However, Sauerbruch, 
Schreiber and Schussler (1984) and Gad (1986) found that there was some 
discrepancy between the endoscopic diagnosis of erosion and confirmation by 
histology of endobiopsies in the human. Gad (1986) suggested that this was most 
probably due to inaccurate translation of the sections produced from the biopsy 
material because the samples obtained by endobiopsy were unsatisfactory in amount 
and content. Therefore one might ask just what is the benefit of taking endoscopic 
biopsies (Karvonen and others 1983, Franzin and others 1984). However, published 
reports suggest that endoscopic examination is one of the most successful methods 
used routinely in the diagnosis of erosive gastritis. Taor and others (1975) found that 
the endoscopic findings in the majority of cases of gastritis agreed with the subsequent 
histological changes in sections prepared from endobiopsies. They also found that a 
third of the samples taken from endoscopically normal mucosa had histological 
changes indicative of gastritis. This tends to suggest that some of the "no diagnosis" 
group that gave negative results on endoscopy may have had gastritis. However, as 
Whitehead, Truelove and Gear (1972) pointed out finding gastritis on one or two 
samples does not necessarily reflect the state of the mucosa as a whole. In one of the 
few studies published relating endoscopic and histological findings in the dog, Roth 
and others (1990) found that none with normal endoscopic findings had abnormal 
histology. In contrast they also reported that a few animals were seen to have 
endoscopic change that was not substantiated histologically. Nevertheless it does 
make the examination of biopsies from the gastric mucosa a possible means whereby 
diagnosis of gastric abnormalities can be made, which currently might go 
undiagnosed.
The histological samples obtained by exploratory laparotomy or post-mortem 
examination presented little difficulty as far as interpretation was concerned in the 
animals in this review. This was because a suitable amount of tissue was obtained by 
these methods. However, despite samples being taken during endoscopic 
examination the results from the sections prepared were inconclusive and a significant 
number of cases were diagnosed on grounds other than endoscopic biopsy. The 
handling and interpretation of endobiopsies has been a problem since endoscopes 
became a major diagnostic aid. Morrissey (1972) in reviewing gastrointestinal 
endoscopy felt that perhaps several different types of endoscopes, such as side-viewing 
as opposed to panendoscopes, might be needed to get adequate biopsies. Danesh 
and others (1985) examined different sizes and types of biopsy forceps as well as the 
technique of actually grabbing the mucosa in an attempt to determine some of the 
factors that might determine the quality of the resultant quality of the endobiopsy.
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They concluded that the endobiopsies obtained using paediatric gastroscopes with 
round cupped forceps gave the most inadequate sample volume and the poorest 
samples since they are small, tend not to penetrate particularly deep into the mucosal 
layer, fragment easily and are difficult to orientate. Unfortunately, this set of 
circumstances prevailed for a large part of this study and the forceps used with the 
video-endoscope were also round rather than ellipsoid. Despite this, it may be 
argued that endoscopy is fairly accurate as there has been good correlation between 
abnormal appearance and histological confirmation, and that the main flaw lies in 
those stomachs that appear to have normal gastric mucosa endoscopically (Dekker 
and Tytgat 1977), which could perhaps be resolved by widespread sampling of the 
mucosa.
Endoscopy is very effective in the identification of ulceration of the gastric lumen and 
on the basis of this series is a much more sensitive investigative aid than radiological 
investigation. Gastric carcinoma ulcers seen in this series were large and presented 
with a "chewed out" appearance in similar fashion to those reported previously 
(Sullivan and others 1987, Scanziani and others 1991). Two of the lymphosarcoma 
dogs had small multiple marginally raised ulcers with a sharp border between normal 
and abnormal so that there was no surrounding rugal change. This type of 
appearance is similar to that reported in man where a comparison between the 
endoscopic appearance of carcinoma and lymphoma showed the same disparate 
appearance of the two tumour types (Fork and others 1985). The third case was 
atypical in that it was a large ulcerated mass located in the fundus on the greater 
curvature. The location would have been uncharacteristic for gastric carcinoma, but 
does raise the possibility of endoscopic confusion because the large ulcer is typical of 
gastric carcinoma, which is easily the commonest gastric tumour (Howson, Hiyama 
and Wynder 1986).
Typically, the benign ulcer is found at the junction between antrum and pylorus 
(Ruding 1967), less than 2cm in diameter and lacks the "chewed out" inner wall with 
overhanging lip and thickened, fixed rugae that are seen in neoplastic ulcers. Six of 
the animals with peptic ulcers had had previous treatment with NSAIDs. 
Interestingly, three of these had been ingesting a particular drug over a fairly long 
period of time before an abrupt switch to another of these preparations was made. 
The endoscopic appearance of several of these ulcers suggested that they had been 
present for longer than the clinical signs, or the length of time that NSAIDs were 
reported to have been ingested by the dog.
In man the use of NSAID drugs has been implicated in peptic ulcer disease, where the 
association seems to be more positive for the person over 60 years of age (Collier and
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Pain 1985, Sommerville, Faulkner and Langman 1986). However, peptic ulcer may 
be silent in many people until the ingestion of NSAIDs cause the peptic ulcer to 
become clinically active (Glise 1990). Certainly 3/6 cases presenting with peptic 
ulcer in this series after ingesting NSAIDs, and the dog with piroxicam toxicity could 
be considered aged, that is over 10 years of age, suggesting that the sequence of silent 
peptic ulcer exacerbated by NSAID administration also pertains in the dog. The 
NSAIDs produce this effect by interfering with the normal defense mechanisms of the 
stomach. The main route of action is by suppressing prostaglandin synthesis 
(Ferreira, Moncada and Vane 1971, Vane 1972, Vane and Botting 1978, Kauffman 
and others 1979). The role played by prostaglandins in the defense of the gastric 
mucosa is well recognised and operates by stimulating blood flow (Cheung 1980, 
Cloud and Ritchie 1982, Konturek and Robert 1982, Pihan and others 1986), by 
playing an integral part in the secretion of bicarbonate into the lumen, the production 
and release of glycoproteins (Johansson and Bergstrom 1982, LaMont and Szabo 
1984), by maintaining the hydrophobic nature of the adsorbed layer of surface-active 
phospholipids (Lichtenberger, Richards and Hills 1985), and cellular restitution 
(Morris 1986). Thus in a situation where the stomach has a pre-existing lesion that is 
attacking the integrity of the stomach, but which is being held in check, the 
administration of a drug that removes the defensive prop will lead to this lesion 
overwhelming the mucosa and the patient experiences obvious symptoms. This 
appears to be what happens to these silent peptic ulcers in the presence of 
prostaglandin suppressing NSAIDs. The NSAID drugs including aspirin, 
indomethacin and phenylbutazone are also capable of producing acute erosions and 
ulcers in a variety of species (Varr6, Csemay and J&vor 1959, Watt and Wilson 1959, 
Davenport 1969, Nicoloff 1968, Bugat and others 1976, Miller and Jacobson 1979).
Thus in the initial investigation of vomiting dogs it is essential to ascertain any 
previous administration either by the owner or by the referring veterinary surgeon of 
this class of drugs, as they are clearly provocative to the gastric mucosa, and their 
potential role in the induction of gastritis, by breaking the mucosal barrier, as 
opposed to exacerbating cases of peptic ulcers needs to be investigated further.
One of the most interesting findings of this study was the identification of a dog with 
ulcers caused by parasites. The parasitic ulcers resembled both endoscopically and 
grossly the other forms of peptic ulcers. The parasite thought to be responsible 
Ollulanus tricuspis is seen most commonly in cats, particularly big cats, and has not 
been described in the dog before (Hargis, Prieur and Westcott 1981, Guy 1984, 
Hasslinger 1984, Wilson and Presnell 1990). Stanton and Bright (1989) reported that 
peptic ulceration is almost always related to a single lesion. They reviewed 43 cases 
of gastroduodenal ulceration and found only one of 21 NSAID-induced cases with
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multiple ulcers in the stomach. All the dogs with peptic ulcers in this study presented 
as having a single lesion. Therefore the multiple lesions found in the dog with the 
parasite helps to differentiate this condition from other cases of peptic ulcers. 
Unfortunately, attempts to demonstrate the extremities of the parasite by scanning 
electron microscopy and thus confirm absolutely the presence of this species of 
parasite were unsuccessful. Therefore although this case of parasitism in the dog 
may be an aberration, this condition must be considered in the future in the 
differential diagnosis of peptic ulcers.
In 1984, Dooley and others published a comparative study of 100 hundred dyspeptic 
patients, evaluating endoscopy versus double contrast radiography as diagnostic aids 
and found that endoscopy was superior. The evidence presented in this series of 
cases tends to concur and suggests that endoscopy is a more sensitive and specific 
diagnostic tool than radiology. However, it would be arrogant to dismiss radiology. 
The two procedures should be considered complimentary in view of the limitations 
inherent in each technique.
The lack of treatment for those where "no diagnosis" was reached did not appear to 
be detrimental to those animals since all had ceased to vomit within three months of 
discharge from the hospital. This may be because those that were scavenging were 
successfully stopped in this behaviour, or in other cases because the underlying cause 
of the vomiting, which had not been determined, disappeared or resolved. The last 
possibility is that these animals had not been followed up for long enough to ensure 
that the problem had truly resolved, and that if relapse occurred the owners did not 
push for re-investigation as the condition was not serious, accepting that the dog was 
going to have bouts of vomiting.
Of those animals that underwent surgery, those that had foreign bodies completely 
recovered, as one might expect. Those animals with hypertrophic gastropathy and 
pyloric stenosis all improved, though some not completely. The possible explanations 
for this are that the degree of gastric distension that existed prior to surgery failed to 
resolve after surgery so that the stomach persisted as a rather large ineffective sac 
leading to excessive retention of food. Alternatively, the pyloric relief surgery 
undertaken in these cases of pyloric outflow obstruction failed to adequately widen 
the outflow tract, resulting in continuing outflow obstruction. This hypothesis is 
difficult to prove in the clinical case as the underlying pathological change and not the 
surgery may be responsible. Certainly experimental work in the dog where the three 
main techniques used to relieve these conditions have been compared has shown that 
all were perfectly capable of allowing adequate emptying of the stomach, though all 
showing a tendency towards slowing of gastric emptying (Fox and Bums 1986,
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Papageorges, Breton and Bonneau 1987, Stanton and others 1987), and produce an 
increase in duodenogastric reflux (Muller-Lissner and others 1983, Muller-Lissner 
and Blum 1984. One last explanation is that neither persistent dilation or surgery are 
responsible for the complete resolution of signs, but the procedures permit excessive 
reflux of bile when the stomach is empty and induce an alkaline gastritis. Alkaline 
reflux gastritis has been identified in man and also in the experimental dog after 
diversional surgery (Lawson 1964, Capper, Butler and Buckler 1966, Keighley, 
Asquith and Alexander-Williams 1975, Muller-Lissner and Blum 1984, Kellosalo, 
Alavaikko and Laitinen 1991), and the fact that bile can cause cell necrosis of the 
surface epithelial cell has been known for some time (Grant and others 1951).
The rationale for treating dogs with chronic, follicular and erosive gastritis with 
potentiated sulphonamide or cimetidine was mainly speculative, but also offered a 
placebo effect. However, there is some evidence to support the use of both these 
type of drugs in the above conditions. One approach to counteract the deleterious 
effect of injury to the stomach is to suppress the acid secretion, since it plays such a 
significant role as an aggravator of mucosal damage (Guth and Code 1978, Guth, 
Aures and Paulsen 1979). Histamine is a mediator in the stimulation of gastric acid 
and its release occurs during the early phases of gastric secretion. Acetylcholine and 
gastrin are also involved in the release of acid. However, the H2 receptor would 
appear to be the major controller of the parietal cell hydrogen ion production line 
(Code 1977). Cimetidine was the first of the commercially successful H2 antagonists. 
It attaches to the receptor and blocks the activation of the parietal cell 
(Brimblecome and others 1975, Burland and others 1975). There are now recognised 
side-effects of cimetidine in man such as pruritus and gynaecomastia (McGuigan 
1981, Gailbraith and Michnovicz 1989) Many of the side-effects and drug 
interactions of cimetidine can be traced to the inhibition of cytochrome P450 (Peura 
and Freston 1987). However, from a patient point of view, one of the drawbacks of 
cimetidine is the requirement for it to be taken four times daily. Ranitidine has 
overtaken cimetidine in terms of market share because it lacks many of the side- 
effects, but importantly needs only be taken twice daily (Bohman, Myren and Larsen 
1980, Woodings and others 1980). Both these drugs will suppress basal and 
stimulated acid secretion (Ostro 1987).
Konturek and others (1981a) noted that at sub-suppressive doses, which did not affect 
prostaglandin levels, ranitidine would protect the stomach of the rat against the 
injurious challenge. This same effect was not noted with cimetidine where the 
healing or protective effect, rather than acid inhibition was due to endogenous 
prostaglandin release (Konturek 1985). Thus the class of drugs to which cimetidine 
belong, because they suppresses acid secretion and as consequence prevent
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pepsinogen becoming active, will in fact allow healing of the stomach in less invidious 
conditions than normally prevail (Gurll and Damianos 1981). Further the reduction 
in acid secretion will limit the amount available for back-diffusion that has been 
shown to stimulate pepsin output in dogs (Johnson 1971). The use of potentiated 
sulphonamide is rather harder to justify. One might argue that there was a possibility 
that these animals may have had a form of Heliobacter pylons (Campylobacter 
pyloridis) specific to the canine. In humans, this bacteria has been established as a 
major cause of gastritis in adults and, perhaps more importantly, in children, and has 
been implicated in the pathophysiology of peptic ulceration (Buck and others 1986, 
Hazell and Lee 1986, Hazell and others 1986, Marshall 1986, Glise 1990, Maaroos 
and others 1991, Wallace 1991). Although a Heliobacter species has been identified 
in the laboratory ferret there is still no convincing evidence of its occurrence and 
pathogenicity in the antrum of the dog (Fox and others 1990), though the presence of 
spiral bacteria on the surface of the gastric mucosa has been recognised for nearly 100 
years (Bensley 1899).
The relationship between previous treatment and the occurrence of peptic ulcers was 
one of the important areas that was investigated. All but three of the dogs with 
peptic ulcers had a history of NSAID ingestion prior to the onset of clinical signs. 
For most of these dogs the delay from the commencement of NSAID ingestion and 
appearance of clinical signs was of the order of 7-10 days, yet on endoscopic 
examination the peptic ulcers looked quite mature. This raises the possibility that 
some of these ulcers may have been clinically quiescent with the animal living in 
balance with the ulcer, and the ingestion of NSAID provoked the ulcer to change 
from a relatively quiescent state to an aggressively active state, and to become 
clinically manifest. In man, superficial severely haemorrhagic 1cm erosions not 
ulcers were present three days after ingestion of aspirin tablets (Roth and others 
1963), and other NSAIDs have been implicated, such as ibuprofen, indomethacin and 
sulindac (Loiudice, Saleem and Lang 1981). Certainly, three of the dogs with NSAID 
induced peptic ulceration had been on prolonged intermittent therapy with 
phenylbutazone that had not appeared to induce signs of illness that the owner was 
able to detect. One cannot discount the possibility that a silent ulcer had been 
induced by the phenylbutazone. Indeed 8/22 cases described by Murray and others 
(1972b) were occult. No single NSAID was common to the cases. The variety used 
indicates the damage inducing capability all NSAIDs appear to have. Reports in the 
literature implicate aspirin, flunixin meglumine, ibuprofen, meclofenamic acid, 
naproxen and phenylbutazone as being associated clinically with peptic ulceration in 
the dog (Ewing 1972, Roudebush and Morse 1981, Cosenza 1984, Walter and others 
1985, Daehler 1986, Thomas 1987). However, Stanton and Bright (1989) in a review 
of 43 cases found that only three dogs had no identifiable underlying disease or drug
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ingestion that might be implicated suggesting spontaneous clinical peptic ulcers do 
occur, but are rarely themselves clinically manifest.
For all but two of the animals with peptic ulcers treatment with receptor blockers 
resolved the problem and allowed the ulcer to heal. The fact that it has not proved 
necessary to treat some of these animals with continued medication adds weight to 
the suggestion that the peptic ulcers in these cases were pre-existing and silent, a 
feature recognised in man (Glise 1990).
For one dog cessation of H2  blocker therapy led to relapses that were accompanied by 
massive haemorrhage - it was necessary to remove the pylorus and antrum of this 
animal’s stomach. Acute upper gastrointestinal haemorrhage is a problem in man 
that can lead to death. In man it has been found that treatment with H2  blockers 
during these episodes makes little substantial difference (La Brooy and others 1979, 
Dawson and Cockel 1982). In the one large published series of peptic ulcers in the 
dog there was a mortality rate of 10/43, however, not all the ulcers were due to 
NSAID therapy (Stanton and Bright 1989).
In a second case the cessation of NSAID ingestion was contraindicated as the severity 
of degenerative joint disease meant that the animal could not lead a satisfactory pain- 
free life without the use of NSAIDs, yet the animal had an active peptic ulcer. Here 
it was found necessary to institute a prophylactic regime of H2 blocker therapy to 
prevent further ulceration, and then to maintain a NSAID regime to control the pain 
associated with the degenerative joint disease. This has permitted the animal to 
follow a relatively pain free and mobile life, without the recurrence of clinical or, 
more importantly, endoscopic evidence peptic ulcer.
It is recognised in both man and experimentally in the dog and rat that ingestion of 
NSAIDs, even if they do not induce or exacerbate peptic ulceration, will produce 
erosions and inflammation in the stomach (Muir and Cossar 1955, Hurley and 
Crandall 1964, Lev, Siegel and Glass 1972, Lanza 1984, Lanza and others 1986, Laine 
and Weinstein 1988). However, it has been shown that the presence of acid in the 
lumen is an essential prerequisite for the full effect of NSAIDs to be exerted (Brodie 
and Chase 1967). This is because the absorption of the NSAID is reduced unless an 
acid pH exists in the lumen allowing the NSAID drug to be undissociated, thus lipid 
soluble in the gastric juice, thus move through the cell membrane, then into ionic 
solution where the damage is done (Brodie and Chase 1969). The damage caused is 
probably accentuated by increased duodenogastric reflux that has been shown to 
occur sometimes following the administration of NSAID. Admittedly the effect was 
most marked for those dogs given aspirin as opposed to indomethacin and 
phenylbutazone (Pantoja and others 1979). The additive effect of bile and NSAID in
106
C h a p t e r  2
the induction of mucosal damage has been demonstrated using indomethacin in the 
dog and other species (Davenport 1964, Ivy 1971, Djahanquiri, Abtahi and Hemmati 
1973, Semple and Russell 1975, Whittle 1977, Moody and others 1978). Whilst 
aspirin has long been recognised as being toxic to the gastric mucosa, Lanza and 
others (1979), Lanza (1984) and Lanza and others (1986) have presented work that 
shows that endoscopically in man the newer NSAIDs including flurbiprofen, 
ibuprofen, indomethacin, naproxen all produce less damage to the stomach mucosa 
than aspirin.
Histamine H2  receptor blockers have been shown to afford protection to the gastric 
mucosa when attacked by barrier breakers experimentally, though this concept is not 
universally accepted (Kenyon, Ansell and Carter 1977, Levine, Sirinek and Pruitt 
1979). However, H2 blockers have been used in man in the treatment of erosive 
gastritis (Gurll and Damianos 1981).
Thus there is clearly need for greater information about the circumstances 
surrounding the use of NSAIDs in the management of the clinical patient where there 
will be conflict between the need to protect the gastric mucosa in the face of drugs 
required by the patient for other conditions. The mechanisms which increase the 
toxicity to the mucosa of these drugs and the action of which can be accentuated by 
the presence of physiological fluids refluxed into the stomach needs further 
investigation.
Thus the overall conclusions drawn from the results produced from these 100 
vomiting dogs clearly indicated that further investigation in almost all aspects of 
diagnosis are required. Whilst endoscopy provided most useful information there is 
obvious room for improvement in the methods used for obtaining suitable biopsy 
material and the ability to translate the histological findings from this source. The 
role played by bile in the production of the variety of different gastric complaints 
known to occur in the canine is of special importance. Finally the gastric problems 
that may be being produced or exacerbated by some of the everyday treatment given 
to dogs for some of the other common complaints in small animal practice requires 
clarification. In an attempt to increase our knowledge in some of these important 
areas it was decided to study changes in the rat under varying experimental 
conditions, including the administration of acid, bile and NSAID drugs. The results 
were investigated by examining the stomach and its contents grossly, and by the 
evaluation of the histological changes by light and scanning electron microscopy.
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3. General Material and Methods
3.1 Experimental Animals
3.1.1.1 Rats
Sprague-Dawley rats bred in-house were employed throughout this study. The rats 
were young adults weighing between 200-225g. The rats were used as batches, no 
attempt was made to distinguish them on basis of sex, and were allocated to groups at 
random. All experiments were carried out between 10.00 and 11.00 GMT.
3.1.1.2 Maintenance
The rats were housed in RC1 cages (North Keat Plastics) and fed on a commercial 
diet (Rat & Mouse Nol, Special Diet Services).
3.1.1.3 Anaesthesia
The rats were deprived of food for 36 hours prior to induction of anaesthesia. Water 
was not withheld but given ad libitum. The rats were anaesthetised with a 
combination of fentanyl-fluanisone (Hypnorm - Janssen Animal Health) at a dose of 
0.2mgkg_1 given as an intramuscular injection into the biceps femoris, followed 
immediately by diazepam 2.5mgkg'1 (Valium - Roche Products Ltd) given via the 
intraperitoneal route. The rats were placed in dorsal recumbency on a bed of cotton 
wool, which was covered in thin plastic and overlaid with a single layer of paper towel 
to circumvent hypothermia. Respiratory rate, depth and palpebral reflexes were 
monitored to assess depth of anaesthesia. Rectal temperature and mucous 
membranes were checked regularly to monitor anaesthesia for adverse effects.
3.1.1.4 Surgical Approach
The stomach was approached via a small cranio-ventral midline laparotomy incision. 
Using the xiphoid as a landmark, a 2cm incision was made through the skin, 
subcutaneous tissue and linea alba commencing 2cm caudal to the xiphoid. The 
hepatic lobes of the liver were easily identified. By pushing the greater omentum 
laterally and cranially, the edges of the left hepatic lobes could be identified. The 
free edge of the medial hepatic lobe was visible as it emerged from beneath the 
lateral hepatic lobe. Using this as a landmark, the proximal duodenum was picked 
up and exteriorised by passing forceps underneath and dorsal to the lobe. The 
constriction and colour difference between the duodenum and pyloric canal made 
demarcation straightforward.
The pyloro-duodenal junction was ligated with 1.5 or 2 metric silk. Care was taken to 
avoid damage to the blood vessels (right gastric and gastroepiploic arteries and veins) 
and accompanying branches of the vagus nerve. Intragastric infusion of agents was
108
Ch a pt e r  3
done by injecting the solutions into the non-glandular region near the greater 
curvature with a 2ml syringe and fine 25 gauge needle. The skin was closed with a 
single 3.5 metric silk suture in those rats where the exposure times were to be greater 
than five minutes. This was to reduce heat loss through fluid evaporation from 
exposed moist tissues.
3.1.1.5 Euthanasia
The rats were sacrificed by injecting sodium pentobarbitone (Euthatal - RMB Animal 
Health Ltd) into the cardiac chambers to cause respiratory and cardiac arrest, and is 
an accepted and humane way to kill animals.
3.2 Harvesting of Tissue
3.2.1 Fixatives used are described in Appendix 9.1
32 2  Gross Examination
The anatomical terminology applied to the stomach for descriptive purposes follows 
that proposed by (Robert 1971). The forestomach refers to that part of the stomach 
which lies proximal to the limiting ridge, the corpus to the area from the limiting ridge 
to the antrum, which is clearly delimited from the corpus by its lighter yellow colour 
and thinner wall. The pylorus is that part of the stomach which separates the 
stomach from the duodenum.
The stomachs were removed from the rats immediately following cardio-respiratory 
arrest. The duodenum was opened along the mesenteric border and the incision 
extended through the pylorus cutting the silk ligature and then along the greater 
curvature of the stomach to the cardia. The contents were gently flushed with 
isotonic saline followed by 0.1M sodium cacodylate buffer to remove any food and 
other lightly adherent particles. The surface of the mucosa was then examined 
grossly. Since the infusions and the opening of the stomachs were made through and 
along the greater curvature, any alterations seen along these margins were ignored 
because of the possibility of iatrogenically induced change.
32 3  Sample Areas
The stomachs were quickly placed mucosal side up on a small cork board. They were 
fastened to the board with mapping pins placed along the greater curvature at the 
non-glandular/corpus, corpus/antral and pyloro/duodenal junctions. The cork board 
and stomach were then placed in a Petri dish filled with Kamovsky’s fixative to 
prevent autolysis and permit more leisurely harvesting of tissue for microscopic 
examination. All the samples were cut from the stomach with a single-edged razor
109
Ch a pt e r  3
blade. From one half of the stomach large samples (approximately 0.5xlcm) of 
corpus and antrum were removed and pinned at one end to small pieces of cork to aid 
orientation. These were then placed in fresh Karnovsky’s fixative. From the other 
half of the stomach small pieces of corpus and antrum were removed for light and 
transmission microscopy.
3.2.4 Light Microscopy
Tissue samples were removed from the Petri dish containing Karnovsky’s and were 
immersion fixed in 4% BNF for a minimum of 48 hours. The samples were removed 
from the BNF and processed in a Shandon-Elliot automatic tissue processor on a 24 
hour cycle (Appendix 9.2). Sections were cut at 3-5/xm at right angles to the surface 
and mounted on glass slides. The sections were stained with haematoxylin and eosin 
and periodic acid Schiff & Alcian blue (PAS/Alcian blue). The preparation of stains 
is described in Appendix 9.2.
3.2.5 Scanning Electron Microscopy
The samples were stored in Kamovsky’s fixative for a minimum of 24 hours and 
dehydrated in a series of acetone baths, critical point dried and mounted on 
aluminium stubs (Appendix 9.2). The samples were examined with a Philips 501B 
scanning electron microscope operating at 15 kilovolts. Photographic records were 
obtained with a Steinheil Optronic camera using Ilford FP4 film.
32.6 Transmission Electron Microscopy
Small pieces of tissue approximately 2mm wide and 4mm long were placed in 2.5% 
gluteraldehdye in isotonic sodium cacodylate buffer (0.075M) for more than 48 hours. 
The samples were processed and on the basis of semi-thin sections areas were 
prepared for examination by transmission electron microscopy by ultra-thin sectioning 
(Appendix 9.2). The resulting grids were examined with a transmission electron 
microscope.
110
Ch a p t e r  3
33  Assessment of Samples
3.3.1 Gross Examination
The stomachs were examined on removal and after
they had been pinned out. Evidence of oedema,
erythema and erosions were looked for in the defined 
anatomical regions of the stomach. The findings were 
recorded on an annotated gastric map (Figure 3.1).
3.3.2 Light Microscopy
The surface epithelial cells, mucus layer and luminal contents were examined. 
Evidence of polymorph accumulation at the lamina propria was evaluated by 
examining 4 fields per section at x400 and counting the number of polymorphs
present to give an average. The submucosal blood vessels were examined for
evidence of congestion. The degree of congestion was assessed subjectively (scored 
0-2) on the basis of the volume of blood cells in the veins between the mucosa and the 
muscularis.
Migration of WBCs to the wall of the blood vessels was noted, if more than two WBC 
were found migrating, and if this was present in more than two blood vessels. 
Emigration of white blood cells was also looked for.
The presence of oedema was assessed by measuring the thickness of the submucosal 
layer against the thickness of the epithelial and submucosal layers. The 
measurements were made at three sites and averaged to produce a representative 
ratio. This was done using a 19mm graticule on a 6.3x eyepiece.
The apical epithelial cells and luminal contents were examined. Damage to the 
apical cells was qualitatively graded 0-3 to describe the severity of involvement. The 
thickness of the overlying mucus was noted either as a trace, otherwise it was 
considered to be thick. The cell content of the mucus was evaluated as none/few or 
many.
3.3.3 Scanning Electron Microscopy
Initial assessment concerned the mucus layer thickness and extent of covering. The 
features then looked for were extrusion of surface epithelial cells, rosette formation, 
enlargement of the gastric pits, loss of the normal cobblestone appearance of the 
surface epithelial apical surface, excessive convexity of the individual cells and 
changes in the intercellular junctions (Table 3.1).
lion-glandular
antmtn
Figure 3.1. Gastric map.
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General Individual
mucus covering 
mucus thickness 
extrusion of cells 
rosette formation 
enlargement of gastric pits 
loss of cobblestoning 
contents
prominence of intercellular junctions 
cell convexity
ruffling of apical surface 
apical holes 
apical concavity
apical erosions 
exposure of intracellular
empty cell shells
Table 3.1. Scanning electron microscopy features.
The stubs were examined at a variety of magnifications, and subjective analysis of the 
surface epithelial cell layer was quantified by assigning the observations to a scale 
from 1-5 (Table 3.2).
Further features noted were absence of microvilli, ruffled apical surface, presence of 
a hole in the luminal surface, concavity of the apical membrane, visible intracellular 
contents and the presence of empty cell shells. Each features was looked for was also 
assessed subjectively and ascribed a score from 1-5. The scores from the general 
features and the individual cell features were summed to give an overall score for 
each grouping.
33.4 Transmission Electron Microscopy
The surface epithelial cells were examined with reference to the general integrity of 
the mucosal surface, integrity of the apical membrane, the distribution of the 
subsurface cluster of mucous granules, nuclear chromatin clumping, alterations in 
mitochondria and assessment of tight junctions.
3.4 Data Analysis
Excel v3.0 (Microsoft) was chosen as the method of entry because of an excellent user 
interface and powerful but simple editing tools. The data from the spreadsheets 
were then exported to the following statistical software packages for further analysis, 
Minitab v7, BMDP and GLIM. The statistical tests used were the t-test, 
Polychotomous Logistic Regression and Generalised Linear Models respectively. 
Stastistical significance was set at the 95% level (p<0.05).
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Qualitative score of features on scanning electron microscopy 
1 2 3 4 5
General
mucus covering none sparse few islands profuse complete
mucus thickness no cover thin distinct outline bare outline not visible
cell extrusion occasional few moderate pronounced marked
rosette formation occasional few moderate pronounced marked
enlargement of gastric pits none few moderate pronounced marked
loss of cobblestoning none few moderate pronounced marked
prominent i/c junctions none few moderate pronounced marked
cell convexity none few moderate pronounced marked
[pooled score 1]
Individual
apical ruffling none few moderate pronounced marked
apical holes none few moderate pronounced marked
apical concavity none few moderate pronounced marked
apical erosions none few moderate pronounced marked
exposed i/c contents none few moderate pronounced marked
empty cells none few moderate pronounced marked
[pooled score 2]
i/c  = intracellular
Table 3.2. Definition of scanning electron microscopy scores.
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4. Normal Rats
4.1 Introduction
Grossly, the rat gastric mucosa can be divided into three regions. The corpus is 
separated from the nonglandular portion by a limiting ridge, and the antrum can be 
distinguished from the corpus, being thinner with a yellow hue, unlike the red 
colouration of the corpus (Berg 1942, Robert 1971). Histologically, these two regions 
are different. The fundus has short foveolae and relatively long straight glands, and 
apart from mucous neck cells are lined by substantial numbers of chief and parietal 
cells. In the antrum, the glands have long foveolae and short coiled glands, which 
make it difficult to see a perpendicular section of the gland itself (Harvey 1906, 
Berger 1934, Grossman 1958, Grossman and Marks 1960).
Although the initial work on scanning electron microscopy of the stomach was done 
by Pfeiffer (1970a) in the man and the ferret, work on the rat has shown that his 
descriptions can also be applied to the rat, as there is relatively little difference 
between species (Parisio and Clementi 1976, Harding and Morris 1977). The surface 
epithelial cells present as a sheet of cells covered by mucus (Pfeiffer 1970a), from 
which the mucus can be cleared Wood and Dubois (1981). Even if the mucus is not 
cleared, there are windows that allow inspection of the surface epithelial cells, albeit 
covered by strands of mucus or debris (Harding and Morris 1977). The sheet of cells 
does not have a flat surface because of the intrinsic convexity of individual cells. In 
normal gastric mucosa, two features are noted as the cells age and are discarded. 
The pattern of change appears to be the development of a small hole or defect in the 
apical membrane followed by some collapse of the surrounding membrane producing 
a degree of concavity. The defect enlarges to become an erosion. Extrusion of the 
cell takes place and the surrounding cells encroach to close the gap so created. In 
doing so, the cells adopt a rosette formation (Pfeiffer 1970b, Harding and Morris 
1977).
Transmission electron microscopy shows the surface epithelial cells to be intimately 
linked by desmosomes and tight junctions. The nucleus is located at the base of the 
cell, and apically the mucous granules are clustered beneath the luminal membrane. 
The apical membrane has numerous short microvilli (Lillibridge 1964, Toner and 
Carr 1971, Parisio and Clementi 1976, Kelly and others 1979).
The rat is well established as an experimental animal for use in gastrointestinal 
modelling. However, it seemed wise to establish the normal appearance, grossly 
histologically and ultrastructurally for tissues harvested and processed in our
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laboratories.
4.2 Material and Methods
Fourteen Sprague-Dawley rats were starved, anaesthetised and the pylorus ligated as 
described in section 3.1. Two rats were euthanased immediately. In the remaining 
12, 2ml of isotonic saline were injected into each stomach, to mimic the volume of 
fluid to be used when infusing the stomach with the injurious agents. Of the 12 rats, 
groups of four rats were killed at 2, 5 and 15 minutes post-infusion. The method of 
gross examination and description of the harvesting of tissues is detailed in section 
3.2.
43  Results
43.1 Gross
All but two of the stomachs removed from the rats appeared normal. The corporal 
mucosa was a glistening pink colour, in contrast to the more translucent and yellowed 
appearance found in the antrum. In one rat killed immediately after anaesthesia, a 
small peptic ulcer/erosion was found. It was located in the body of the stomach near 
the corpus/antral border, just off the lesser curvature. The erosion was 2mm in 
diameter, with a crater lined by fresh and changed blood extending onto the 
surrounding mucosa. In a second rat, there was a small 4mm area of reddening on 
the dorsal aspect of the corpus. Six of the rats contained small quantities of what 
seemed to be ingesta.
4 3 3  Light Microscopy
The surface epithelial cells presented as columnar cells covered by occasional thin 
strands of lumenal mucus. On H&E sections the cytoplasm was poorly stained but 
the nuclei were visible at the base. At the tips some of the cells were rather 
triangular in shape with a pinched base. Little or no mucus was evident on the H&E 
sections. A thin coating of mucus was visible, as was periapical intracellular 
accumulation of mucus, when sections were stained with PAS/Alcian Blue. None of 
the sections examined had evidence of areas with apical damage or disruption with 
sloughing of the cells into the lumen (Figures 4.2-4.5).
No time effect was detectable statistically (p<0.05), therefore the results from all the 
rats for oedema, and numbers of WBCs in the lamina propria were pooled. The
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mean scores obtained for oedema in the corpus (0.2) and antrum (0.21) were 
compared and no statistical difference was detectable (p<0.05). A similar lack of 
region effect for WBCs was also confirmed (p<0.05).
In the corpus the mean number of neutrophils was 3.9 (range 1-6), and in the antrum 
4.38 (range 1.5-8). The submucosal vessels showed no evidence of congestion in any 
of the sections examined, and thus were scored zero. Consequently, no WBCs were 
found to be migrating or emigrating through the blood vessels.
A specific section was obtained from the rat with the erosion and this showed 
destruction of the surface epithelium and the proximal part of the glands. The wall 
was fairly sharp, and there was an obvious intense inflammatory infiltrate into the 
base and lamina propria.
Figure 4.1. Gross appearance of normal rat stomach. The mucosa is pinned out and 
the red mark (arrow) is iatrogenic.
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Figure 42. Photomicrograph of corpus of normal rat. (H&E x30)
Figure 4.3. Photomicrograph of corpus of normal rat. (PAS/Alcian Blue xl50).
117
Original in  colour
Ch a pt e r  4
Figure 4.4. Photomicrograph of antrum of normal rat. (H&E xl50).
Figure 4.5. Photomicrograph of antrum of normal rat. (PAS/Alcian Blue x300).
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4.3.3 Scanning Electron Microscopy
The surface of the stomach was seen as a sheet with the cell contour giving a 
cobblestone appearance. On closer examination, the entrances to the foveolae were 
either seen clearly or as indentations in the mucus layer (Figures 4.6-4.8). Individual 
cells were polygonal, with relatively smooth surface at lower magnifications. At 
higher magnifications the surface had a gentle undulating appearance. The 
intercellular junctions were visible as raised ridges surrounding the apical membrane.
There was no time effect or difference between scores for corpus and antrum 
(p < 0.05). The surface epithelial cells were covered by a layer of mucus which did 
not appear in all rats as a complete carpet over the cells (Table 4.1). In eight rats 
the covering was complete or substantially so. However, even in these rats there 
were always windows of exposed sheets of cells. In the rest, the covering was seen as 
scattered islands surrounded by extensive windows (Figure 4.9). These areas had 
little mucus, or only strands covering the cells (Figure 4.10). The thickness was 
assessed by determining how easily the underlay of cells was visible. The thickness in 
each individual rat showed little variation over the area of the stub. However, there 
was some variation between individuals, but all, except three rats, scored less than 4.
Figure 4.6. Scanning electron micrograph (SEM) of normal luminal surface of the rat 
antral mucosa The entrance to a gastric pit is evident with epithelial cells partially 
covered by a lacy mucous overlay. (x2800)
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Features Corpus Antrum
General
mucus covering 3.57 3.14
mucus thickness 2.87 2.57
cell extrusion 1.71 1.36
rosette formation 1.57 1.43
enlargement of gastric pits 1.07 1.00
loss of cobblestoning 1.07 1.00
intracellular junctions 1.71 1.86
cell convexity 1.43 1.50
[pooled score 1] 15.00 ±0.61 13.86 ±0.51
Individual
apical ruffling 1.14 1.50
apical holes 1.36 1.37
apical concavity 1.07 1.21
apical erosions 1.21 1.07
intracellular contents 1.07 1.13
empty cells 1.29 1.29
[pooled score 2] 7.14 ±0.72 7.36 ±0.8
Table 4.1. Scanning electron microscopy scores obtained from normal rats.
In general, extruding cells were not, or only occasionally, seen in nearly all the rats 
(12/14). Scores for rosettes of cells seen in the interfoveolar areas essentially 
matched those given for extruding cells (13/14 scoring 1 and 2) There was no 
evidence of enlargement of the gastric pits. The cobblestone appearance of the 
whole surface was obviously affected by the convexity of the individual cells and the 
scores for both these were small. Excessive convexity of the cells was found in three 
rats, which also had prominent intracellular junctions. However, this appearance was 
focal rather than generalised. In a number of stubs (6/14) small clumps of debris 
were found lying above the general contour of the mucus layer. Degeneration of 
cells in situ was seen occasionally in most of the rats. The individual cellular change 
observed most frequently was apical holes.
Since there was no statistical evidence of a time effect the results for all the rats in 
this group were pooled. The pooled mean scores and standard deviations are given 
in Table 4.1.
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Figure 4.7. SEM of normal corpus. The surface cells are outlined beneath the 
mucous layer. (x720)
Figure 4.8. SEM of normal corpus On the mucus layer strands of mucus can be seen. 
(x!440)
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Figure 4.9. SEM of a mucus window. (x720)
Figure 4.10. SEM of the surface epithelium. Strands of mucus overlie the epithelial 
cells, an intercellular junction is visible (arrow). (xl440)
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43.4 Transmission Electron Microscopy
The nuclei of the cells were located at the base of the cell. The various organelles 
were distributed throughout the cytoplasm between the nucleus and the apical area. 
The apical membrane in many cells had small intraluminal projections or microvilli, 
and beneath this membrane were aggregations of mucous secretion granules. The 
tight junctions and desmosomes were all intact (Figures 4.11-4.12).
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Figure 4.11. Transmission electron micrograph (TEM) of the surface epithelium of 
the normal rat mucosa (x5400).
Figure 4.12. TEM showing the normal dense aggregations of discoid mucous granules 
found at the apex of surface epithelial cells (xlOOOO).
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4.4 Discussion
The gross appearance of the mucosa was normal in all but two rats, lacking any 
evidence of hyperaemia and with clear divisions between the darker fundus and the 
pale antrum (Robert 1971). Histologically, the surface epithelium was intact with the 
occasional cell with a pinched base at the tip of a foveola, presumably in the process 
of being ejected, and a few leucocytes in the submucosa (Kammeraad 1942). 
Scanning electron microscopy showed the surface epithelium as a sheet of cells with 
an undulating surface caused by the slightly bulging apical membranes that gave the 
overall surface a distinct cobblestone appearance (Ogata and Murata 1969, Harding 
and Morris 1977). The mucus covering was more or less complete and relatively thin 
in most of the rats. Surprisingly very few extruding cells were seen, considering that 
the surface cell layer is a dynamic covering, with cell turnover every 3 days (Leblond 
and Walker 1956, Messier 1960, Baker 1964). Where a few rats had exaggerated 
bulging apical membranes causing some noticeable convexity, this feature was focal 
and not generalised. Transmission electron microscopy confirmed the healthy nature 
of the surface cells with sub-apical accumulations of mucus granules and the nucleus 
with a relatively even density.
No attempt was made to remove the mucus covering on the surface of the stomach 
other than to flush away surface debris. This is worthy of explanation. In one of the 
earliest descriptions of the surface topography of gastric mucosa using scanning 
electron microscopy, Pfeiffer (1970a) noted that precipitated strands, globules and 
flakes of mucus could be observed on the gastric surface, and that in areas, mucus did 
obscure the microvilli of the surface epithelial cell. He also found that the surface 
topography in man and the laboratory ferret were essentially similar and this masking 
effect of mucus was present in both species. Consequently, there is a question mark 
over the value of removing the mucus as it forms part of the normal appearance of 
the gastric mucosa. A few reports specifically state that no attempt was made to 
remove mucus, despite the masking feature of mucus in parts of the scanned stubs 
(Baskin and others 1976, Harding and Morris 1976). But in most publications 
reporting the use of scanning microscopy of the luminal surface, no mention is made 
of the subject of the mucus layer as far as specimen preparation is concerned 
(Frenning 1973, Zoli and others 1986). Takagi and others (1974) in attempting a 
systematic survey of the normal foetus and adult stomachs, coupled with some 
pathological conditions in the adult, decided to remove the mucus layer after fixation. 
This was done by twice washing the specimens in fixative with an ultrasonic unit 
operating at a frequency of 28kHz for 30-60 seconds. They felt that this removed 
more of the mucus and was safer than the spray method. Parisio and Clementi 
(1976) and Trabucchi and others (1986) adopted a different technique for mucus
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removal. First they washed the surface with saline to allow gross examination, then 
continued washing for a further 15 minutes in saline with N-acetyl-L-cysteine. 
However, Fallah and others (1976) compared various washing solutions used before 
fixation and found that they produced surface alterations in the canine stomach. 
Continuing in the same vein, Wood and Dubois (1981) compared, brushing - which 
left abundant coating material and caused denuding and rupture of the SEC, 
acetylcysteine - which removed little material, and glycosidase coupled with 
mechanical agitation - which seemed to achieve the best results. In contrast, Al- 
Tikriti and others (1986), using tissues from cats, compared flushing with saline alone, 
brushing with a cotton bud and washing and rubbing the mucosa with a surgically 
gloved hand. Their findings suggested that washing and rubbing with a gloved hand 
to remove mucus was successful, and did not damage the underlying cells. Jet action 
with fixative was used by Fringes, Lorenz and Oehlert (1979), though no comment 
was made of the efficacy of this course of action. Ohno, Ohtsuki, Okabe (1985) 
found that vigorous spraying with phosphate buffered saline was needed to remove 
adherent mucus.
Thus there is no established technique for the removal of mucus that does not run the 
risk of damaging the underlying cells. Since the mucus layer is considered to be an 
essential component of the barrier (Allen and Garner 1980), it seemed prudent not to 
interfere with that aspect of the barrier, nor to run the risk of damaging the 
underlying cells. This leaves one open to the argument that by not removing the 
mucus layer, surface cell change may be being masked. However, it is recognised 
that even in the normal stomach there are discontinuities in the mucus layer through 
which one can gain an appreciation of the surface cells (Morris 1985). Indeed these 
windows may in fact be due to preparation of the specimens, rather than actual 
defects in the unprepared tissue and by altering the preparation of tissues it is 
possible to increase the mucus coverage on a section (Morris and Harding 1974). 
Bollard and others (1986) pointed out that mucus is a hydrated complex of 
glycoproteins. The usual techniques for histology, and more importantly for scanning 
electron microscopy, result in the dehydration of the mucus, which may result in loss 
or distortion of the mucus layer. It was decided not to attempt to remove the mucus 
layer in the study of the stomach of the rats
Further, later work was aimed at examining the effect of sucralfate on the physical 
barrier and to have removed the mucus would have obviated part of that evaluation.
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The range of change seen in these sections with scanning electron microscopy was 
rather restricted. In situ degeneration was visible in a small number of cells with a 
hole in the centre of the apical surface and other groups of cells in rosettes, indicating 
progression. These changes have been established as normal (Pfeiffer 1970b).
Pfeiffer (1970a) and Frenning (1973) amongst others have described what they took 
to be microvilli on the surface at very high magnifications. Microvilli were seen on 
many stubs of the normal rats gastric mucosa, but it was not possible generally to 
bring these into sharp focus on the machine being used, and so no further attention 
was paid to this feature of the cell because of the difficulty of ascribing change to the 
machine, and/or, to the experiment. Indeed, Parisio and Clementi (1976) found that 
microvilli were not homogeneously distributed amongst cells.
In two rats the gross appearance was not considered normal. The erosion that was 
visible grossly was seen by light microscopy as a typical chronic erosion, with 
significant localised epithelial loss and pronounced surrounding leucocyte infiltrate. 
In the other rat, there was no histological evidence to support the gross finding of 
reddening. It is possible that either the suspected area was not accurately sampled, 
or that it was a visual artefact created by an anomaly in that particular rat, for 
example vascular.
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5. Challenged Rats
5.1 Introduction
It is strange that of all the organs of the body, the stomach must defend itself against 
such an inimical environment, particularly as this circumstance is self-generated. The 
stomach produces acid that serves to destroy ingested organisms and transform 
pepsinogen into the proteolytic enzyme pepsin. This combination creates an 
environment that axiomatically must be countered by the stomach itself in order to 
prevent autodigestion. The stomach is able to do this by regulating, in co-operation 
with other parts of the body, the production of acid and enzyme precursor 
(Andersson, Nilsson and Uvnas 1967, Elwin and Uvnas 1967, Walsh and Grossman 
1975, Albinus and others 1977). The main stimulants of secretion are, of course, 
expectation of and actual ingesta. These stimuli serve to enhance the two secretions 
(Feldman and Richardson 1986). The stomach is able to protect itself against these 
two by several methods. The stomach wall becomes more resistant to the back- 
diffusion of hydrogen ion by actively secreting acid (Moody and Davis 1970, Fromm, 
Silen and Robertson 1976, Smith and others 1977). Additionally, the stomach will be 
under the influence of gastrin that not only stimulates acid secretion, but is also 
thought to tighten the gastric mucosal barrier and minimise back-diffusion of 
hydrogen ions (Wlodeck and Leach 1966). The mucus, a covering mixture of 
glycoproteins, water and bicarbonate ions, forms a hydrophobic barrier resisting the 
incursion of acid, pepsin and other ingested materials, creating a gradient against 
which incoming hydrogen ions are buffered and a layer against which pepsin will 
dissipate (Hollander 1954, Allen and Garner 1980, Hills, Butler and Lichtenberger 
1983). The gross function of the stomach helps in this process, serving as a transient 
repository for incoming ingesta. This ingesta furnishes a large volume of material, 
which admittedly stimulates these relatively noxious secretions in the first place, to 
dilute and neutralise the secreted acid and pepsin. Luminal contents are constantly 
being churned to ensure thorough mixing of the food, acid and pepsin, and thence 
forced from the stomach into the more neutral environment of the small bowel 
(Cannon 1898). Here secreted bile is then mixed with the outpourings from the 
stomach (Jensen 1980, Guyton 1981). Unfortunately, this bile can also reflux back 
into the stomach. In the normal animal, this situation tends to occur during 
alimentation and thus the bile is diluted by the contents of the stomach, and it does 
not remain there for long before being returned to the duodenum (Ehrlein 1981), and 
in the normal human, at least, is present in only small concentrations in the region of 
0.13mM (Rhodes and others 1969). Reflux movement of bile may also occur 
"normally" during alimentary upset when vomiting occurs, due to retrograde peristalsis
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(Alvarez 1925, Thompson and Malagelada 1982, Lee, Park and Chey 1985, Lang, 
Sama and Condon 1986).
Nevertheless, not only is bile refluxed into the stomach in patients who have had 
diversional surgery (Keighley, Asquith, and Alexander-Williams 1975, Heading 1983), 
but also by normal animals when the stomach is empty. In man, proof has come from 
normal conscious volunteers (Rhodes and others 1969), whilst the evidence for this in 
animals comes from anaesthetised or sedated animals (Happ6 and van den Brom 
1982).
Thus the stomach may be confronted by three inimical body-generated agents, 
namely; acid (yielding a pH of 1), pepsin and bile. Whilst the bulk of the material 
swallowed by animals, including man, tends to be somewhat neutral as far as acidity 
and chemical activity are concerned, both take or are given products that, despite 
their recognised therapeutic benefits, are more than capable of injuring the stomach. 
Against this background it has long been recognised that one of the most common 
drugs taken and still taken in large quantities is aspirin (Hammond 1971). Aspirin 
(acetylsalicylic acid) may be considered the progenitor of the class of drugs known as 
non-steroidal anti-inflammatory drugs. Acetylsalicylic acid, distinguished for its 
antipyretic properties for many years, was also recognised as being potentially 
harmful to the stomach (Dodd, Minot and Arena 1930). Work by Martin (1963) 
defined quite clearly that because of the nature of aspirin as a molecule having a pKa 
value of around three, that in the stomach most of the ingested aspirin would be in an 
undissociated form, and as Davenport (1964), pointed out would therefore be lipid 
soluble and able to move through the membrane of the surface epithelial cell. There 
in the more neutral intracellular environment the aspirin becomes ionised and more 
chemically active. Garner (1978) has shown, using 20mM aspirin, that high 
concentrations of aspirin were found in the cells of the upper part of the mucosa 
within 10 minutes, though tending to dissipate after 30 minutes.
Precise evidence has emerged that whilst this influx of aspirin can take place in the 
stomach, the damage done by this drug is singularly enhanced by the presence of acid 
(Brodie and Chase 1967). The reasons for this are twofold. First, the acid generates 
a pH environment that is most accommodating for the formation of the lipid soluble 
form of the agent. Second, should aspirin damage the epithelium, it then permits the 
back-diffusion of hydrogen ions from the lumen that do much of the additional injury 
(Davenport 1967a), compounded by the increase in pepsin output engendered by the 
back-diffusion of acid (Johnson 1971). The main mode of action in the damage 
generated by aspirin is the suppression of prostaglandins produced by the stomach to 
moderate the defensive mechanisms of the gastric barrier (Miller and Jacobson 1979,
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Miller 1983). The consequence is that aspirin will sweep aside the normal 
cytoprotective influences. Whilst maintaining the gastric barrier prevents deep 
mucosal injury, the superficial or surface epithelium suffers, as has been 
demonstrated ably by Hingson and Ito (1971) using electron microscopy.
There has been a deluge of new NSAIDs over the last 20 years, to compete in the very 
lucrative market for anti-inflammatory drugs (Simon and Mills 1980ab). Each 
succeeding drug is synthesized to be more powerful and hopefully with fewer side- 
effects, and perhaps work in those patients who appear to be unresponsive to other 
NSAIDs (O’Brien and Bagby 1987). Whilst this is laudable, it is unfortunate that this 
side-effect profile is not always the case. An example is the belated discovery of the 
intense and, in some cases, permanent photo-sensitizing effect that "Opren" (Eli Lilly) 
had on many users. Indomethacin, in man, is a powerful NSAID and a potent 
suppressor of the generation of prostaglandins in the alimentary tract (Levine and 
Schwartzel 1984). Though, this drug has found a niche in the human market, its 
untested use in the dog resulted in anecdotal reports of the induction of severe 
gastrointestinal bleeding in many dogs, but only one precise report (Ewing 1972). 
These examples serve to highlight the variation in inter-species response to these 
potent drugs, which is frequently underestimated.
Carprofen (pKa4.7) is a recent non-steroidal anti-inflammatory agent with 
pronounced anti-inflammatory and analgesic effects. It’s anti-inflammatory, 
analgesic and anti-pyretic activities were identified by Randall and Baruth in 1976. It 
has a half-life in dogs of 40 hours compared to 13-26 hours in man (Rubio and others 
1980, Brogden 1986), and is rapidly absorbed following oral administration (Schmitt 
and Guentert 1990). The introduction of carprofen has been mooted as a NSAID 
that would have the required potency as far as the control of arthritis is concerned, 
but have minimal gastric irritancy. Strub, Aeppli and Muller (1982) have shown 
carprofen to have marked anti-inflammatory and analgesic effects. In experimental 
animals intestinal ulcers were the only recognisable gross side-effect. The relative 
lack of ulceration was related to the poor inhibition of prostaglandin synthesis. As 
far as PGE2 is concerned, a prostaglandin associated with the gastrointestinal tract, a 
lack of inhibition in the stomach has been reported by Frolich and others (1984). 
However, carprofen will suppress another prostaglandin, PGF2a, in the stomach to 
the same extent as indomethacin, and also in the post-partum cow, carprofen, just like 
indomethacin, has been shown to reduce the levels of PGE2 in the synovial fluid 
(Minuz and others 1986, Thun and others 1989, Seppala and others 1990).
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Aim
Thus it was determined to examine and compare the short-term effects (minutes), 
rather than the long-term (hours), of acid, bile and aspirin on the gastric mucosa, and 
compare any effects to those obtained with aspirin. Further, the additive effect of 
bile with these two NSAIDs was also to be studied.
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5.2 Material & Methods
Pairs of Sprague-Dawley rats were starved, anaesthetised and the pylorus ligated as 
described in section 3.1. Pairs were killed at 2, 5 and 15 minutes post-infusion. The 
method of gross examination and description of the harvesting of tissues is detailed in 
section 3 2.
The agents used were hydrochloric acid, sodium taurocholate (Sigma Chemical 
Company), acetylsalyclic acid {Aspirin lg  B.P.) and carprofen (Imadyl 150mg 
Hoffman-La Roche).
The rats were divided into three groups. Rats in Group I received hydrochloric acid 
or a single injurious agent. Those in Group II and Group III received a combination 
of injurious agents. The agents and combinations used are shown in Tables 5.1-5.4.
Agent concentrations
hydrochloric acid (HC1) 0.05N 0.1N
sodium taurocholate (bile) 2.5mM 5mM
aspirin 20mM 40mM
carprofen 0.23mM 0.46mM
Table 5.1 Group I. Single injurious agent concentrations given to rats.
Agent concentrations
aspirin & bile 20mM & 2.5mM
aspirin & bile 20mM & 5.0mM
Table 52  Group Ila. Aspirin combinations used in rats.
Agent concentrations
carprofen & HC1 0.23mM & 0.05N 0.23mM & 0.1N
carprofen & HC1 0.46mM & 0.05N 0.46mM & 0.1N
carprofen & bile 0.23mM & 2.5mM 0.23mM & 5mM
carprofen & bile 0.46mM & 2.5mM 0.46mM & 5mM
Table S3  Group lib. Carprofen combinations used in rats.
Agent concentrations
carprofen & HC1 & bile 
carprofen & HC1 & bile
0.23mM & 0.05N & 2.5mM 
0.46mM & 0.1N & 5mM
Table 5.4. Group III. Triple injurious combinations given to rats.
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53  Results
53.1 Gross Appearance
5.3.1.1 Single Agents 
Acid
With one exception, no gross change was evident in any of the rats exposed to either 
0.05N or 0.1N HC1. The exception was a rat given 0.05N HC1 acid where there was a 
generalised erythema after 15 minutes exposure in both the corpus and antrum.
Bile
There was no alteration detectable after 2 minutes exposure to bile at either 2.5mM 
or 5mM. In one rat after 5 minutes exposure to 2.5mM bile, there was a generalised 
erythema restricted to the corpus with widespread pin-point areas of deeper 
reddening. This change was not observed in the second rat, nor was it repeated at 
the same time interval in those rats exposed to 5mM bile. This concentration (5mM) 
and time interval only produced a focal mild reddening of corpus. More consistently 
were the findings after 15 minutes exposure. Bile at 2.5mM caused patchy erythema 
of the mucosa of the corpus, and at 5mM the erythema was widespread, though still 
visually mild. In summary, the changes detected were of erythema that appeared to 
be more time constrained than a consequence of concentration.
Aspirin
No gross change was demonstrable at either 20mM or 40mM at any of the three 
exposure times (Figure 5.1).
Carprofen
With 0.23mM carprofen there was reddening of the antral mucosa in 5/6 rats. This 
was widespread in 3/5 rats, but localised to the corporo-antral margin in the other 
two. At 15 minutes, there was no change in one rat and a localised intense change in 
the other. When 0.46mM carprofen was used the reddening was again centred on the 
corporo-antral margin, but accompanied by linear streaking in 4/6 rats. Time did not 
seem to make any difference to the gross change (Figure 5.2).
5.3.1.2 Combination o f Agents 
Aspirin & Bile
All rats exposed to 2.5mM bile/20mM aspirin showed erythematous change in both 
antral and corpal regions. In all rats it appeared moderate, with the exception of one 
rat where after 15 minutes the alteration was classified as mild. In the corpus, the 
reddening was extensive in contrast to the antral area where the change was more
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focal in nature. The corpus of one rat after 5 minutes, also had what could be 
described as a cobblestone glistening appearance, ascribed to mucosal oedema.
When the concentration of bile was increased to 5mM in combination with 40mM 
aspirin the erythema was again widespread in the corpus varying from a mild after 5 
minutes to a severe reddening at 15 minutes. However, in the antrum the reddening 
was again somewhat localised and gave the impression of linear streaking on the rugal 
crests. Therefore, there appeared to be a time and concentration effect.
Carprofen & Acid
The level of reddening was much less intense in the rats given carprofen 
0.23mM/0.05N HC1 than was seen in those rats given carprofen alone. Furthermore, 
the area of involvement was more focal in nature, essentially restricted to the antrum. 
Oedema was apparent in one rat after 15 minute along the incisure. A linear streak 
was found in the antrum of one rat after 5 minutes. Increasing the concentration of 
acid served to extend the area of reddening into the corpus, but linear streaks were 
again found in only one 5 minute rat.
Doubling the concentration of carprofen to 0.46mM coupled with 0.05N HC1 caused 
reddening of the mucosa around the corporo-antral junction, which involved 
progressively more of the mucosa of the corpus as the time interval was increased 
from 2 minutes to 15 minutes. Linear streaking was only observed in one rat after 5 
minutes exposure, and in the second 5 minute rat the rugae were more prominent 
than in other rats: there was also oedema in this rat. Applying 2ml of fluid containing 
0.46mM carprofen/O.lN acid to the gastric mucosa resulted in essentially the same 
changes as those detected with lesser concentrations of carprofen and acid. There 
was widespread reddening of the corpus and antrum centred on the corporo-antral 
junction, with no linear streaking in the antrum.
Carprofen & Bile
A solution of carprofen (0.23mM) and bile (2.5mM) produced a similar degree of 
reddening of the mucosa to that caused by carprofen and acid. Four of the six rats 
had generalised hyperaemia of the corpus mucosa, but in only one (15 minute) did 
this extend to include the antrum, where it was widespread. In two further rats there 
were single focal areas which resembled erosions. Oedema was a notable feature 
being present in 5/6 rats. Linear erosions were not however seen in any rat.
Doubling the concentration of either the bile (5mM) or carprofen (0.46mM) made no 
appreciable difference to the range of hyperaemia and oedema noted in the corpus. 
However, antral hyperaemia was seen in 2/6 rats with doubled concentration of bile. 
In those rats given carprofen 0.46mM there was a focal reddening in 4/6, with the
134
C h a p t e r  5
other two having widespread involvement at 5 and 15 minutes.
Further, the application of a solution containing 0.46mM carprofen and 5mM bile 
caused a more intense reddening of the mucosal surface when compared subjectively 
to that seen with other mixtures of bile and carprofen. This change affected all six 
rats and was accompanied by oedema in 3/6, with erosions in the corpus in two of 
these rats (Figure 5.3).
Carprofen & Acid & Bile
Solutions containing either 0.23mM carprofen/2.5mM bile/0.05N acid or 0.46mM 
carprofen/5mM bile/0. IN acid produced much more marked change. The mucosa 
was a deeper red and involved the complete surface of the corpus. In the antrum the 
presence of linear erosions was noted in 10/12 rats. The solution containing the 
higher concentration produced corporal pin-point erosions superimposed upon the 
generalised hyperaemia at 15 minutes.
In summary, the single agents produced sparse evidence of grossly visible mucosal 
change, with the most consistent change being produced by those rat given carprofen. 
The addition of acid to carprofen also produced reddening of the mucosa, particularly 
in the antrum, with the development of what appeared to be linear erosions in some 
rats. Carprofen/bile caused reddening of the corpus, which spread to involve the 
antrum as time and concentrations were increased. Bile and aspirin produced 
hyperaemia in both corpus and antrum and at the higher concentrations caused some 
linear streaking. The effect of using triple concentrations was to enhance the 
reddening induced in the mucosa and produce in nearly all the rats linear erosions 
and some pin-point erosions at the higher concentrations.
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Figure 5.1. Gross appearance - aspirin.The normal colour of the corpus and antrum is 
unchanged.
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Figure 52. Gross mucosal appearance - 0.46mM carprofen. There is deepening of 
the colour of mucosa at the corporo-antral border causing loss of the normally distinct 
margin.
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Figure S3. Gross mucosal appearance - 0.46mM carprofen & 5mM bile. There is 
marked reddening of both corpus and antrum.
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532  Light Microscopy
(See Figures 5.5-50.17)
5.3.2.1 Oedema
In group I, four potentially injurious agents were injected singly into the stomachs of 
paired rats. No time effect was detectable with the oedema scores obtained from the 
corpus and antrum of the rats given single injurious agents. The scores were also 
compared to those obtained from the control rats (Table 5.5). There was no 
observable difference in tissue taken from the corpus of rats given single injurious 
agents. However in the antrum, there was a statistically significant (p < 0.05) increase 
in oedema score for the antrum of rats given aspirin 40mM and carprofen at 0.23mM. 
Comparison of the different concentrations of individual agents showed that there 
was no difference in the oedema score generated with acid, aspirin, bile or carprofen, 
but 40mM aspirin induced a higher score than 20mM aspirin (p<0.05).
The scores generated by carprofen were compared to those from the other single 
agents. In the corpus there was no difference between agents. In the antrum, the 
scores were also similar for acid, bile concentrations. However, 40mM aspirin and 
0.23mM carprofen produced significantly higher scores than the other agents, though 
there was no difference between the these two.
In group Ha combinations of aspirin and bile were placed in the stomachs of the rats 
(Table 5.5). No time effect was demonstrable in the corpus or antrum. When the 
two combinations were compared with each other there was a significant difference in 
the antrum only, with 40mM aspirin/5mM bile producing a higher score than the 
lower concentration combination. This same antral effect was evident when the 
higher concentration of aspirin/bile was compared with corresponding single agents, 
but not with the lower concentration combination.
In group lib the effect of adding different agents and concentrations to carprofen was 
tested (Table 5.6). No time effect was demonstrable amongst this group of 
combinations, nor were there any significant differences between corpus and antrum. 
Almost all combinations of carprofen induced more oedema in the corpus and antrum 
compared with the controls. The exceptions were 0.23mM carprofen & 0.05N HC1 
and 0.46mM carprofen & 2.5mM bile.
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Group Agent mean corpus ±sd mean antrum ±sd
Control none 0.18 0.01 0.19 0.01
Iiyuiy
Group I IA1 0.24 0.03 0.22 0.09
IA2 0.24 0.03 0.26 0.08
IB1 0.23 0.07 0.23 0.06
IB2 0.20 0.07 0.26 0.08
IS1 0.24 0.06 0.24 0.06
IS2 0.24 0.01 0.32 0.08
IR1 0.22 0.10 0.30 0.07
IR2 0.23 0.04 0.24 0.04
Group Ila IS1B1 0.23 0.06 0.24 0.06
IS2B2 0.25 0.06 0.34 0.04
Group lib IR1A1 0.22 0.03 0.28 0.03
IR1A2 0.26 0.04 0.28 0.02
IR2A1 0.24 0.03 0.28 0.02
IR2A2 0.24 0.04 0.29 0.05
IR1B1 0.26 0.06 0.30 0.04
IR2B1 0.24 0.05 0.28 0.03
IR1B2 0.25 0.04 0.30 0.04
IR2B2 0.25 0.04 0.30 0.04
Group III IR1B1A1 0.25 0.02 0.30 0.04
IR2B2A2 0.28 0.04 0.27 0.03
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric acid, B1 & B2 =2.5mM & 5mM bile, SI & S2 =20mM 
& 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen
Table 5.5. Oedema ratios determined by light microscopy for those rats given 
injurious agents.
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agent vs agent
corpus antrum 
(p<0.05)
IR1A1 none ns S
IR1A2 none S S
IR2A1 none S s
IR2A2 none s s
ER1B1 none s s
IR2B1 none ns s
IR1B2 none S s
IR2B2 none S s
IR1A1 IR1 ns ns
IR1A1 LAI ns s
IR1A2 IR1 ns ns
IR1A2 IA2 ns ns
IR2A1 IR2 ns ns
IR2A1 LAI ns S
IR2A2 IR2 ns S
IR2A2 IA2 ns ns
IR1B1 IR1 ns ns
IR1B1 IB1 ns S
IR2B1 IR2 ns ns
IR2B1 IB1 ns ns
IR1B2 IR1 ns ns
IR1B2 IB2 S S
IR2B2 IR2 S ns
IR2B2 IB2 ns S
IR1B1 IS1B1 ns S
IR2B2 IS2B2 ns ns
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 = 2.5mM & 5mM bile, SI & S2 
= 20m M & 40m M aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen
Table 5.6. Oedema ratios. Comparison of carprofen combinations with other 
injurious agents and combinations.
There were few differences between the ratios induced by single agents and carprofen 
combinations. The limited number of combinations that did show increased ratios did 
so mainly in the antrum (6/8). Those combinations that did show an increase in 
ratios over single agents in the antrum were found slightly more often among the bile 
combinations. It was only amongst carprofen and bile combinations that there 
appeared to be higher corporal oedema ratios than were found with the single agents 
that made up the combination. When the carpofen/bile combinations were 
compared to the equivalent aspirin/bile mixtures, there was only a difference between
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the lower carprofen/bile and asprin/bile mixtures in the antrum.
In group III, rats were given triple combinations of injurious agents (Table 5.5). 
Again no time effect was evident. No difference was detectable between the corpus 
and antrum or between the lower and higher concentrations used in the two triple 
combinations. The lower concentrations were compared with rats given single or 
double injurious agents at the same concentrations (Table 5.7). No differences were 
found between double agents and the triple agents as far as oedema was concerned. 
Comparison with single agents provided sparse evidence of an additive effect. In the 
antrum, there was a significant difference between those rats given acid or bile and 
those given carprofen 0.23mM with bile 2.5mM and acid 0.05N, and in the antrum 
when this combination was compared to bile at 2.5mM. At the higher concentration 
blend the only significant effect was when this blend was compared to bile in the 
antrum.
agent vs agent
corpus antrum 
(p < 0.05)
IR1B1A1 LAI ns S
IB1 S S
IR1 ns ns
IR1A1 ns ns
IR1B1 ns ns
IR2A2B2 IA2 ns ns
IB2 S ns
IR2 ns ns
IR2A2 ns ns
IR2B2 ns ns
I = injury, A1 & A2 =0.05N & 0.1N hydrochloric acid, B1 & B2 =2.5mM & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen
Table 5.7. Oedema ratios. Comparison between triple combinations and
single or double agents.
5.3.12 White Blood Cells
There appeared to be a time effect as far as infiltration into the submucosa was 
concerned. However, this was only really apparent after 15 minutes exposure. This 
time effect was found in 10/20 combinations in both the antrum and the corpus. In 
general, if a time effect was noted in the corpus, a corresponding time effect was 
demonstrable in the antrum. The exceptions to this were 0.46mM carprofen and 
0.46mM carprofen & 0.05N HC1 where no antral time effect was found, and the triple
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combinations that had no corporal time effect. Excluding the triple agent 
combination, there was no time effect in 5/6 combinations that included bile. Time 
effect was noted in all those combinations where acid was present. There was little 
difference between the 2 and 5 minute samples, as the time effect was largely 
restricted to the 15 minute sample.
To aid analysis, the WBC counts for each combination were pooled regardless of time 
effect (Table 5.8). This was to determine if there was any difference between the 
numbers found in the corpus and the antrum with various combinations. The results 
are also shown graphically in Figure 5.4.
Group Agent corpus ±sd antrum ±sd
Normal Rat 3.90 1.50 4.38 2.07
Group I LAI 9.21 2.76 11.00 2.41
IA2 10.00 2.10 10.80 4.59
IB1 8.21 1.49 11.00 2.62
IB2 13.00 2.62 8.29 3.59
IS1 6.80 3.58 16.10 4.61
IS2 10.50 3.92 14.60 6.37
IR1 15.56 5.46 14.50 6.10
IR2 3.75 2.73 3.63 2.14
Group Ha IS1B1 9.50 1.82 8.13 2.21
IS2B2 13.50 3.01 12.90 2.49
Group lib IR1A1 3.71 1.26 3.00 1.84
IR1A2 12.80 6.68 9.75 4.64
IR2A1 5.75 2.98 4.92 1.04
IR2A2 5.00 2.00 5.75 2.38
IR1B1 4.50 0.84 4.46 1.60
IR2B1 4.38 133 3.29 1.17
IR1B2 7.08 2.09 11.30 4.04
IR2B2 4.96 0.89 5.64 1.20
Group III IR1A1B1 5.60 0.78 6.89 3.62
IR2A2B2 6.99 238 8.05 3.03
I = injury, A1 & A2 =0.05N & 0.1N hydrochloric add, B1 & B2 =2.5mM & 5mM bile, SI & S2 =20mM 
& 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen
Table 5.8. Mean white blood cell infiltrates found with different injurious agents.
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Figure 5.4 shows the numbers of WBCs in corpus tended to mirror those found in the 
antrum. Significant differences were only found with bile (5mM) which had more 
infiltration in the corpus, whereas both concentrations of aspirin had greater antral 
infiltrate.
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I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric acid, B1 & B2 =2.5mM & 5mM bile, SI & S2 = 20mM 
& 40mM aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen.
Figure 5.4. Bar graph of white blood cell numbers found in rats given injurious 
agents.
There were significant increases in the number of WBCs in both corpus and antrum 
when the single agents were compared to the control rats in most instances. In the 
antrum only those rats given 0.46mM carprofen had similar numbers as the control 
rats, and similarly in the corpus of those given 20mM aspirin and 0.46mM carprofen 
(Table 5.9).
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agent vs agent
corpus antrum 
(p<0.05)
LAI control S S
IA2 control S S
IB1 control S S
IB2 control S S
IS1 control ns S
IS2 control S S
IR1 control S S
IR2 control ns ns
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 = 2.5mM & 5mM bile, SI & S2 
=20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen. S = significant, ns=not 
significant
Table 5.9. White blood cell infiltrate. Rats given single injurious agents 
compared to control rats.
When the double combinations were compared with the controls, there was a more 
varied response, which could not be related to the constituent agents or area. Five of 
the 12 combinations had a significant increase and the remaining seven did not.
The WBC counts for carprofen were compared with the other single agents. Against 
carprofen 0.23mM, the numbers found in the other single agents were significantly 
less. In contrast, against 0.46mM carprofen, the numbers for the other agents were 
significantly more.
agent vs agent
corpus antrum 
(p<0.05)
IR1 LAI S S
IR1 IB1 S S
IR1 IS1 S ns
IR2 IA2 @S @S
IR2 IB2 ns @S
IR2 IS2 @s @s
I= injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 =2.5mM & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen. S = significantly more, 
ns=not significant, @S = significantly less.
Table 5.10. WBC counts. Comparison between carprofen and single agents.
The combinations of aspirin and bile from Group Ha were compared with control rats 
and those given the constituents as individual agents. Against the controls both 
aspirin/bile combinations produced a significant increase in the number of WBCs
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found in the corpus and antrum. In contrast, the effect of 20mM aspirin & 2.5mM 
bile was no different to that produced by the single agents. When the higher (5mM) 
concentration of bile was used, there was a significant difference in all areas, except in 
the antrum when compared with 40mM aspirin alone.
agent vs agent
corpus antrum 
(p < 0.05)
IS1B1 control S S
IS2B2 control S S
IS1B1 IS1 ns ns
IS1B1 IB1 ns ns
IS2B2 IS2 S ns
IS2B2 IB2 S S
I = injury, B1 & B2 =2.5mM & 5mM bile, SI & S2 =20mM & 40mM aspirin, S = significant, 
ns=not significant.
Table 5.11. WBC count. Comparison of aspirin combinations.
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agent vs agent
corpus antrum 
(p<0.05)
IR1A1 control ns ns
IR1A2 control S S
IR2A1 control ns ns
IR2A2 control ns ns
IR1B1 control ns ns
IR2B1 control ns ns
IR1B2 control S S
IR2B2 control ns ns
IR1A1 LAI @s @s
IR1A1 IR1 @s @s
IR1A2 IA2 ns ns
IR1A2 IR1 S S
IR2A1 LAI ns @s
IR2A1 IR2 ns ns
IR2A2 IA2 @s ns
IR2A2 IR2 ns ns
IR1B1 IB1 @s @s
IR1B1 IR1 @s @s
IR2B1 IB1 s s
IR2B1 IR2 ns ns
IR1B2 IB2 ns ns
IR1B2 IR1 S ns
IR2B2 IB2 @s @s
IR2B2 IR2 ns ns
IR1B1 IS1B1 @s @s
IR1B2 IS2B2 @s ns
I = injury, A1 & A2 =0.05N & 0.1N hydrochloric add, B1 & B2 =2.5mM & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen, S = significant, ns = not 
significant, @S = significantly less.
Table 5.12. WBC count. Comparison of carprofen with controls, single agents 
and aspirin combinations.
The comparison between carprofen combinations with controls and other agents is 
shown in Table 5.12. When the combinations from Group II were compared with 
control rats, significantly more WBCs were found only in those rats given 0.23mM 
carprofen & 0.1N HC1 and 0.23mM carprofen & 5mM bile. This difference was 
apparent in both corpus and antrum.
When carprofen plus a second agent was compared with the single agents significantly 
fewer cells were apparent in a number of instances. Against the individual agents,
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three of the four 0.23mM carprofen & acid combinations showed significantly fewer 
in WBCs in both the antrum and corpus, the exception being carprofen and 0.1N HC1. 
With the higher concentration of carprofen (0.46mM) and acid significantly smaller 
counts were noted only in the antrum when compared with 0.05N and corpus with 
0.1N HC1.
Fewer WBCs were also found when the carprofen/bile combinations were compared 
with single agents. This was the case in both the corpus and antrum of those rats 
given 0.23mM carprofen & 0.05N HC1 when compared with carprofen 0.23mM, and 
0.05N HC1. When the concentration of bile was increased, change was only noted in 
the corpus when compared with 0.23mM carprofen, indicating a bile effect. When 
the carprofen concentration was increased to 0.46mM and compared, lower cell 
counts were apparent only when compared with bile in both antrum and corpus. No 
change was evident when 0.46mM carprofen & bile was compared with carprofen 
alone.
The highest and lowest carprofen/bile combinations were also compared with similar 
combinations of aspirin and bile. Significantly less WBCs were found in the corpus 
and antrum of rats given 0.23mM carprofen/2.5mM bile compared to 20mM 
aspirin/2.5mM bile, but only in the corpus of those rats given the higher 
concentrations compared with 40mM asprin and 5mM bile.
When the triple combinations were compared with single or double agents there was 
a distinct lack of change in the WBC numbers. Only when the triple agents at the 
lower concentrations were compared with 0.23mM carprofen in the corpus and 
antrum, and compared with 0.23mM carprofen/2.5mM bile was there any difference. 
In these comparisons it was an increase in WBC counts that was noted. With the 
triple blend at the higher concentration only when the numbers found in the corpus 
were compared with 0.1N HC1 was a significant reduction found.
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agent vs agent
corpus antrum 
(p<0.05)
IR1B1A1 IA1 ns ns
IB1 ns ns
IR1 S S
IR1A1 ns ns
IR1B1 ns S
IR2A2B2 IA2 @s ns
IB2 ns ns
IR2 ns ns
IR2A2 ns ns
IR2B2 ns ns
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 =2im M  & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen, S = significant, ns = not 
significant, @S = significantly less.
Table 5.13. WBC count. Comparison between rats administered triple 
combinations and those given single or double agents.
5.3.2.3 Congestion
The rats dosed with potentially injurious agents were examined for evidence of 
congestion (Table 5.14). There was little demonstrable evidence of an agent or time 
effect arising from any of the agents or combinations. Of the 240 areas (120 rats) 
examined, 175 (73%) had no evidence of congestion, which was most apparent in the 
corpus.
total = 
240 areas 2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
Congestion n % n % n % n % n % n %
0 26 10.83 34 74.17 25 10.42 32 7333 22 9.17 36 75
1 14 5.83 6 2.5 13 5.42 6 2.5 14 5.83 4 7.67
2 0 o 0 0 2 0.83 2 0.83 4 1.67 0 o
Table 5.14. Congestion in rats given injurious agents broken done by area and time, 
and expressed as a percentage of 240 areas.
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Congestion was scored as 1 in 57 areas. In these rats congestion was more than twice 
as likely to be present in the corpus as in the antrum. The most intense congestion 
(scored 2) was uncommon, being only found in eight areas from different rats, and in 
six of the eight rats the area congested was the corpus. There was a suggestion of 
some time effect and some agent effect, in that a score of 2 was not found at 2 
minutes, and 4/8 areas were in rats given either aspirin or carprofen in combination 
with bile. However, the small numbers make the validity of these results uncertain.
5.5.24 Apical Damage
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
Damage
0 30 24 29 28 29 24
1 10 16 9 12 9 12
2 0 0 2 0 2 6
Table 5.15. Apical damage versus time in rats given injurious agents.
Apical damage was assessed on the degree of disruption of the apical cells in the 
foveolae and the extent of disruption in the section. The breakdown of the findings 
of apical damage are given in Table 5.15. There was no evidence of a time or 
concentration effect in terms of raw numbers. However, when the apical damage (1) 
was broken down into occurrence in corpus and antrum, it appeared that the corpus 
was spared apical damage compared with the antrum. The antrum sustained 
between 30-50% more damage than the corpus at each of the time intervals. Severe 
damage (2) was not commonly encountered. In addition, bile as a single agent 
produced twice as many sections with apical damage (41.67%) as did the other single 
agents, with aspirin producing little apical damage (12.5%). The corpus and antrum 
were equally affected with bile induced apical damage.
The addition of a second agent increased the apical damage but without an 
observable concentration effect. Examples of this effect are shown in Table 5.16. 
The most marked increase was that caused by combining aspirin and bile, when 
compared with the combination of carprofen and bile.
There was no additive effect demonstrable with the triple combinations which 
produced apical epithelial damage approximating that induced by some of the single 
agents.
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agent N N with damage (scorel) %
IA 24 5 20.83
IB 24 10 41.67
IS 24 3 12.50
IR 24 5 20.83
ISB 24 11 45.83
IRB 48 13 27.00
IRA 48 15 31.25
IRAB 24 4 16.67
I = injury, A =hydrochloric add, B = bile, S=aspirin, R = carprofen, N=number of areas.
Table 5.16. Apical epithelial damage (score 1) caused by various agents and 
combinations in rats.
5.3.25 Luminal Contents
Accepting the fact that processing the sections will remove much of the normal mucus 
covering of the mucosa, nevertheless luminal contents were found in a number of 
sections (Table 5.17).
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
contents
NF 26 22 33 28 28 275
TF 6 7 4 6 6 5
NM 3 7 2 2 3 3
TM 5 4 1 4 3 7
NF=little mucus, few cells, TF=thick mucus few cells, NM = little mucus, many cells, TM = thick
mucus, many cells
Table 5.17. Luminal contents found in sections of gastric mucosa rats given 
injurious agents, by time and area.
No obvious time or area effect was apparent. Only in those rats given the carprofen 
and acid combinations was there a pronounced effect where the mucus was thickened. 
The cells that were present appeared to be those sloughed by the surface epithelial 
layer and trapped in the overlying mucus. However, thickened mucus was not always 
accompanied by the presence of cells embedded in the mucus.
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Corpus
Luminal Contents
Antrum
agents NF TF NM TM NF TF NM TM
IA 24 12 0 0 0 10 0 1 1
IB 24 7 0 2 3 5 1 1 5
IS 24 12 0 0 0 9 0 0 3
IR 24 11 0 0 1 8 0 4 0
ISB 24 8 0 4 0 10 0 1 1
IRB 48 20 3 1 0 20 3 0 1
IRA 48 7 n 1 3 6 n 2 3
IRAB 24 9 0 1 2 7 1 3 1
I = injury, A = hydrochloric acid, B=bile, S = aspirin, R = carprofen, NF=little mucus, few cells, TF=thick 
mucus few cells, NM = little mucus, many cells, TM = thick mucus, many cells, N =number of areas.
Table 5.18. Luminal contents found with some combinations.
There was no obvious correlation between apical damage and the presence of 
excessive luminal contents. However of the eight areas found to have apical damage 
with a score of 2, six of these had a thick overlay of mucus containing many cells. 
This represents only 25% (6/24) of those areas found to have thick mucus with many 
cells.
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In summary (Table 5.19), there was a failure to find a consistent correlation between 
the findings of gross oedema and histological evidence of oedema. This inconsistency 
was even more marked when gross erythema and histological congestion were 
compared, with gross erythema being infrequently substantiated histologically.
Group
Corpus
G
Oedema
H
Antrum
G H
Erythema/congestion 
Corpus Antrum 
G H G H
Control _ _ _ _ _
Iqjuiy
IA1
IA2 - - - - - + +
IB1 - - - - - + -
IB2 - - - - + + -
IS1 - - - - - + + -
IS2 - - - + + - + -
IR1 - - - - - + + + +
IR2 - - - + + + + + - + + +
IS1B1 - - - - + + + + + + +
IS2B2 - - - + + + + + + + + + +
IR1A1 - - - - - - + + +
IR1A2 - + + - + + - + + + + + + +
IR2A1 + + + + + + + + + + + + -
IR2A2 + + + + + + + + + + + - + + +
IR1B1 + + + + + + + + + + + - -
IR2B1 + + - + + + + + + + - -
IR1B2 + + + + + + + + + + + - +
IR2B2 + + + + + + + + + + + + + + + +
IR1B1A1 + + + + + + + + + + + + + +
IR2B2A2 + + + + + + + + + + + + + +
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric acid, B1 & B2 =2.5mM & 5mM bile, SI & S2 =20mM 
& 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen, G=gross evidence, H = histological evidence, 
+ = 2 rats.
Table 5.19. Comparison between gross and histological evidence of oedema and 
erythema/congestion in those rats given injurious agents.
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Figure 5.5. Photomicrograph of corpus exposed to 0.1N HC1. There is no obvious 
change after 5 minutes exposure. (H&E x!50)
Figure 5.6. Photomicrograph of corpus exposed to 0.1N HC1. There is no obvious 
change after 15 minutes. An enlarged apical cell can be seen to be in the process of 
being extruded (arrow). (H&E x300)
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Figure 5.7. Photomicrograph of corpus exposed to 2.5mM bile. After 5 minutes 
exposure there are traces of debris in the lumen over an area of apical epithelium that 
is distorted (arrow). (H&E x75)
Figure 5.8. Photomicrograph of corpus exposed to 20mM aspirin. After 2 minutes
exposure the apical epithelium is unaffected. (H&E x300)
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Figure 5.9. Photomicrograph of corpus exposed to 40mM aspirin. After 15 minutes 
the surface epithelial cells are unaffected, though there is a little mucus on the 
surface. (H&Ex75)
Figure 5.10. Photomicrograph of corpus exposed to 0.46mM carprofen. After 5
minutes exposure the epithelium is unaffected. (H&E x75)
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Figure 5.11. Photomicrograph of antrum exposed to 0.46mM carprofen. After 15 
minutes exposure there is an area of surface epithelial disruption (arrow). There is a 
modest white blood cell infiltrate and an element of congestion. (H&E xl50)
Figure 5.12. Photomicrograph of corpus exposed to 5mM bile. After 15 minutes
exposure there is a prominent loss of apical epithelial cells. Overlying the damaged
area is a layer of mucus with entrapped cells. (H&E x300)
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Figure 5.13. Photomicrograph of corpus exposed to 0.23mM carprofen/2.5mM bile. 
After 5 minutes there is a little lumenal debris. The underlying surface epithelium is 
unaffected, but the blood vessels are prominent. (H&E x30)
Figure 5.14. Photomicrograph of antrum exposed to 20mM aspirin/2.5mM bile. 
After 15 minutes exposure there is a little lumenal mucus and a prominent blood 
vessel present. (H&E xl50)
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Figure 5.15. Photomicrograph of antrum exposed to 0.46mM carprofen/5mM bile. 
After 15 minutes there is extensive apical damage and an increased number of cells 
appear to be being extruded. Underlying this is oedema. (H&E xl50)
m ii  JaftTO f i  ,
Figure 5.16. Photomicrograph of corpus exposed to 0.46mM carprofen/O.lN HC1. 
After 5 minutes exposure there is a thick overlying layer of mucus. (PAS/Alcian Blue 
x75)
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Figure 5.17a & 5.17b. Photomicrographs of corpus exposed to 0.23mM carprofen/ 
0.05N HC1/ 2.5mM bile. After 15 minutes there is overlying layer of mucus with a 
distinct cellular content. (H&E and PAS/Alcian Blue xl50)
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S33 Scanning Electron Microscopy
When the summed mean scores for general and individual change of the rats given 
injurious agent/s were compared with normal, the scores obtained from the corpus 
for general change were essentially similar to those found in the normal rats (see 
Tables 5.20 and 5.21). Only those rats given 2.5mM and 5mM bile, aspirin 20mM 
with 5mM bile and 0.46mM carprofen with 2.5mM bile showed a significant increase 
in score 1 (Figure 5.18). In contrast score 2, which represented individual as opposed 
to general change, was significantly increased in 15/20 injurious agent/combinations. 
With the single injurious agents, score 2 was increased with bile and carprofen, but 
not aspirin (Figure 5.19). Where combinations were applied, only rats given 0.23mM 
carprofen/5mM bile were spared. Of particular note is that 20mM aspirin/5mM bile 
also produced marked increase in individual as well as general change.
In the antrum, there was an increase in scores over normal for 10/20 injurious agents. 
Single agents, with the exception of bile, produced no significant increase in scores. 
All combinations of agents with carprofen produced significant increases in general 
change with the exception of 0.23mM carprofen mixed with acid at both 
concentrations and the higher concentration triple combination (Figure 5.20). The 
individual scores in the antrum again showed that only bile produced significant 
increase. All combinations of agents with carprofen produced significantly increased 
damage with one exception - carprofen and acid at the higher concentrations (Figure 
5.21). The combination of 20mM aspirin/5mM bile produced marked increases in 
both general and individual scores - this effect was similar to that in the corpus 
(Figures 5.22 and 5.23).
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S2 = 20mM & 40mM aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen
Figure 5.18. Bar graph of corpus scanning electron microscopy general scores 
obtained from rats given injurious agents.
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Figure 5.19. Bar graph of corpus scanning electron microscopy individual scores 
obtained from rats given injurious agents.
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Figure 5.20. Bar graph of antrum scanning electron microscopy general scores 
obtained from rats given injurious agents.
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Figure 5.21. Bar graph of antrum scanning electron microscopy individual scores 
obtained from rats given injurious agents.
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Figure 5.22. Bar graph of scanning electron microscopy general scores obtained from 
the corpus and antrum of rats given injurious agents.
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Figure 5.23. Bar graph of scanning electron microscopy individual scores obtained 
from the corpus and antrum of rats given injurious agents.
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agent score 1
Corpus 
±sd score 2 ±sd score 1
Antrum 
±sd score 2 ±sd
Normal 15.00 0.61 7.14 0.72 13.86 031 7.33 0.80
IAl 15.67 0.25 8.32 0.16 14.33 039 7.33 0.33
IA2 14.33 0.71 6.84 0.20 14.83 0.81 6.34 0.09
IB1 17.67* 0.52 14.67* 0.17 19.99* 0.42 14.67* 036
IB2 21.69* 0.48 12.00* 0.57 19.85* 0.79 14.66* 0.62
IS1 16.49 0.68 8.34 0.20 12.82 039 7.99 0.18
IS2 16.17 0.73 9.99 032 13.51 0.72 8.17 0.27
IR1 13.68 0.71 12.51* 033 15.00 0.86 10.17 0.38
IR2 15.50 0.60 14.84* 037 14.34 0.73 9.84 0.43
IS1B1 16.66 0.92 10.49* 0.42 15.00 0.95 9.84* 0.34
IS2B2 20.49* 0.51 13.17* 0.37 18.66* 0.38 14.16* 0.40
IR1B1 16.99 0.58 11.84* 0.55 16.50* 0.76 10.01* 0.18
IR1B2 16.99 0.55 12.18 0.39 16.34* 0.86 10.83* 0.48
IR2B1 17.34* 0.53 13.00* 0.35 18.16* 036 10.00* 0.44
IR2B2 18.66 0.53 14.16* 039 17.32* 0.55 11.33* 0.47
IR1A1 17.51 0.90 10.99* 0.45 16.99 0.68 11.17* 036
IR1A2 15.51 0.43 14.00* 0.72 16.66 0.72 12.50* 0.68
IR2A1 15.50 0.59 11.34* 0.60 17.49* 0.79 10.50* 0.17
IR2A2 15.99 0.64 11.50* 0.48 17.01* 0.74 9.16 0.27
IR1A1B1 16.67 0.64 9.84* 0.51 18.15* 0.76 10.00* 0.28
IR2A2B2 17.67 1.07 11.33* 0.63 16.17 0.64 13.00* 1.26
no (p< 0.05) 4 15 10 13
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 =2.5mM & 5mM bile, SI & S2 =20mM 
& 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen. * indicates were statistically different from 
normal (p<0.05).
Table 5.22. Mean summed scores for variables of change seen by scanning electron 
microscopy.
Comparison of the summed scores from the corpus and antrum failed to establish a 
difference based on area of the stomach in nearly all rats. Only the general change 
(score 1) in the corpus of the rats given 20mM aspirin and the individual change 
(score 2) of rats given 0.46mM carprofen were statistically greater than in the antrum.
The results obtained at the three time intervals were evaluated, and there was no 
demonstrable time effect between two and five minutes. However, there was a 
significant time difference between 15 minute samples and those taken at 2 and 5 
minutes with single agents bile, aspirin, carprofen, but not acid. This time effect was 
also evident with all the combinations.
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The scores generated by carprofen are shown in Tables 5.20-22, with the comparison 
of carprofen with other single agents shown in Table 5.23. When 0.23mM carprofen 
was compared with other single agents, there was either no significant difference 
between scores or else 0.23mM carprofen produced lower scores. In contrast, there 
was no difference in the general scores produced by 0.46mM carprofen when 
compared with other agents. There was more inconsistency amongst the 
comparisons of individual scores, where carprofen induced more damage in the 
corpus than 0.1N acid or 5mM bile but less that aspirin.
agent* vs
score
agent*
1
corpus
2
antrum 
1 2
IR1 IA1 ns ns ns ns
IR1 IB1 @s ns @s @s
IR1 IS1 @s ns ns ns
IR2 IA2 ns S ns ns
IR2 IB2 ns S ns @s
IR2
(p < 0.05)
IS2 ns @s ns ns
I = injury, A1 & A2 =0.05N & 0.1N hydrochloric acid, B1 & B2 =2.5mM & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen, S = significantly higher, 
ns=not significant, @S = significantly lower.
Table 5.23. Scanning score. Comparison of carprofen and single agents.
There was no significant difference between the scores obtained with 20mM aspirin 
alone and when in combination with bile (Tables 5.20-22, 5.24). However, 2.5mM 
bile alone produced higher scores than when in combination with aspirin. Aspirin in 
combination with 5mM bile produced significantly higher scores than aspirin alone. 
However, there was no significant difference between aspirin/5mM bile and bile 
alone, both producing more degeneration and damage than most other agents and 
combinations (Figures 5.18-5.23).
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C h a p t e r  5
agent vs
score
agent
1
corpus
2
antrum 
1 2
IS1B1 IS1 ns ns ns ns
IS1B1 IB1 ns @s @S @S
IS2B2 IS2 S s s s
IS2B2 IB2 ns ns ns ns
(p<0.05)
I =injury, B1 & B2 = 2.5mM & 5mM bile, SI & S2 * 20mM & 40mM aspirin, score 1 = general
change, score 2= individual damage, S=significantly higher, ns=not significant,
@S = significantly lower.
Table 5.24. Scanning scores. Comparison of aspirin combinations.
The comparison of scanning scores of carprofen and other agents is shown in Table 
5.25. When carprofen and a second agent combination were compared with the 
single agents a number of significant changes was apparent, which lacked a consistent 
pattern.
The addition of acid to carprofen failed to enhance the scores generated in most 
areas. In four areas where there was an effect on the scores two were positive and 
two negative. Carprofen on the other hand produced an increase in 7/16 scores 
when compared to those caused by acid alone. Neither the antrum of the corpus 
predominated, but the individual score being enhanced in 5/7 where there was an 
accentuation of damage.
When the results of carprofen and bile combined were compared to the single agents 
a somewhat different picture arose. Compared with bile, the addition of carprofen 
made no difference to the general or individual scores obtained from the corpus. In 
the antrum, this combination produced lower general and individual scores (6/8) than 
bile alone. Compared to carprofen alone, carprofen/bile combinations caused 
higher scores (5/16) with no area or bile concentration standing out. However this 
accentuation of scores was associated with general scores in most cases. Only in the 
antrum of the rats given 0.46mM bile with 5mM bile were both scores similarly 
increased.
There was no difference found when the scores generated by the lower concentrations 
of carprofen/bile were compared with those of aspirin/bile. At the higher 
concentrations aspirin/bile caused more general change to the corpus and antrum 
than the corresponding carprofen/bile combination. The individual scores were only 
found to be different only in the antrum, where aspirin/bile was more damaging than
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carprofen/bile (Table 5.25).
C h a p t e r  5
score
agent vs agent
corpus 
1 2
antrum 
1 2
IR1A1 LAI ns ns ns S
IR1A1 IR1 S ns ns ns
IR1A2 IA2 ns S ns S
IR1A2 IR1 ns ns ns ns
IR2A1 LAI ns ns S S
IR2A1 IR2 ns @s @s ns
IR2A2 IA2 S S ns ns
IR2A2 IR2 ns ns S ns
IR1B1 IB1 ns ns @s @s
IR1B1 IR1 S ns ns ns
IR2B1 LB1 ns ns @s @s
IR2B1 IR2 ns ns s ns
IR1B2 IB2 ns ns @s @s
IR1B2 IR1 S ns ns ns
IR2B2 IB2 ns ns ns ns
IR2B2 IR2 ns ns S S
IR1B1
IR2B2
IS1B1
IS2B2
ns
@s
ns
ns
ns
@s
ns
@s
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 = 2.5mM & 5mM bile, SI & S2 
= 20m M & 40m M aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen, score 1 = general change, 
score 2= individual damage, S = significantly higher, ns=not significant, @S = significantly lower.
Table 5.25. Scanning scores. Comparison of carprofen with other 
agent/combinations.
There was also a lack accentuation and of consistency in the results obtained when 
the triple combinations were compared with single or double agents (Table 5.26). 
Against acid alone the triple agents caused higher general and individual scores in the 
antrum). However, the comparison between triple and double agent combinations 
showed that supplementation with a third agent did not appear to make any 
significant difference to the general or individual damage induced.
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agent vs
score
agent
1
corpus
2
antrum 
1 2
IR1B1A1 IAl ns ns S S
IB1 ns @s ns @s
IR1 S ns S ns
IR1A1 ns ns ns ns
IR1B1 ns ns ns ns
IR2A2B2 IA2 S ns S S
IB2 ns ns S ns
IR2 ns @s ns ns
IR2A2 ns ns ns ns
(p < 0.05)
IR2B2 ns ns ns ns
I = injury, A1 & A2 = 0.05N & 0.1N hydrochloric add, B1 & B2 =2.5mM & 5mM bile, SI & S2 
= 20mM & 40mM aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen, score 1 = general change, 
score 2= individual damage, S = significantly higher, ns=not significant, @S = significantly lower.
Table 526. Scanning scores. Comparison of triple combinations and single or 
double agents.
More rigourous statistical evaluation by polychotomous logistic regression (BMDP) 
confirmed the bile, aspirin and carprofen effects, but only the bile effect was further 
substantiated by generalised linear modelling (GLIM).
5.3.3.1 Individual Components of Scores
Those features such as mucus covering and thickness, rosettes and extrusions, which 
composed the summed mean scanning scores, found in rats given acid at either 
concentration were essentially the same in those rats given acid as those found in 
normal rats (Tables 5.20-21). One feature noted in some of the rats given acid, but 
not ascribed a score, was that some areas on the stubs showed a flattening of the cells 
(Figures 5.24 and 5.25). Generally, concentration and time seemed to have no effect 
on the individual features of cells or cell areas, which were very similar to those found 
in normal rats.
With bile in the corpus, the surface of mucus appeared to be patchily overlain with 
precipitated mucus. The mucus thickness and extent of covering were rather similar 
to that found in the normal rats and in those rats given acid. The gastric pits 
appeared enlarged, accompanied by a reduction in the cobblestone facade, with 
accentuation of the intercellular junctions and reduction in the convexity of the 
cobbles (cells). More cells were found to be extruded and there was a concomitant
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rise in the numbers of rosettes seen (Figures 5.26 and 5.27). Individual cell changes 
such as apical ruffling, erosions and holes were also more apparent. In the antrum, 
the changes were of the same magnitude, but were slightly more severe when 
compared with normal antrum. In several rats, where the surface epithelial layer had 
been stripped away, a more severe damage was manifest as a few foci of exposed 
lamina propria. Increasing the bile concentration increased the number of rosettes 
and extruded cells, reduced the cobblestoning and convexity in both the corpus and 
antrum, and the mucus covering and thickness in the antrum. However, the 
prominence of intercellular junctions was unchanged. The individual cell change in 
the corpus was similar to that with the lower concentration of bile. In the antrum, 
however, apical erosions and empty shells were more frequent in occurrence (Figures 
5.28 and 5.29).
With aspirin there was little variation between rats given 20mM and 40mM aspirin in 
those features that made up the summed scores. The exceptions to this were the 
increased thickness and covering of antral mucus with 40mM aspirin. Compared with 
the normal rats the only aspects that markedly differed were an accentuation of the 
gastric pits and intercellular junctions, and cobblestoning in both corpus and antrum 
(Figure 5.30). With 40mM aspirin, the number of cells which appeared concave or 
had apical holes was greater than in the lower concentration of aspirin or in normal 
rats (Figure 5.31). The addition of bile to aspirin caused little difference at the lower 
concentrations used. However at the higher concentrations there was an increase in 
the numbers of rosettes and extruded cells, as well as cell convexity in both the corpus 
and antrum (Figures 5.37-5.38).
The general changes produced by carprofen were essentially similar in the corpus and 
antrum of both concentrations. The mucus covering however, was rather more 
extensive in the antrum, and with both concentrations in both areas the level of cell 
convexity was much higher than in the normal rats. This accentuated convexity 
resulted in many of the cells appearing larger than adjacent cells or taking on a 
rounded, rather than the normal oblong or rhomboid shape (Figure 5.32). Carprofen 
produced means for score 2 from the corpus that were significantly higher than 
normal. The particular features that caused this difference were a marked increase 
in the extent of apical ruffling, holes, erosions and intracellular contents. These 
features gave many areas of cells a crumpled or imploded appearance. This was 
more pronounced in the corpus than in the antrum (Table 5.27, Figures 5.33-5.36).
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normal
C A
carprofen 
0.23mM 0.46mM 
C A C A
apical ruffling 1.2 1.1 2.0 1.5 3.0 2.2
apical holes 1.4 1.2 2.0 1.8 2.5 1.5
concavity 1.1 1.1 2.0 1.7 1.7 1.2
apical erosions 1.3 1.4 2.7 23 3.2 2.2
intra/c contents 1.1 13 22 1.7 2.5 2.5
empty shells 1.3 13 1.7 1.2 2.0 1.3
C =corpus, A =antrum, intra/c=intracellular
Table 527. Individual scanning scores for rats given carprofen.
5.3.3.2 Addition of Acid
The effect of the addition of 0.05N acid in infused solution containing 0.23mM 
carprofen was to increase the convexity of the surface cells, and the number of 
rosettes and extruded cells in the corpus and the antrum respectively. These 
increases did not cause the mean scanning score to be significantly different from that 
obtained from normal rats. The individual cell damage was significantly different. 
This was caused by increased apical ruffling, holes, concavity and erosions. 
Increasing the concentration of acid to 0.1N produced very similar effects to that 
produced by the lower concentration of acid/caprofen with increased convexity and 
loss of cobblestoning, but also a reduction in mucus covering. Apical ruffling, holes 
and concavity were all increased, but the most marked change compared with 
0.23mM carprofen/0.05N HC1 was the increase in apical erosions. Changing the 
concentration of carprofen to 0.46mM and adding 0.05N acid also reduced the mucus 
covering and thickness in the corpus. In the antrum, cell extrusions and rosettes were 
increased. In situ cell features were more commonly encountered with apical 
ruffling, apical erosions and intracellular contents exposed in both corpus and antrum. 
In those rats given 0.46mM carprofen and 0.1N acid the mucus covering and thickness 
were again lower. There was some loss of cobblestoning, accentuation of convexity 
of the cell surfaces and intercellular junctions. The change in the mucus coat was not 
mirrored in the antrum, though there was a similar change in cobblestoning, convexity 
of the surface and intercellular junctions (Figures 5.41-5.42).
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5.3.3.3 Addition of Bile
The combination of 0.23mM carprofen & 2.5mM bile showed more extrusions, loss of 
cobblestoning and convexity than normal. Individual cell injury features were all 
increased, particularly apical erosions. These changes were evident in both corpus 
and antrum.
Increasing the concentration of bile to 5mM caused a reduction in the mucus 
covering, an accentuation of the intercellular junctions and convexity of the 
cobblestones (cells). Damage included increased apical ruffling, holes, erosions, 
surface concavity and empty shells. The distribution was similar between corpus and 
antrum, though the severity was more marked in the antrum.
With carprofen at 0.46mM and bile at 5mM mucus covering was reduced. Rosette 
formation, gastric pit enlargement, loss of cobblestoning, increased convexity and 
marked accentuation of the intercellular junctions were all visible. In the antrum 
there was no change in the mucus covering, but cell extrusion was more prominent 
than rosette formation.
When both bile and carprofen concentrations were increased to 5mM and 0.46mM 
respectively, mucus covering in the corpus was reduced, though not in the antrum. 
The gastric pits were enlarged in both areas, as was surface convexity, but there were 
more rosettes in the antrum (Figures 5.39-5.40). Marked accentuation of the 
intercellular junctions was clear. Individual damage was pronounced in all the 
features noted with the exception of intracellular contents.
5.3.3.4 Triple Combinations
Although score 1 from the corpus of those rats given the lower concentration 
combination, was not statistically different from the normal rats, some features were 
more pronounced. There was an increase in the number of rosettes detected and 
there was some loss of cobblestoning with increased convexity of the cells. From 
score 2, apical ruffling erosions and concavity of the cell surface were prominently 
increased. In the antrum extrusions, rosettes and generalised convexity were more 
obvious. More specific change was restricted to increased number of cells with 
apical erosions and concavities.
When the higher concentrations were used, the changes in the corpus were similar to 
those at the lower concentrations, but much more marked as far as prominence of 
rosettes, intercellular junctions and convexity were concerned. In the antrum the 
mucus covering was reduced and the mucus thinner. There was loss of 
cobblestoning, increased prominence of the intercellular junctions and marked
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convexity of the cell surface. Apical ruffling stood out accompanied by increase 
numbers of holes, accompanied by apical erosions and empty shells (Figures 5.43).
Linear erosion/ Anical damaee/ SEM score 2
Corpus Antrum
Group G H SEM G H SEM
Control
Iiyiuy
- - - - - -
LAI - - - - - -
IA2 - - - - + -
IB1 - - + + + - + + + + +
IB2 - + + + + - + + + + +
IS1 - - - - - -
IS2 - - - - + -
IR1 - + + + - + -
IR2 + + - + + + + + + -
IS1B1 - + + - + +
IS2B2 - + + + + + + + + +
IR1A1 - - + + - - + +
IR1A2 - + + + + + - + + + +
IR2A1 - + + + - + + +
IR2A2 - + + + + - + -
IR1B1 - + + + - + + + +
IR2B1 - - + + + - - + +
IR1B2 - - - - - + +
IR2B2 + - + + + + + + +
IR1B1A1 + + - + + + + +
IR2B2A2 + + + - + + + + + - + + +
SEM = scanning electron microscopy. I = injury, A1 & A2 =0.05N & 0.1N hydrochloric acid, B1 & B2 
= 2.5mM & 5mM bile, SI & S2 =20mM & 40mM aspirin, R1 & R2 =0.23mM & 0.46mM carprofen, 
G =gross evidence, H = histological evidence, + = 2 rats.
Table 5.28. Comparison of gross erosion and histological evidence of apical damage 
in rats given injurious agents.
A comparison of the evidence gleaned from gross, light and scanning microscopy for 
linear erosions/apical damage shows that there was poor correlation between these 
examinations (Table 5.28). Scanning electron microscopy was the most sensitive 
method of detecting damage to the apical membrane of the surface epithelial cell.
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Figure 524. Scanning electron micrograph (SEM) following exposure to 0.1N HC1. 
There is a moderately thick layer of mucus masking the surface epithelial cells. 
(x360)
Figure 5.25. SEM following exposure to 0.1N HC1. After 15 minutes there is some 
flattening of the polygonal cells in the corpus. (xl440)
175
Ch a p t e r  5
Figure 526. SEM following exposure to 2.5mM bile. There is variable swelling of 
cells some with apical erosions. Large discarded cells lie in the lumen and a rosette is 
arrowed. Areas of eroded cells are also present. (x2800)
Figure 5.27. SEM following a 5 minute exposure to 2.5mM bile. The cells are 
swollen and centrally a cell has imploded and is being encroached upon by 
neighbouring cells. (x5600)
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Figure 5.28. SEM following exposure to 5mM bile. After 5 minutes the apical 
membrane has been lost by many cells exposing intracellular contents. (x2800)
Figure 529. SEM following exposure to 5mM bile. After 15 minutes apical
membranes have been lost and intercellular junctions are exaggerated. (xl440)
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Figure 530. SEM following exposure to 20mM aspirin. After 5 minutes there is only 
some anisocytosis. (x2800)
Figure 531. SEM following exposure to 40mM aspirin. A number of cells show 
apical erosions. Others have lost the apical membrane. (x2800)
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Figure 532. SEM following exposure to 0.23mM carprofen. The antral cells are 
swollen and there is apical ruffling after 5 minutes. (x5600)
Figure 533. SEM following exposure to 0.23mM carprofen. After 5 minutes the 
corporal cells are swollen with apical ruffling, several present as empty shells. (x5600)
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Figure 5.34. SEM following exposure to 0.46mM carprofen. After 2 minutes corporal 
cells are swollen, some of the apical membranes are peppered with holes and the 
membrane lost in others. (x2800)
Figure 5.35. SEM following exposure to 0.46mM carprofen. After 5 minutes there 
are small tears in apical membranes with intracellular contents visible. (x5600)
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Figure 2.36. SEM following exposure to 0.46mM carprofen. After 15 minutes the 
antral cells are markedly swollen and distorted. The apical membranes are very 
ruffled. The intracellular contents are exposed and in one cell the apical membrane 
can be seen peeled back (large arrow). The intercellular junctions are evident (small 
arrow). (x5600)
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Figure 5.37. SEM following exposure to 40mM aspirin/ 5mM bile. After 15 minutes 
the corporal cells are enlarged and numerous small holes are present on the apical 
membrane. (xl440)
Figure 5.38. SEM following exposure to 40mM aspirin/ 5mM bile. After 15 minutes 
many antral cells are more convex than normal and the intracellular contents are 
exposed. (x5600)
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Figure 539. SEM following exposure to 0.46mM carprofen/ 5mM bile. After 15 
minutes the corporal cells have extensive apical erosions. (x2800)
Figure 5.40. SEM following exposure to 0.46mM carprofen/ 5mM bile. After 15 
minutes the antral cells are distorted and show apical damage. The normal 
cobblestone appearance is lost. (x2800).
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Figure 5.41. SEM following exposure to 0.23mM carprofen/ 0.1N HC1. The cells 
show large numbers of apical erosions.(x5600)
Figure 5.42. SEM following exposure to 0.23mM carprofen/ 0.1N HC1. After 15 
minutes the cells are swollen with marked ruffling of the apical cells. One cell has a 
concave apical membrane (arrow). (x5600)
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Figure 5.43. SEM following exposure to 0.46mM carprofen/ 0.1N HC1/ 5mM bile. 
After 15 minutes the intercellular junctions are extremely prominent. The apical 
membranes appear to be collapsed. (x5600)
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5.3.4 Transmission Electron Microscopy
The surface epithelial cell structure and integrity of those rats given acid were similar 
to those found in the normal rats (Figure 5.44). In the rats given carprofen or 
aspirin the change was characterised at 5 minutes by numbers of cells showing 
swelling and a marked decrease in cytoplasmic and nuclear density, with cytoplasmic 
vacuolation. The apical mucous granule packs were dissipated but the junctional 
complexes were intact. Many of these abnormal cells abutted relatively normal 
looking neighbouring surface epithelial cells (Figures 5.45 and 5.46). At 15 minutes, 
those cells showing decreased cytoplasmic density appeared to have imploded with 
apical membrane rupture with more marked loss of mucous granules. The nuclear 
chromatin was more marginated (Figure 5.47). Bile produced essentially similar 
change, though in places the severity of cell disruption was more marked (Figure 
5.48). The combination of acid or bile with carprofen or aspirin caused more 
extensive and more severe damage to the surface epithelial cells. This progression of 
damage was most pronounced where the nsaid was paired with bile (Figures 5.49- 
5.52).
Figure 5.44. TEM of surface epithelium following exposure to 0.1N HC1. The 
distribution of organelles, nucleus, cytoplasmic density, junctional complex and 
mucous granule pack are normal (x8000).
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Figure 5.45. TEM of surface epithelial cells following 5 minutes exposure to 40mM 
aspirin. The cell shows intracellular swelling with a decrease in cytoplasmic. There 
are organelle remnants dotted throughout and a loss of apical mucous granule 
aggregations (x5400).
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Figure 5.46. TEM of surface epithelial cells following 5 minutes exposure to 0.46mM 
carprofen. The cell shows intracellular swelling with a decrease in cytoplasmic 
density. There are organelle remnants dotted throughout and a loss of apical mucous 
granule aggregations. The junctional complex with the adjacent cell is normal, but 
this cell also shows some decrease in cytoplasmic density with a few cytoplasmic 
vacuoles formed. There is only a thin line of mucous granules beneath the apical 
membrane (x5400).
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Figure 5.47. TEM of surface epithelium following 15 minutes exposure to 0.46mM 
carprofen. There is surface debris beneath which is a collapsed cell showing loss of 
cytoplasmic density and vacuolation. The apical membrane appears disrupted and 
there are few mucous granules present (x8000).
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Figure 5.48. TEM of surface epithelium following 5 minutes exposure to 5mM bile. 
The nuclei seem relatively unharmed, but there is extensive disruption of the 
cytoplasm, and absence of the apical membrane and mucous granules. The cytoplasm 
appears to be confluent with the lumen (x8000).
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Figure 5.49. TEM of surface epithelium following 5 minutes exposure to 40mM 
aspirin/5mM bile. The cytoplasm is disorganised, has lost its homogeneity and 
appears to have exploded into the lumen. The neighbouring cells appear to be 
encroaching to close this defect in the epithelial integrity (x5400).
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Figure 5.50. TEM of surface epithelium following 15 minutes exposure to 0.46mM 
carprofen/O.lN acid. There is a thick acellular lumenal layer covering the cells. 
Several cells are seen to have been disrupted in situ, though the junctional complexes 
are still visible and intact. The one relatively normal cell has lost the bulk of its 
mucous granules (x5400).
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Figure 5.51. TEM of surface epithelium following 5 minutes exposure to 0.46mM 
carprofen/5mM bile. The apical membrane has been stripped away exposing the 
cytoplasm to the lumen. The cytoplasm shows numbers of large vacuoles and a 
decrease in density. The adjacent cell, whilst still having an apical membrane, shows 
a loss of mucous granules with the remaining granules forming as thin peripheral 
layer (x8000).
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Figure 5.52. TEM of surface epithelium following 15 minutes exposure to 0.46mM 
carprofen/5mM bile. Extensive destruction and damage to a number of cells is 
visible. The junctional complexes still appear to be intact (x5400).
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5.4 Discussion
In the rat the exposure of the gastric mucosa to injurious agents such as aspirin and 
ethanol has been reported as inducing reddening and erosions of the surface within 
two minutes of application (Morris and Harding 1974, Szabo 1987). The reddening is 
caused by an increase in blood flow and a reduced venous return resulting in stasis 
and congestion in the post-capillary blood vessels (Guth 1984, Pihan and others 1986). 
An increase in blood flow to the gastric mucosa can be induced by the release of 
histamine arising from cell damage (Szabo 1987). Grossly visible erosions are 
considered to represent defects in the epithelial layer. Pin-point areas of reddening 
or erosion may also be the result of submucosal petechial haemorrhage, which occurs 
quite commonly in man following administration of aspirin (Cohen and MacDonald 
1982). If more necrotising agents, such as ethanol, are used then haemorrhaging 
erosions develop and even ulceration with sloughing of large areas of the mucosa. In 
these cases the colour of the surface varies between a deep red to almost black 
(Tamawski and others 1985a). Similar changes can occur in the gastric mucosa as 
the result of other injurious agents - examples are dogs treated with NSAID drugs 
(Chvasta and Cooke 1972, Ewing 1972), and in man and dog with bile (Byers and 
Jordan 1962, Davenport 1968, Kivilaakso, Fromm and Silen 1978, Houghton and 
others 1986, Lipowitz, Boulay and Klausner 1986). However, changes of a superficial 
nature are not likely to be visible to the naked eye (Lacy 1987) where there is no focal 
accumulation of erythrocytes. Further, minimally injured cells may not be detectable 
by light microscopy (Parisio and Clementi 1976, Schmidt and others 1985).
The distribution of lesions throughout the stomach can be variable. Reports in the 
literature tend to suggest that the corpus region is more often affected than the 
antrum (Bommelaer and Guth (1979). One explanation suggested is that there are 
many more parietal cells present in the corpus than in the antral region of the 
stomach (Berger 1934, Read and Johnstone 1961, Ritchie, Barzilai and Delaney 
1966). Thus the greater energy and oxygen demands required for acid production 
may leave the corpus more prone to attack that impairs the blood flow (Cheung and 
others 1978, Fromm 1981). However, parietal cells induce a lowering in pH by the 
production of acid, and in view of the evidence that active acid secretion protects the 
mucosa one might expect that the antrum would be more easily damaged than the 
corpus (Fromm, Silen and Robertson 1976, Bugat and others 1976, Smith and others 
1977). Furthermore, the antrum is more permeable and thus will absorb more H+ 
ions than the corpus, again making it more prone to back-diffusion induced damage 
(Dyck and others 1969). On the other hand, Davenport (1967a) and Whittle (1976) 
found that certain agents, for example NSAID drugs, required the presence of 
exogenous luminal acid to stimulate marked lesions suggesting that acid had some
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damaging capabilities. Further it has been shown that both NSAIDs aspirin and 
phenylbutazone cause a rise in luminal acidity (Kirsner and Ford 1955ab). The 
disparate conclusions reached in publications may reflect different experimental 
methods, for example the authors quoted above have found either corpus or antrum 
more prone to damage, whilst Cooke and Kienzle (1974) found that both areas 
responded in a similar fashion. Thus the reason why more lesions are found in the 
corpus than the antrum of the stomach in some situations is as yet not fully 
understood.
Erosions of the gastric mucosa tend to develop in a linear pattern on the ridges of the 
rugal folds, the explanation being that they are further from the blood vessels and 
therefore have poorer perfusion (Mersereau and Hinchey 1982, Lipowitz, Boulay and 
Klausner 1986). The effect of blood supply in the types of lesions produced in the 
stomach has been shown to be quite important in man and the experimental animal. 
Stress ulceration occurs in man after severe spinal trauma, burns or shock when there 
is hypotension (Lucas 1981). The effect of curtailing the blood supply, and the lack 
of or decreased effect that potentially injurious agents exhibit in the presence of a 
normotensive stomach in some experimental situations has been demonstrated clearly 
in the rat and canine gastric mucosa (Ritchie 1975, Cheung and Chang 1977).
In contrast to several previous reports, which include Harding and Morris (1984), no 
very obvious gross changes were found in the majority of the rats to which individual 
injurious agents were given in this study. This could be associated with the fact that, 
apart from the ligation of the pylorus, the stomachs of these animals were not 
otherwise tampered with in contrast to previous workers who, for example, 
manipulated the stomach to produce a gastric chambers. In addition some workers 
used larger volumes (10ml) of the substances tested (Harding and Morris 1984) than 
those used in the investigations described in this thesis.
The results of the application of diverse agents to the different regions of the stomach 
can be very variable and depend on the concentration of the agent used, and the 
length of exposure. Ethanol, for example, will produce almost total denudation of all 
areas of the stomach (Tamawski and others 1985a). Bile, on the other hand, has 
been reported as producing gross lesions restricted to the corpus (Fringes, Lorenz and 
Oehlert 1985). Considering each of the specific agents used in the investigations 
described in this thesis, first the application of HC1 acid either as 0.05 or 0.1N to the 
rats’ gastric mucosa did not cause any obvious marked effects on gross examination. 
The acid concentration used (0.1N) in the rats investigated was no higher than the 
stomach is capable of generating but even when Mersereau and Hinchey 1973, Moody 
and others (1978) experimentally covered the gastric mucosa of rats with higher
196
Ch a p t e r  5
concentrations of HC1 (0.15N), they did not find any gross changes such as reddening 
or oedema. A similar lack of change was noted by Ritchie (1981). These 
observations may be related to there being no experimental interference with 
prostaglandin formation and release (Osada and others 1990). The concentration of 
acid used in the investigations discussed here was chosen because it was hoped, by 
exposing the gastric mucosa of the rats to these concentrations of acid for different 
periods of time, to identify preliminary changes caused by application of acid alone. 
In the one rat in which generalised erythema was seen it was assumed that this 
particular rat had gastric problems prior to the beginning of the experiment. The 
consistent lack of change in the rats to which acid was applied to their gastric mucosa 
was confirmed by light and scanning electron microscopy where almost all the 
parameters assessed were not significantly different from those found in the control 
group of rats. However, one notable change was the increased number of white cells 
found in the antral and corporal areas of the stomachs of the acid-challenged rats. It 
is difficult to explain why the relatively innocuous concentrations of acid should 
trigger white cell infiltration in view of not finding any other abnormalities, and 
indeed the numbers of white cells seen may be of little significance. However, the 
liberation of histamine from damaged cells sets in train the body’s inflammatory 
defense mechanisms against damage. This includes the migration of white blood 
cells and so the invasion of the gastric mucosa by increasing numbers of white cells 
could represent an actual response by the gastric mucosa when exposed to any 
abnormal circumstances. The white blood cells themselves may contribute to 
mucosal injury by producing large amounts of reactive oxygen metabolites (Grisham 
and Granger 1988, Wallace and Granger 1992). However, using agents as mild 
irritants Robert and others (1978) found that infiltration of white blood cells was 
detectable at 24 hours but not at one hour after exposure. Thus the finding of 
increased WBC infiltrate with a number of injurious agents reported in this thesis is at 
odds with some previously published work. One explanation that may be advanced 
for this is that the numerical distribution of WBC numbers in the rat gastric wall 
varies widely and this finding with particular agents may be merely coincidental. 
Evidence of congestion was seen on histological examination of gastric mucosa 
sections in two of the rats given 0.1N acid. Congestion being a change associated 
with inflammation may lend support to the inference that the increased white cells 
found may indeed indicate change caused by the acid.
When the sections of gastric mucosa from the rats subjected to the acid treatment 
were examined by scanning electron microscopy one further interesting feature was 
seen. This was the general flattening of the apical membrane of many of the cells 
causing them to loose their convexity and to produce a loss of the normal cobblestone 
appearance. This feature has been reported before by Fringes, Lorenz and Oehlert
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(1985) in rats given higher concentrations of acid (0.2N). No explanation was offered 
by these workers for this appearance and they did not report finding any cellular 
abnormality of this region on examination with light microscopy. No swelling of the 
cells were detected in either investigations. The apical flattening of the cells in these 
circumstances is at odds with the changes produced by certain other injurious agents 
that induce a loss of normal convexity caused by swelling of the cells. This also 
results in a loss of the cobblestone appearance. An explanation for this flattening 
may be that the luminal acid caused shrinkage of the cell and reduction of the contact 
surface area. Alternatively, the increase in hydrogen ion concentration may stimulate 
the release of large volumes of bicarbonate from the superficial cells (Konturek and 
others 1984b) resulting in shrinkage of the cell. The scanning electron microscopic 
appearance did not resemble that reported after administration of 0.1N HC1 by 
Fujita, Tanaka and Tokunaga (1981)1, who found what appeared to be marked 
anisocytosis, nor the loss of apical membrane after 0.15N HC1 reported by Wood and 
Dubois (1983). Therefore, although there were no dramatic changes seen in the rats 
investigated with low concentrations of acid used for the length of time the rats’ 
mucosa was exposed to this agent, there were some changes seen at microscopic level 
which may indicate that some minor degree of damage was produced. This could 
explain some of the findings recorded when acid was given in conjunction with other 
agents and one cannot overlook the possibility that with time the damage might have 
become more severe and changes may have become apparent.
Bile was the other single endogenous product that was used in this study as it has been 
recognized as being injurious to the gastric mucosa in a number of species including 
man (Domellof, Reddy and Weisburger 1980, Houghton and others 1986), the dog 
(Black, Hole and Rhodes 1971, Moody, Zalewsky and Larsen 1981) and the cat 
(Smith 1914). Bile causes the release of histamine (Rees and others (1977b). On 
gross examination, exposure of the rat gastric mucosa to even the higher 
concentration of bile used for up to five minutes produced inconsistent results. 
However, after exposure for 15 minutes, mild reddening was a consistent finding even 
at the lower of the two concentrations of bile applied. When sections were examined 
microscopically the erythema seen on gross examination of the corpus in some of the 
rats mucosa was corroborated by finding evidence of congestion in the sections 
prepared from this region of the stomach of rats treated with bile for 15 minutes. 
Furthermore, there was also histological evidence of congestion in the corpus of two 
rats given the lower concentration (2.5mM) of bile, again after exposure for at least 
15 minutes. These results tend to suggest that the length of time that the gastric 
mucosa is exposed to bile is probably more important than the concentration used. 
The concentrations of bile chosen for this study were those frequently used in 
experimental models and are similar to those present in stomachs with
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duodenogastric reflux (Ritchie 1975 and Ritchie and Shearbum 1976), in which 
situation gastric ulceration is reported. Although ulceration of the gastric mucosa 
was absent in the rats treated with bile in this study, both concentrations of bile 
induced a significant WBC infiltration compared to the controls. In those rats where 
2.5mM bile was administered, there were greater numbers of white cells in the 
antrum than the corpus but the converse was true when 5mM bile was used, but these 
findings were not statistically significant, though perplexing. Robert and others 
(1978) have shown that bile will stimulate the infiltration of neutrophils into the 
gastric mucosa and the overall results in this study suggest that there is not a regional 
effect. The longer the mucosa is exposed to the injurious agents the more histamine 
will be released and stimulate greater white blood cell movement, the results in these 
rats suggests that it takes longer than 5 minutes for this effect to be occur when bile is 
the agent used. It has been reported that acid plays a role in the formation of "bile" 
ulcers (Rees and Bowen 1982, B6nichoux, Durlik and Mainard 1986). The gastric 
acid environment in the rats exposed to bile may not have been that required to 
produce erosions or ulcerations.
Interference with mucosal blood flow has been shown to cause a back-diffusion of 
hydrogen ions, which again has been suggested as part of the mechanism involved in 
the production of the ulcerated lesions associated with bile in the dog (DenBesten 
and Hamza 1972, Cheung and Chang 1977, Moody, Zalewsky and Larsen 1981). As 
already stated no deliberate attempt was made in the experiments reported in this 
thesis to interfere with the blood flow to the gastric mucosa. Another aspect that 
must be considered in translating the results of the bile experiments is that when 
consistent superficial ulceration and submucosal haemorrhage was induced - it was 
after a five hour exposure (Mann 1976). In the rats described here the longest period 
of exposure to bile was 15 minutes. Failure to identify oedema, and consistent 
erythema in these studies of rat gastric mucosa could therefore have been due to a too 
short exposure of bile at these concentrations.
Although no dramatic changes were apparent on gross examination, microscopic 
examination revealed more damage by bile to the apical membrane of the gastric cells 
than with any other single agent. Nearly 42% of the rats treated showed varying 
degrees of this type of damage when bile was present. The explanation for this may 
be because bile, in addition to being capable of reaching the basal lamina beneath the 
cell, also acts as a detergent destroying the lipid membrane of the surface cell 
(Davenport 1968, Duane and Weigand 1980). Although bile has detergent properties 
and is able to diffuse through the mucus layer, there has been some debate over 
whether it is capable of disrupting and damaging the adsorbed layer of mucus (Allen, 
Bell and McQueen 1984, Tumberg and Ross 1984). However, the apical changes
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seen were not as marked as those described in the literature where the damaged cells 
were reported as forming a luminal arcade or arch over the exposed in situ cells (Lacy 
and Ito 1984), or where the necrotic cells were scattered haphazardly over the intact 
cells (Schmidt and others 1985). The results here were mainly concerned with the 
surface epithelial cell, its apical membrane and the damage that bile might exert 
compared to that already reported (Davenport 1967b, Davenport 1968, Duane and 
Weigand 1980, Eastwood 1975). Certainly, exfoliating cells were present in larger 
numbers than with any of the other single agents and this was most marked in the 
corpus and antrum of those rats given 5mM bile. This increase in cell extrusion was 
accompanied by increased rosette formation, which represents the stage following 
complete extrusion of cells (Pfeiffer 1970b). Fringes, Lorenz and Oehlert (1985) 
found that the lesions in their rats, where bile was the agent used, were largely 
restricted to the corpus and that apocrine secretion with the associated loss of the 
apical membrane was a constant feature. Whilst the results found in the present 
work concurred with the corporal damage, there was also a similar degree of damage 
in the antrum in contrast to the results reported by the above workers. It is difficult 
to explain this difference on the basis of the concentration of bile used as they used a 
considerably higher concentration of bile (80mM). One explanation could be that 
the above authors examined their rats after two hours, whereas in these studies the 
rats were sacrificed after 15 minutes. The longer period of time may have allowed 
the antrum to recover by cellular restitution. Work by Morris and Wallace (1981) 
and Lacy and Ito (1984) supports this hypothesis, as they showed that restitution is 
virtually complete after one hour. The scanning electron microscopy demonstrated 
apical ruffling, cell extrusion, apical membrane swelling and apical erosions. These 
findings are in agreement with those reported by Winbom, Guerrero and Hodge 
(1978) and Fringes, Lorenz and Oehlert (1985). The latter authors obtained their 
results using a much higher concentration of bile, as already stated. However, rats 
given 2.5mM bile showed many cells with ruffled apical membranes, and although this 
was not such a feature in those given 5mM bile, these had many cells with apical 
erosions, which might be the preliminary stage leading to the ultimate loss of the 
apical cell membrane (Forte, Silen and Forte 1976, Easmann and others 1984). It 
has been suggested that the loss of the apical cell membrane may result in an apical 
expulsion of mucus, representing an epithelial response to injurious agents, where 
exocytosis fails to meet the mucus requirements of the mucosa. This could explain 
the finding of cells containing no inclusion bodies as described by Zalewsky and 
Moody (1979). Thus although the mucosa of the rats examined after treatment with 
bile alone showed only limited gross changes, mainly erythema, microscopic 
examination both at light and electron microscopic level revealed varying degrees of 
cellular damage including extrusion and death of cells, apical membrane collapse and 
erosion, and yet the junctional complexes were intact concurring with previous work
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(Forte, Silen and Forte 1976, Eastwood 1985). These findings indicate the capability 
of bile to enhance degeneration of the gastric mucosa. These specific changes that 
can be attributed to bile on its own are of interest particularly in understanding the 
changes that subsequently occurred when a mixture of agents including bile was 
applied.
The concentrations of aspirin selected for this study were similar to those used 
previously to study its effect on the gastric mucosa and gastric mucosal barrier 
(Davenport 1964, Hingson and Ito 1971, Garner 1978, Bommelaer and Guth 1979). 
Again, as with acid and bile, aspirin produced no marked gross changes. Blanching 
reported by Morris and Harding (1974) and ulceration (Konturek and others 1981b) 
were not seen. Time and concentration cannot be used as an explanation for the 
failure to repeat the above results, because these findings were obtained shortly after 
exposure. The probable explanation is that the exposure of rat mucosa to aspirin 
reported here was not supplemented with acid as is frequently done in other 
experimental situations (Brodie and Chase 1967, Morris and Harding 1974). Indeed 
Gottschalk and Menguy (1970) showed that achlorhydric rats did not develop gastric 
erosions after receiving large doses of aspirin for two days.
Oedema was demonstrated histologically in the rats challenged with aspirin, 
especially in the antral region of the stomach of those given 40mM. When the gastric 
mucosa is exposed to damaging agents, the release of histamine causes the leakage of 
fluid into the interstitium giving rise to oedema (Davenport 1966, Johnson and 
Overholt 1967). Davenport (1969) proposed that this fluid released from the 
damaged mucosa would dilute and neutralise endogenous acid helping to protect the 
mucosa from the luminal acid. The release of histamine will also lead to vasodilation 
and increased blood flow (Moody 1967, Gerber and Nies 1982). In this series some 
of the rats given aspirin demonstrated congestion of the gastric mucosa. The 
inconsistent finding of congestion in the face of recognised damaging concentrations 
of aspirin may again be explained by the lack of exogenous acid present in the 
stomachs (Augur 1970).
All the rats treated with aspirin showed increased white blood cell migration with the 
highest numbers found in the antrum. Apart from these features, in general the 
epithelium looked substantially normal without any real evidence of erosions as has 
been reported by previous workers. St. John and others (1973) found that a single 
dose of aspirin was sufficient to produce erosions, which were largely restricted to the 
corpus of the stomach in their groups of rats. A possible explanation for this regional 
effect is that aspirin exerts most of its effect on areas of the mucosa which secrete acid 
because then the aspirin is more likely to be in an undissociated form. Eastwood and
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Quimby (1982) found chronic administration of aspirin to rats caused epithelial 
proliferation in the corpus and not the antrum, and suggested that the failure of antral 
proliferation was the reason why ulcers were usually located there. Antral lesion 
predeliction was noted by Bugat and others (1976) following intravenous 
administration of aspirin to cats. However, this does not explain the preferential 
corporal damage that has been reported in the literature. The reason may be that 
there are in fact two separate responses. The initial acute effect may cause cell 
degeneration in the corpus of the stomach, followed in the long term by epithelial 
proliferation to replace the cell loss induced by aspirin-like substances. The antrum 
on the other hand may be able to resist the initial assault, possibly by its ability to 
produce more prostaglandin than the corpus (Konturek and others 1981c).
However, the development of acute lesions in aspirin treated rats may also be related 
to the length of exposure, which in the case of St. John and others (1973) was four 
hours. Rainsford (1978), on the other hand, found that maximum lesion 
development had taken place after two hours of exposure. In the rats treated with 
aspirin in these investigations, there was little evidence of the exfoliation of cells or 
loss of the thick mucus layer over damaged areas as has been described by Morris and 
Harding (1974) after only five minutes exposure. Nor was there any evidence in the 
rats discussed in this thesis, of the more severe superficial layer detachment described 
by Yeomans, St. John and de Boer (1973).
The results of the studies using scanning electron microscopy were similar to those 
obtained from normal rats. In those rats given 40mM aspirin there appeared 
subjectively to be more cells with holes and somewhat concave apical membranes 
than were found in normal rats or those given 20mM aspirin possibly indicating some 
increased mucus production. In contrast, Frenning and Obrink (1971) found in the 
cat, that 17mM aspirin caused exaggeration of the normal convexity of the surface 
epithelial cell, but they supplemented the aspirin with acid therefore enhancing 
intracellular absorption of the aspirin and ions.
Scanning electron microscopy showed that the mucus layer was thinner in the antrum 
than was found with other single agents, though this was not as definite in the corpus. 
The most likely reason why the mucus appeared to be thinner is that aspirin had to a 
certain extent affected the hydrophobic layer of adsorbed surface-active 
phospholipids on the luminal aspect of the surface epithelial cells (Lichtenberger, 
Richards and Hills 1985). The effect of damaging the hydrophobic layer would be to 
make it more soluble and thus allow it to be dissolve in the gastric juice and not 
contribute to the mucus layer that is maintained during processing of the samples and 
present on the stubs available for scanning electron microscopy.
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Overall the response of the gastric mucosa in the rats treated with aspirin was not as 
expected from previous reports in the literature in that although as with exogenous 
acid there were changes which could represent the early stages of cell damage they 
were not consistent and were mainly of a minor nature.
It is well recognised that the use of non-steroidal anti-inflammatory drugs produces 
gastric mucosal damage (Dodd, Minot and Arena 1938, Douthwaite and Linott 1938, 
Muir and Cossar 1955, Lanza and others 1979, Fromm 1981). Carprofen is said to 
have less harmful effect on the gastric mucosa as measured by effect on gastric 
potential difference, microbleeding, and prostaglandin generation in healthy human 
volunteers and those with peptic ulcer disease (Konturek and others 1982b, 1983). 
This was one of the agents used in the studies of the rats mucosa when single agents 
were applied. The dose of carprofen used was at the lower end of the therapeutic 
range quoted for the dog (McKellar and others 1990). Previous workers using the 
same dosage claimed that a reduction in the inflammatory swelling and an analgesic 
effect was achieved in cases of adjuvant arthritis in rats (Strub, Aeppli and Muller 
1982). In contrast to the rats given aspirin the gross appearance of the gastric 
mucosa of the rats given carprofen was of consistent antral reddening, and even a 
suggestion of linear streaking and erosion in a few animals where the higher 
concentration of carprofen was used. The duration of exposure to carprofen did not 
appear to make any difference to the type or number of changes produced. The 
linear erosions seen on gross examination in a few rats were not substantiated 
histologically. There are several possible explanations for this disparity. First, the 
sections prepared may have failed to include these specific areas. Second, the linear 
erosions may in reality have been hyperaemic areas and not actual epithelial damage. 
Supportive evidence for this supposition comes from work in man, where the 
ingestion of sub-therapeutic doses of aspirin gave gross change of linear and punctate 
erosions that failed to be confirmed on histological examination - loss of mucus was 
the main finding (Cohen and MacDonald 1982). Similarly in the dog, the endoscopic 
finding of hyperaemia was not always substantiated by examination of endoscopic 
biopsies (Roth and others 1990). Histological examination of the antrum showed 
oedema, with lower frequency in the corpus. In many instances the oedema evident 
on microscopic examination was not apparent on gross examination and as already 
stated, repeated evidence of gastric erosion was lacking. This could be due to acid 
secretion present in normal circumstances but not present in these starved rats, where 
only basal acid secretion would have been present. The development of erosive 
gastritis in association with injurious agents has been reported to require the presence 
of acid (Moody, Zalewsky and Larsen 1981). As with the other single agents 
carprofen (0.23mM) resulted in an increase in white cells in the tissues of both the 
corpus and antrum. However, this feature was not so apparent in the mucosa of the
203
Ch a p t e r  5
rats treated with the higher dose of carprofen used. It is rather difficult to find a 
suitable explanation for the discrepancy as the higher dose is unlikely to have 
suppressed WBC infiltrate. With both concentrations of carprofen some cellular 
damage was evident on scanning electron microscopy. This consisted of swelling of 
the cells which was different from the shrinkage of the cells that resulted from the 
treatment with acid alone. The swelling of the cells led to a loss of convexity and has 
been attributed to the accumulation of the injurious agents intracellularly (Hingson 
and Ito 1979). Such an effect has been reported previously in rats to which aspirin 
was applied - contrary to the findings in the rats in this study. Again cell damage was 
seen most often in the corpus and the damage to the cells was the same as that seen 
with aspirin and bile. However, the mucus layer of the corpus area of the gastric 
mucosa in the rats treated with carprofen was generally thinner overall than with any 
of the other single agents used, suggesting that carprofen was producing a greater 
degree of change than the other agents investigated, possibly by affecting mucosal 
hydrophobicity as aspirin has been shown to do (Goddard, Hills and Lichtenberger 
1987).
The single agents used in these studies did not produce the superficial epithelial 
damage that has been reported by previous workers (Grant 1945, Hingson and Ito 
1971, Yeomans, St. John and de Boer 1973). The various reasons presented in 
explanation for these different findings are the concentrations used, the length of time 
of exposure, and the fact that the rats were starved beforehand and therefore their 
mucosa was not actively producing acid. Thus the most important finding from the 
experimental studies presented here with regard to the use of single injurious agents 
such as bile, aspirin and carprofen at the concentrations used is that the length of time 
that the stomach is exposed to these agents would appear to dictate the extent of the 
damage done to the gastric mucosa. Finally the role of acid, a normal secretory 
product of the stomach, may be controversially one of protection (Smith and others 
1977) or not (Hansen, Aures and Grossing 1978), and acid alone, in a concentration 
similar to those found in the normal stomach, is apparently harmless.
Much as been written in the literature of the effects of combinations of agents on the 
gastric mucosa of man and animals (Gottschalk and Menguy 1970, Semple and 
Russell 1975). The combinations investigated in the work reported in this thesis were 
aspirin/bile, carprofen/acid and carprofen/bile, and carprofen/acid/bile. Of 
particular interest were the combinations including the NSAID drug carprofen as this 
drug has the potential to be used increasingly in the treatment of animals. It is 
believed to be associated with minimal gastric abnormalities (Randall and Baruth 
1976), and certainly not the major effect of inducing gastro-duodenal ulcers (O’Brien 
and Bagby 1987). The lower dose of carprofen with the addition of acid caused
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reddening of the mucosa in the antrum in particular, though increasing the 
concentration led to reddening in the corpus as well. The higher concentration of 
carprofen with the addition of acid also gave rise to reddening of the mucosa around 
the corporo-antral junction in particular, with more involvement of the corpus as the 
time of exposure increased. However, this degree of reddening was not subjectively 
that much more dramatic than that obtained from carprofen alone in the antrum, but 
the addition of acid appeared to cause extension of this reddening to the corpus. 
This spread to the corpus, which was not present with the single agents alone, suggests 
that the addition of acid was enhancing the change induced with carprofen. This 
effect would be due to the provision of exogenous acid for back-diffusion of H + ions 
into the mucosa as suggested by Davenport (1967a) and Whittle (1976).
Doubling the concentration of carprofen increased the hyperaemia and induced gross 
appearance of oedema in one of the rats. The changes appeared to originate in the 
antrum and spread from there to the corpus. In these circumstances the fact that the 
antral area of the stomach is not normally in as much contact with acid compared to 
the corpus, and does not secrete acid, may play a part in the way in which these areas 
of the stomach responded to the addition of acid to carprofen. Those rats given the 
higher concentrations of both carprofen and acid did have the most severe changes 
suggesting that either carprofen or acid at the higher concentrations was enough to 
maximise the effect.
It has already been elaborated that acid enhances the damaging effects of barrier 
breakers. Davenport (1967ab) having noted the fact that the mucosa, if damaged by 
salicylates, became more permeable, wondered what would happen if bile was present 
in such a situation. He found that with luminal concentrations of taurocholate from 
lOmM that bile could be found in the venous blood of dogs with Heidenhain pouches. 
He concluded that bile salt was absorbed when the mucosal barrier was broken by 
salicylates. Bile itself will not only be absorbed but will induce back-diffusion of 
hydrogen ions (Ivey, DenBesten and Clifton 1970, Werther and others 1970), but that 
erosive lesions required an additional agent such as acid (DenBesten and Hamza 
1972).
The combination of bile and aspirin in this series of experiments produced a gross 
reddening that was extensive in the corpus, but focal in the antrum. This appearance 
was not evident when the agents were used singly implying that there may have been a 
synergistic action. The effect of increasing bile concentration gave rise to an 
enhancement of reddening at 15 minutes suggesting that there was both a time and 
concentration effect. The finding that 2.5mM bile was able to enhance the gross 
change induced by aspirin compliments the work of Semple and Russell (1975), who
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used a similar concentration of bile and found that it was sufficient to significantly 
amplify the mucosal lesions detected in rats given aspirin. However, these workers 
and Kauffman (1984) found that the production of haemorrhagic lesions was 
dependent on the concentration of aspirin. Thus in the rats used in this study it is 
suggested that the concentration of aspirin used was not sufficient to induce severe 
lesions, but enough to induce to evidence of mucosal response. Similar evidence of 
the synergistic action was demonstrated by Djahanguiri, Abtahi and Hemmati (1973) 
by testing the hypothesis in a different way. They ligated the pylorus to prevent 
reflux of bile and showed that aspirin-induced ulcerations were prevented. Similarly, 
in this study, the pylorus was ligated to prevent the exposure of the gastric mucosa to 
regurgitated endogenous bile and confirmed the combined effect of bile and aspirin 
on the gastric mucosa.
The evaluation of oedema and WBC counts demonstrates that a concentration effect 
was evident when bile and aspirin were used together, which again supports the 
findings of Semple and Russell (1975). Whilst oedema was only observed grossly in 
one rat, it was a feature when the tissues were examined by light microscopy where 
corporal oedema was present. However, the higher concentrations did evince 
oedema more frequently in the antrum which confirms the work of Ritchie (1981b) 
that bile has a concentration effect on the gastric mucosa as far as cytotoxicity is 
concerned.
Scanning electron microscopy confirmed the damaging effect caused by the 
combination of aspirin and bile. The individual scores in the both corpus and antrum 
of the lower concentrations were the only scores that were not significantly higher 
than control rats. The general scores were enhanced by cell extrusion and rosette 
formation and by enlargement of the gastric pits and cell swelling. Evidence that 
damage was caused was seen in the increased numbers of cells showing holes in the 
apical membrane, and with increased concentration produced more cells with 
erosions and concave membranes suggesting collapse of the cell. This was 
substantiated by the changes to the cytoplasm and mucous granules, which is 
supported by previous work (Hingson and Ito 1971, Rainsford 1975, Baskin and 
others 1976)
The combination of carprofen and bile induced the same degree of hyperaemia 
caused by carprofen and acid except that the reddening originated in the corpus and 
extended into the antrum as the concentration of agents used increased. Reflux of 
bile can occur in the normal animal and healthy man and the area of the stomach 
most likely to come into contact with that refluxed bile is the antrum (Faber and 
others 1974, Sonnenberg and others 1980, Ehrlein 1981, Happ6 and Van den Brom
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1982, Mattioli and others 1990). The antrum may therefore be more capable than 
the corpus of withstanding exposure to bile through prior cytoprotective adaptation 
(Chaudhury and Robert 1980, Scheurer and others 1981). In the experiments 
undertaken in this thesis bile flooded the corpus and antrum equally, producing the 
initial reaction in the corpus and, speculatively, only after overcoming the natural 
barrier in the antrum did this area of the stomach react.
The evidence of apical damage in more sections obtained from rats given aspirin and 
bile than given other combinations suggests that regardless of other features 
carprofen may well be less destructive to the apical cell.
In addition, it would appear from the studies undertaken here that there is still some 
confusion over the area effect of damage. Experimental work has implicated the 
corpus as being more weak, yet the antrum is more permeable and it is this region 
where peptic ulceration occurs (Ruding 1967) and is exacerbated by administration of 
NSAIDs indicating that this area demonstrates a weakness in this line of defence. 
The results from scanning electron microscopy confirmed this effect and showed that 
carprofen/bile caused less damage than did aspirin/bile, at the higher concentrations 
only. There were no differences at the lower concentrations.
The application of mixtures of carprofen, acid and bile produced the most consistent 
and obvious gross change seen with any of the agents or combinations. The 
reddening of the mucosa and presence of linear erosions and pin point corporal 
erosions are typical of those described when asprin/acid has been used in other 
experimental situations (Cooke 1976). However, this appearance was not 
substantiated when sections of tissue were examined histologically for congestion of 
apical damage indicating that gross evaluation can be suspect as far as 
hyperaemia/erythema is concerned. These triple combinations failed to produce 
higher oedema scores or, in general, WBC infiltrate than was obtained with either 
carprofen/acid or carprofen/bile indicating that the addition of either bile or acid to 
double combinations of carprofen did not enhance inflammatory change. Despite 
this lack of aggravation seen at light microscopy level, some features detectable with 
scanning electron microscopy were affected, but the effect was mainly restricted to the 
antrum. In the corpus the features were little different from that obtained with 
carprofen and acid or bile combinations.
In the antrum, the addition of bile at the lower concentrations accentuated the 
number of extruded cells and convexity of the cells, but other than these features the 
supplementation of the challenging mixture with a third agent made no difference. 
The higher concentrations of triple agents appeared to reduce the thickness and 
coverage of the mucus layer and exaggerated the intracellular junctions, but left the
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other general features unaltered. However, the number of cells demonstrating apical 
ruffling and presence of apical membrane damage such as holes and erosions, and 
loss of intracellular contents was increased over those rats given just carprofen with 
acid or bile.
Thus the triple combinations whilst producing apparently more spectacular gross 
change did not have light and microscopic evidence to support this finding. The 
exception to this was the accentuation of antral damage of individual cells possibly by 
the alteration in mucus layer that was demonstrated by thinning and poorer coverage. 
However, this antral damage is what might be expected in the clinical situation where 
the combination of acid, refluxed bile and ingested NSAIDs come together either to 
cause erosive gastritis and hence peptic ulceration, or aggravate pre-existing peptic 
ulcers by attacking the peptic ulcer base (Semple and Russell 1975, Cooke 1976).
Thus in this series of experiments it was found that aspirin and bile produced more 
obvious damage than carprofen mixed with bile and that the creation of an 
environment with three agents did enhance damage produced by double 
combinations in the antrum only.
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6. Pre-treated Rats
6.1 Introduction
Drugs that are used to manage gastric lesions are generally designed to interfere with 
the auto-destructive capabilities of the gastric mucosa, and thus be able to counteract 
the gastric effects of endogenous and exogenous noxious agents.
Early drugs were antacids, which were basic compounds and neutralised the secreted 
acid. However, several limiting factors are inherent in this type of drug since it is 
rendered ineffective once it has neutralised the secreted acid, and further antacid is 
needed for the next wave of acid secretion. Following administration, the drug, like 
any other ingestant, is emptied from the stomach, possibly before the full antacid 
potential of the drug has been realised. This drawback may be compounded by the 
particular formulation allowing a slow acid-base reaction - magnesium trisilicate is an 
example of this.
Amongst the basic anions used are bicarbonate, trisilicate and hydroxide. The 
metallic ion used in combination with the basic anion is very important in determining 
the efficacy of the antacid. Aluminium and magnesium, in the hydroxide forms, are 
those most commonly used. The advantage of magnesium hydroxide is that the 
compound is not very soluble and the hydroxyl ions are not available to corrode the 
stomach mucosa, yet are still very reactive with hydrogen ions.
Commercial preparations are usually a mixture of magnesium and aluminium. This 
is because the combinations have a greater effect than would be expected from the 
simple sum of each drug’s effect. Aluminium hydroxide will adsorb pepsin (Berstad 
1982), stimulate mucus secretion (Caspary 1982) and promote prostaglandin release 
(Berstad and others 1987) and will also adsorb bile and lysolecithin. The delay in 
gastric emptying induced by Al3+ is countered by the Mg2+ (Brunton 1990).
The underlying flaw in the use of compounds to 
neutralize acids in the lumen is that they are 
short acting; 1-2 hours at the most (Brunton 
1990). An alternative approach is to choose a 
compound capable of protecting the injured 
stomach by forming a layer adherent to the top 
of damaged epithelium. One such compound is 
sucralfate, a complex formed from sucrose 
hydroxide. If the pH is less than 4, there is extensive polymerisation and crosslinking 
of the sucralfate, and it forms a sticky and viscid whitish gel (Brunton 1990). The
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Figure 6.1. Structure of sucralfate, 
octasulphate and polyaluminium
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efficacy of sucralfate is substantially increased if the intra-gastric environment has a 
pH of less than 4 (Konturek and others 1991b).
CH, CH *SC H »C N =C N H C H 3  
H N —C S N
HN
CH ^SCH2CH 2NH CNH CH i 
CHNO?
0
H2N (C H 3)2
r
c h 2s c h 2c h 2c n h 2
NSO^NH*
A separate approach to counteract the 
deleterious effect of agents in the stomach is to 
suppress acid secretion, as it plays such a 
significant role as an aggravator of mucosal 
damage. Histamine is a mediator in the 
stimulation of gastric acid and its release occurs 
during the early phases of gastric secretion.
Acetylcholine and gastrin are also involved in 
the release of acid. However, the histamine H2 
receptor would appear to be the major 
controller of the parietal cell hydrogen ion 
production line (Code 1977). Cimetidine was 
the first of the commercially successful 
antagonists. It attaches to the H2 receptor and 
blocks the activation of the parietal cell 
(Brimblecome and others 1975, Burland and 
others 1975). However, there are now 
recognised side-effects to cimetidine such as 
pruritis and gynaecomastia, male sexual 
dysfunction and mental confusion (Delle and antagonists (from ,op) cimetidine^
others 1977, Van Thiel and others 1979, ranitidine and famotidine.
McMillen, Ambis and Siegel 1978, Galbraith
and Michnovicz 1989). Many of the side-effects and drug interactions of cimetidine 
can be traced to the inhibition of cytochrome P450 (Peura and Freston 1987). 
However, from a patient compliance point of view, one of the drawbacks of 
cimetidine is the requirement for it to be taken four times daily. Ranitidine, another 
H2 antagonist, has overtaken cimetidine in market share because it lacks the side- 
effects, but importantly needs only to be taken twice daily (Bohman, Myren and 
Larsen 1980, Woodings and others 1980). Both these drugs will suppress basal and 
stimulated acid secretion (Ostro 1987).
A newer H2 antagonist, famotidine has had the imidazole ring of histamine, which 
was retained in cimetidine, replaced by a thiazole (Takagi, Takeda and Maeno 1982) 
(Figure 6.2). It offers further opportunities for improved patient/ owner compliance, 
since it need only be given once daily in the evening (Dammann and others 1987), and 
has been shown to be as effective as other H2 receptor antagonists at permitting ulcer 
healing (Cochran and others 1989). Further, it has been demonstrated to be more
N = C ( N H 2X.
F ig u re  62. Structure of H,
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potent as an acid suppressor than cimetidine (Bertaccini and others 1986, Ostro 
1987).
There have been a number of studies comparing the efficacy of sucralfate and the 
older H2  antagonists such as cimetidine. In experimental feline oesophagitis pre- 
treatment with sucralfate was shown to be more effective than cimetidine (Clark and 
others 1987). In a similar study of the naturally occurring disease in man, sucralfate 
and cimetidine were found to be comparable when assessed endoscopically (Tytgat 
1987). In the stomach of rats challenged with 100% ethanol, cimetidine was 
ineffective in reducing the number and extent of the induced lesions compared with 
sucralfate where there was a significant reduction (Kuwayama, Miyake and Matsuo 
1987).
Aim
The aim of the work presented in this chapter is to compare the effect on the gastric 
mucosa of the administration of famotidine and sucralfate to rats for five days. The 
effect of challenging these rats with several injurious agent/combinations, including 
carprofen, was also examined. This was done with a view to compare the two drugs 
and any differences between the effects of the injurious agents on pre-treated rats.
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6.2 Material and Methods
Batches of six Sprague-Dawley rats were housed and fed as described in section 3.1. 
Rats were given either 1ml famotidine (O^Smgml-1) or 1ml sucralfate (200mgml-1) 
for five days. The drugs were given fresh as a mixture of drug and distilled tap water 
and the bottles were always well agitated prior to drawing up the mixture to be given 
to the individual rat. The drugs were administered per oesophagus using a syringe 
and Spreull needle.
The rats were starved, anaesthetised and the pylorus ligated as described in section 
3.1. Control rats were given either the drug or were sham-tubed with 1ml saline daily 
and killed after 5 days. Groups of six rats had carprofen, carprofen & bile, aspirin 
and aspirin & bile infused into their stomachs (Table 6.1).
agent concentration
aspirin 40mM
aspirin & bile 40mM & 5mM
carprofen 0.46mM
carprofen & bile 0.46mM & 5mM
Table 6.1. Injurious agents used in rats given protective drugs.
Pairs were killed at 2, 5 and 15 minutes post-infusion. The method of gross 
examination and description of the harvesting of tissues is detailed in section 32.
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63 Results
63.1 Gross
6.3.1.1 Controls
No abnormalities were seen on the mucosa of the rats given either the protective 
agents alone or which had been sham tubed.
63.12 Sucralfate pre-treatment followed by
6.3.1.3 Aspirin
Aspirin alone produced little or no gross change to the mucosa. In one rat there was 
coating of the antrum with sucralfate.
6.3.1.4 Aspirin & Bile
When a mixture of bile and aspirin was used there was widespread reddening of the 
mucosa in the corpus, with spread of this erythema to the antrum in 3/6 rats. There 
was minimal coating of the mucosa with sucralfate, but it was more obvious in the 
corpus than the antrum.
6.3.1.5 Carprofen
After the infusion of 0.46mM carprofen, sucralfate was found as an adherent lacey 
layer in the antrum of all six rats. Some hyperaemia in the corpus was found in two 
rats, at 2 and 5 minutes.
6.3.1.6 Carprofen & Bile
In contrast to carprofen on its own, when bile (5mM) was added there was much less 
antral binding of sucralfate in 2/6 rats (Figure 6.3). Corporal hyperaemia was found 
in all six rats, either quite generalised or restricted to the greater curvature, with 
sparing of the lesser curvature.
6.3.1.7 Famotidine pre-treatment followed by
6.3.1.8 Aspirin
There was widespread reddening of the corporal mucosa in 4/6 rats, in the other two 
it was more localised to the dorsal and ventral surfaces of the mucosa. In the two 15 
minute rats there was also involvement of the antrum with focal reddened areas on 
the ridges of the rugal folds.
6.3.1.9 Aspirin & Bile
With the infusion of both bile and aspirin there was widespread erythema in two rats 
after 5 and 15 minutes. In the other four the reddening was restricted to small areas 
on the dorsal or ventral surfaces. Alteration in mucosal colour was only found in the
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antrum in one rat as focal change on the rugal ridges.
6.3.1.10 Carprofen
Moderate erythema was present in 5/6 rats following infusion of 0.46mM carprofen. 
This was evident in the corpus only, which although generalised in three of the rats 
was most pronounced on the greater curvature. In two rats there was oedema of the 
antrum and corpus, both of which had a few linear erosions on the antral rugae.
6.3.1.11 Carprofen & Bile
Erythema was less pronounced in the corpus of those rats exposed to bile and 
carprofen, again most noticeable in the corpus along the greater curvature (4/5 rats). 
Little or no gross change was evident after 15 minutes.
Figure 63. Gross mucosal appearance - sucralfate// carprofen/bile. The mucosa of 
the corpus and antrum is reddened and sucralfate can be seen as a white lacy 
covering.
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632 Light Microscopy
(see Figures 6.5-6.19)
6.3.21 Oedema
No obvious time effect was found in either the corpus or antrum when the oedema 
ratios obtained from each of the combinations were examined. There was no 
difference in oedema ratios detectable between normal rats, sham-tubed rats and 
those unchallenged rats given famotidine and sucralfate (Table 6.2). The exception 
to this was the antrum of the rats given sucralfate. The antra of these rats had 
significantly higher ratios than the corpus and those rats forming the rest of the 
protection control subgroup.
The effect of sucralfate and famotidine under challenge conditions was compared 
with normal and sham-tubed rats. All rats, with the exception of those pretreated 
with famotidine and challenged with carprofen and carprofen/bile, had significantly 
higher ratios in the corpus, and all had more oedema in the antrum compared to the 
normal and sham-tubed rats.
In the sucralfate group, the corpus of the rats challenged with NSAID alone had 
higher ratios compared to the control sucralfate rats. In the antrum, all the 
challenged rats had significant evidence of being oedematous compared to the pre­
treated controls. Of the famotidine rats, the antra of all challenged rats produced 
higher oedema ratios than the pre-treated famotidine controls. In the corpus there 
was no difference between controls and challenged rats, with the exception of the rats 
given aspirin/bile (Table 6.3).
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Group Agent mean corpus ±sd mean antrum ±sd
Control NC 0.20 0.02 0.20 0.01
CT 0.21 0.03 0.19 0.03
CSO 0.22 0.03 0.28 0.03
CFO 0.22 0.04 0.24 0.03
Iiyuiy IS2 0.24 0.01 0.24 0.08
IS2B2 0.25 0.06 - 0.34 0.04
IR2 0.23 0.04 0.24 0.04
IR2B2 0.25 0.04 0.30 0.06
Challenge SS2 0.30 0.04 0.36 0.03
SS2B2 0.25 0.04 0.37 0.05
SR2 0.26 0.03 0.33 0.04
SR2B2 0.25 0.07 0.34 0.04
FS2 0.26 0.02 0.29 0.04
FS2B2 0.29 0.02 0.28 0.03
FR2 0.22 0.03 0.27 0.02
FR2B2 0.24 0.03 0.29 0.02
NC=normal, CT=sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, prefix 
F=famotidine, prefix S=sucralfate, R2=0.46mM carprofen, B2=5mM bile, S2=40mM aspirin.
Table 62. Oedema ratios of rats given protective drugs, and those obtained from rats
given injurious agents.
The effect of the different challenging agents on the oedema ratio obtained from the 
rats was evaluated, and also a comparison was made between the effect of famotidine 
versus sucralfate (Table 6.3). The different combinations of challenging agents made 
no statistical difference to the oedema ratios from either those rats given famotidine 
or sucralfate. When sucralfate and famotidine were compared there was no 
demonstrable effect in the corpus. The antra of rats challenged with 0.46mM 
carprofen/5mM bile had significantly more oedema if they had been pre-treated with 
sucralfate rather than famotidine. Sucralfate rats given aspirin or aspirin/bile had 
higher ratios than comparable famotidine rats, again only demonstrable in the 
antrum.
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drug V5 agent
corpus
(p<0.05)
antrum
SR2 CS S S
SR2B2 CS ns S
SS2 CS S S
SS2B2 CS ns S
FR2 CF ns S
FR2B2 CF ns S
FS2 CF ns S
FS2B2 CF S S
SR2 SR2B2 ns ns
SR2 SS2 ns ns
SR2B2 SS2B2 ns ns
SS2 SS2B2 ns ns
FR2 FR2B2 ns ns
FR2 FS2 ns ns
FR2B2 FS2B2 ns ns
FS2 FS2B2 ns ns
SR2 FR2 ns ns
SS2 FS2 ns S
SS2B2 FS2B2 ns S
SR2B2 FR2B2 ns s
NC=normal, CT=sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, 
prefix F=famotidine, prefix S = sucralfate, R2=0.46mM carprofen, B2=5mM bile, S2=40mM 
aspirin.
Table 63. Oedema ratios. Comparison between challenged rats and 
unchallenged, between different injurious agents, and between different 
protective drugs.
When the pre-treated and challenged rats were compared to those that had been 
given comparable injurious agents in the injury group there was little evidence of any 
effect on the corporal oedema ratios. In the antrum of those rats pretreated with 
sucralfate the oedema ratio was higher in those rats given carprofen, carprofen/bile 
or aspirin/bile. No trend was evident between those given famotidine and those 
from the injury group that were given no pre-treatment. Famotidine caused a 
lowering of the ratio compared to those given aspirin/bile in the injury group.
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drug vs agent
corpus antrum 
(p<0.05)
SR2 IR2 ns S
SR2B2 IR2B2 ns S
SS2 IS2 S S
SS2B2 IS2B2 ns ns
FR2 IR2 ns ns
FR2B2 IR2B2 ns ns
FS2 IS2 ns S
FS2B2 IS2B2 ns @s
Prefix F =famotidine, prefix S=sucralfate, I = injury, R2=0.46mM carprofen, B2=5mM bile, 
S2=40mM aspirin, S=significantly higher, ns=not significant, @S=significantly lower.
Table 6.4. Oedema ratios. Comparison between pre-treated and challenged 
rats.
6.3.2.2 White Blood Cells
There was no difference in the infiltration of WBCs in those rats that were not tubed 
and those sham-tubed. Nor was there any difference in the numbers found in the 
corpus of the control rats given sucralfate and the normal rats whether sham-tubed or 
not. However, the numbers found in the antrum of the control sucralfate rats were 
significantly higher. In both the antrum and corpus of rats given famotidine alone, 
the numbers of cells were higher compared with both the normal and sham-tubed 
rats.
No time trend was apparent. As was done with the results from the injurious groups 
(4.3.2), the WBC counts for each combination were pooled. This was to establish if 
there was any difference between corpus and antrum with the various combinations of 
protective drug and challenging agents. There was substantially no difference 
between the numbers found in the corpus and antrum of the sham tubed, control rats 
and those given famotidine. The rats given sucralfate as controls had much higher 
numbers of WBCs in the antrum than in the corpus (Figure 6.4).
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Agent mean corpus ±sd mean antrum ±sd
Control CR 2.90 0.88 3.40 0.18
CS 4.00 1.41 17.00 2.47
CF 13.30 3.24 10.50 2.12
Injury IR2 3.75 2.73 3.63 2.14
IR2B2 4.96 0.89 5.76 1.2
IS2 10.50 3.92 14.60 6.37
IS2B2 13.50 3.01 12.90 2.49
Challenge SR2 13.80 8.51 29.50 7.06
SR2B2 24.80 6.83 46.30 18.60
SS2 14.00 4.66 26.90 8.86
SS2B2 7.38 2.40 11.30 3.10
FR2 6.67 2.50 13.90 4.82
FR2B2 6.29 3.09 7.25 2.06
FS2 6.21 2.97 5.08 1.30
FS2B2 10.02 4.59 8.21 2.01
CR = normal and sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, prefix 
F =famotidine, prefix S = sucralfate, I = injury, R2=0.46mM carprofen, B2=5mM bile, S2=40mM aspirin. 
Table 6.5 Mean white blood cell numbers found in control, pretreated rats and those 
challenged with injurious agents.
M ea n  WBC c o u n t  
2 ,0________ 3 0
S R 2 B 2
W S S 2 B 2
D 3 3
 ♦
6.0
CR = normal & sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, prefix 
F =famotidine, prefix S=sucralfate, prefix I =injury, R2=0.46mM carprofen, B2=5mM bile, S2=40mM 
aspirin.
Figure 6.4. Bar graph of the white blood cell infiltrate in control, selected injury 
groups and those pre-treated with sucralfate and famotidine.
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The WBC infiltrate into the antrum of those rats pre-treated with sucralfate and given 
carprofen combinations was significantly higher than the corporal infiltrate. A 
matching difference was found between the corpus and antrum of those rats given 
aspirin after sucralfate. However, this disparity between corpus and antrum was not 
present in the rats challenged with aspirin/bile. No difference was detectable in the 
numbers found in the corpus and antrum of those rats pre-treated with famotidine 
given and challenged with injurious agents.
The infiltrate of WBCs into the corpus and antrum of the rats pretreated with 
sucralfate and then challenged was significantly higher than the numbers found in 
those rats that were sham-tubed or those given the sucralfate alone. A similar 
significant difference was found when the famotidine rats were compared with the 
sham-tubed rats, with the exception of the antrum of the rats given aspirin. However, 
this effect was not present when the challenged rats were compared with the rats 
given famotidine alone (Table 6.6). Indeed, in the corpus there was a drop in the 
numbers of WBCs found in comparison to the pre-treated famotidine controls, but 
generally no difference in the antrum.
drug/agent vs drug
corpus antrum
(p<0.05)
SR2 NR S S
SR2B2 NR S S
SS2 NR S S
SS2B2 NR S S
SR2 CS S S
SR2B2 CS S S
SS2 CS S S
SS2B2 CS S ns
FR2 NR S S
FR2B2 NR S S
FS2 NR S ns
FS2B2 NR S S
FR2 CF @s ns
FR2B2 CF @s ns
FS2 CF @s @s
FS2B2 CF s ns
NR= normal and sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, 
prefix F=famotidine, prefix S=sucralfate, I =injury, R2=0.46mM carprofen, B2=5mM bile, 
S2=40mM aspirin. S = significantly higher, ns= not significant, @S=significantly less.
Table 6.6. White blood cell infiltrate. Comparison between rats given 
protective drugs and controls.
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Next the results were compared to define if any effect could be attributed either to 
the addition of bile or the effect of the two drugs (Table 6.7).
SR2 SR2B2 SS2 SS2B2 FR2 FR2B2 FS2
c a c a c a c a c a c a c a
SR2
SR2B2
SS2
SS2B2
FR2
FR2B2
FS2
FS2B2
<S ns 
ns ns
tS tS
tS tS
tS tS
tS tS 
tS tS
ns ns
ns tS 
ns tS
ns ns ns <S
Prefix F =famotidine, prefix S = sucralfate, I = injury, R2=0.46mM carprofen, B2=5mM bile, S2=40mM 
aspirin. c=corpus, a =antrum, < and t point to the combination producing the significantly larger 
WBC infiltrate..
Table 6.7. White blood cell infiltrate. Effect of injurious agents on protected rats.
Taking the sucralfate pool first, the addition of bile to carprofen had the effect of 
increasing the WBC infiltrate in the corpus alone. It had no effect on the antral 
score, nor was there any difference between aspirin and carprofen given alone as 
injurious agents in the presence of sucralfate. The mixture of aspirin and bile 
produced significantly lower WBC counts when compared either to the similar 
carprofen/bile mixture or to aspirin alone. A comparison of the sucralfate pool to 
the famotidine pool showed that rats pretreated with sucralfate and given any of the 
agents with the exception of the aspirin/bile combination, had a heavier infiltrate of 
WBCs than in those receiving famotidine.
As can be seen from Figure 6.4, the famotidine pool had very similar infiltrates in 
both corpus and antrum regardless of the injurious challenge. Two significant 
exceptions were i) carprofen in the antrum having a higher infiltrate than those given 
aspirin alone, and ii) increased numbers found in the antrum of rats given aspirin/bile 
compared with aspirin alone.
Compared with the mean WBC infiltrate found following the application of injurious 
agents those rats pre-treated with sucralfate and those given the same injurious agents 
alone, on the whole, gave rise to significantly greater infiltrates of WBCs (Table 6.8). 
The exceptions to this generalisation in the sucralfate group were the corpus of those 
rats given aspirin, the antrum of those given aspirin/bile and the corpus of those rats
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given famotidine and aspirin & bile. There was a significant reduction in numbers 
compared with the similar injurious pool, but only in the antrum of the rats given 
aspirin/bile and pretreated with famotidine.
drug vs agent
corpus
(p < 0.05)
antrum
SR2 IR2 S S
SR2B2 IR2B2 S S
SS2 IS2 ns S
SS2B2 IS2B2 S ns
FR2 IR2 S S
FR2B2 IR2B2 s S
FS2 IS2 s ns
FS2B2 IS2B2 ns @S
Prefix F=famotidine, prefix S = sucralfate, I = injury, R2=0.46mM carprofen, B2=5mM bile, 
S2=40mM aspirin, S = significantly greater, ns=not significant, @S = significantly less.
Table 6.8. White blood cell infiltrate. Comparison between protected rats and 
those given injurious agents alone,
6.3.2.3 Congestion
The rats given the protective agents were examined for congestion as were those 
given injurious agents (Table 5.14).
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
total=96 n % n % n % n % n % n %
Congestion
0 11 11.5 14 14.6 6 6.2 12 12.5 7 7.3 11 11.5
1 4 4.2 2 2.1 7 7.3 4 4.2 1 7.3 3 3.1
2 1 i.O 0 - 3 3.1 0 - 2  2.1 2 2.1
Table 6.9. Protection. Congestion in corpus and antrum with time.
The figures for congestion at the different time intervals failed to reveal evidence of a 
time effect. An examination of the congestion found in the sections from the rats 
treated with different drug and injurious agent combinations also failed to show a 
drug effect (Table 6.10). Sixty-one areas (63.5%) had no congestion noted, which at
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time 5 and 15 minutes was more apparent in the antrum. Congestion (scored 1) in 27 
areas (28.2%) and was twice as likely to be present in the corpus as the antrum. 
Intense congestion (scored 2) was uncommon and found in only eight areas. In 6/8 
rats this congestion was in the corpus. A time effect was suggested here in that this 
severity of congestion was found in 4/8 at 15 minutes. There was no difference in the 
distribution of congestion in the corpus and antrum when sucralfate and famotidine 
were compared (Table 6.10).
0
no congestion
1
mild congestion
2
marked congestion
area corpus antrum corpus antrum corpus antrum
Sucralfate 11 18 11 5 2 1
Famotidine 13 19 7 4 4 1
Table 6.10. Numbers of rats with congestion. Comparison between sucralfate and 
famotidine.
Expressed as a percentage the number of rats with scores of 1 or 2 in those given 
protective drugs was much higher than those given the same injurious agents, but not 
pretreated at 5 and 15 minutes (Table 6.11)
Time
2min 5min 15min
area corpus antrum 
I P  I P
corpus antrum 
I P  I P
corpus antrum 
I P  I P
Congestion
0
1
2
%
9.3 11.5 12.1 14.6 
5.0 4.2 2.1 2.1 
0 1 0  0
%
8.9 6.2 11.0 12.5 
4.6 7.3 2.1 4.2 
0.7 3.1 0.7 0
%
7.9 7.3 12.9 11.5 
5.0 7.3 1.4 3.1 
1.4 2.1 0 2.1
I =rats given injurious agents, P=rats given protective drugs and challenged with injurious agents. 
Table 6.11. Comparison of congestion in pretreated rats with challenged rats.
6.3.2.4 Apical Damage
The figures for apical damage as far as time and area are concerned are given in 
Table 6.12, without consideration of the drug and injurious agent.
There appeared to be some anomalous increase in damage with time in that those 
rats showing the least apical damage were found after 2 minutes, most rats with 
damage were found in 5 minute rats, but fewer after 15 minutes. This being more
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marked in those rats with severe damage (score 2). With specific combinations only 
those given aspirin and famotidine showed a definite time trend with damage 
becoming more severe as time progressed.
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
Damage
0 9 8 8 3 5 5
1 7 4 5 9 9 3
2 0 4 3 4 0 3
3 0 0 0 0 2 2
Table 6.12. Protection. Apical damage versus time.
In those rats with a damage score of 1 there was a disparity between corpus and 
antrum. At 5 minutes, compared with the antrum, the corpus appeared to be spared, 
yet at 15 minutes the position seemed to have been reversed with the antrum being 
spared. When the damage was scored as 2 there was a more pronounced 
involvement of the antrum regardless of the time at which the rats were sacrificed.
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
damage drug
0 S 5 2 4 1 2 2
F 4 6 4 2 3 3
1 S 3 2 2 3 6 3
F 4 2 3 6 3 0
2 S 0 4 2 4 0 3
F 0 0 1 0 0 3
3 S 0 0 0 0 0 0
F 0 0 0 0 2 2
S=sucralfate, F =famotidine
Table 6.13. Protection. Apical damage versus time and drug given.
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The results were split on the basis of the drug given (Table 6.13). There was little 
difference between sucralfate and famotidine where there was no apical damage, 
except that there were fewer sucralfate rats with no antral damage at 2 minutes. 
There was more damage (scored as 1) in the antrum of famotidine rats at 5 minutes 
than in the corpus or the sucralfate rats. In contrast at 15 minutes there more 
sucralfate rats with this level of damage, with the corpus being twice as affected as the 
antrum. Damage (scored as 2) was found in rats given sucralfate, predominatly in 
the antrum. The two rats found to have most severe (scored as 3), had been given 
famotidine and exposed to aspirin for 15 minutes. This level of damage was not 
found in those rats given injurious agents alone.
score
Area
0
both
1
corpus antrum
Damage
,
corpus
2
antrum
3
corpus antrum
SR2 3 2 1 2 4 0 0
SR2B2 1 5 0 0 6 0 0
SS2 5 2 4 0 1 0 0
SS2B2 7 2 3 0 0 0 0
FR2 6 3 2 0 1 0 0
FR2B2 10 1 1 0 0 0 0
FS2 6 0 1 1 0 2 2
FS2B2 0 5 4 1 2 0 0
IR2 9 0 1 2 0 0 0
IR2B2 9 1 2 0 0 0 0
IS2 9 1 2 0 0 0 0
IS2B2 6 3 3 0 0 0 0
NC=normal, CT=sham-tubed, CS = unchallenged sucralfate, CF=unchallenged famotidine, prefix 
F=famotidine, prefix S = sucralfate, R2=0.46mM carprofen, B2=5mM bile, S2=40mM aspirin.
Table 6.14. Protection. Apical damage and injurious agent combinations.
When those rats that had been pre-treated with sucralfate were compared with those 
that had been given injurious agents alone, only those rats challenged with aspirin and 
bile had the same range of apical damage as those pre-treated with sucralfate. In the 
other three combinations pre-treatment increased the level of apical damage.
When the same comparison was made with rats pre-treated with famotidine, there 
was more damage amongst rats pre-treated and given carprofen alone, whereas there 
was no difference with those given carprofen and bile. Those pre-treated rats given 
aspirin combinations had more damage than rats given the same injurious agents
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without pre-treatment. This was most apparent in those given aspirin and bile where 
all pre-treated rats had apical damage recorded.
6.3.15 Luminal Contents
The luminal contents of the protected rats was examined, but no time-related pattern 
was apparent (Table 6.15).
2min
Time
5min 15min
area corpus antrum corpus antrum corpus antrum
contents
NF 10 9 10 4 7 4
TF 0 0 0 0 0 0
NM 4 2 4 4 7 6
TM 2 5 2 8 2 6
NF= little mucus, few cells, TF= thick mucus few cells, NM= little mucus, 
many cells, TM= thick mucus, many cells
Table 6.15. Luminal contents by time and area.
Luminal Contents
corpus antrum
agents NF TF NM TM NF TF NM TM
Sucralfate
Famotidine
Injury
13 0 7 4 6 1 5 12
14 0 8 2 11 0 10 3
20 0 3 1 17 0 3 4
NF= little mucus, few cells, TF= thick mucus few cells NM= little mucus, 
many cells, TM= thick mucus, many cells
Table 6.16. Luminal contents. Comparison between rats grouped as protected 
and injured.
In Table 6.16 the results for the luminal contents were placed in three groups 
determined by the presence or absence of a protective agent and the particular agent. 
Those animals pre-treated with protective agents had a different range of intraluminal 
contents compared with similar rats infused with injurious agents alone. Most of the 
injured rats had no mucus and few if any cells in the lumen. Over half of the rats 
given sucralfate had no mucus and few cells on the surface of the corpus, though a
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significant number (11/24) had many cells littering the lumen. In the antrum 50% of 
the rats had an apical surface coated with a thick mucus layer containing large 
numbers of cells, though in five only the cells were present.
The corpus of those rats given famotidine was rather similar to the corporal region of 
the sucralfate group, as 50% had a little in the way luminal contents. However, 
10/24 rats had many cells lining the lumen. In the antrum, more of the injured rats 
compared with those of the sucralfate group had no luminal contents. In contrast to 
the sucralfate group, which had a profusion of both mucus and cells, those in the 
famotidine group had large numbers of cells in the lumen unaccompanied by mucus.
The three groups were then broken down into their constituent parts in Table 6.17.
Luminal Contents
Corpus Antrum
agents NF TF NM TM NF TF NM TM
SR2 3 0 1 2 0 1 1 4
SR2B2 0 0 4 2 0 0 0 6
SS2 5 0 1 0 3 0 1 1
SS2B2 5 0 1 0 2 0 3 1
FR2 5 0 1 0 2 0 3 1
FR2B2 6 0 0 0 4 0 2 0
FS2 2 0 3 1 3 0 1 2
FS2B2 1 0 4 1 2 0 4 0
IR2 5 0 0 1 4 0 2 0
IR2B2 6 0 0 0 6 0 0 0
IS2 6 0 0 0 3 0 0 3
IS2B2 3 0 3 0 4 0 1 1
prefix F=famotidine, prefix S = sucralfate, I = injury, R2=0.46mM carprofen, B2=5mM bile, 
S2=40mM aspirin. NF= little mucus, few cells, TF= thick mucus few cells NM= little mucus, 
many cells, TM= thick mucus, many cells
Table 6.17. Protection. Luminal contents in rats with and without pre- 
treatment with sucralfate and famotidine.
In the sucralfate group, the addition of bile to those rats given carprofen appeared to 
contribute to the proliferation of cells in the lumen of the corpus when compared with 
the other injurious combinations. Indeed in the corpus those rats given aspirin were 
found to have little luminal contents. In the antrum, carprofen caused the production 
of large numbers of cells in a thick layer of mucus, being possibly accentuated by the
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addition of bile. Comparing those given sucralfate with those challenged with 
injurious agents alone, it appeared that only three of the rats challenged with 
carpofen alone or with bile had any luminal contents. When pre-treated with 
sucralfate, many of those rats challenged with carprofen combinations had luminal 
contents containing either cells alone or a layer of mucus with cells embedded. The 
difference between those rats given aspirin with and without pre-treatment was not as 
marked.
There was substantially little difference between the corpus of those rats injured with 
carprofen, with and without bile, and those pre-treated with famotidine. In the 
antrum, however, there was an increase in the cell content. In the famotidine group 
the main contributor to the increase in luminal contents compared with the injurious 
group was in those rats given aspirin, regardless of the inclusion of bile in the injected 
solution. Similar to the antral region of the rats given carprofen and famotidine, 
there was an increase in the number of cells in the lumen, but not in the volume of 
mucus detected.
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Figure 6.5. Photomicrograph of corpus pre-treated with sucralfate. There is some 
debris in the lumen. (H&E x30)
Figure 6.6. Photomicrograph of antrum pre-treated with sucralfate. There is an area 
of epithelium covered by a layer of mucus/sucralfate with a heavy cellular infiltrate. 
(H&E, PAS/Alcian Blue x75)
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Figure 6.7. Photomicrograph of corpus pre-treated with famotidine. (H&E xl5 )
Figure 6.8. Photomicrograph of antrum pre-treated with famotidine. There is some 
mucus on the surface. (PAS/Alcian Blue x75)
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Figure 6.9a & 6.9b. Photomicrographs of antrum following sucralfate// 0.46mM 
carprofen. Two and 5 minutes exposure to carprofen. There is a thick overlay of 
mucus/sucralfate and ghost cells. The surface epithelium is disrupted and there is an 
intense white blood cell infiltrate visible. (H&E x75, x!50)
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Figure 6.10. Photomicrograph of antrum following sucralfate// 40mM aspirin. Five 
minutes exposure to aspirin. There is a thick overlay of mucus/sucralfate and ghost 
cells. (H&E x30)
Figure 6.11. Photomicrograph of corpus following sucralfate// 40mM aspirin. Five 
minutes exposure to aspirin. There is debris in the lumen and there is an underlying 
white blood cell infiltrate with oedema evident. (H&E x75)
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Figure 6.12. Photomicrograph of antrum following sucralfate// 0.46mM carprofen/ 
5mM bile. Two minutes exposure to the injurious combination. There is a marked 
overlay of mucus/ sucralfate containing ghost cells. (H&E x30)
Figure 6.13. Photomicrograph of antrum following sucralfate// 0.46mM carprofen/ 
5mM bile. Fifteen minutes exposure to the injurious combination. There is a an 
overlay of mucus/ sucralfate containing ghost cells, beneath this the surface 
epithelium is disrupted. There is an obvious cellular infiltrate with some congestion. 
(H&E x75)
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Figure 6.14. Photomicrograph of antrum following sucralfate// 40mM aspirin/ 5mM 
bile. Two minutes exposure to the injurious combination. There is an overlay of 
mucus and sucralfate. (PAS/Alcian Blue x75)
Figure 6.15. Photomicrograph of corpus antrum following sucralfate// 40mM 
aspirin/ 5mM bile. Two minutes exposure to the injurious combination. Oedema is 
evident and there is an obvious infiltrate of white blood cells. There is some 
disruption of the apical epithelial cells. (H&E, x75)
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Figure 6.16. Photomicrograph of antrum following famotidine// 0.46mM carprofen. 
Five minutes exposure to carprofen. There is a marked cellular infiltrate, and 
although the apical epithelium appears intact there are some free lumenal cells 
visible, which may be arising from an area at the base of the rugal fold (arrow). 
(H&E x75)
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Figure 6.17a & 6.17b. Photomicrographs of corpus following famotidine// 0.46mM 
carprofen/ 5mM bile. Fifteen minutes exposure to the injurious combination. There 
is a moderately thick acellular layer of mucus overlying substantially normal surface 
epithelium. (H&E xl50, PAS/Alcian Blue x75)
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Figure 6.18. Photomicrograph of corpus following famotidine// 40mM aspirin. Five 
minutes exposure to aspirin. There is disruption of the apical epithelial cells and a 
thin overlay of mucus. (H&E x300)
Figure 6.19. Photomicrograph of antrum exposed to following famotidine// 40mM 
aspirin/ 5mM bile. Five minutes exposure to the injurious combination. There is an 
erosion of the surface epithelial cells. There is a heavy overlay of mainly ghost cells. 
(H&E, PAS/Alcian Blue x75)
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633 Scanning Electron Microscopy
The general and individual mean summed scores obtained from the control rats given 
protective agents for five days were compared with the untreated rats. There was no 
statistical difference found between these rats and those sham-tubed with saline, or 
those not tubed (see Tables 6.18-6.22).
There was also no difference found between the mean scores derived from the corpus 
and antrum of those rats sham-tubed and those given sucralfate or famotidine (see 
Tables 6.18-6.22, Figures 6.26ab). Though graphically pre-treatment appeared to 
have caused and increase in both general and individual scores (Figures 6.20-6.25).
The results of summed scores obtained at the three time intervals from the rats given 
both drug and injurious agents were evaluated, and there was no demonstrable time 
effect for either drug or drug/agent combination.
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S2 = 20mM & 40mM aspirin, R1 & R2 = 0.23mM & 0.46mM carprofen
Figure 6.20. Bar graph of corpus scanning electron microscopy general scores 
obtained from pre-treated rats given injurious agents.
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Figure 621. Bar graph of corpus scanning electron microscopy individual scores 
obtained from pre-treated rats given injurious agents.
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drug/ Corpus Antrum
agent score 1 score 2 score 1 score 2
Controls
Normal 15.50 7.33 13.90 7.33
Sham-tubed 11.50 7.00 12.00 6.50
Famotidine 14.00 6.00 12.00 6.00
Sucralfate 14.00 7.00 15.50 7.00
SR2 18.17* 9.00 16.17 7.83
SR2B2 15.83 7.83 17.17 7.17
SS2 16.83 8.00 17.17 8.67
SS2B2 13.33 9.83 16.50* 12.33*
FR2 13.67 8.83 15.50* 9.17
FR2B2 14.83 9.17 16.33 10.00
FS2 14.67 8.50 17.00 9.17
FS2B2 16.50 11.50 17.83 11.17
Prefix F =famotidine, prefix S = sucralfate, R2=0.46mM carprofen, B2=5mM bile, S2=40mM 
aspirin. * indicates a significant difference between corpus and antrum.
Table 6.20. Mean summed scores of variables for change seen by scanning 
electron microscopy.
drug/
agent
sham-tubed 
C A
Controls 
sucralfate 
C A
famotidine 
C A
SR2 S S S ns
SR2B2 S S ns S
SS2 S S S S
SS2B2 ns S ns ns
FR2 ns S ns S
FR2B2 ns S ns S
FS2 ns S ns S
FS2B2 S S S S
(p<0.05)
C=corpus, A =antrum, prefix F=famotidine, prefix S = sucralfate, R2=0.46mM carprofen, 
B2=5mM bile, S2=40mM aspirin, S=significant, ns=not significant.
Table 621. Comparison between scanning electron microscopy score 1 for rats 
given drug & injurious agents and controls.
Score 1 from protected rats then challenged with injurious agents was compared with 
the control rats and is illustrated Figure 6.21 and in Table 6.21.
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With those rats given sucralfate and agent/s, score 1 was significantly higher when 
compared with the sham-tubed rats in both corpus and antrum, with the exception of 
the carprofen/bile combination. Differences were less consistent against sucralfate 
controls. Only those given aspirin alone had significant increases in score 1 in both 
antrum and carpus. With those given aspirin and bile there was no significant 
difference in either corpus or antrum.
With those rats given famotidine and agent/s, score 1 was significantly increased in 
the antrum of all the combinations compared with the sham-tubed rats. Only in the 
rats given aspirin/bile was there a corporal effect. Against famotidine controls there 
was similar a significant increase in the antrum, and a corporal effect in the rats given 
aspirin/bile.
Score 1 from the corpus and antrum were compared in an attempt to establish an 
area effect (Table 6.20). In only three of the combinations could an area effect be 
shown. Of these three, sucralfate with carprofen induced a significantly higher score 
in the corpus. The other two were antral area effect in rats given sucralfate with 
aspirin/bile, and famotidine with carprofen alone.
Score 2 from those rats then challenged with injurious agents were compared with the 
control rats and the results are illustrated in Figure 6.22 and in Table 6.20.
drug/
agent
sham-tubed 
C A
Controls 
sucralfate 
C A
famotidine 
C A
SR2 ns ns ns ns
SR2B2 ns ns ns ns
SS2 ns S ns S
SS2B2 S S S S
FR2 ns ns S S
FR2B2 S S S S
FS S ns S S
FS2B2 S S S S
(p < 0.05)
C=corpus, A =antrum, prefix F=famotidine, prefix S = sucralfate, R2=0.46mM carprofen, 
B2=5mM bile, S2=40mM aspirin, S = significant, ns=not significant.
Table 6.22. Comparison between scanning electron microscopy score 2 for rats 
given drug with injurious agents and controls.
In the sucralfate subgroup, there was no significant difference in either corpus or
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antrum in those given carprofen alone or in combination. Those given aspirin 
combinations had a significant increase in all areas except the corpus of rats given 
aspirin alone. The difference between the corpus of sham-tubed and those given 
aspirin/bile was most marked. Compared with the sucralfate controls a similar 
pattern emerged. There was no difference in those given sucralfate alone and those 
given carprofen combinations. The same aspirin combinations and areas showed 
significant increase in score 2.
In the famotidine subgroup, there were significant increases in score 2 against both 
sham-tubed and famotidine control rats. The exception to this was the lack of 
difference between carprofen challenged rats and sham-tubed rats. A lack of effect 
was also apparent in the antrum of rats given aspirin alone.
Only in the rats given sucralfate and aspirin/bile was there an area effect, with the 
antrum having a significantly higher score than the antrum.
The scores from the different injurious agents used were compared where appropriate 
to each other to see if there was an agent effect. Within the sucralfate subgroup, only 
the corpus of the rats given aspirin/bile showed any difference (decrease) from the 
same areas of rats given other combinations (carprofen/bile and aspirin). In the 
famotidine subgroup there were no intra-group differences detected.
A similar exercise was carried out between sucralfate and famotidine subgroups for 
score 1 (Table 6.23) and score 2 (Table 6.24).
drug/
agent
SR2 SR2B2 SS2 SS2B2 
C A C A C A  C A
FR2 S ns
FR2B2 ns ns
FS2 S ns
FS2B2 @S ns
(p<0.05)
C=corpus, A =antrum, prefix F=famotidine, prefix S = sucralfate, R2=0.46mM carprofen, 
B2=5mM bile, S2=40mM aspirin, S=significantly higher, ns=not significant, @S = significantly 
smaller.
Table 6.23. Comparison of score 1 between sucralfate and famotidine 
subgroups.
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There was no difference in the antrum between those given sucralfate and famotidine. 
The score 1 for those given carprofen or aspirin alone was higher in the corpus of 
those rats tubed with sucralfate than for famotidine. Those rats given aspirin/bile 
had lower scores in corpus when given sucralfate than those given famotidine.
drug/
agent
SR2 SR2B2 SS2 SS2B2 
C A C A C A  C A
FR2 ns ns
FR2B2 @S ns
FS2 ns ns
FS2B2 ns ns
(p<0.05)
C=corpus, A =antrum, prefix F =famotidine, prefix S = sucralfate, R2=0.46mM carprofen, 
B2=5mM bile, S2=40mM aspirin, S = significantly higher, @S = significantly smaller, ns=not 
significant.
Table 624. Comparison of score 2 between sucralfate and famotidine
subgroups.
For score 2, there was little difference between the drugs used. The only significant 
difference was in the corpus of rats challenged with carprofen/bile, where the 
individual score was higher for famotidine pre-treated rats.
The effect of pre-treating rats with sucralfate and famotidine was examined by 
comparing the scores obtained from pre-treated rats and those from the injurious 
group given the same concentration of agents (Table 6.25).
For score 1 the results of comparison were rather uneven. In the sucralfate subgroup 
5/8 areas demonstrated no significant difference. Of the remaining three areas, two 
showed an increased score with sucralfate compared with the comparable injured rats. 
In the famotidine subgroup, 4/8 areas showed significant differences. In three of the 
four, the corpus pre-treated rats had lower scores than corresponding rats from the 
injurious groups.
With score 2, the individual features indicative of damage were lower in those rats 
pretreated with sucralfate and challenged with carprofen ±bile compared with rats 
from the injurious group. With famotidine pre-treatment only the corpus of rats 
challenged with carprofen ±bile had lower scores. Pre-treatment with sucralfate and 
famotidine made no significant difference to the scores obtained with asprin ±bile 
challenge.
Subjecting the data to polychotomous logistic regression (BMDP) suggested that
247
Chapter  6
sucralfate had a more protective effect than famotidine, but this was not substantiated 
by generalised linear modelling (GLIM).
drug/
agent C
score 1
A C
score 2
A agent
SR2 <s ns S> S> IR2
SR2B2 ns ns s> S> IR2B2
SS2 ns <S ns ns S2
SS2B2 S> ns ns ns S2B2
FR2 S> ns S> ns IR2
FR2B2 s> ns S> ns IR2B2
FS2S> ns <S ns ns S2
FS2B2
(p<0.05)
S> ns ns ns S2B2
C=corpus, A =antrum, prefix F =famotidine, prefix S = sucralfate, R2=0.46mM carprofen, 
B2=5mM bile, S2=40mM aspirin, S = significant, ns=not significant. < > points to 
combination giving significantly higher score.
Table 6.25. Comparison between scores 1 and 2 obtained from injurious 
groups and protective groups.
6.3.3.1 Individual Control
There was little variability in the individual grades ascribed to the different features 
noted between those rats not tubed and those sham-tubed (Tables 6.18 and 6.19). 
There were a few differences between the control rats given sucralfate and 
famotidine. The rats given famotidine had a much more complete mucus covering in 
the corpus than either the sucralfate or sham-tubed rats. This finding was not 
mirrored in the antrum. In both the corpus and antrum the thickness of the mucus 
covering was much greater in the sucralfate rats than in the famotidine rats. Apart 
from these changes the only other change worthy of note was an increase in the 
number of rosettes found in the antrum of the sucralfate rats. The features ascribed 
to damage were the same in both groups. No time effect emerged from examination 
of the individual scores from any of the groups of rats, regardless of injurious agent.
6.3.3.2 Sucralfate
When the rats were challenged with aspirin alone the corporal mucus covering was 
much more complete, but the thickness was reduced in both corpus and antrum 
(Figures 6.30-6.32). An increased number of extruded cells and enlarged gastric pits 
were also a feature in both corpus and antrum. In the corpus more cells had
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intracellular contents exposed. In the antrum there was loss of cobblestoning and 
more prominent intracellular junctions, but no increased individual scores.
The addition of bile to aspirin resulted in a further reduction in the thickness of the 
mucus covering in the corpus and antrum (Figures 6.35 and 6.36). An additional 
feature evident in both corpus and antrum was an increase in the number of cells 
showing apical ruffling and apical holes.
Carprofen alone caused an increased mucus covering with a reduction in thickness, 
and a rise in cell extrusions. In the corpus a loss of cobblestoning and some increase 
in apical erosions were manifest. In the antrum, only apical ruffling was accentuated 
amongst the individual scores (Figures 6.28 and 6.29).
With the addition of bile, the mucus covering and thickness in the corpus matched the 
control rats and therefore a reduction over carprofen alone. In the antrum the 
mucus covering and thickness were similar to the carprofen alone, showing a decrease 
in thickness over the control rats. As with carprofen alone there was an increase in 
the number of extruded cells (Figures 6.33-6.34). The carprofen and bile mixture 
caused an increased convexity of the cells in both areas.
When the effect of carprofen and aspirin alone on those rats given sucralfate was 
assessed the differences were mainly in the general scores. A more complete mucus 
covering and thinner coat was found in those rats given carprofen. Also in the 
corpus, more apical erosions were found in the carprofen than the aspirin group. 
Aspirin caused a greater widening of the gastric pits in both corpus and antrum 
compared with carprofen.
Comparison between those rats given bile in addition to the NSAIDs showed that in 
aspirin/bile rats there was greater mucus covering, reduction in the thickness of the 
coat, more apical erosions and holes in the corpus. In the antrum the scores for 
gastric pits, apical ruffling, holes, concavity and empty shells were all greater in the 
aspirin/bile than in the carprofen/bile group.
6.3.3.3 Famotidine
The rats given aspirin alone following pre-treatment with famotidine had a more 
incomplete covering of mucus in the corpus than the control rats (Figures 6.39 and 
6.40). The mucus thickness was similar in the antrum as was the mucus covering. 
There was an accentuation of the gastric pit openings and convexity of the surface 
cells in the corpus and antrum. The only damage feature in the corpus that differed 
from the controls was an increased number of cells showing concavity of the apical 
membrane. In contrast in the antrum, all the general scores; cell extrusion, rosettes,
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loss of cobblestoning, prominence intercellular junctions and convexity were higher 
than controls. Of the individual scores, concavity, apical erosions and empty shells 
were much more prominent.
Aspirin & Bile
The addition of bile to the injurious mixture served to produce higher general and 
individual scores. In comparison to the corpus of the rats given aspirin alone, four of 
the six individual scores were much higher (Figures 6.43 and 6.44).
Carprofen
Compared with the control rats the corporal mucus covering was less complete 
(Figures 6.37 and 6.38). Apart from this, the only other general score that showed a 
difference was the number of cells showing increased convexity. Evidence of damage 
was confined to more cells showing a concave surface or apical erosions. In the 
antrum, rosette formation, prominence of intracellular junctions and convexity of cells 
was increased. The only individual score which was greater than controls was apical 
erosions.
Carprofen/Bile
The addition of bile caused a further diminution in mucus covering in both corpus 
and antrum (Figures 6.41 and 6.42). No other change was apparent in the corpus 
compared with those given carprofen alone. In the antrum, other features with 
increased scores were extruded cells, loss of cobblestoning and apical ruffling.
6.3.3.4 Injury versus Protection
When the individual scores obtained from rats pre-treated with sucralfate and 
challenged with aspirin alone were compared with the injured rats, sucralfate caused 
increased mucus covering and thickness of the mucus blanket in both corpus and 
antrum. In the corpus, cell convexity and extruded cells were greater in those given 
sucralfate. In the antrum, gastric pit enlargement and loss of cobblestoning were 
reduced with the use of sucralfate. From the score obtained for "damage" the scores 
for sucralfate were higher or unchanged in the corpus and antrum.
In contrast, when the effect of added bile was examined, the general and individual 
scores from both corpus and antrum were reduced with the pre-treatment of 
sucralfate in most of the features looked at, with the exception of increased cell 
extrusion in the antrum,.
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When carprofen was substituted for aspirin the general scores for the corpus were 
higher in those rats given sucralfate, but the individual scores were reduced for all six 
features. In the antrum there was little difference in the scores obtained for rats with 
or without sucralfate, apart from increased mucus covering in sucralfate rats.
With the addition of bile to the carprofen challenge solution, the scores obtained 
from the protected rats were for, almost all features, lower than those obtained from 
rats injurious agents alone.
The general scores obtained from rats pre-treated with famotidine before challenge 
with aspirin were little different from those from the injury group with the exception 
of a poorer mucus covering in the corpus and accentuation of the cell convexity in 
both the corpus and antrum. In the antrum, the rosette formation and intercellular 
junctions were more prominent. However, the individual scores in the corpus were 
all much lower with famotidine, but this was not evident in the antrum.
With the addition of bile to the challenge solution of aspirin, famotidine had a similar 
effect on the general scores in the corpus reducing cell extrusion, rosette formation 
and enlargement of gastric pits. In the antrum no sparing effect was evident. An 
amelioration in the individual scores was restricted to reduced apical ruffling and cell 
concavities in the corpus and antrum, with a reduction in empty shells in the antrum.
Comparison between the rats given famotidine & carprofen and the injured group 
given carprofen at 0.46mM showed that there was little difference in the scores 
obtained from the antrum, with the pre-treated rats having higher intercellular 
junction and concavity scores, but the injured group having higher apical ruffling and 
hole scores. In the corpus the scores for almost all the features were lower with those 
rats given famotidine.
The effect of the addition of bile to the equation showed very similar findings as far as 
the scores were concerned. In the corpus the scores were nearly all lower for those 
given famotidine, in none were the scores for famotidine higher. In the antrum, the 
both mucus covering and thickness were reduced with the addition of bile and no 
sparing effect from famotidine was detected in individual scores.
6.3.3.S Sucralfate versus Famotidine
The scores from the rats given famotidine and sucralfate and challenged with 
injurious agents were summed separately and compared. Rats given sucralfate had 
thicker mucus coats and increased numbers of extruded cells in the corpus. In the 
antrum the mucus covering famotidine caused an increased loss of cobblestoning.
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Figure 6.26a & 6.26b. Scanning electron micrographs following pre-treatment with 
sucralfate. An island of mucus topped with sucralfate is present in the corpus (6.26a). 
In the antrum a much thicker layer is present and the outlines of embedded cells are 
visible (6.26b). (x!440)
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Figure 6.27a & 6.27b. Scanning electron micrographs following pre-treatment with 
famotidine. This part of the corpus is incompletely covered by a medium layer of 
mucus (6.27a). The antrum shows some strands of mucus, but the underlying 
superficial epithelial cells look normal (6.27b). (x!440)
253
Chapter 6
Figure 6.28. SEM following pre-treatment with sucralfate and exposure to 0.46mM 
carprofen. After 5 minutes the epithelium is substantially normal though the cells 
look slightly ruffled. (x5600)
Figure 629. SEM following pre-treatment with sucralfate and exposure to 0.46mM 
carprofen. After 15 minutes the cells are quite swollen and there are small blobs 
emanating from the surface, possibly mucous granules. (xll250)
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Figure 6JO. SEM following pre-treatment with sucralfate and exposure to 40mM 
aspirin. After 2 minutes there are areas of damaged cells with extruded cells present 
{small arrows). In places there are small pieces of sucralfate (large arrow). (x!440)
Figure 631. SEM following pre-treatment with sucralfate and exposure to 40mM 
aspirin. Antrum after 15 minutes, the pits are somewhat enlarged and the cells show 
some apical erosions, and numbers are discarded into the lumen (arrows). (xl440)
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Figure 632. SEM following pre-treatment with sucralfate and exposure to 40mM 
aspirin. Antrum after 15 minutes, the mucus layer has trapped large numbers of cells 
and strands of sucralfate can be seen. (x2800)
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Figure 6.33. SEM following pre-treatment with sucralfate and exposure to 0.46mM 
carprofen/ 5mM bile. Large numbers of extruded cells are trapped in the 
mucus/sucralfate layer in the antrum.
'  V
Figure 6.34. SEM following pre-treatment with sucralfate and exposure to 0.46mM 
carprofen/ 5mM bile. The cells have a marked beaded appearance due massive 
mucous release. Some of the apical membranes have collapsed highlighting the 
intercellular junctions (arrow). (x5600)
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Figure 6.35. SEM following pre-treatment with sucralfate and exposure to 40mM 
aspirin/ 5mM bile. The extensive coating of mucus/sucralfate almost completely 
obscures this rugal fold. (x360)
Figure 636. SEM following pre-treatment with sucralfate and exposure to 40mM 
aspirin/ 5mM bile. Extensive coating of sucralfate/ mucus is present and the outlines 
of trapped cells are visible. Beneath relatively normal pits are present. (x720)
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Figure 637. SEM following pre-treatment with famotidine and exposure to 0.46mM 
carprofen. Traces of mucus cover essentially normal epithelium in the corpus. 
(x!440)
Figure 6.38. SEM following pre-treatment with famotidine and exposure to 0.46mM 
carprofen. In the antrum the cells are swollen but have an extremely smooth surface, 
a few cells have apical erosions. (x!440)
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Figure 6.39a & 6.39b. SEM following pre-treatment with famotidine and exposure to 
40mM aspirin. Traces of mucus cover the epithelium after 2 minutes in the corpus. 
In the antrum after 2 minutes there are large islands of debris sitting on top of the 
normal mucus carpet. (x!440, x720)
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Figure 6.40. SEM following pre-treatment with famotidine and exposure to 40mM 
aspirin. The walls of this rugal fold are covered in a thick granular mucus coat. On 
the rugal tip a number of foci of cell damage is apparent (arrows). (x360)
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Figure 6.41. SEM following pre-treatment with famotidine and exposure to 0.46mM 
carprofen/ 5mM bile. The gastric pit cells show some derangement and overlying this 
the mucus carpet is covered by granular debris. (xl440)
Figure 6.42. SEM following pre-treatment with famotidine and exposure to 0.46mM 
carprofen/ 5mM bile. After 5 minutes the pits show some derangement and many 
rosettes and extruded cells are evident. (x!440)
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Figure 6.43. SEM following pre-treatment with famotidine and exposure to 40mM 
aspirin/ 5mM bile. There is thick debris present but the visible cells show extensive 
apical erosions and exposed intracellular contents. (x2800)
Figure 6.44. SEM following pre-treatment with famotidine and exposure to 40mM 
aspirin/ 5mM bile. Many of the cells have holes, are swollen, and some are in the 
process of being extruded. (x2800)
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63.4 Transmission Electron Microscopy
The surface epithelial structure and integrity of those rats given sucralfate and 
famotidine alone were not similar to the normal rats or those sham-tubed. In those 
given sucralfate alone had the apical mucous granule packs, but debris covering the 
apical membrane (Figure 6.45). In contrast those given famotidine alone the apical 
membrane was generally intact, but there was a lack of mucous granules and in 
numbers of cells occasional and patchy areas of vacuolation (Figure 6.46).
In those rats pre-treated with famotidine and challenged with injurious agents the lack 
of mucous granule packs was again evident. In addition there was a decrease in 
nuclear and cytoplasmic density with extensive vacuolation, giving the cytoplasm a 
very lacy appearance (Figures 6.47-6.49).
In those rats pre-treated with sucralfate and challenged with injurious agents there 
was a characteristic coating of debris above the apical membrane. In addition many 
of the cells had also a loss of cytoplasmic density with missing nuclei and cell contents 
exposed or streaming into the lumen. Only after 15 minutes in those rats given 
aspirin/bile was the type of in situ disruption that was seen in the injured rats seen, 
with extensive disruption of the cytoplasm and clumping of nuclear chromatin 
(Figures 6.50-6.52).
Figure 6.45. TEM of surface epithelium following sucralfate pre-treatment. There is 
marked lumenal debris present (xlOOOO).
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Figure 6.46. TEM of surface epithelium following famotidine pre-treatment. The 
apical membrane is intact and there is a distinct lack of mucous granules (x8000).
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Figures 6.47 & 6.48. TEMs of surface epithelium following famotidine pre-treatment 
and 5 minutes exposure to 0.46mM carprofen and 15 minutes 0.46mM 
carprofen/5mM bile. There is a distinct lack of mucous granules, vacuolation of the 
cytoplasm and nuclear clumping (xlOOOO).
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Figure 6.49. TEM of surface epithelium following famotidine pre-treatment and 15 
minutes exposure to 40mM aspirin. There is lumenal debris and there appear to be 
cytoplasmic contents in the lumen (xl3400).
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Figures 6.50 & 6.51. TEMs of surface epithelium following sucralfate pre-treatment 
and 5 minutes exposure to 40mM aspirin and 0.46mM carprofen. There is a decrease 
in cytoplasmic density with vacuolation. The apical membrane is absent and 
cytoplasm is confluent with the lumen which contains debris (x5400, x8000).
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Figure 6.52. TEM of surface epithelium following sucralfate pre-treatment and 15 
minutes exposure to 40mM aspirin. The normal cell architecture is lost as is the 
normal intercellular relationship (x8000).
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6.4 Discussion
Initially it was established that there was no difference in any of the parameters 
investigated between control rats that were not tubed, and sham rats that had been 
anaesthetised, tubed and had saline introduced, implying that this method of delivery 
of fluid per oesophagus did not result in iatrogenic damage to the gastric mucosa. 
Thus any changes recorded after the administration of famotidine or sucralfate to rats 
by this approach were the result of the drugs, not the act of tubing, nor the effect of 
anaesthesia.
The results of the initial gross and microscopic examinations indicated that sucralfate, 
caused oedema of the antral mucosa and migration of large numbers of white cells 
into the antrum, and of a smaller number of cells into the corpus. On the other hand, 
famotidine produced no evidence of oedema in either antrum or corpus, but did seem 
to stimulate the appearance of increased numbers of white cells in the mucosa of both 
regions of the stomach. Thus the administration of both types of protective 
medication seemed to have marshalled the rats’ defense mechanisms, especially in the 
case of sucralfate where there was increased blood supply and oedema as well as 
white cell migration. Sucralfate has also been shown to cause disruption and 
exfoliation of superficial epithelial cells with the release of mucus (Tamawski and 
others 1986). Both of which may well create a luminal surface environment that is 
analogous to the mucoid cap (Wallace and McKnight 1990), but more stable. It has 
been proposed sucralfate may achieve some of these changes by acting as mild irritant 
increasing the luminal levels of prostaglandins, and then binding to any albumin and 
fibrinogen so released (Guth 1987). Hollander and others (1984) have shown that 
the effect of sucralfate is not completely mediated by prostaglandin release and there 
is little evidence that sucralfate has any effect on the biosynthesis of prostaglandins 
(Coleman and others 1987, Quadros, Ramsamooj and Wilson 1987). Further, Shea- 
Donohue and others (1986) found that sucralfate increased mucus production and 
protected against aspirin damage, but did not counter the effect of aspirin-induced 
prostaglandin suppression. Sucralfate produces a protective coat and famotidine 
suppresses the acid environment thus aiding restitution (Grenbech and others 1987), 
so that both drugs may protect in differing ways. It would appear on these first 
investigations that sucralfate overtly causes more response in the mucosa than 
famotidine. It is of interest to note that none of the rats pre-treated with sucralfate 
showed evidence of the reactive white coating associated with this form of 
medication. Although it has been established that sucralfate forms such a coating 
over damaged epithelium (Sasaki and others 1983) some reports have suggested that 
it will also adhere to uninjured gastric mucosa (Nagashima 1981b). The results in 
this thesis indicate that this did not happen. However, as the production of this white
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coating depends on the pH of the stomach being less than four, it would have been of 
interest to have checked the pH of the gastric environment of these particular rats 
that had been treated with sucralfate for five days prior to being sacrificed. This was 
not done in these examinations but warrants further investigation.
Following five days pre-treatment with sucralfate when the two injurious agents 
aspirin and carprofen were administered to rats, different changes in the gastric 
mucosa occurred. Aspirin produced little evidence of gross change to the mucosa, 
with only one rat showing some antral coating. This coating, which is the result of 
electrostatic binding with transudate proteins (Sasaki and others 1983), would tend to 
suggest that gastric mucosal damage was present in the one rat in the aspirin treated 
group. In contrast to these findings, all antra of the rats administered carprofen had 
a white layer on the mucosa indicating sucralfate adherence. Thus at the gross level, 
carprofen appeared to have caused sufficient mucosal damage in the antrum to lead 
to sucralfate adherence.
The addition of bile to both aspirin and carprofen produced widespread reddening of 
the corporal mucosa in rats pre-treated with sucralfate. Although some reddening of 
the antral region occurred in these rats it was not as consistent as in the corpus. This 
pattern of reddening of the gastric mucosa was similar to that found when 
unprotected rats were given carprofen suggesting that the carprofen caused this effect 
and that sucralfate did little to prevent it. However, as this reddening did not induce 
a coating of the mucosa with sucralfate in the aspirin plus bile treated rats it suggests 
that the epithelium was intact. The addition of bile to carprofen led to less binding 
of sucralfate to the mucosa in the antrum compared to those given carprofen alone 
implying that this mixture caused less damage to the epithelial layer than carprofen 
alone, but this may have been due to the sucralfate binding to the bile in preference 
to the mucosa (Spiro 1982, Steiner and others 1982).
In none of the rats pre-treated with sucralfate and subsequently challenged with the 
injurious agent, either alone or combined with bile, was mucosal oedema seen grossly. 
This would tend to suggest that the capability of the sucralfate to induce a degree of 
oedema as shown in the control rats was overcome by the action of the injurious 
agent/s. However, another possible explanation for the lack of oedema could be 
that, where the lacy white pattern of sucralfate was present, it may have been masking 
underlying oedema in those areas.
The increased migration of white blood cells associated with the administration of 
sucralfate was maintained when the rats were challenged with either aspirin or 
carprofen, but neither of these injurious agents caused any further increase in the 
numbers of white cells infiltrating into either region of the stomach. This may have
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been because the initial response initiated by sucralfate was sufficient to meet the 
further challenge to the integrity of the mucosa from either of these substances.
However, the effect of sucralfate administration in causing a WBC infiltrate that was 
as great in the sucralfate rats before as after the addition of injurious agents may be 
related to the fact that the sucralfate had been given over a relatively prolonged 
period (five days), in contrast to the relatively short period of time (minutes) that the 
gastric mucosa had been exposed to the injurious agents.
Famotidine pre-treated rats subsequently given either aspirin or carprofen had 
marked corporal hyperaemia within fifteen minutes. This was rather unexpected 
especially as no such reddening was found in the pre-treated sucralfate rats in similar 
circumstances.
Sucralfate does not suppress acid secretion but reduces local acidity by forming a 
protective barrier and limits the diffusion of hydrogen ions, with the aluminium ion 
acting as a buffer (Slomiany, Laszewicz and Slomiany 1986). Famotidine, on the 
other hand, is an H2 antagonist and thus does suppress acid secretion by the parietal 
cell of the gastric mucosa One would have expected that the mode of action of the H2 
receptor antagonist would have resulted in marked acid suppression that has been 
shown to occur in rats (Okabe and Nobuhara 1984), and so reduction in back- 
diffusion and thus hyperaemia (Ryan and others 1986). However, the capability of 
sucralfate to reduce reddening may not only have been due to the buffering of 
hydrogen ions, but also to limiting the action of the injurious agents by coating the 
surface of the mucosa (Garnett 1982). However, Tesler and Lim (1981) have shown 
in man that sucralfate does not affect the serum salicylate levels achieved after the 
oral administration of aspirin. The addition of bile to the famotidine pre-treated rats 
appeared to make the reddening less severe with both NSAIDs. These findings are 
in contrast to those obtained from the sucralfate rats and tends to suggest that the bile 
in the famotidine pre-treated rats interfered with capability of the carprofen and 
aspirin to produce some of the gross changes associated with injury.
Famotidine alone did not induce oedema in the antrum as sucralfate did. However, 
like sucralfate, the rats pre-treated with famotidine and challenged with injurious 
agents showed more evidence of antral oedema. However, there was little evidence 
of oedema in the corpus - the exception was those rats given carprofen/bile. The 
induction of oedema can be related to ion movement induced by taurocholate, which 
O’Brien and Carter (1975) and Lewi and Carter (1983) have shown is not affected by 
H2 receptor antagonists. Therefore although famotidine did not in itself induce 
oedema, it does not suppress oedema, and so when challenged the famotidine treated 
rats were still capable of producing this reaction. MacKercher and others (1977)
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reported that H2  receptor antagonists, like famotidine, protect the mucosa against 
aspirin by raising the gastric pH above that of the pKa value of the NSAID, but in the 
rat famotidine may not affect basal acid secretion (Bertaccini and others 1986). 
However, other workers have presented evidence that the limiting of the damage by 
aspirin may not be solely due to acid suppressive activity of the H2 receptor 
antagonists (Kauffman and Grossing 1978, Guth, Aures and Paulsen 1979). Thus just 
how the damage thought to be caused by aspirin, as well as other NSAIDs, comes 
about is as yet not fully understood.
Challenging the famotidine rats with injurious agents appeared to have the effect of 
reducing the numbers of white blood cells found in the corpus of pre-treated 
famotidine rats - an anomalous finding. The reduction in the numbers of the white 
blood cells already present in the gastric mucosa in the famotidine treated rats when 
subsequently challenged by either aspirin or carprofen may have been by leakage into 
the gastric lumen through areas of damaged gastric mucosa. Preliminary studies on 
long-term treatment with H2 receptor antagonists have appeared to show that H2 
receptor antagonists can cause a decrease in gastric mucosal defence mechanisms 
(Goto, Wakabayashi and Murakami 1985).
Thus in assessing the two forms of protection given to the rats subsequently 
challenged with injurious agents it was difficult to suggest that one gave more 
protection than the other, based on the consideration of the initial gross and light 
microscopic examinations results.
Despite the fact that sucralfate generally induced a more marked WBC infiltrate than 
famotidine, this was not associated with congestion. Indeed there was no clear cut 
evidence that either drug caused congestion. If there was little congestion then there 
would also be little transudation of proteins to which sucralfate could bind 
electrostatically to (Nagashima and others 1983) and this could explain why in the 
pre-treated sucralfate rats there was no evidence of sucralfate adhering to the 
mucosa. Neither sucralfate nor famotidine pre-treatment prevented apical damage 
in the challenged rats (Hollander and others 1985). In the sucralfate group this was 
observed in those rats given carprofen or carprofen/bile, whereas it was aspirin alone 
which gave rise to this in the famotidine pre-treated rats. These results were not 
unexpected in the rats pre-treated with sucralfate as carprofen was found continually 
to be the more damaging agent than aspirin, which makes the findings with aspirin in 
the famotidine rats rather unusual. It is a readily held belief that aspirin is one of the 
medications most likely to cause gastric mucosal problems and indeed there are 
plenty of reports in man to substantiate this. However, this usually occurs after 
longer treatment with this drug and the exposure time in this study was very short.
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However, it did not give the overall indications of being nearly as damaging as 
carprofen.
The administration of famotidine and sucralfate appeared to have a definite effect on 
the luminal contents. In both corpus and antrum both agents caused the shedding of 
increased number of cells into the gastric lumen suggesting that both drugs caused 
some superficial changes to the gastric mucosa, which resulted in a speeding up of the 
exfoliation of the epithelial cells. The findings with sucralfate are in agreement with 
those previously reported by Tamawski and others (1986). Furthermore, sucralfate 
produced thicker than normal layers of mucus that also contained cells in many of the 
rats. The mixture of sucralfate, mucus and cells is probably achieved by the 
sucralfate preventing the normal rate of dissolution of the mucus into gastric luminal 
contents. Though this thick layer could be construed as damage, it may in fact be 
evidence of sucralfates cytoprotective action (Hollander and others 1984, Ligumsky, 
Karmski and Rochmilewitz 1984, Konturek 1985, Stern, Ward and Hartley 1987) and 
may represent a form of protection in addition to the increased release of 
prostaglandins that sucralfate is known to produce (Hollander and others 1984, 
Coleman and others 1987). The presence of a mode of action other than 
prostaglandin release is supported by work carried out by O’Brien and others (1990) 
who showed that the administration of indomethacin, which suppresses the release of 
prostaglandins did not prevent the protective effect of sucralfate. On the other hand, 
famotidine by its direct effect on the parietal cell inhibiting acid production, leading 
to a decrease in acid secretion, ought to protect the apical cells to a certain extent. 
This did not appear to have been the overall position with the rats in these 
investigations as increased amounts of exfoliated cells were also found in the luminal 
contents of the famotidine treated rats. One possible explanation for the amount of 
debris found in the famotidine rats is that the suppression of acid secretion altered 
the gastric flora in the rat, which in turn increased the epithelial turnover with 
increased numbers of exfoliated cells. One might have expected in these 
circumstances to find more obvious retention of mucus on the epithelial surface with 
famotidine as loss of mucus is caused by abrasion and pepsinolyis (Allen, Bell and 
McQueen 1984). However, in the famotidine treated rats investigated in this study, 
this did not appear to be the case. One explanation for the thinner layer of mucus 
found in the famotidine rats than in either the sucralfate treated or normal rats may 
be that the sucralfate binding makes removal of the mucus more difficult in contrast 
to the removal of essentially normal mucus in famotidine rats. Another explanation 
for the decrease in the layer of mucus present in the famotidine treated rats could be 
that as mucus secretion is stimulated by antral pH (Menguy 1969), the raised antral 
pH produced by receptor antagonists prevents the normal copious secretion of 
mucus. Menguy (1969) found that fasting in the dog caused a fall in the output of
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mucus. In the rats investigated in this study, fasting was carried out as part of the 
preparation for the study and could explain the reduction in the mucus layer in the 
famotidine rats (Menguy and Thompson 1967). However, if this was the cause then 
it would suggest that the sucralfate treated rats, which were also starved, must have 
been stimulated to produce more mucus by this alternative type of medication 
(Quadros, Ramsamooj and Wilson 1987).
Scanning electron microscopy demonstrates cellular detail and can either lend 
support to the findings of light microscopy, but because of the increase in detail can 
challenge some of the interpretations made by light microscopy. In addition, 
scanning electron microscopy may identify some changes not seen by the light 
microscopic examinations. The scanning electron microscopic changes seen in the 
normal rats and the sham-tubed rats supported the assumption deduced from the 
previous examinations that the oesophageal route of administration caused no 
damage to the gastric mucosa. Time of exposure to any of the combinations 
examined including the protective agents and the injurious substances did not 
apparently have any real significance in the damage caused. However, one must 
accept that the length of exposure time of the injurious agents was short. The 
scanning results of mucus thickness and cover also agreed with those recorded by light 
microscopy in that sucralfate produced a thicker layer of mucus than did famotidine 
and again carprofen was as damaging as aspirin. One interesting feature that was 
noticed in the preliminary studies and further supported by electron microscopy was 
the effect the addition of bile had on the injurious agents. Apart from the antrum of 
those rats given sucralfate followed by aspirin/bile, bile in most instances made little 
difference overall. The reflux of bile is not thought to be a normal situation, but with 
the increase use of endoscopy as a means of examination of the gastric environment it 
may be that this assumption is proved to be false and that bile may be present in the 
stomach much more frequently than supposed. This aspect of gastric protection 
obviously warrants further examination. The scanning electron microscopy identified 
some interesting cellular changes that ranged from apical erosion but the cells still 
containing their contents to shells where only the empty torn membrane of the cells 
were found. The preliminary stages to these different degrees of damage were also 
in evidence where some cell had convex protruding upper regions, whilst others 
showed an imploding of the membrane with a concave appearance with the 
development of apical holes. This range of changes may be the result of accelerated 
mucus expulsion by the cells (Forte, Silen and Forte 1976, Fringes, Lorenz and 
Oehlert 1985). What the actual chain of events leading to these different changes are 
as yet not fully understood but obviously as our understanding of the mechanisms of 
medications in use, either harmful or protective to the gastric mucosa become better 
understood then, these specific changes may play a useful part in identifying just what
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the true situation is.
The investigations carried out in rats which were pre-treated with either sucralfate or 
famotidine as a protective agent against the subsequent effects of aspirin or carprofen 
indicated that they produced different changes in the gastric mucosa. Both drugs 
apparently affected the antral region of the stomach more than the corpus. If one 
accepts that sucralfate only adheres to damaged epithelium as would appear to be the 
case in the rat, then its action as a mild irritant on its own does not cause any actual 
damage to the epithelial cells as in the rats so treated, at least at the gross level. This 
view is reinforced by the findings of Parisio and Clementi (1976) and Schmidt and 
others (1985), who found that minimally injured cells were difficult to identify at the 
gross and even light microscopic level. It was only after the administration of 
injurious agents that the protective white layer that sucralfate produces in the face of 
damaged epithelium was formed. Both drugs caused an increase in the numbers of 
epithelial cells shed from the luminal surface of the gastric mucosa. However, in the 
case of famotidine the mucus coat, that can act as a barrier to injurious agents 
reaching the mucosa itself, was much thinner than that produced by sucralfate 
(Hollander and others 1985, Quadros, Ramsamooj and Wilson 1987). One might be 
tempted to suggest that sucralfate gave greater protection than did famotidine but 
statistically this was not shown and there was no real evidence from the electron 
microscopic studies that the degree of damage to gastric mucosa was in any way less 
by using sucralfate against famotidine. Therefore overall both drugs appeared to 
show a measure of protection with scanning electron microscopy showing less 
evidence of degeneration and damage in those rats pre-treated than those which were 
not. One explanation for the failure to find more demonstrable evidence of 
protection is that neither sucralfate or famotidine are adequately able to protect the 
superficial epithelial layer (Lacy 1986), and in the time span used in these 
experiments the effect of restitution was not adequately observed (Silen and Ito
1985).
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7. General Discussion
The stomach is on occasion challenged by injurious agents. Whilst the skin and 
oesophagus are in a similar situation as regards challenge, they are inured to these 
influences by the provision of a tough external surface or by permitting short contact 
time. In contrast, the stomach has no toughened epithelial layer and serves as a 
temporary repository for a variety of ingesta. To make matters worse the stomach 
produces two chemicals designed to deal with ingesta, which also have the capability 
of attacking the gastric mucosa. However, nature has provided the stomach with 
mechanisms to cope with this anomalous situation under normal circumstances. 
Gross detrimental agents such as foreign bodies can be retrieved from the stomach. 
Unfortunately, this is not possible where the inimical agent is a product of the 
stomach itself as is the case with acid, or as with bile that is produced by an associated 
area of the alimentary tract and may flow backwards into the stomach. Finally, it is 
now recognised that certain forms of treatment administered orally in the form of 
tablet or powder can have harmful effects on the gastric mucosa.
The findings in the vomiting dogs agreed with those of previous workers and with 
those in the human in that the commonest disorders affecting the canine stomach 
were gastric carcinoma and the gastritides. Although one may suspect gastric 
carcinoma from the history and clinical signs it is essential to substantiate the 
diagnosis by further investigation. The studies described in this thesis identified 
endoscopy as being the best investigative method for making a positive diagnosis of 
this condition. Endoscopy allows observation of the entire gastric mucosal surface 
and identification of the typical volcano-like ulcers associated with gastric carcinoma, 
whose walls protrude above the surrounding mucosa. With experience the majority 
of gastric carcinomas can be positively diagnosed by endoscopic examination alone. 
Thus this technique is one that should be used in cases of vomiting dogs in which such 
a condition is suspected. Endobiopsies are not essential in the diagnosis of gastric 
carcinoma if an experienced endoscopist carries out the examination in the dog. 
Indeed, unless a series of biopsies are taken in cases of gastric carcinoma this method 
of confirmation can be misleading (Hatfield and others 1975).
The gastritides, the other commonest abnormality in the dog, are so grouped because 
it is as yet unclear whether these various forms have a common origin, or represent 
truly different underlying pathophysiological responses to disparate challenges, or 
reflect errors in the diagnostic evaluation of the case. Here again endoscopy proved 
to be more rewarding as a means of investigation than radiology. However, unlike 
carcinoma endoscopic examination of gastritis can produce great variation in the 
appearance of mucosa from only excessively reddening to multiple areas of erosion.
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In some cases of gastritis indeterminable by endoscopy, endobiopsies are often 
resorted to as a possible means of differential diagnosis. However, one of the 
underlying problems in this situation is correlating the endoscopic and histological 
findings. The endoscopic appearance may not be substantiated histologically for a 
variety of reasons; because inadequate numbers of biopsies are taken, the depth of 
the biopsy samples is too shallow to penetrate beyond the superficial epithelial layer, 
what appears to be a normal stomach on endoscopic examination may prove on 
histological examination to have areas that are abnormal. This last set of 
circumstances may not indicate a pathological condition of the gastric mucosa but 
merely the results of the insults that the mucosa faces daily (Whitehead, Truelove and 
Gear 1972, Taor and others 1975, Karvonen and others 1983, Franzin and others 
1984, Roth and others 1990). Thus correlation between endoscopic findings and 
histological changes need further investigation.
The value of scanning electron microscopy has been demonstrated as a very useful 
investigative tool as it permits detailed examination of the surface of a much greater 
area of mucosa than does transmission electron microscopy. Therefore scanning 
electron microscopic investigations could shed light on some of the unexplained 
endoscopic findings found in dogs with conditions such as erosive gastritis. This 
method of examination could explain, the, as yet, poorly understood measles-like 
appearance that was associated with many of the gastric conditions in the dogs 
investigated. However, this will only be feasible if the quality of endobiopsies is 
improved. The opportunity for such improvement should be possible with the 
development of video-endoscopes that do not need large bundle tracts to carry the 
visual information back to the eyepiece. Then, after initial studies to establish the 
significant differences between the appearance of the normal and abnormal stomachs 
and relating these to changes at electron microscopy level of tissue initially obtained 
at post-mortem, these findings could be used to determine how to obtain biopsies 
from the canine stomach of patients, which should achieve similar results. The 
outcome of such an investigation would hopefully increase our knowledge of the 
various forms of gastritis and allow a less empirical approach to management of this 
range of conditions.
Treatments for gastric problems adopted at present include some which minimise the 
harmful environment, that is acid production, and others like sucralfate that act by 
producing a protective coating on the gastric mucosa (Harrington, Schegel and Code 
1981). Famotidine is the most potent and selective H2 receptor antagonist currently 
available. However, there is disagreement over its acid suppression power compared 
to other H2 receptor antagonists in the dog (Takagi, Takedo and Maeno 1982, 
Pendleton and others 1983, Katz, Tobia and Shriver 1987). However, one advantage
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famotidine has is that it only requires to be given once daily (Bertaccini and others 
1986, Dammann and others 1987, Mann 1987). It has further been shown to 
stimulate an enhanced mucosal blood flow (Schunack 1989) that might offer a degree 
of cytoprotection unrelated to the acid suppressive effect. In the investigations 
reported in this thesis there was no conclusive evidence that famotidine, given as a 
premedicant, was any more effective than sucralfate at moderating damage to the 
surface epithelium. Further, in man studies have shown that both H2 receptor 
antagonists and sucralfate can be used as co-medicants with NSAIDs (Czamobilski 
and others 1985, Ungethum 1991). Therefore its use in the dog in preference to 
sucralfate needs to be considered and clinical trials in canine patients using these two 
and other drugs, such as omeprazole, warrants further investigation (Scheiman 1992).
A somewhat unexpected result in the canine investigations was a frequent endoscopic 
finding of a bile pool and duodenogastric reflux of bile in both the control dogs and 
the non-neoplastic group. Davenport (1968) reported that bile acting as a detergent 
could damage the gastric mucosal barrier, and Lawson (1964) that it has an 
inflammatory effect. Endoscopy has revealed that reflux of bile can be seen in 
normal animals and humans and such was the case in a number of the control dogs 
examined in these investigations where a bile pool or bile reflux was noted. It has 
been suggested that bile acting as a mild irritant can stimulate the mucosal barrier 
and so protect the stomach against more deleterious challenge (Robert and others 
1978). However, in the rats exposed to bile there was an increase in the numbers of 
surface epithelial cells with altered or damaged membranes. Thus the significance of 
bile on the gastric mucosa is still not fully resolved, in that it is found in normal 
patients (Rhodes and others 1969), but more frequently in those with abnormal 
stomachs (Ritchie 1977). Nonetheless, it has been found to stimulate the 
cytoprotective mechanisms of the gastric mucosa (Chaudhury and Robert 1980, 
Takeuchi, Nobuhara and Okabe 1984), yet has been implicated as a factor in the 
development of gastric carcinoma (Domellof 1979). This aspect of the gastric 
environment needs further investigation.
The study of the vomiting dogs supported previous findings in that significant damage 
was induced by the consumption of NSAIDs, a treatment frequently used in both dogs 
and humans for degenerative joint disease and other painful conditions (Urquhart
1986). In the dog, the most obvious damage caused by this type of treatment is peptic 
ulceration or widespread mucosal haemorrhage. Both these clinical entities respond 
to a certain extent to the use of H2 receptor antagonists. But some dogs with this 
damage require prolonged medication that the owners are unable to provide, and 
surgery has to be resorted to remove the areas of the stomach which are susceptible 
to peptic ulceration (Bollman, Stalker and Mann 1938) - the pylorus and antrum.
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The subsequent investigations carried out in the rats gave some interesting results. 
However, the question arises as to how many of these findings can be applied directly 
to the canine, whose gastric structure and function differs from that of the rat. The 
rat is the species most commonly used in biological research because it is readily 
available, cheap to maintain, and the recent tightened welfare laws allow more 
intensive research to be undertaken in this species than in the dog. One specific area 
that needs further investigation is the question of the increased white blood cell 
migration in various situations. Does this indicate a role in the defence of the 
mucosa, or is this merely a consequence of the condition and plays no part in the 
defense of the mucosal barrier? One further question is whether this infiltrate by 
WBCs is species specific? All these aspects need clarification.
Therefore it may appear that the investigations reported in this thesis have produced 
more questions than answers about the very important clinical range of gastric 
abnormalities in the canine. However, it has demonstrated the advantages of 
endoscopic examination in this situation, proposed the extension of haematological 
and biochemical investigations and suggested that medication believed to be ideally 
suited for certain forms of gastritis might well not be so. Finally, these studies have 
demonstrated the need for specific clinical trials to be undertaken in the canine itself 
rather than extrapolate from studies undertaken in either the human or the rat. 
Much remains to be done.
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I9. Appendices
9.1 Appendix 1 Fixatives
Karnovsky’s: Solution A was prepared from lOg of paraformaldehyde in 100ml of 
distilled water in 10 drops of IN sodium hydroxide. This mixture was placed in an 
oven at 60°C until the solids were dissolved. The resulting solution was then allowed 
to cool. Solution B, the stock solution, was made from 250ml 0.2M sodium 
cacodylate, 50ml 25% gluteraldehyde, 100ml distilled water. Solution B was then 
added to solution A.
Buffered Normal Formalin 4% (BNF) was prepared by dissolving 4g of sodium 
dihydrogen orthophosphate (NaH2P04 anhydrous) and 8g of potassium hydrogen 
phosphate (K^HPO^ in 900ml of tap water. To this was added 40% formaldehyde 
(formalin) in 100ml of water.
Gluteraldehyde 2% was made by first making the phosphate buffer with 8g disodium 
hydrogen orthophosphate and 2g potassium dihydrogen orthophosphate in 1000ml of 
water. To 23ml of this buffer was added 2ml of commercial 25% stock 
gluteraldehyde.
Isotonic cacodylate buffer (0.075M pH7.3) was made from 16.05g sodium cacodylate, 
3.8g sodium chloride, 0.055g calcium chloride and 0.012g magnesium chloride 
dissolved in water to make 1000ml. The pH was adjusted to 7.3 with 1M hydrochloric 
acid.
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9.2 Appendix 2 Tissue Processing
9.2.1 Light Microscopy
The tissues were dehydrated through ascending concentrations of alcohol, double 
embedded in 1% celloidin in methyl benzoate and cleared with xylene. The resulting 
samples were then embedded in paraffin wax.
The periodic acid Schiff & Alcian blue staining was carried out as follows. The wax 
was dissolved using histoclear and the sections hydrated first with absolute alcohol 
and then with methylated spirits before being immersed in water. With the wax 
removed, the sections were immersed in iodine, rinsed in water, bleached in 5% 
sodium thiosulphate and rinsed in water to remove any mercuric precipitate. The 
sections were then stained in 0.5% Alcian blue 8GX in 3% acetic acid for 30 minutes. 
Following a wash in water, the sections were oxidised in 1% periodic acid for 5 
minutes, rinsed in water and placed in Schiff reagent (B.D.H.) for 20-30 minutes 
depending upon age of the reagent. The sections were washed in water for 5 minutes 
and counterstained in Mayer’s haemalum for 1 minute and rinsed in water. 
Following blueing in Scott’s tap water substitute for 10 seconds, the sections were 
rinsed again in water. The resulting sections were routinely dehydrated through 
methylated spirits, absolute alcohol and Histoclear and mounted in D.P.X.
9.2.2 Scanning Electron Microscopy
The tissues were removed from the Karnovsky’s fixative and washed in 0.1M sodium 
cacodylate buffer (pH7.4) for a minimum of 4 hours. The buffer was 2.1403g sodium 
cacodylate made up to 100ml with distilled water. The pH was checked and adjusted 
if necessary with 1M hydrochloric acid. The samples were removed from this and 
stepped through a series of acetone baths; 70% acetone for 4 hours, 90% acetone for 
2 hours, 100% acetone for 2 hours, and finally 100% acetone overnight.
The last acetone was replaced with fresh 100% acetone prior to placing the samples 
in acetone-filled boats for critical point drying.
The specimens were dessicated by liquid carbon dioxide (C02) substitution using a 
Polaron critical point dryer. The inlet and vent valves were opened periodically to 
remove acetone and replace it with C02, until acetone could no longer be seen, 
indicating complete replacement by C02. Once all the acetone had been removed, 
the dryer was warmed to 48°C at 8963kPa. This changed the carbon dioxide from a 
liquid to a gaseous phase. The C02 was vented slowly from the dryer. Once the 
C02 had been exhausted, the boats were removed from the dryer.
Following drying the samples were mounted on aluminium stubs. To aid adhesion
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and bond the samples to the stubs, the stub was first coated with silver paint and the 
sample placed mucosal side up on the stub before the paint dried. The stubs and 
samples were placed in an Emscope SC500 sputter coater. The sample height was 
set at 20mm. The air was removed and replaced by argon gas at 34.5kPa. The stubs 
were then coated with gold/palladium for 3 minutes. The stubs were stored in an 
oven set at 38°C until examined.
9.2.3 Transmission Electron Microscopy
Samples were stored in a refrigerator at 4°C until processed. The gluteraldehyde- 
fixed samples were then post-fixed. The samples were removed from the 
gluteraldehyde and washed in isotonic cacodylate buffer for 30 minutes. They were 
secondarily fixed in 1% osmium tetroxide in isotonic cacodylate buffer for 2 hours, 
then washed in isotonic sodium cacodylate buffer. The samples were dehydrated 
through a series of alcohols; 50%, 70%, 90% & absolute alcohol for 15 minutes in 
each. This was completed by two further 20 minute rinsings in absolute alcohol. 
The samples were removed and washed in propylene oxide twice for 15 minutes and 
left overnight in 1:1 resin/propylene oxide. The following morning, the mixture was 
replaced with 3:1 resin/propylene oxide for the rest of the day. The next day the caps 
of the bottles were removed to allow the propylene oxide to evaporate. The blocks 
were embedded overnight in pure resin and polymerised in a 60°C oven.
The Araldite resin consisted of 30g Araldite CY212, 25.2g dodenyl succinic anhydride 
(DDSA) as a hardener, 1.2ml 2,4,6,-tri(dimethylaminomethyl) phenol (DMP 30) as an 
accelerator and 1ml dibutylphthalate as a plasticiser.
Semi-thin sections (1/x) were stained with methylene blue/ azur II (1% methylene 
blue and 1% azur II in 1% borax) and examined by light microscopy to determine the 
best areas for ultrastructural scrutiny. Ultra-thin sections were cut using a Reichert 
OmU3 ultratome or Reichert ultracut E, supported on 200 mesh copper grids and 
stained with uranyl acetate and Reynolds lead citrate.
The uranyl acetate used was 20% uranyl acetate in 50% alcohol centrifuged before 
use. The grids were placed in stain for 5min in the dark. The grids were then 
rapidly rinsed six times in 50% alcohol and in water several times before being 
blotted dry.
Lead citrate was made with 1.33g lead nitrate and 1.76 sodium citrate. Each salt was 
dissolved in 15ml distilled water and the two solutions mixed. This solution was left 
for 30 minutes, but shaken occasionally. Eight millilitres of IN NaOH was added to 
dissolve the precipitate and then made up to 50ml with distilled water. The resulting
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solution was filtered before use.
Staining was carried out in a sodium hydroxide chamber. The grids were placed face 
down on drops of the staining solution for 5 minutes, then rinsed rapidly in 0.02N 
sodium hydroxide once, followed by rapid rinsing in distilled water and blotted dry.
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radiolucent line seen near the neck of a peptic ulcer
hydrochloric acid
kilogram
kiloHerz
kiloPascals
Litre
metre
Molar
milligram
minutes
millilitre
minimum
maximum
millimetre
millimolar
Normal
degrees
prostaglandin
the negative value of the logarithm of the hydrogen ion 
concentration
the negative logarithm of the ionization constant 
post meridiem
scanning electron micrograph 
transmission eletron micrograph 
weight volume
v .. . :ow
316
